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Abstract 
Community Engagement (CE) is often presented by bio-ethicists and scientists as a 
straightforward and unequivocal good which can help to minimize the risks of exploitation, 
ensure a fair distribution of research benefits and improve the quality of informed consent 
in the conduct of health research in developing countries. The main objective of my thesis is 
to critically analyse the relationship between CE and ethical practice in vaccine research. I 
do this by drawing on ethnographic fieldwork undertaken between 2007 and 2009. In my 
fieldwork I explored how CE is understood, talked about and enacted in two paediatric 
vaccine trials conducted by a collaborative partnership between the Kenyan Medical 
Research Institute and the US Centers for Disease Control (KEMRI/CDC) in Western Kenya. 
The first 3 chapters of my thesis contain introductory material. Chapter 1 describes the 
geographic and institutional context of my fieldwork and provides a summary of the 
paediatric vaccine trials. It also documents my conceptual framework with reference to 
relevant literature. Chapter 2 provides an overview of the history of immunization and 
related research in Sub-Saharan African, with a particular focus on East Africa. In chapter 3 
describe my ethnographic research design and provide a detailed account of my fieldwork, 
methods and data analysis. 122 people from the following groups consented to participate 
in this study: 1) KEMRI/CDC Staff Members (n=18), 2) Community Representatives (e. g. 
Village Reporters (VRs), Community Advisory Board (CAB), Government & Political 
Gatekeepers) (n=71), 3) Parents/Guardians of Vaccine Trial Participants (n=20), and 4) Other 
Community Members (n=7). With the support of 3 Kenyan research assistants I observed CE 
related activities, compiled field notes and conducted 83 semi-structured interviews and 7 
focus group discussions. 
The 8 findings chapters are grouped as follows: 1) 'The Historical Emergence & Framing of 
Community Engagement' (Ch. 4-5); 2) ? he Social Construction of Community Engagement' 
(Ch. 6-9); and 3) 'Responses and Negotiations in Community Engagement' (Ch. 10-11). 
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1) Between the years of 1979-2009 the KEMRI/CDC research programme grew from 
involvement in community-led health projects into a global enterprise. This 
inevitably resulted in changes in the control and direction of interactions between 
researchers and community members. The contemporary framing of CE relies 
heavily on researchers teaching laypeople about science. 
2) The concept of 'positioning' is critical to the contemporary social construction of CE. 
KEMRI/CDC's primary goal is to convey accurate messages, present a positive image 
and demonstrate 'attachment' to the local community. VRs' (paid volunteers) 
smooth the passage of research but find it difficult to balance allegiances, and 
respond to local expectations for material assistance. CAB members function as 
KEMRI/CDC patron-clients rather than community advocates, and Gatekeepers argue 
that a research agenda cannot be applied without accounting for inadequate district 
health services. 
3) Increasing interactions between KEMRI/CDC and the community have helped 
address inherent cultural suspicions about research, thereby diverting attention to 
the benefits of trial participation. Hence questions of exclusion rather than inclusion 
have started to dominate discussions during CE activities. When it comes to 
engagements in public health facilities attention is focussed on how to balance 
differences between two paradigms of care-giving; namely 1) 'research' and 
'general' care. 
In chapter 12 1 synthesize my findings and argue that far from being an unproblematic good 
CE offers a lens into new and pre-existing inequalities which affect the implementation of 
research in resource-limited settings. CE emerges from my data as highly complex and 
challenging work, which requires continuous efforts and cannot be limited simply to 
information exchange. In order to address the tensions and contradictions which arise in CE 
it is essential to discuss questions of social justice and to engage materially, through a 
broader distribution of resources, with the community where research takes place. 
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Chapter 1: 
Thesis Overview: Object of Study & Conceptual Framework 
A collaborative partnership between researchers and sponsors in developed countries 
and researchers, policy makers, and communities in developing countries helps to 
minimize the possibility of exploitation by ensuring that a developing country determines 
for itself whether the research is acceptable and responsive to the community's health 
problems (Participants in the Conference on Ethical Aspects of Research in Developing 
Countries, 2002). Moreover, without the engagement of researchers and host communities 
in the developing country, a study is unlikely to have any lasting impact, and, without the 
investment of makers of health policies, the research results are unlikely to influence policy 
making and the allocation of scarce health-care resources'. 
Excerpt from Emanuel et al. (2004) Paper: What Makes Clinical Research in 
Developing Countries Ethical? The Benchmarks of Ethical Research 
Introduction 
The purposes of this chapter are to define and describe the object of study of this thesis, 
namely the relationship between community engagement and ethical practice in the 
conduct of bio-medical research in resource-limited settings, and to provide an overview of 
the thesis structure and a summary of the core findings. The first section sets out the 
premise of this research, describes the geographic and institutional context of my fieldwork 
and introduces the two vaccine trial case studies. This is followed by an account of my 
interest in the object of study and a review of the key literature which informed the focus of 
my ethnographic enquiry. Finally I provide an outline of the thesis and a synopsis of the 
main questions addressed in my findings chapters and the core findings which cut across 
these chapters. 
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The Object of Study 
My object of study is the understandings and practices of community engagement (CE) in 
international health research conducted in resource-limited settings. I studied this in the 
context of two paediatric vaccine trials run by the Kenyan Medical Research Institute in 
collaboration with the US Centers for Disease Control and Prevention (KEMRI/CDC) in 
Western Kenya. The conduct of such research in vulnerable target groups raises important 
ethical considerations regarding participants' understanding of research, voluntariness, 
coercion, the potential exploitation of trial participants, benefit sharing and the social value 
of research. CE and associated collaborative partnerships between researchers and 
communities have been proposed as a benchmark for ethical research and a tool for 
addressing such concerns (Emanuel et al., 2004). In the Emanuel et al. (2004) framework CE 
is presented as an unproblematic and unequivocal good which can help to minimize the 
risks of exploitation, ensure a fair distribution of research benefits and improve the quality 
of informed consent in the conduct of health research in developing countries. By means of 
ethnographic fieldwork undertaken between 2007 and 2009 I explored how CE is 
understood, talked about and enacted in the implementation of two paediatric vaccine trials 
undertaken by KEMRI/CDC. The thesis argues that, in this setting, CE needs to be 
understood within the context of historical models for working with target communities, 
and the long-standing and developing relationships between researchers, their staff and 
assistants and members of the wider community in which trials take place. Furthermore, far 
from being an unproblematic good in terms of ethical practice, CE offers a lens into new and 
pre-existing inequalities which affect the implementation of research in this kind of setting. 
CE emerges from my data as complex and challenging work, which requires continuous 
efforts and cannot be limited simply to information exchange. In order to address the 
tensions and contradictions which arise in CE it is essential to discuss questions of social 
justice and to engage materially, through a broader distribution of resources, with the 
community where research takes place. 
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The Study Site 
I conducted my ethnographic fieldwork in Karemo Division where the paediatric vaccine 
trials conducted by KEMRI/CDC were taking place. Karemo Division is part of Siaya District 
and is located an hour's drive north-west from Kisumu, the provincial capital of Nyanza. 
Nyanza Province is located in Western Kenya and borders Uganda and Tanzania. 
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Map 1: Nyanza Province, Kenya, East Africa 
The main offices of KEMRI/ CDC are situated on the outskirts of Kisumu. Karemo Division 
(shaded in green in Map 2) is a rural area within Siaya District which forms part of the 
KEMRI/CDC Health and Demographic Surveillance System (HDSS). This system includes the 
three areas highlighted in the above map, and serves as a platform on which to base a range 
of studies to examine specific disease issues, including descriptive epidemiology, diagnosis, 
treatment, prevention, behaviour, and economics. Surveillance of households is carried out 
by trained FWs every four months, and in 2008 a total of 54,367 households provided 
demographic, health and socio-economic data (KEMRI/CDC Health and Demographic 
Surveillance System (HDSS), 2008). 
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The Demographic Surveillance System (DSS) 
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Map 2: The KEMRI/CDC Health and Demographic Surveillance Area 
Health indicators are poor in the health and demographic surveillance area. Immunisation 
coverage in 2008 was well below the World Health Organisation (WHO) target of 90% with 
only 74% of children under 2 years of age being fully immunised, the highest coverage was 
in Karemo, at 81%. The infant and under-five mortality ratios are 110.5/1,000 live births and 
202.8/1,000 live births respectively and average life expectancy at birth is 45 years (42 years 
for men and 47 for women) - which is lower than the national 
figure of 53 years (KEMRI/CDC 
Health and Demographic Surveillance System (HDSS), 2008). HIV is twice as prevalent as the 
national average of 7.1% (National AIDS/STI Control Programme (NASCOP), September 
2009) and, in spite of the successful implementation of an HIV care and treatment 
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programme, AIDS-related mortality and suffering affects almost every family in the area 
(Prince and Geissler, 2010). In 2008 the major causes of death in adults living in the areas 
where the HDSS operated were HIV and Tuberculosis. In contrast, among children, aged 0- 
11 years, malaria was the leading cause of mortality accounting for 27% of deaths, followed 
by HIV (14%) and malnutrition (12%) (KEMRI/CDC Health and Demographic Surveillance 
System (HDSS), 2008). 
Inhabitants of the HDSA mainly engage in farming, fishing and petty trade, and it is 
estimated that 64-74% of the population live below the poverty level (Kenya Central Bureau 
of Statistics, 2005). In 2008,63% of the household heads reported to be engaged in 
subsistence farming, 13% reported to be engaged in small businesses (kiosk, jua-kali' and 
selling maize) and only 5% were salaried employees. Among the resident population aged 
18 years and above, 64% had at least primary education, 23% had secondary education and 
only 13% had no education at all. Over three-quarters of houses surveyed in the HDSA in 
2008 were mud houses, while 12% were semi-permanent (houses built with mud and 
plastered with cement), and 11% were permanent houses (house built of cement blocks or 
burnt bricks). Half of the households surveyed owned livestock and the number of cattle 
ranged from 1 to 110 with a median of 3 cattle per household. Access to safe water is a 
major challenge in the HDSA with approximately 90% of the households having no access to 
safe water sources and 44% of households using untreated water. 
The KEMRI/CDC Public Health and Research Collaboration 
The Kenyan Medical Research Institute (KEMRI) and the United States Centres for Disease 
Control and Prevention (CDC) have been working together since 1979. In Western Kenya 
this collaboration is officially termed the KEMRI/CDC Public Health Research Collaboration, 
is generally referred to as 'KEMRI/CDC' or simply 'CDC'. The KEMRI/CDC offices are situated 
within secure grounds which belong to the KEMRI Centre for Global Health Research 
(CGHR). These grounds are located in a rural area called Kisian, which is 20 minutes' drive 
from Kisumu. The grounds house the KEMRI-CGHR offices, offices used by other research 
1 Small-scale craft or artisanal work, such as making tools or textiles-literal translation: 'in the hot sun' 
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groups collaborating with KEMRI-CGHR, the extensive KEMRI/CDC science wing, transport 
offices and garages, and modern laboratory facilities. The grounds are very well landscaped 
and maintained and cordoned off by a high concrete wall. In order to enter the grounds one 
must pass through 2 security gates. These gates are manned by contracted security guards 
from a multinational security firm. On arrival at the gates one either has to show proof of 
employment status or have been registered as a visitor in order to be granted access. 
KEMRI/CDC employees are required to wear identification at work and have to swipe their 
ID cards to enter the KEMRI/CDC science wing and laboratories. The layout shown in the 
aerial view of the KEMRI-CGHR and KEMRI/CDC grounds below illustrates how the research 
centre is cordoned off from the surrounding areas. The following photographs provide 
evidence the size of the complex and the quality of the buildings, particularly those used by 
KEMRI/CDC. 
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Photo 2: Aerial View of the KEMRI-CGHR and KEMRI/CDC Grounds at Kisian 
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Photo 3: Landscape View of the KEMRI-CGHR & KEMRI/CDC Grounds & Facilities 
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Photo 4: The KEMRI/CDC Science Wing 
The research facilities at Kisian are colloquially referred to by members of KEMRI/CDC as the 
'field station'. Hence I use this term whenever I refer to these grounds and their constituent 
buildings and laboratories. As noted above the field station is extensive and in addition to 
these research facilities there are two other smaller clinical research centres (CRC) 
maintained by KEMRI/CDC in Kisumu and Siaya. Both of these CRCs are located within the 
grounds of government hospitals. The Kisumu CRC located at Nyanza Provincial Hospital is 
17 
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purely used for HIV-related research whereas the Siaya CRC at Siaya District Hospital (SDH) 
also houses patient care and support services for routine HIV+ clients. Research studies 
coordinated from these sites take place either within the CRCs, at peripheral health clinics, 
or in rural communities and, to a lesser extent in urban dwellings. The HDSS, described 
above, hosts the majority of research which is conducted by KEMRI/CDC although some 
malaria research also takes place in the highland areas of South Nyanza. These research 
areas share common characteristics in terms of health and demographic indicators: high 
infant mortality rates; high prevalence of malaria, HIV and Tuberculosis; and high levels of 
poverty (KEMRI/CDC Health and Demographic Surveillance System (HDSS), 2008, Central 
Bureau of Statistics Ministry of Health Kenya and ORC Macro, 2004, National AIDS/STI 
Control Programme (NASCOP), September 2009). 
KEMRI/CDC employs a very large staff body of approximately 1000 people and in addition to 
these contracted employees KEMRI/CDC also works with casual workers such as Village 
Reporters (VRs) and volunteers such as community advisory board (CAB) members. The 
total number of contracted employees can fluctuate since employment depends on 
research projects which usually have a lifespan of 1-3 years. The majority of staff are 
employed on annually renewable contracts and these contracts are issued by KEMRI-CGHR. 
Hence all KEMRI/CDC employees are officially employed by KEMRI and subject to KEMRI 
supervision and pay scales. The largest group of staff are Field Workers (FWs), who are 
based in the rural and urban areas where health research is conducted. FWs only come to 
the field station for administrative visits or training. FWs mainly originate from the places 
where research is conducted and are usually secondary school leavers. The next main group 
of employees are those with technical and graduate training who perform clinical or 
laboratory duties, carry out quality management, coordinate studies, manage or analyse 
data, provide computer services, manage community liaison and communications, manage 
human resources or undertake other administrative duties. Most of this group are Kenyan 
nationals with a few exceptions where specific expertise is not available in the country. 
Some of these employees are based at the field station or CRCs, others work both at the 
field station and in the areas where research projects are taking place (i. e. the field), while 
others are based full-time in the field. Finally there are the research investigators and the 
senior scientists who direct the KEMRI/CDC research programme. This group comprises 
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international and national scientists who are employed by KEMRI or CDC or by means of 
consultancy agreements. In chapter 51 elaborate on the KEMRI/CDC personnel structure in 
relation to my object of study. 
The KEMRI/CDC research portfolio is far-reaching and includes epidemiological and clinical 
research in the fields of malaria, HIV, Tuberculosis, schistosomiasis, emerging infections, 
zoonotic infections and other infectious and viral diseases. Research findings are published 
in high profile journals and, in addition to core funding from CDC, the collaboration also 
attracts funding from organisations like the European and Developing Countries Trials 
Partnerships. KEMRI/CDC's extensive infrastructure including the HDSS and its access to 
areas where the target diseases for global health research are prevalent makes it an 
attractive trial site. This was the case for vaccine programmes like the Malaria Vaccine 
Initiative which brought together a range of pharmaceutical, philanthropic and government 
sponsors to accelerate the development of new vaccines. 
The Vaccine Trial Case Studies 
The two vaccine trial case studies which formed the basis of my field work were a paediatric 
rotavirus vaccine trial (RVT) and a paediatric malaria vaccine trial (RVT). The RVT assessed 
the efficacy and safety of the oral rotavirus vaccine (RotategTM) and determined 
immunogenicity in HIV + infants. The ongoing MVT is assessing the efficacy of the 
RTS, S/AS01 malaria vaccine candidate. Both trials involved randomisation and blinding of 
participants and study staff. The RVT was a placebo controlled trial, while infants in the 
control arms of the MVT receive either a meningococcal or rabies vaccine. All participants 
received a course of study vaccines, underwent relevant medical screening and home 
follow-up and some were required to provide either stool or blood samples. 
The hospital and three of the peripheral health centres where the RVT and MVT took place 
are administered by the Kenyan Ministry of Public Health and the Ministry Medical Services. 
The other health centre is run by a faith-based non-governmental organisation under the 
supervision of the above ministries. SDH serves a population of 525000; the hospital has a 
capacity of 220 beds and is served by 3 specialists (Gynaecology, Surgery and 
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Ophthalmology) and 3 recently qualified medical officers who joined the hospital in the 
course of the MVT. A team of nurses, clinical officers, lab and x-ray technicians, support staff 
and a pharmacist support the medical colleagues. The health centres are usually manned by 
a couple of nurses and in some cases a clinical officer who can perform some medical duties. 
Two of the health centres offer basic laboratory services and some medicines are available 
at all the health centres. At these peripheral sites and the maternal child health (MCH) clinic 
at SDH, enrolling or outpatient participants are seen in rooms or tents that are adjacent to 
the regular clinical spaces. Hospitalised participants are admitted to the SDH paediatric 
ward where they are cared for by KEMRI/CDC staff alongside regular patients. KEMRI/CDC 
nurses, clinicians and medical officers, including a paediatrician, also assist with the care of 
general patients and KEMRI/CDC clinical officers support MCH and HIV patient care and 
support services. 
From a scientific perspective the RVT and MVT represented significant promise for public 
health programmes seeking to reduce paediatric mortality and morbidity caused by malaria 
and rotavirus-related diarrhoeal disease. The efficacy and safety of the rotavirus vaccine 
(Rotateq'M) has in fact already been confirmed (Armah et al., 2010), and this vaccine is now 
recommended for use in all national immunisation programmes by the WHO (WHO, 2009). 
Discussions are currently underway on how to support the inclusion of rotavirus vaccines 
into the Expanded Programme of Immunisation (EPI), so that children in all countries can 
benefit from rotavirus immunisation (WHO, 2011). Meanwhile the phase III trial of the 
RTS, S/AS01 malaria vaccine is ongoing. RTS, S/ASO1 is the first vaccine candidate to progress 
to Phase III testing and preliminary results suggest it could prevent 50% of malaria attacks in 
children aged 5-17 months, and reduce the incidence of severe malaria by 40% in this age 
group (The RISS Clinical Trials Partnership, 2011). These interim results have received 
considerable attention in the international media and given rise to much public hope and 
expectation (Briggs, 18th October 2011, Stobe, 18th October 2011, Ratemo, 19th October 
2011). Malaria experts are expressing cautious optimism and drawing attention to the need 
to await the final analyses from this trial which are due in 2013/14 (White, 2011, LSHTM 
Malaria Centre, 2011). While the MVT is still ongoing, for the purposes of this thesis I will 
mostly refer to both trials in the past tense. This is both for ease of reference and to reflect 
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that my fieldwork and empirical data relate principally to a period in time between 2007 and 
2009. 
Conceptual & Theoretical Framework 
As a PhD student with a background in community health development in Haiti, clinical 
vaccine research and related applied qualitative research in the UK, the two vaccine trials 
allowed me to expand my understanding of community relations in an international context. 
My previous research had explored parental decision-making about trial participation, and 
parental and health professionals attitudes to the introduction of new vaccines (Chantler et 
al., 2007b, Chantler et al., 2006, Newton et al., 2006, Chantler et al., 2007a). In my PhD I 
wanted to build on this work and develop a richer theoretical and practical understanding of 
the use of anthropological methods in ethics research. This was made possible through a 
collaborative agreement between the Kenyan Medical Research Institute (KEMRI) and the 
London School of Hygiene and Tropical Medicine (LSHTM) established by my primary 
supervisor. At the time I was designing my PhD research my primary supervisor had 
commenced ethnographic fieldwork within the KEMRI/CDC collaborative research 
programme. Together with colleagues from KEMRI, the US Centres for Disease Control (CDC) 
and LSHTM, Dr Geissler is studying the 'ethos' and social life and everyday practices of 
medical research within international collaborations. This work is not focussed on the 
application of ethical and regulatory guidelines such as 'Good Clinical Practice' (International 
Conference on Harmonisation of Technical Requirements for Registration of 
Pharmaceuticals for Human Use, 1996b); rather it seeks to understand the practice of 
medical research as a wider societal project. Core foci are how questions of social justice are 
voiced and addressed in practice. The 'ethos' of medical research in this work is understood 
to be 'the visions, and projects that orientate and direct the discourses and practices of 
different actors and groups, in different places, situations and periods' (Geissler, 2011). 
In approaching my study I started from the premise that the international research 
programme and the communities where the vaccine trials are taking place constitute a set 
of informal and formal social relations, a trial community (Geissler, 2011). My thesis looks at 
one particular segment of the KEMRI/CDC social network, namely the interaction between 
vaccine trial teams and the communities where my vaccine trial case studies took place. 
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These relations are my lens to understanding the practice of CE in this setting. Among the 
wider range of community relations, my focus has been relations between researchers and 
the following groups: community leaders who act as gatekeepers and collaborators; 
community representatives who act as intermediaries between researchers and community 
members; trial participants and their families; and community members. I explored the 
practice of CE from as many different angles as possible in order to understand the work 
that CE is meant to do, and the work it actually does, critically interrogating the assumptions 
and meanings behind this mode of intervention as well as its power and social effects. I 
traced the history of community relations, explored the perspectives of groups of people 
involved in CE and observed the social relations and interactions which characterise CE at 
the sites where the trials were conducted. 
This thesis speaks primarily to debates in ethics around the nature and goals of CE, and the 
social value and practice of solidarity in bio-medical research conducted in resource-limited 
settings. It also seeks to contribute to the anthropology of clinical research by providing a 
rich description of the social construction of CE at KEMRI/CDC. This construction arises from 
a particular history, is shaped by the local context, and is informed by distinct ideas 
regarding who constitutes the 'community' and what 'engagement' with science and 
'collaboration' in bio-medical research involve. 
To complement this conceptual overview I now review pertinent literature which guided my 
initial thinking about CE and its relevance to research ethics, trials, health and development 
with due consideration to the cross cultural nature of my topic. 
Ethical Challenges & Considerations of Context in International Research 
Particular ethical challenges can arise when important health research is carried out in 
resource-limited settings. A classic example of this is the 'standard of care debate' which 
was sparked by criticism of perinatal HIV transmission trials conducted by Western 
researchers in developing countries in the late 1990s. The inclusion of placebos in the HIV 
transmission trials and observation in viral transmission studies rather than the 'best' 
proven treatment available in developed countries ignited debate about what constitutes a 
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fair and reasonable standard of care for human research subjects in developing countries 
(Lurie and Wolfe, 1997, Quinn, 2000). Specific questions arose about whether 'best' current 
treatment should equate to what is locally available or instead what is available in the 
countries sponsoring the research. Strong arguments were made against moral relativism 
which could lead to breaches of ethical imperatives (i. e. ensuring that research subjects are 
not used as a means to an end), being justified by the scientific value of research and its 
potential to improve the care of future patients (Angell, 1997). Others associated criticism 
voiced in this debate with imperialistic attitudes and expressed concern about its threat to 
the continuation of medical research in less affluent countries (Gambia 
Government/Medical Research Council Joint Ethical Committee, 1998, Varmus and Satcher, 
1997, Benatar, 1998). 
Considerations of context were central to questions sparked in this debate, and 
philosophers and ethicists argued that the ambit of the debate over the standard of care 
was too narrow and failed to account for the reality of global health inequalities (Benatar 
and Singer, 2000). They drew attention to the arbitrariness of equating equal standards of 
medical care with the provision of particular drugs, and urged the scientific community to 
consider the broader context of care-giving and disparities in health research expenditure 
per capita between developed and developing countries. Inherent to their perspective is an 
understanding of ethics as moral reasoning rather than strict adherence to guidelines or 
similar prescriptions. This reasoning requires a distinction to be drawn between moral 
relativism and morally relevant issues of context. To support closer consideration of such 
factors, Benatar (2001) did however advocate for the introduction of new components to 
the Declaration of Helsinki. These components included: greater access to research for 
vulnerable groups in all countries; ensuring that research is relevant to research participants 
and their communities; encouraging the involvement of research participants in the 
planning and conduct of research; and linking research in developing countries with 
capacity-building in health-care. Some of these components have been integrated in 
subsequent revisions - for example, point 5 of the current declaration now states, that 
'Populations that are underrepresented in medical research should be provided access to 
participation in research' (World Medical Association, 2008). The wording of point 17 is also 
now more explicit about the need for research involving disadvantaged communities to be 
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responsive to the health needs of such communities and the benefits that such communities 
stand to gain from the results of research. These revisions and ethics review capacity- 
building reflect a move towards a more proactive research ethics which is intrinsically 
concerned about the inequities in global health 
Considerations of context require a greater appreciation of the different cultural lenses and 
frameworks of thinking which co-exist in the application of multinational collaborative 
research. The worldview and experience of privileged international researchers differs 
substantially from that of potential research participants from disadvantaged communities 
(Benatar, 2002); it also can differ from that of national colleagues with whom they are 
collaborating. National researchers may also not be able to identify fully with the social and 
economic realities which characterise trial participants' daily lives; however they will share 
more in common in terms of history and culture. Ugandan researchers have suggested that 
socio-economic inequalities between investigators and subjects can result in subjects feeling 
that they have no choice when asked to participate in research; they also consider how the 
legacy of colonialism evokes ethnic divisiveness between researchers and subjects (Loue et 
al., 1996). 
Kleinman (1999) makes the case for the 'New Bioethics' to adopt a two-pronged approach 
to ethics; one that combines the guidance of universal principles (e. g. Beauchamp and 
Childress' (2009) framework of four prima facie2 principles) with proper accounting for local 
moral experience. From the perspective of an anthropologist he argues that bio-ethicists 
need an understanding of 'what is locally at stake' in order to focus their ethical 
deliberation appropriately. This is particularly important where intrinsic inequities related to 
poverty, deprivation or other circumstances pre-exist in the places where research is 
proposed. Kleinman argues that principle-based formulations of justice used to review the 
ethics of trials can seem irrelevant if they do not account for pre-existing inequities. Like 
other authors (Benatar and Singer, 2000, Emanuel et al., 2004, Tangwa, 2004) Kleinman calls 
for a reframing of the relationship between universal principles and communitarian 
concerns in international health research. 
2 Prima facie is understood by Beauchamp & Childress 2009 p. 198 to mean: no one principle of ethics should 
be viewed as the sole principle of ethics, nor as one that justifies or overrides all other principles'. The idea of 
prima facie obligations draws on the writings of the British moral philosopher W. D Ross (ROSS, W. D. 2002. The 
right and the good, Oxford, Clarendon Press 
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Benatar (2002) suggests that in order to make scientific and moral progress scientists have 
to do the following: be critical of the status of current knowledge, method and dogma; be 
willing to raise critical questions (e. g. about how research can ameliorate health conditions 
in resource-limited settings): acquire an understanding of their own base within a specific 
context; recognise the limitations of their own worldview; acknowledge that their insights 
are not always correct or better than those of others; and be willing to debate differences 
with an open and scholarly attitude. Adopting this approach may foster reciprocity, 
interdependence and candid discussion in international health research collaborations and 
help to ensure that studies reflect the health needs of the immediate beneficiaries (Benatar, 
2002, Robertson, 1998). 
The rhetoric of collaboration and partnership in multinational research can however also 
result in uncomfortable truths about unequal relationships being relegated to the 
background. This may be inadvertent or simply reflect the enormity of confronting these 
fundamental challenges head on. We may believe that health research should account for 
and respond to inequalities in global health, yet struggle to realise these ideals in practice. 
Farmer (2005) argues passionately against such apathy stating that more must be done to 
insert social justice into medical ethics. To remain credible bio-ethicists and researchers in 
particular must address key fundamental questions which formed the basis for a code of 
ethics (Tavistock Principles) drafted by professionals involved in health-care (Berwick et al., 
2001, Tavistock Group, 1999, Farmer, 2005). The Tavistock code of ethics presents health- 
care as a human right, and hence Farmer argues (2005) (p. 206): 'If access to health-care is 
considered a human right, who is considered human enough to have that right? ' 
Collaborative Partnerships & Community Engagement 
Partnership has become a dominant paradigm within the field of global health and has been 
defined by Buse & Walt (Buse and Walt, 2000) as 'a collaborative relationship which 
transcends national boundaries and brings together at least three parties, among them a 
corporation (and/or industry association) and an intergovernmental organization, so as to 
achieve a shared health-creating goal on the basis of a mutually agreed division of labour (p. 
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550)'. This definition captures the working relationships between sponsors, research 
organisations and governmental bodies in health research. However it does not include the 
beneficiaries of health interventions. I will follow up on this point in a subsequent 
paragraph; for now I want to consider the practice of partnership in global health and 
development, and outline some of the challenges and benefits. 
Partners may share common goals but it is very likely that they will have diverse priorities 
and expectations. Diverse agendas - for example the prioritisation of gaining new knowledge 
over a desire to solve immediate problems or differing expectations concerning the nature 
of collaboration (on a continuum of perfunctory consultation to authentic partnership) have 
been documented in endeavours which seek to increase the participation of all players 
(Wallerstein, 1999, Huberman, 1991, Arnstein, 1969). The lines of accountability to the 
community or donors, organisational structures and cultures can also differ substantially 
between international partners, as can access to resources and professional support. The 
rhetoric of partnership can be both egalitarian and obscure. It is egalitarian in that it works 
from the premise that international partners have equal authority over and responsibility 
for projects. It is obscure since in practice the lines of duty are blurred, and it is difficult to 
tell who has more say over the direction of projects. This contrasts significantly from the 
autocratic colonial administration of the past in some African countries, where the hierarchy 
was unquestionably dominated by foreign officials. With the discourse of partnership 
Western researchers attempt to distance themselves from this unpalatable autocratic 
model, and yet the health research agenda is still primarily driven by sponsors, and research 
institutes based in the West-hence semi-colonial in nature (Costello and Zumla, 2000). There 
are exceptions e. g. the African Malaria Network Trust (AMANET) and some of the INDEPTH 
(The International Network for the Demographic Evaluation of Populations and Their Health 
in Developing Countries) Network sites, e. g. the Navrongo Demographic Surveillance Site. 
There the senior leadership is predominantly African. They have a defined research agenda, 
links with government ministries and have attracted funding from international bodies, e. g. 
the European Developing Countries Clinical Trials Partnership (EDCPT). This goes some way 
to reflect the partnership model described by Costello and Zumla (2000) which prioritises 
national capacity building, and seeks to reverse the 10/90 health research gap (i. e. the fact 
that developing countries bear 90% of the global disease burden but only 10% of health 
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research funding used to address these diseases). However even these institutes have to 
adapt their programmes to fit the funding priorities of Western agencies, and Kilama (2007) 
argues that more needs to be done to reverse the 10/90 gap. 
Since the late 1990s increasing emphasis has been placed on CE in international health 
research as a means of promoting dialogue between researchers and people who live in the 
places where trials are taking place. In fact collaborative partnership between researchers 
and community representatives is cited by Emmanuel et al. (2004) as one of 8 principles of 
ethical research in developing countries. These authors who represent the US National 
Institutes of Health state that, at a minimum, proposed research should respect local values, 
culture and social practices and be regarded as important by community members. 
Accordingly community representatives' capacity should be augmented so that they can be 
involved in planning and overseeing research as community advocates. This focus on 
collaborative partnerships and CE in the arena of health research in developing countries 
was partly a response to the writings of Benatar and Singer (2000) and the increased 
attention being paid to the challenges involved in conducting medical research in 
developing countries. It also reflects the desire of the authors from the National Institutes of 
Health for pre-existing ethical constructs to become more responsive to community needs 
in a manner characterised by negotiation and agreement. In essence they were trying to 
insert more communitarian considerations into pre-existing western ethics models, which 
are predominately influenced by liberal philosophy and deontology and which prioritise 
individual autonomy. 
The publication of this paper sparked much interest in what it means to engage a 
community in research; how do you do this, who should be engaged, by whom and how 
does this promote ethical practice. This is not to say that there had not previously been 
interest or an acknowledgement of the importance of collaborative partnerships or CE in 
international health research. To the contrary ongoing research from different parts of East 
Africa was highlighting the need for closer attention to be paid to community interactions in 
the application of health research. Questions of trust, consent, community acceptability, 
coercion and the role of community representative and local FWs were core themes in some 
of these publications (Molyneux et al., 2004, Mitchell et al., 2002, Molyneux et al., 2005a). 
However the term CE and associated practices acquired a new legitimacy in international 
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health research with the inclusion of CE explicitly in ethical frameworks (Emanuel et al., 
2004). 
CE in research is a very broad and complex term which can be difficult to define succinctly. 
Writing mainly for a national audience the US Centers for Disease and Prevention defined it 
in 1997 as 'the process of working collaboratively with groups of people who are affiliated by 
geographic proximity, special interests, or similar situations with respect to issues affecting 
their well-being' (CDC/ATSDR Committtee on Community Engagement, 1997). This definition 
is elaborated on in 9 principles (Appendix I, Doc. 1) as part of a first edition of an electronic 
resource about CE which has recently been updated (Clinical and Translational Science 
Awards Consortium Community Engagement Key Function Committee Task Force, 2011). Of 
particular interest to this thesis is the fact that these principles are not cited in documents 
which describe the framing of CE at KEMRI/CDC. I was also not introduced to these as part 
of my initial discussions with collaborators from the head office of CDC in Atlanta or at 
KEMRI/CDC. This may have been because these principles were primarily written for 
national programmes whereas CDC's main mission is domestic. This is apparent from the 
fact that promoting global health and related research was allocated only US$340 million 
out of an overall budget of US$10.8 billion in the financial year 2011 (Centers for Disease 
Control and Prevention, 2011). 
Writing for an international audience involved in global health research Tindana et al. (2007) 
define CE as 'the process of working collaboratively with relevant partners who share 
common goals and interests'. They believe that CE goes beyond notions of community 
participation and they draw attention to the importance of authentic partnerships, mutual 
respect, active inclusive participation, power sharing and equity and mutual benefits (Zakus 
and Lysack, 1998). It is evident that such thinking about CE is significantly influenced by 
ideas of what constitutes a 'community'. Hence it is essential to consider how the concept 
of 'community' is applied and defined in the overlapping fields of development, health and 
research. 
'The Community' as a Concept in Development, Health & Research 
The term 'community' as applied to international health and medical research can refer to a 
geographical location and its inhabitants, a professional group (e. g. 'the scientific 
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community'), or those at particular risk of certain diseases. At another level groups who 
share a belief system, culture or ethnicity are referred to as 'communities', as are economic 
and political alliances between countries, e. g. the EASCO (East African Common Services 
Organization) or the European Union. In essence the concept denotes a certain 
commonality - such as shared characteristics, similarities in beliefs, behaviour and attitude 
and/or living in a particular location. Communities are frequently characterised 'small-scale, 
having relative boundedness, strong affective ties, traditionalism, and face-to face contact' 
(Calhoun, 2002). This ideal typical view of a community can however fail to acknowledge 
external influences, internal heterogeneity and inherent power dynamics. Community 
boundaries have become more dynamic and difficult to delineate due to increased mobility, 
periodic migration for work or education and greater access to communication 
technologies. Inherent power dynamics are directly related to socio-economic factors such 
as gender, age, assets, family ties and education. Guijt & Shah (1998) argue that a naive view 
of community as a harmonious and internally equitable collective can result in the opinions 
and priorities of those less able to voice themselves publicly being disregarded. 
Weijer & Emanuel (2000) distinguish between 7 different types of communities and assess 
their cohesiveness by applying a defined set of characteristics. These characteristics are: 
common culture and traditions, cannon of knowledge, and shared history; 
comprehensiveness of culture; health-related common culture; legitimate political 
authority; representative group/individuals; mechanism for priority-setting in health-care; 
geographic localization; common economy/shared resources; communication network; and 
self-identification as a community. They suggest that these characteristics can help ethicists 
to determine where and when specific ethical protections need to be applied in the conduct 
of bio-medical research. They also argue that the level and type of collaboration between 
communities, health-care staff and researchers is dependent on the existence of some of 
these characteristics. 
The previous paragraphs focused on the conceptualisation of 'community' as an entity with 
which outsiders engage for a variety of reasons. The process of engagement itself can 
however also give rise to the formation of 'community' and the development of new 
relationships between internal and external agents. Medical anthropologists studying health 
and, in particular, research interventions have coined the term 'trial community' to capture 
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the broader social networks that are created in the planning and implementation of health 
research (Geissler and Molyneux, 2011). A 'trial community' encompasses not only the 
target population of the intended research but also those coordinating, conducting, funding 
and acting upon the research and its' findings. The shared sense of identity in this case is 
derived from the trial, and the shaping of 'community' results from the social relations 
constituted in the process of the trial. Research participants can derive significant social 
meaning and concrete benefits from belonging to a trial community (Leach and Fairhead, 
2011). A paper about a malaria vaccine trial in the Gambia also depicts how relationships 
within a 'trial community' can contribute to the successful implementation of research 
(Geissler et al., 2008). FWs who were posted to the villages where the vaccine trial was 
taking place, developed kinship-like relationships with residents. Their interactions were 
guided by a concrete and relational form of ethics which the anthropologists differentiated 
from the abstract and vertical formal ethical principles that underwrite medical research. 
Rather than the one negating the other they argued that both kinds of ethics are needed to 
position trials between the networks of global science and its attendant legal frames on the 
one hand, and the concrete relations in which science is made on the other (Geissler et al., 
2008, Fairhead et al., 2006a). 
The 'community' as a political entity and an interface or a point of interaction was central to 
ideas about development and health in developing countries in the 1970s to 1980s 
(Chambers, 1983, Freire, 1972). While this focus on the recipients of care and their social 
worlds has been of great benefit there are drawbacks to this 'community-focused' 
approach. One of these is that, in their desire to reach out to the 'community', well- 
intentioned project implementers bypass (at times intentionally) governmental, political and 
medical actors that ought to mediate between citizens and larger health organisations. 
Thus, instead of operating through ministries and health-care facilities, projects access 
'communities' directly. While this democratic impetus can sometimes be justified, direct 
access by outside power-holders to citizens also risks devaluing existing or possible 
structures of democratic representation. It is also important to remember that the concept 
of 'community' as a political entity is relatively new. In colonial times the 'community' as an 
entity would not have been recognised as a legitimate agent, it gained more recognition in 
the 1970s and 1980s. And although it has been partly replaced by reference to civil society 
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and citizenship during the 1990s and 2000s (Comaroff and Comaroff, 1999), communities 
and plans to involve them continue to feature prominently in health and development 
plans. 
Community Participation in Health Programmes 
Community participation is one of the pillars of primary health care (PHC). PHC was a pivotal 
health policy adopted by WHO member states in 1978 following a conference held in Alma 
Ata (World Health Organisation, 1978). According to this, health planners and policy-makers 
expected community participation interventions to: increase the utilisation and 
sustainability of health services; achieve changes in health behaviours; and augment self- 
efficacy. Rifkin (1996) argues that community participation's failure to meet planners 
expectations can be traced back to a misguided paradigm; a paradigm which viewed 
community participation as a magic bullet for the resolution of problems rooted in health 
and political power structures. Within this paradigm community participation 
characteristically adopted one of 2 frameworks. Either a 'means to an end' (i. e. an 
intervention that will succeed in meeting programme planners aims) or 'a means in itself' 
(also termed the 'empowerment' approach, influenced by the Brazilian educationalist, Paulo 
Freire (1972)). Both the 'means to an end' and the 'means in itself frameworks place 
immense pressure on mobilisation techniques to fulfil wide and varied agendas and are 
usually applied with mutual exclusivity. It is also important to note that what Freire (1972) 
was proposing was fundamental structural change by encouraging rural peasants to 
question the status quo. He voiced strong criticism about a 'banking style' approach to 
education which filled people's heads with factual knowledge but did not teach them to 
question or challenge political authority. His main work, 'Paedagogy of the Oppressed', was 
written based on his experiences of teaching literacy to adults in impoverished communities 
in the Northeast of Brazil. His writings are significantly influence by liberation theology and 
Marxist critical theory. Freire (1972) coined the popular educational and social concept 
'conscientization' which derives from the Portuguese term 'conscientintizacäo'. This is 
translated as critical consciousness; the process of developing a critical awareness of one's 
social reality through reflection and action. This philosophy is of relevance to community 
development and possibly to CE in health research. However in order for social change to be 
lasting there is also a need to work together with authorities to reshape social reality. 
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To apportion more realistic expectations to community participation in health Rifkin (1996) 
promotes the adoption of an iterative approach to community participation, informed by 
the rural development work of Chambers (1983,1992) in the United Kingdom and Uphoff 
(1992) in the USA. Uphoff (1992) describes the need to move from an 'either-or', where the 
above-cited frameworks are applied in a mutually exclusive manner, to a 'both-and' 
approach which lends more flexibility to working in contexts that may require both linear 
and non-linear solutions. Rifkin (1996) considers 'both-and' to be a way of accommodating 
differing perspectives and achieving change in an iterative rather than a mechanistic 
manner. The 'both-and' approach to community participation requires mutual respect 
between professionals and community. Professionals need to be non-judgemental and 
willing to engage in dialogue whilst guarding against a one-solution-fits-all approach, which 
fails to reflect the local context. 
Practical Experiences of CE in International Health Research 
Those seeking to optimise methods of community participation or CE, as it is mainly referred 
to in international health research, will recognise the 'means to an end' and 'a means in 
itself' frameworks. In workshops opinions have differed about 'the feasibility and 
appropriate timing of consultation and priority setting in researcher civil society 
partnerships' (Hankins, 2006) (p. W4); and target-driven and comprehensive strategies are 
reported in the literature (Diallo et al., 2005, Hantman and Gottemoeller, 2004). 
Diallo (2005) describes a 6-step approach for obtaining community permission for research 
in cohesive, traditional societies. Similarly, Doumbo (2005) reiterates the importance of 
gaining permission from local leaders in research preparations. These 'means to an end' 
strategies can achieve important groundwork, yet they may fail to capture other community 
members' perspectives. Molyneux (2005b) provides an illuminating quote from a Kenyan 
mother living in the Kilifi district (p. 446): 'It is important for the fieldworkers to get 
permission from the chief to move around the area, but the chief cannot decide for my child. 
No way! Is he my husband.... is he the one who has bought our unga flour? ' To promote open 
dialogue with diverse communities in the vicinity of the Kilifi research station, Marsh et al. 
(2008) developed a district level communication strategy. This work focused more on the 
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'means in itself' rather than the research goals (e. g. recruitment rates) and set out to build 
collaborative partnerships and strengthen ethical practices across a broader research 
programme. 
Respectful relationships are core to the Emanuel et al. (2004) framework and their detailed 
reference to benchmarks for measuring good practice has initiated broader discussion about 
ethics and community. Overreliance on formal guidance, principles and a related 'tick box' 
mentality can stifle ethical reflection. Accordingly, Geissler et al. (2008) argue that 'research 
ethics should make space to unfold ethical relations; relations which either pre-exist or 
which develop in the implementation of public health trials. Drawing on ethnographic 
research into interactions between FWs and villages hosting vaccine research, they highlight 
the importance of attachment and familiarity versus detachment. Whilst attachment made 
it difficult for FWs to uphold certain trial restrictions (e. g., medication being available only to 
trial participants), the formation of social bonds allowed FWs' interactions to be guided by 
their 'ethical impulse' or moral compass. Geissler et al. (2008) argue that, in order to achieve 
a correct balance, ethical guidance should be complemented by considerations arising out 
of interactions characterised by trust. 
Trust is a relational notion which describes a voluntary relationship between two or more 
people (inter-personal trust) or between a person and an institution (institutional trust) 
(Gilson, 2003). Molyneux and colleagues demonstrate its importance with particular 
reference to consent and community perceptions of research (Molyneux et al., 2005a, 
Molyneux et al., 2005b). Their work emphasises the need to understand the social context 
and ensure that research teams incorporate both technical and inter-personal competence. 
The latter may be achieved by employing community-based assistants who are known and 
trusted by local residents (Gikonyo et al., 2008). It can also be achieved by collaborating 
with community representatives such as traditional authorities or members of community 
advisory boards (CABs) (Morin et al., 2003, Tindana et al., 2011). The selection of 
community representatives however raises questions about which people are best able to 
serve as spokespersons for the community and what the role of such representatives should 
be. 
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To maintain the integrity of individual consent processes and safeguard against a lack of 
voluntariness, incomplete disclosure and confusion about study terminology, Strauss (2001) 
proposed the use of CABs. These are bodies composed of community members who share a 
common history, symbols, language and culture with the study population. The proposed 
remit for CABs is to serve as a liaison between participants and researchers, by representing 
participants' concerns, protecting their rights and possibly facilitating the development of 
study materials. The demands of HIV+ activists' for input into setting the AIDS research 
agenda in the USA during the early 1990s was the original impetus for the formation of 
CABs. This CE mechanism is now commonly used in clinical research, albeit with widely 
differing outcomes. At one extreme CABs have halted trials due to concerns about the 
quality of evidence available on investigational products; at the other CAB members are 
noted to aligned themselves too closely with researchers and become less able to represent 
community views (Strauss et al., 2001). 
Based on research conducted at 6 HIV prevention research sites, Morin et at. (2003) 
distinguish between 2 CAB models: a 'broad community' model which involves 
representation from a cross-section of the larger community, including government officials, 
educators, religious leaders, representatives of non-governmental organisations and people 
living with HIV/AIDS; and a 'population specific' model which reflects the needs of a 
particular at-risk group. In terms of application the 'broad community' model entails a more 
long-term view of a CAB's mission to respond to future research projects; whereas the 
population-specific model focuses on a specific protocol and its impact on study 
participants. Sustainability, the capacity of a CAB to contribute something of 
lasting value to 
its community, and compensation for CAB members have been commonly encountered 
problems. A CAB can function both as 'a means in itself' whilst also acting as a 
'means to an 
end'; the ability of a CAB to build bridges between researchers and communities depends 
on its' mission, composition, training, remit and internal capacity. 
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Summary of the Literature Review 
Over the last decade, the concept of CE has made its way into international ethics guidelines 
and reports from organizations such as the Council for International Organisations of 
Medical Sciences (CIOMS) (2002), the US National Bioethics Advisory Commission and the 
UK's Nuffield Council on Bioethics (2002). This has resulted in calls to improve the processes 
of CE by conducting rigorous qualitative research to identify best practices (Newman, 2006). 
Current responses include the development and revision of UNAIDS and the AVAC (Global 
Aids Advocacy for HIV Prevention) guidelines on 'Good participatory practices in HIV 
prevention research' (UNAIDS and AVAC, 2011) and the development of frameworks for 
practice based on examples of CE (Bandewar et al., 2010, Tindana et al., 2007, Lavery et al., 
2010, Nyika et al., 2010). Less research focuses on understanding how CE activities and 
related partnerships serve to address ethical challenges that emerge prior to and during the 
implementation of internationally sponsored bio-medical research. Hence, in my PhD 
research I attempt to redress this balance by describing and critically analysing the 
relationship between CE, ethics and the conduct of vaccine trials. 
Outline of the Thesis 
This chapter has described the object of study and the context in which my ethnographic 
fieldwork was conducted. A detailed review of the key literature is given and my main 
findings are summarised to provide a road map for the rest of the thesis. In the next chapter 
I document the history of immunization and related research in Sub-Saharan Africa. In 
chapter 3I describe my research design and present an account of my fieldwork. The 
subsequent chapters 4-11 contain my findings. Each findings chapter draws out key themes 
which I synthesise in chapter 12 in order to formulate an overarching conclusion. 
Chapter 4 documents the history of community relations at KEMRI/CDC over the past 30 
years and draws out central themes related to the rapid growth of the research programme, 
its' location and accountability, expressions of disconnect and the control and direction of 
interactions between researchers and community members. Chapter 5 provides a detailed 
overview of the contemporary framing of CE at KEMRI/CDC which suggests that CE is about 
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researchers reaching out to the community where trials take place. Much emphasis is 
placed on the transfer of information, transparency about the purpose of research and 
reaching out to as many people as possible. CE is viewed of as a learning process and 
something that has to be planned carefully to mitigate the influence of latent cultural idioms 
and related rumours. These rumours influence researchers' thinking about the local 
community and underscore boundaries and demarcations already drawn between the 
KEMRI/CDC and the place where trials take place. 
In chapters 6-9 I present the social construction of CE among different people attached to 
the KEMRI/CDC trial community. I start by exploring the perspectives and experiences of 
those working for KEMRI/CDC and determine that the following aspects are key to 
understanding people's approach to CE: promoting a positive image; careful attention to 
the content of information shared with the media and general public; and demonstrating 
'attachment' to the local community. In chapters 7 and 8I shift my attention to community 
intermediaries that is those who connect researchers with community members. In chapter 
7 we learn that VRs are employed casually to perform defined tasks for the HDSS and some 
trials. Their role is shaped by ambiguities related to their employment status and their dual 
accountability to researchers and their villages. VRs' position of being both with the 
community and with KEMRI/CDC emerges as advantageous for the conduct of research but 
clearly problematic in terms of exercising trust, balancing allegiances, adequately 
representing community views and responding to implicit and explicit expectations for 
material assistance. The concept of 'positioning' relating to people who travel across the 
imagined boundary between the community and KEMRI/CDC, which emerges in the chapter 
about VRs, gains further prominence in chapter 8 on CABs. CABs are voluntary bodies 
whose mandate at KEMRI/CDC is to foster partnership between researchers and the local 
community. In practice CAB members highly value their association with a modern and 
progressive project and assume the role of KEMRI/CDC patron-clients rather than 
community advocates. The influence of patronage is also apparent in chapter 9 which 
documents 'gatekeepers' experiences of CE. 'Gatekeepers' represent those who have the 
power to grant or withhold access to the setting in which one wants to conduct research. 
For KEMRI/CDC these people comprise those who hold positions of leadership within the 
government administration, the political leadership and the ministries of public health and 
36 
medical services. In chapter 9I focus on the first two groups and key themes which emerge 
from this chapter are the importance of material engagements and meaningful and ongoing 
collaboration. Gatekeepers argue that you cannot apply a research agenda without 
accounting for inadequate health services and the poverty of most trial participants. For 
them the material expression of solidarity is central to CE and provides the basis for ongoing 
collaboration. 
In the last two findings chapters I explore the diversity of community responses to the 
vaccine trial case studies, and the negotiations involved in hosting these trials in public 
health facilities. My analysis in chapter 10 shows that, as community members started to 
interact more closely with KEMRI/CDC, they began to lay aside hesitations and inherent 
suspicions which were heavily influenced by latent cultural idioms, such as 'blood stealing' 
rumours. Their attention became increasingly drawn to the benefits of trial participation 
and questions of exclusion began to dominate public concerns. In chapter 11 I describe how 
differences in health-care provision between research participants and routine patients are 
negotiated in the SDH general paediatric ward, where sick MVT participants are cared for by 
researchers. Whilst researchers and their MOH counterparts are in principle committed to 
the integration of research in places where general routine care is being provided, 
boundaries between scientific practice and general care are drawn in order to facilitate 
practice. 
Conclusion 
The objective of this thesis is to study the understandings and practices of CE and the 
relationship between collaborative partnerships and ethics. The foci of my ethnographic 
enquiry are two paediatric vaccine trials being conducted by KEMRI/CDC in a rural area in 
Western Kenya. KEMRI/CDC is an international research collaboration which conducts public 
health research in impoverished communities with high levels of disease burden. The two 
paediatric vaccine trials represent significant promise in terms of medical advance and the 
reduction of infant mortality rates across Africa. The conduct of such clinical trials in 
resource-limited setting also gives rise to ethical challenges such as the voluntariness of trial 
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participation, informed consent, relative standards of care-giving, the social value of 
research and related distribution of benefits. 
CE has been proposed as a means of addressing such ethical concerns. Hence increasingly 
attention is being paid to establishing ways of working with communities and their 
representatives in the implementation of bio-medical research. This interaction may also 
help promote a better understanding of contextual realities, and facilitate partnership 
between researchers and communities who are characterised by diverse experiences and 
worldviews. CE is therefore influenced by notions of relational ethics rather than the 
adherence to regulations and bio-ethical constructs, such as Beauchamp and Childress's four 
'Principles of Biomedical Ethics' (2009): respect for autonomy; informed consent; non- 
maleficence/beneficence; and justice. At the same time social justice is presented as a core 
feature of CE by Emanuel et al. who present it as a way of minimising the risks of 
exploitation when trials take place in developing countries (Emanuel et al., 2004). In this 
thesis I critically analyse the basis of this argument by observing, discussing and 
documenting how the 'community' was engaged by KEMRI/CDC between 2007 and 2009 in 
the implementation of paediatric RVT and MVT. 
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Chapter 2: 
The History of Immunization & Vaccine Research in Sub- 
Saharan Africa 
'One tool we don't have yet today and that will be important in the future fight 
(against malaria) is a vaccine. A fully-effective vaccine is a wonderful thing, It's the 
simplest, most cost-effective way to save lives. The smallpox vaccine ... led to the eradication 
of smallpox. The polio vaccine has gotten us quite close to the threshold of eradicating 
polio. Vaccines have slashed the number of deaths caused by diphtheria, measles, tetanus, 
and a host of other diseases. But developing a malaria vaccine has been a long and 
frustrating process. There have been certainly more failures than success, because this is a 
parasitic disease and the scientific complexity is significant. 
Today however we are closer than ever before to tackling that complexity. ' 
Bill Gates, 1&h October 2011 Malaria Forum Address 
Introduction 
This chapter outlines the history of immunization and related research in Sub-Saharan Africa 
(SSA) with a particular focus on East Africa. I also refer to core milestones in immunization in 
other parts of the world as these intersect with the trajectory of immunisation practices in 
SSA. The primary aim of this historical narrative is to facilitate a grounded understanding of 
concerns which came to light in my field work and are reported in the findings chapters. 
A paper on the advance of medical research in West Africa provides a historical framework 
of four periods namely: 'The pre-European period'; 'The colonial period'; 'The era of primary 
health care'; and 'The era of DNA' (Greenwood, 1998). The pre-European period includes 
early contact with European explorers and missionaries, referred to by Greenwood (1998) 
as the age of explorers, with the shift from this time to the colonial period occurring 
towards the end of the 19th century. Greenwood (1998) appears to use the term 'period' to 
denote more defined historic time spans that are set according to political events, whereas 
'era' is applied to describe time frames which are influenced either by new thinking about 
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health services provision or technical developments. Drawing a specific timeline or 
boundary between the latter eras, 'The era of Primary Health Care (PHC)' and 'The era of 
DNA', is difficult, as one has not replaced the other. 
In this chapter I use this framework lightly to trace developments in vaccine-related disease 
prevention from early variolation practices to colonial vaccination programmes, scaling up 
to the internationally organized and state controlled smallpox eradication campaign. The 
success of this campaign provided the impetus for the launch of the World Health 
Organization (WHO) Expanded Program of Immunization (EPI) in 1974. I have divided this 
chapter into two main sections with relevant sub-divisions. The first section concerns the 
milestones in immunization from the early 17`h century to the development and 
implementation of the WHO EPI, and the second section considers current developments in 
immunization as we move into the era of DNA. 
Milestones in Immunization 
Milestones in immunization (Text Box 1) are inextricably linked to human endeavours to 
prevent and cure smallpox. Earliest attempts included the practice of 'variolation' (from 
variola, a synonym for smallpox) which seeks to seeks to prevent smallpox by exposing 
healthy people to matter from the lesions caused by the disease, either by putting it under 
the skin, or by inserting powdered scabs from smallpox pustules into the nose. Variations of 
this practice have been observed across different cultures with earliest reports originating 
from China. 
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Text Box 1: Milestones in Immunization 
429 BC: Thucydides notices smallpox survivors did not get re-infected 
900 AD: Chinese practise variolation 
1700s: Variolation reaches Turkey and rest of Europe 
1796: Edward Jenner: from variolation to vaccination 
1803: Royal Jennerian Institute founded in London, UK 
1870s: Violent opposition to vaccination in UK 
1880s: Louis Pasteur - sheep trials and rabies 
1890: Emil von Behring discovers basis of diphtheria and tetanus vaccines 
1920s: Diphtheria, tetanus, pertussis (whooping cough) and BCG (against 
tuberculosis) vaccines available 
1955: Polio immunization programme begins in UK 
1956: WHO launch global drive to eradicate smallpox 
1980: Smallpox eradicated 
Reference: http: //www. immunisation. nhs. uk/About_Immunisation/History/TimeIine 
Variolation in Africa during the pre-European Period 
Herbert's (1975) survey of smallpox inoculation in Africa provides evidence that variolation 
was practised in scattered parts of Africa during the pre-European period. Geographically it 
was most extensively used in Western and Central Sudan, Ethiopia and Southern Africa. The 
survey draws on secondary sources, dated from the 18th century onwards, and describes a 
variation in techniques both in terms of the material used and the variolation site. A table 
(pp. 554-5) indicates that pus rather than scabs was the main choice of material and the arm 
the preferred site; other sites commonly referred to are the forehead, the space between 
the thumbs and fingers, legs, and the dorsal hand (Herbert, 1975). Sources cited also 
describe mixing the inoculating material with medicines, herbs and clay, honey or butter, 
animal deposit, or milky juice of a tree. According to the survey variolation was mainly used 
in response to outbreaks, epidemics or reports of disease in nearby areas. 
The cultural and ritual significance of variolation in African contexts is discussed by the 
social historian Luise White (1997), who suggests that variolation was not only used for 
smallpox prevention but also applied to diseases and misfortunes that were not epidemic. 
She states that 'women and men were routinely variolated for everything from wealth and 
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fertility to protection from lion bites' (White, 1997) (p. 12). Thus a technique used to acquire 
immunity against smallpox is reinterpreted both as a means of warding off danger and 
obtaining status. Conceptually this suggests that people associated variolation with certain 
magical or spiritual qualities, as implied in Malian elders' descriptions of smallpox 
variolation scars as charms (Imperato, 1968) (p. 869). Indeed in Ethiopia hundreds of 
people were variolated during religious ceremonies which continued until the Ethiopian 
Emperor banned the practice in favour of vaccination in 1905. 
Despite such bans, variolation was sustained, both amongst those who actively sought 
vaccination and those who resisted immunization. Variolation continued to be popular 
during epidemics and at the time of the WHO eradication campaign in the 1960s. There is 
evidence across the continent that variolation continued into the 20th century. Imperato 
(1968) for example provides a detailed account of the practice amongst the Songhai of Mali 
in 1967. He reports how people who had not been previously variolated or vaccinated were 
voluntarily inoculated with the use of a thorn or a bird plume. In both instances pus from a 
light case of smallpox was rubbed into superficial skin incisions. Whilst the attack rates 
reported did not indicate any advantage to variolation, Imperato (1968) reports no 
disadvantages either. He differentiates between superficial variolation techniques and those 
that caused more skin trauma (Imperato, 1968). The latter have been associated with 
causing severe smallpox disease rather than inferring immunity. This risk is referred to in 
reports of resistance to variolation in Kenya (Leakey, 1977), and is also the main reason why 
variolation was outlawed in England and Wales in 1840, at a time when Jennerian 
vaccination was gaining prominence (Stewart and Devlin, 2006). 
The Birth of Vaccination 
The birth of vaccination is attributed to Edward Jenner (1749-1823), a family doctor, who 
became famous in 1798 when he published all of his research into smallpox (Jenner, 1798). 
In experiments Jenner tested the old folklore that 'people who catch cow pox don't get 
smallpox'. Cow pox is a mild viral infection which causes weeping spots on cows' udders. 
Milk maids were exposed to this in their daily work. When a local dairy maid came to Jenner 
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with weeping spots on her hand, Jenner seized the opportunity to conduct his first 
experiment. He took James Phipps, his gardener's eight year old son, and made some 
scratches on his arms. Then he rubbed some of the material from one of the pocks on the 
milk maid's hand into these wounds. A few days later James became mildly ill with cowpox 
but was well again a week later. This demonstrated that cowpox could be transmitted from 
person to person as well as from cow to person. To test whether the cowpox exposure 
would protect the boy from smallpox Jenner variolated James. James did not develop 
smallpox on this occasion or on the many subsequent ones when his immunity was tested. 
Jenner's technique of introducing material under the skin to produce prevention against 
disease has become known as vaccination. Whilst this technique bears some similarities 
with variolation there is a critical difference. In variolation matter that could cause disease 
in recipients is introduced, whereas in vaccination the material that is in inserted will not 
cause the disease that the procedure seeks to prevent. Jenner used live cowpox to vaccinate 
against smallpox since it was a similar virus. Today a wide range of vaccines are used to 
prevent viral and bacterial diseases-attenuated live vaccines, inactivated vaccines and 
genetically engineered vaccines-and all such vaccines undergoing significant safety testing 
before they are administered to the general public. 
Jenner's findings were translated into the main European languages of the time, and he 
travelled widely to demonstrate his technique and distribute cowpox serum. Whilst he 
awakened the interest of fellow scientists, some of whom confirmed his findings in their 
own experiments (Blake, 1957, Dixon, 1962), he also encountered a lot of opposition 
particularly in his home country (Stewart and Devlin, 2006). 
43 
Figure 1: The COW POCK or the Wondeiful Effects of the New Inoculation! 
The Publications of ye Anti-Vaccine Society. Illustrated by James Gillray 
(colour engraving) published June 12,1802 by H. Humphrey, St. James's Street. 
Compulsory vaccination in England was not introduced until 1853 at a time when liberal 
sentiments in support of freedom of choice were growing, and there was a lot of opposition 
to the Vaccination Acts both amongst the middle and working classes. For many the 
vaccination question became symbolic of uncompromising governmental intervention in the 
daily lives of individuals (Fenner et al., 1988a). 
Vaccination in African during the Colonial Period 
Luise White's (1995) descriptions of colonial vaccination programmes in Africa also raise 
concerns about the incursion of outside authorities into people's lives. She writes '... that 
distrust about vaccination had more to do with who was vaccinated by whom and whose 
body was being marked for what ends'. The first smallpox vaccines were brought to Africa 
by missionaries whose good intentions were often applied zealously. The diaries of one 
missionary (Cook, 1945) describe a scenario that ensued at the time of a smallpox epidemic 
in Uganda in 1899. Two African boys were vaccinated with all that was left of vaccines 
brought from England and did not return to the clinic as instructed. So another young boy 
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with 'an obvious vaccination' mark was spotted at the market and dragged back to the 
clinic, where drops of lymph were extracted from him and used to vaccinate 6 others who 
were kept in observation. Eventually, by recursion to the arm to arm method, 800 people 
were vaccinated, in a manner resembling variolation with which local people may have been 
familiar. Cook, the missionary in question, never established how the young boy in the 
market came to have a vaccination mark in the first place. Instead he recounted how keen 
the population was to be vaccinated, so eager 'that they almost stormed the dispensary to 
get it' (Cook, 1945). 
White's (1995,1997) analyses of the literature suggest that African responses to missionary 
and colonial vaccination were varied and polarised. Some accounts capture the enthusiasm 
related by Cook (1945), while others portray deep-seated distrust or even violent resistance. 
In 1929, for example, a European sanitation officer lost his hand in a struggle during plague 
vaccination campaigns in Uganda. Rumours were widespread, and repeatedly challenged 
the 'intentions' of immunization. Speculations that vaccines were designed to poison the 
population were rife; with one report cited African fears that Europeans had developed a 
vaccination that could cause 'bottled babies' or render women infertile (District Officials, 
1939). Vaccination efforts were further undermined by reports of defective vaccines being 
responsible for the Kenyan smallpox epidemic in 1916 (Dawson, 1992), and the deaths of 
African soldiers stationed in the Belgian Congo in 1944 (Fetter, 1969). With this in mind it is 
not surprising to read about villagers who would flee from vaccinators (Patterson, 1981), 
and mothers from Nyasaland (present-day Malawi) who, even well into the 1950s, would 
hide their children to avoid vaccination (Vaughn, 1994). 
Those targeted for immunisation were understandably suspicious of the process and the 
product. Colonial vaccination campaigns allowed for medical invasion into private lives and 
spaces (White, 1997), and employed methods such as hut burning, segregation and 
curtailment previously associated with forced labour and taxation (Vaughn, 1994). These 
kinds of campaigns that focused on vaccinating as many people as possible resulted in 
immunization being understood as a political tool of control and did little to promote the 
medical purpose of vaccination. Indeed, White (1997) argues that the power of the needle 
and dubious meanings attributed to vaccines meant that immunization hardly ever 
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impacted on African concepts of disease, contagion or prevention. This is not to say that 
Africans did not understand the theories of Western preventative medicine; rather these 
theories did not address their beliefs about the causation of disease, as illustrated in the 
following quote (Wilson, 1951 p. 313): 'It may be quite true that typhus is carried by lice, but 
who sent the infected lice and why did they bite one man and not another? Ultimately the 
origins of disease were either ascribed to the will of a higher deity, or thought to be caused 
by divine punishment or personal malevolence. So whilst colonial authorities measured the 
success of smallpox campaigns in terms of numbers vaccinated, those vaccinated 
questioned how this could prevent disease caused by malevolence spite and anger (White, 
1997). 
During the colonial period vaccination was not routine in SSA, and inoculation campaigns 
were usually organised in response to an outbreak of smallpox or ad hoc when other 
vaccines became available. In 1951, for example, health officials in Nairobi vaccinated 
43,000 people against typhoid and paratyphoid even though these diseases were rare in 
that city. The majority of the recipients did not associate the vaccine with protection against 
typhoid; instead they were seeking relief from a broad range of symptoms or expecting the 
vaccine to meet other needs such as safe travel. White (1997) suggests that people ascribed 
their own meanings to receiving the vaccine according to their personal needs; hence the 
actual medical use became immaterial for them. 
A larger range of vaccines became available from the 1940s onwards according to staff3 at 
the Kenyan Extended Programme of Immunisation (KEPI) offices in Nairobi. Their 
administration was prioritised in a way typical of the colonial medical system of the time, 
with vaccines being given to colonialists and their children first, then to their staff, and 
finally to Kenyan school children. Vaccines were also generally only available in major 
centres such as Nairobi or at Mission Hospitals. Around this time Kenya started to produce 
its own liquid smallpox vaccine at the Medical Research Laboratory in Nairobi. This meant 
that East African countries no longer solely relied on imports from the Lister Institute in 
England. Smallpox vaccines produced in England and Kenya shared a core limitation; they 
became sub-potent when exposed to ambient temperatures. Inadequate transportation and 
3I visited the KEPI offices on 30th October 2008 and talked to the Deputy Head and the Director. The latter had 
been involved in KEPI since 1980 and immunised children before that as a Medical Doctor. 
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storage facilities therefore raised questions about the effectiveness of the smallpox 
vaccination campaigns. 
In the mid-1950s the World Health Organisation (WHO) began to develop a smallpox 
eradication campaign that changed the way in which immunization was organised. The 
campaign was initiated in the 1960s at a time when African nation states were in the throes 
of gaining independence and dealing with dwindling resources. Many nation states had 
become increasingly dependent on international support in the provision and prioritisation 
of medical care. Thus they found it difficult to refuse whatever medical programmes or 
vaccination campaigns donors requested. White (1997) describes the rise of sovereign 
agencies such as WHO and US Centers for Disease Control (CDC), and claims that these 
agencies prioritised global humanitarian concerns at the expense of local sovereignty and 
local humanitarian concerns. Her claims are valid to the extent that, amongst the many 
health problems faced by SSA countries in the early 1960s, smallpox was not a high priority. 
National involvement was also limited with the organisation of regional smallpox 
eradication campaigns being overseen by technical advisors contracted by WHO. Concerns 
with process have to be weighed however against the results of the campaign: the 
eradication of small pox in 1980. 
Vaccination in the Era of Primary Health Care 
The East African smallpox eradication campaign in the late 1960s was an enormous 
encouragement to the global eradication programme. The productivity of staff led to the 
rapid and successful completion of the task at little cost and minimal effort (Fenner et al., 
1988b). This example contributed to a realization that immunization could be delivered 
effectively through country-wide networks which could make it possible to protect all 
children against vaccine-preventable diseases. Hence in the spirit of the era of primary 
health care WHO launched its Expanded Programme of Immunization (EPI) in 1974. 
EPI provides countries with guidance and support to improve vaccine delivery and to help 
make vaccines available for all children. The original EPI vaccines were the Bacille Camille 
Guerette vaccine against Tuberculosis, the diphtheria-tetanus-pertussis vaccine and oral 
polio and measles vaccines. This standardized immunization schedule was introduced in 
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1984 based on immunological data. In a span of 30 years EPI achieved a substantial increase 
in childhood immunization rates from 5% to 80%. However in 2003 it was estimated that, 
worldwide, 27 million children still remain unimmunized (WHO and UNICEF, 2005). Today 
EPI has a decentralized management structure with national programmes responsible for 
improving access to traditional EPI antigens and introducing new vaccines. 
EPI in Kenya was formalised in 1980 when it was launched by the then Ministry of Health 
(MOH) as an official strategy based within the Division of Family Health. Despite 
government endorsement this 2-3 man operation, referred to as KEPI (Kenyan Expanded 
Programme of Immunization), relied heavily on funding from donors, UNICEF, SIDA and 
DANIDA. In 1984 an agreement was drawn up between DANIDA and the Government of 
Kenya (GOK) stated that DANIDA would run the programme and gradually hand back 
responsibility to the GOK within a specific timeframe. Under DANIDA management KEPI had 
three goals: capacity building, increasing the range of facilities, and consolidation. In the first 
instance health workers were trained and capacity built up across the country to allow the 
programme to extend beyond Nairobi to the other Provinces. This investment led to good 
vaccination coverage rates across the country. Setbacks occurred however in the 1990s 
when the GOK, under President Moi, began to renege on its obligations linked to the 
phasing out of DANIDA funding. DANIDA finally withdrew all support early in 2000 and KEPI 
was left with no stocks and no plan. The GOK was forced to take action and it injected 40 
million Ksh (approximately US $6 million at that time) into the programme. This cash 
enabled KEPI to continue vaccinating against polio and tuberculosis but they required the 
support of other donors for the provision of other antigens. It also had to negotiate with the 
Department of Health to meet running costs such as the provision of gas to maintain the 
cold chain. Parents were even asked to bring their own syringes and needles if they wanted 
their children to be immunized. 
In 2001 the Global Alliance Vaccine Initiative (GAVI) supported the introduction of a new 
pentavalent vaccine that provided protection against two additional diseases, Haemophilus 
Influenzae type b and Hepatitis B. Initial excitement waned when health facility staff 
realized that the auto-disposable syringes provided were reserved for the administration of 
the new vaccine. This led to more confusion amongst parents; why were there syringes for 
some vaccines and not for others? It finally reached a point when health workers said that 
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this amounted to discrimination, and started to use the auto-disposable syringes for 
everything and anybody. GAVI was informed and as a result agreed to provide a3 year grant 
for all vaccines and equipment. This grant came to an end in 2004 when the new 
government headed by President Kibaki introduced the first expanded budget on 
immunization. 
Today KEPI has a larger staff body and works closely with the Ministry of Public Health and 
Sanitation to implement their programme across the country. It has witnessed a lot of 
achievements most remarkably the control of measles, over the past 20 years. In the 1980s 
there were measles wards in hospitals; today deaths due to measles are rare and the 
incidence of sequelae, such as blindness, has decreased dramatically. Diphtheria is also very 
rare although Kenya has not yet been certified as diphtheria free. Random cases of tetanus 
still occur and pertussis is seen sporadically. Tuberculosis remains a major challenge and 
KEPI also plans to target additional childhood diseases in the near future. 'The race for 
improved vaccines in battle against pneumonia is on' writes Mwangi (2010 ) in a Daily 
Nation news article published on 5th December 2010. Eleven years after the pneumococcal 
conjugate vaccine (PCV-10) was licensed and made widely available in North America, 
Europe and South Africa, the Ministry of Public Health acted to introduce the vaccine across 
Kenya from January 2011. This initiative was sponsored by GAVI and the Advanced Market 
Commitment (AMC) Funds which have pledged to lower the cost of PCV-10 from KSh 4000 
(US $ 53) to KSh 12 (US $ 0.16) based on the success of roll out studies conducted by the 
KEMRI-Wellcome Trust in Kilifi and Thika districts (Kamadi, 2010). 
This story of the KEPI demonstrates how national immunization programmes in resource- 
limited settings continue to rely heavily on external support. The main decisions about the 
priorities of the programme are still taken at an international level. This is not to say that 
the prevention of childhood disease is not a national priority; rather, it shows how access to 
new vaccines and changes to national policy depend heavily on support from international 
sponsors, philanthropists and global alliances. 
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Current Developments in Immunization: Moving into the Era of DNA 
Although I have situated the launch of the EPI within the era of primary health care, 
developments in vaccine technology have moved this programme into the era of DNA. 
Currently the era of DNA is most prominent in vaccine research and new candidate vaccines 
are being tested in phase 1-4 trials across SSA. This testing and the subsequent inclusion of 
proven vaccines into national immunization programmes will result in wider public debate 
about the risks and potential benefits of new generations of vaccines. Public debate can 
take on many mantles from rumours, press coverage of different perspectives, conferences 
and advocacy group meetings, to forums which promote dialogue between health 
professionals and lay persons. 
In the 20th century unforeseen severe side effects have resulted in the withdrawal of certain 
vaccines and led to vaccination scares. A notable example occurred when a whole cell 
pertussis vaccine used in the UK in the 1970s resulted in an increase in febrile convulsions 
post- immunization. More recently RotashieldTM, a live attenuated rotavirus vaccine 
approved by the FDA in 1998, was removed from the market little more than a year later. 
Post-licensure surveillance reported an increase in intussusception of the bowel following 
vaccination with RotashieldTM. Others scares could be more accurately described as anti- 
vaccination rumours, since their supporting arguments and related evidence have not been 
accepted by the scientific community. In Western Europe, a prime example is widespread 
speculation about the association of the MMR vaccine with autism and inflammatory bowel 
disease (Dyer, 2010, Greenhalgh, 2010) 
In SSA different rumours have been successful in capturing the imagination of the populace 
and the media. For example claims that polio vaccine is laced with HIV virus, or may have 
introduced HIV to Africa (Hooper, 1999), and fears that some immunizations are used to 
control fertility are common across the sub-continent and have led to resistance against 
vaccination (UNICEF, 2001, Feldman-Savelsberg et al., 2000, Milstien et al., 1995, Pascal, 
1991, Jegede, 2007). Such scares and controversies are often the result of 
misunderstandings or mistrust in scientists' motivations, state information and official 
reasons for seeking to control public health. This has led authorities to stress the need for 
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both improved social mobilization built on stronger community relationships and better 
information strategies with consistent and clear messages (UNICEF, 2001) (pp 65-67). 
Laudable in principle and practice, these recommendations may go some way towards 
reducing vaccine anxieties in SSA. However controversies like Hooper's (1999) Origin of AIDS 
Theory are not easy to dispute or debunk by forensic epidemiological argument alone. A 
social scientist quoted in a news article about a Royal Society meeting on the origin of the 
AIDS virus correctly surmised that controversial theories will continue to capture the 
imagination of people (Cohen, 2000). This was my experience in a conversation with two 
professional women from Kenya and Ghana, who are both actively involved in aid and 
development in their countries. They expressed a lot of suspicion about scientists' role in 
the origin of HIV and surreptitious testing of drugs which they believe continues to happen 
today despite improved national ethics review capacity. 
Vaccination Discourse 
Official communication about vaccination in SSA tends to rely on the packaging and delivery 
of pre-defined messages to the populace. Messages are disseminated in the form of posters, 
leaflets, media clips or by healthcare workers. Little attention has been paid to the 
importance of developing a vaccine discourse that builds on local understandings, is 
informed by contextual factors and promotes dialogue. 
In the absence of meaningful dialogue it is not surprising that anti-vaccination rumours have 
abounded in SSA and, in one incidence resulted in a regional boycott of a Polio vaccination 
campaign (Jegede, 2007). In post-colonial SSA core arguments against vaccination have been 
of a religious or political nature with rumours mainly occurring in response to 
internationally-sponsored eradication campaigns involving oral polio and injectable tetanus 
vaccines (UNICEF, 2001). In Tanzania, Cameroon, Uganda, Kenya and Nigeria rumours have 
claimed that these vaccines contain anti-fertility drugs that would sterilize women and 
children, with East Africans also voicing fears that oral polio vaccines used in campaigns 
were laced with HIV (UNICEF, 2001, Feldman-Savelsberg et al., 2000, Jegede, 2007, Milstien 
et al., 1995). These rumours suggest that vaccination campaigns are interpreted as 
governmental or 'Western' plots to subdue certain population groups (Jegede, 2007, 
51 
Feldman-Savelsberg et al., 2000, UNICEF, 2001). Indeed the 2003-2004 polio vaccine boycott 
in the predominantly Muslim northern Nigerian states was resolved in part when Muslim 
leaders demanded that an Indonesian company become the new supplier for polio vaccine 
(Jegede, 2007). In the political climate of post 9/11 Nigeria's Muslim leaders were only 
willing to entrust fellow Muslims with the testing and production of what had become a 
controversial vaccine. 
Considering the history of anti-vaccination rumours in West Africa Leach and Fairhead 
(2005) suggest that they take root where: a) top-down, coercive campaign-type approaches 
are used; b) where technological and management practices intersect with cultural 
conceptions that make anxieties 'make sense' (i. e. targeting certain population groups, like 
young girls); c) where the motivations of vaccine-providing institutions are interpreted 
within the context of local, national of international political tensions; and d) where 
rumours are spread by influential individuals or media networks. Rumours are therefore not 
simply illegitimate misconceptions that can be overcome by providing 'accurate' 
information (Leach and Fairhead, 2005). Instead they are complex expressions of people's 
understandings or misunderstandings of events within a particular time and context; a 
'collective consciousness' which is informed by past experience and collective memory 
(Geissler et al., 2008). A tetanus vaccination campaign that took place in Cameroon in 1990 
illustrates how collective memories of French colonial medical efforts to wipe out sleeping 
sickness and smallpox were highly influential. The colonial military-run medical services had 
targeted these diseases through mass forced vaccinations and treatment regimes (Feldman- 
Savelsberg et al., 2000). Memories of these events and associated collective consciousness 
are thought to have contributed to the terror witnessed in response to the 1990 
internationally supported and state run tetanus campaign (Feldman-Savelsberg et al., 2000). 
Rumours can be viewed as a form of individual and collective information-seeking when a 
formal information gap exists, either due to incomplete information or mistrust of the 
information sources (Rosnow and Fine, 1976). Miscommunication does not however explain 
the origin, content or ramifications of rumours, since the roots of these are found in 
'contextual features' such as social structure and political climate. Typically rumours emerge 
in an atmosphere of general anxiety, credulity and ambiguity (Rosnow, 1988), or when 
people are seeking to explain relationships between groups having unequal political, 
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economic or social power (Turner, 1993). The latter in particular is true of blood-stealing 
rumours that have been documented across SSA, which in the past have been associated 
with colonial healthcare or more recently with internationally sponsored medical research 
(Geissler and Pool, 2006a, White, 2000). 
Vaccination rumours can be interpreted as a particular local engagement with global and 
national projects. As such they must be taken seriously and responded to in a way that 
addresses underlying political and cultural dynamics which are often the root causes. 
Appropriate responses should aim to mitigate any negative consequences, and equally 
importantly create open forums in which dialogue can take place. In chapters 5 and 10 
return to the topic of rumour, and explore in detail the nature, genesis and implications of 
rumours which circulated during the course of my fieldwork. 
The Social Shaping of Immunization 
According to Streefland et al (1999) responses to immunization and vaccination demand are 
thought to be shaped by 'local vaccination cultures', defined as 'prevailing beliefs about 
disease aetiology, ideas about the potency and efficacy of modern medicine, and views 
about the need for preventive health measures within a specific socio-cultural context' 
(p. 1706). These are shared notions which emerge when community members exchange 
accounts of their vaccination experiences and their interactions with healthcare providers. 
Vaccination encounters themselves are also influenced by contextual factors such as the 
physical location (dispensary, health centre or hospital) and organizational structure of a 
specific immunization programme. Streefland (1999) distinguishes between routine 
vaccination and campaign vaccination, describing the former as familiar in terms of location, 
timing, personnel, language and technology and the latter as unfamiliar in all those 
elements. He suggests that campaign conditions make people reflect on basic questions 
regarding vaccination and that the introduction of a new vaccine in routine conditions can 
alter normal responses to immunization. 
In Kenya today, most immunizations are integrated into the regular healthcare services. 
Routine KEPI vaccines are administered at dispensaries, health centres and hospitals 
by 
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nurses, clinical officers and doctors, who also attend to other healthcare needs. In contrast 
KEPI campaigns, usually part of international eradication programmes, are held as separate 
events and referred to as National Immunization Days. Kenya's experience of these 
programmes, particularly the Polio campaigns in 1996 which were a source of great 
controversy, confirms Streefland's view that campaign conditions raise difficult questions 
about the purpose and intention of vaccination (UNICEF, 2001). 
In relation to social demand for vaccination recent research from the Gambia suggests that 
this is not typically based on general trust in biomedicine or disease-specific knowledge. 
Instead mothers have a 'culturally-grounded active demand' (Leach and Fairhead, 2005). 
This demand is based on a set of concepts of infant health and vaccine actions in: a) 
preventing disease in general; b) 'chasing out' illness from a child's body; c) attenuating 
disease effects; and d) promoting strength and weight. Nichter (1995) describes similar 
cultural understandings of vaccinations where demand is either triggered by a perception 
that all vaccinations are good for infants' growth or health or by a marked sense of 
vulnerability to serious illness that may or may not be protected against with the vaccine 
sought. In the Gambia vaccination is also understood as complementing everyday and 
traditional practices performed to protect health (Leach and Fairhead, 2005). The mother 
attends to the child's basic daily needs, comports herself in a moral manner and believes 
that immunization, traditional medicines and 'talismen' can work together to promote her 
child's health. 
These findings illustrate the importance of developing an approach to vaccination education 
and service provision that builds on local conceptual frameworks rather than delivering 'top- 
down' messages that rely on political leverage and prodding of health staff to secure 
compliance (Leach and Fairhead, 2005, Nichter, 1995). 
Vaccine Research: A Growing Agenda 
Over the past two decades an increasing amount of vaccine research has taken place in SSA 
and this is likely to increase as we move more firmly into the era of DNA. Much of this 
research takes place in large research centres that have been developed as a result of 
collaborations between national and international research institutes. These research 
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centres, equipped with state-of-the-art technology and comfortable working environments, 
are often situated in impoverished regions. This juxtaposition that focuses attention on the 
global economic inequalities against the backdrop against which transnational research 
throughout most of Africa is now being conducted (Fairhead et al., 2006b). These 
inequalities are interpreted in the transactional logic that those who are targeted for 
participation apply when deciding for or against participation. Fairhead, Leach and Small 
(2006a) describe how a decision to take part in a trial run by the Medical Research Council 
(MRC) in the Gambia, can involve balancing the benefit of free medical care against the 
perceived danger of one's child being drained of blood for sale to Europe. In the context of 
medical research blood-stealing rumours have been interpreted in contrasting manners. 
Biomedical scientists usually understand them as misconceptions that can be dispelled by 
demystification of science and visits to laboratories. Historians and anthropologists on the 
other hand have interpreted them as an indigenous idiom of resistance to colonial 
oppression or millennial capitalism (Fairhead et al., 2006b p. 3). Research findings from the 
Gambia suggest a more pragmatic interpretation in which blood is seen to be central to the 
political economy of the global medical and medical research industry and viewed by 
research participants as a commodity that can be used for reasonable transactions (Fairhead 
et al., 2006b). Rather than simply focusing on the demystification of science, Fairhead et al 
(2006b p. 14) argue that medical researchers need to acknowledge such thinking and related 
socio-economic relationships in their encounters with community members. 
Willingness to participate in trials, including vaccine trials, is shaped by the historical legacy 
of research institutions undertaking such research. Fairhead et al, (2006a p. 104), for 
example, found that knowledge of the aims of a particular study was less significant to 
people's decisions about participation than their longer term experiences of the MRC as an 
institution. Of interest here too is the fact that the MRC was also often mistaken for a 
healthcare provider raising a further question about whether vaccine research is perceived 
as 'routine' rather than 'campaign', i. e. out of the ordinary. 
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Conclusion 
The profile of immunization and vaccine research is set to grow in SSA over the coming 
decades particularly with new developments in the search for a malaria vaccine, HIV vaccine 
and improved Tuberculosis vaccines. DNA technology has also opened the way to the 
development of new generations of vaccines, indicating that the era of DNA could be one of 
promise and will involve challenges for SSA. This review of the history of immunisation and 
vaccine research in SSA and elsewhere suggests that the intentions and motivations of 
scientists, governments and health policymakers will be questioned. The provision of 
accurate information alone will not suffice to address suspicions; instead more attention will 
need to be paid to understanding the 'collective consciousness' which shapes public opinion 
in regard to immunisation and vaccine research. 
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Chapter 3: Research Design, Fieldwork and Analysis 
'The only way to make sense out of a phenomenon and its context is to plunge into it, 
move with it, and join the dance. ' 
Adaptation of a quote by Alan Watts (2011 p. 177) 
Introduction 
The purpose of this chapter is to describe my research design and provide a detailed 
account of my fieldwork. In the first section I state the purpose of my research and give 
reasons for my choice of Ethnography as a study methodology. I outline the main features 
of an ethnographic approach paying particular attention to the practice of participant 
observation. The way in which an ethnographer enters into and operates within the 'field' is 
of primary importance in this type of research. Accordingly, I then provide an appropriately 
detailed account of my fieldwork, with reference to how I got in, stayed in and pulled away 
from the place which was the focus of my ethnography. 
My ethnographic fieldwork took place in a rural area in Western Kenya, where KEMRI/CDC 
was implementing paediatric vaccine research. In chapter 1I introduce the KEMRI/CDC 
research programme and described the geographic and socio-economic context in which 
the RVT and a malaria vaccine trial (MVT) took place. Hence in this chapter I concentrate 
on the way in which I studied these trials, how I collected data, who I worked with and how I 
analysed the data. Overall I spent two and a half years in the 'field' which, for me, 
represented the KEMRI/CDC research programme in Western Kenya. 
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Research Design 
The conceptual and theoretical framework outlined in chapter 1, a scoping visit to the 
KEMRI/CDC research programme in February 2007, and ongoing discussions with 
supervisors, academic peers and co-investigators at KEMRI/CDC informed the development 
of my research design. The premise on which this thesis is built is that the KEMRI/CDC 
research programme and the communities in which the vaccine trials are taking place 
constitute a set of informal and formal social relations, a 'trial community' (Geissler, 2011). 
These relations are my lens to understanding the practice of CE in this setting. From the 
spectrum of trial community relations I focus on those between researchers and the 
following groups: community leaders who act as gatekeepers and collaborators; community 
representatives who act as intermediaries between researchers and community members; 
trial participants and their families; and community members. I explore the practice of CE 
from as many different angles as possible in order to understand the work that CE is meant 
to do, and the work that it actually does, critically interrogating the assumptions and 
meanings behind this mode of intervention as well as its power and social effects. 
To observe and record the relevant interactions and relate them to ethical debates I chose 
to conduct ethnographic fieldwork. In bio-ethics there is a growing awareness of the value 
of ethnography to elucidate the moral dilemmas encountered in the social worlds in which 
bio-medical technologies are conceived, tested and applied (Marshall and Koenig, 2001). 
Sociologists, anthropologists and philosophers concur that ethnography can represent a 
valid conduit for understanding the lived moral experiences of social actors, who can be 
both subjects and objects of ethical deliberation (Parker, 2007, Kleinman, 1999, DeVries, 
1995). 
Broadly speaking this piece of research asks two interlinked questions: how does CE work in 
practice, and in what ways does CE support ethical practice vaccine research in resource- 
limited settings? My literature review suggests that the normative 'ought' of CE is 
established. What is less clear is what CE means in practice and whether CE and related 
collaborative partnerships can be framed as a principle of ethical practice. How do 
engagements between researchers and community representatives, community members 
58 
and trial participants support decision-making about the conduct of vaccine trials, facilitate 
deliberation on fundamental concerns and help to identify ways of addressing or 
negotiating emerging challenges? Accordingly I started this piece of ethnographic research 
with the following research questions and study objectives. 
Research Questions 
How does the KEMRI/CDC Kisumu field station engage with the 'community' when 
preparing for and implementing multi-site vaccine trials in resource poor settings, and in 
what ways do these community engagement activities support 'ethical practice' in vaccine 
research? 
Study Objectives 
1. To review the way community engagement is planned and practised over the course 
of vaccine trial preparations and implementation. 
2. To explore community representatives' and staff members' understanding and use 
of the concepts 'community', 'community engagement' and 'ethical practice' in 
vaccine research. 
3. To observe vaccine trial related community engagement activities and document 
community concerns that are raised during these events. 
4. To describe the way that community concerns and ethical challenges emerge during 
community engagement events and how they are negotiated and addressed. 
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Methodology 
To frame my ethnographic work I draw on Kleinman's (1999 p. 5) definition of ethnography 
which conveys critical points about presence, distance and the tensions of balancing insider 
('emic') and outsider ('etic') obligations and perspectives. This definition captures some of 
my experiences which I recount in the fieldwork section of this chapter. 
'Ethnography is a method of knowledge production by which the ethnographer enters into 
the ordinary, everyday space of moral processes. The ethnographer, no matter how 
successful she is in participant observation, either is or becomes an outsider - even if she 
begins as an indigenous member of the community she studies. She feels the tug of local 
obligations and the push of local practices, but for all that she is never so completely 
absorbed by what is most at stake for community members that their world of experience 
is entirely hers'. 
Participant observation, also referred to as presence, is the hallmark of ethnographic 
fieldwork. It implies that the researcher joins the group (in my case the KEMRI/CDC 
collaboration) which is to be studied, participates in its activities, and spends extended 
periods of time in this place. This raises some questions about the balance of involvement in 
the phenomena being studied. Bernard (2011p. 260-261) distinguishes between 2 different 
types of participant observers; the 'participating observer', and the 'observer participant'. 
Participating observers immerse themselves in the study setting but are not actively 
involved in all activities. Observing participants on the other hand may assume certain 
responsibilities in order to be able to gain access to areas and situations that would be 
otherwise out of bounds. Fluidity exists between these stances of participant observation 
and ethnographers can use different types of observation at different points of time. Both of 
these differing stances had a bearing on my research and I comment on this in my fieldwork 
account. 
Fetterman (1998 p. 31) describes the participant observer as a human instrument who, 
armed with a research question/problem, a theory of social interaction or behaviour, and a 
variety of conceptual guidelines in mind, strides into a culture or social situation to explore 
its terrain and to collect and analyse data. Whilst the human instrument relying on all its 
senses, thoughts and feelings can be a highly sensitive and perceptive data collection tool, 
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at the same time the human instrument can also be open to subjectivity and lose its 
bearings in unfamiliar behaviours and situations. By understanding one's position, working 
with a group of trusted researchers who are accustomed with the research setting, and 
checking the validity of findings and observations the researcher can guard against 
subjectivity. 
The influence of the participant observer on the setting and resulting actions needs to be 
recognised and thus ethnography has been described as 'performative' (Fabian, 1990). 
Ethnographers do not apply neutral methods in the collection of data; rather they seek to 
observe circumstances and conditions in which data is enacted and can be talked about. 
Whether and how the presence and the length of stay of a participant observer in the place 
of study distorts the data collection are valid questions, which are captured in the following 
quotation by Tedlock (1983 p. 287). 
'The more a fieldworker [or ethnographer] knows and is known, the less that fieldworker 
can avoid joining the action. The other side of this is that the less a fieldworker knows and 
is known, the greater will be that fieldworker's inability to interpret the actions of others, 
whether those actions take him into account or not. ' 
Ethnographers try to be reflexive about how their presence can influence social processes, 
how they balance observation and data collection with involvement in the phenomena they 
are studying, and how their interpretations can be shaped by the 'cultural lenses' through 
which they perceive and make assumptions about the world. The value of being transparent 
is stressed by Pool and Geissler (2006 p. 287) who argue that: 'all social knowledge is 
positional and shaped by the observers' point of view, and there is no independent vantage 
point from which to view, neutrally, a given society'. In my fieldwork I attempted to practice 
reflexivity, and I also complemented my perspective by working with three Kenyan research 
assistants, two of whom were resident in and originated from the area where I conducted 
my fieldwork. The next section provides an account of my fieldwork and methods. I 
differentiate between 3 stages of fieldwork and consider how my position as an 'observer 
participant', 'participant observer' and a 'semi-removed analyst' framed my enquiry. 
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Fieldwork & Methods 
To provide a descriptive and critical analysis of the substance and meaning of CE I conducted 
ethnographic fieldwork in Western Kenya from June 2007 to December 2009. My fieldwork 
focussed on the places of coordination and sites of implementation of paediatric rotavirus 
and malaria vaccine trials. I spent time in the KEMRI/CDC field station and in the rural area 
where CE and trial-related activities took place. I interviewed KEMRI/CDC staff and 
accompanied KEMRI/CDC members of the vaccine trial teams as they conducted CE and trial 
related activities. This gave me unique opportunity to study the trials from within the 
culture of the organisation. I also interviewed and spent time with community 
intermediaries, community members and parents of vaccine trial participants. This meant 
that I was able to describe the institutional structures and official representations of CE, and 
explore the experiences and understandings of CE both from the perspectives of those 
enacting it and those exposed to it. 
Participant observation formed the basis for my data collection and guided my sampling and 
the topics I explored in informal conversations, semi-structured interviews (SSIs) and focus 
group discussions (FGDs). The strength of combining observation with interviews is that one 
can triangulate the data and compare what people say with what they do. My approach to 
data collection was inductive and SSIs and FGDs tended to follow participant observations. 
For example, where possible I tried to interview parents/guardians of vaccine trial 
participants who had allowed me to observe the consent process they underwent before 
being enrolled on the trial. 
I used purposive sampling to identify information-rich cases to take part in interviews and 
FGDs. According to Silverman (2005) purposive sampling allows researchers to select cases 
that demonstrate particular features or processes whilst also requiring them to think 
carefully about the parameters of the population they are studying (p. 129). I took care to 
achieve maximum variation according to age, gender and residential area in order to 
achieve a fair representation of outcomes. I also used theoretical sampling to test emerging 
ideas or theories e. g. paternal hesitation about infant participation in research. Theoretical 
sampling is an extension of purposive sampling and has been defined as 'the process of data 
collection for generating theory whereby the analyst jointly collects, codes, and analyzes his 
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data and decides what data to collect next and where to find them, in order to develop his 
theory as it emerges' (Glaser and Strauss, 1968 p. 45). 
My study participants included people from four different groups which I describe below. 
When quoting members of these groups in the thesis I use the following acronyms followed 
by the participants' number: Research Staff (RS, 01), Community Representative (CR, 02), 
RVT Participant (RP, 03), MVT Participant (MP, 04), Community Member (CM, 05). Study 
participants either took part in a SSI or a FGD and in some instances I interviewed a few 
people on more than one occasion. This was the case for 6 researchers and 7 VRs. Table 1 
provides the number of participants in each group, the overall sample size and the number 
of FGDs and SSIs held with each group. More details about study participants including their 
background information, gender and age range and the dates when interviews of FGDs were 
held can be found in Appendix I Doc. 2. 
Groups Participating in this Ethnographic Study 
I. KEMRI/CDC Staff Members: Senior Scientists, Trial Investigators, Community Liaison 
Staff, Communications Team, Technical Staff, FWs 
II. Community Representatives: VRs, CAB members, Government & Political Gatekeepers, 
Health Facility Partners 
Ill. Parents/Guardians of Vaccine Trial Participants: Mothers and a few fathers who had 
enrolled their children in the RVT or the MVT. 
IV. Community Members: Religious leaders, Herbal medicine practitioners, Young 
professionals (working with community based organisations), Parents/guardians of 
children not taking part in the vaccine trials 
63 
Table 1: Number of Study Participants, SSIs & FGDs 
Group No. of No. of SSIs No. of 
Participants FGDs 
ist 2nd Interview 
interview with both 
Interview parents or 
two family 
members 
Research Staff (RS) 18 18 6 N/A 0 
Community Representatives 71 37 0 N/A 6 
(CR) 
Parents of RVT 20 9 0 2 1* 
participants (RP) 
Parents of MVT 6 4 0 1 0 
participants (MP) 
Community Members (CM) 7 5 0 1 0 
73 6 4 
Total 122 83 7 
1 interview with extended family members 
Stages of Fieldwork: Getting in, 'Staying in, Pulling Back' 
My fieldwork can be divided into 3 stages: 'Getting in'; 'Staying in'; and 'Pulling back'. In 
referring to these stages in this manner I draw on the writings of Smith (1997); although 
instead of naming the last stage 'Getting out' I call it 'Pulling back'. The latter I believe more 
accurately reflects my relationship as an ethnographer with the field. I do not believe it is 
possible to get away completely from the field once one has spent a long period there and 
built up the relationships which are necessary to undertake sensitive and in-depth 
fieldwork. 
The 'Getting in' stage covers the period from my arrival in Western Kenya and traces my 
gradual immersion into the KEMRI/CDC 'trial community'. The 'Staying in' stage starts at the 
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point when I officially commenced data collection and stops at the point when I left the field 
to return to England. The final stage of 'Pulling back' represents a period of intense analysis 
and writing up during which I visited Western Kenya on two occasions to verify and discuss 
interim findings with study participants and colleagues at KEMRI/CDC. To all intents and 
purpose this stage will continue until the point I feel I have communicated my findings 
effectively, and have discussed their implications and application sufficiently with academic 
peers, research collaborators and participants. 
'Getting in': February 2007 - September 2008 
My first visit to KEMRI/CDC in Western Kenya was in February 2007 and involved meeting 
senior Kenyan and American staff at KEMRI/CDC and discussing my research plans with 
them. Initially these plans focussed on a planned HIV vaccine trial which was due to 
commence within the HIV research branch at KEMRI/CDC later that year. The HIV research 
branch is primarily based at a clinical research centre in Kisumu and works mainly with 
urban and perl-urban communities. The trial was a multi-site vaccine trial which was 
referred to as PAVE 100. With the permission of trial investigators I was keen to study the 
implementation of this trial at KEMRI/CDC as a case study in my ethnographic fieldwork. 
During my visit the American HIV research branch chief, who was employed by CDC, 
orientated me to the research set up and infrastructure, introduced me to key personnel 
and gave me access to relevant PAVE trial documents and protocols. I was able to attend 
presentations, CAB meetings and a presentation arranged for the visiting deputy American 
ambassador. I was also given the opportunity to conduct informal discussions with the 
KEMRI/CDC community liaison officer and staff responsible for community relations in an 
ongoing HIV incidence cohort study. The former invited me to attend a community meeting 
during which community members would be nominated to become CAB members for an 
infant rotavirus vaccine trial (RVT) due to start within a couple of months in a rural area one 
hour's drive away from Kisumu. This meeting made a marked impression on me and 
provided me with unique insights into the CE approach adopted at KEMRI/CDC. An 
appended field notes excerpt describes this community meeting and conveys underlying 
questions of control in the relationship between researchers and community members and 
amongst research staff (Appendix I, Doc. 3). International staff responsible for the 
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coordination of the RVT felt they had to script their input for this meeting and be careful to 
communicate the pre-decided content without diverting to other subjects. The community 
liaison officer employed a more relaxed approach in his interactions and this resulted in 
some strain between him and the RVT coordinators. From the point of view of my thesis this 
observation is very relevant and speaks to some of the key messages and lesson that arise 
from my findings. 
By the end of my week-long scoping visit it was apparent that the KEMRI/CDC HIV vaccine 
trial investigators, HIV research branch behavioural scientists and their respective 
colleagues at the CDC offices in the US were interested in my proposal. A few became 
research collaborators and provided input and supported the submission of my research 
proposal to the relevant ethical approval bodies. In Kenya these included (in sequential 
order) the KEMRI-Centre for Global Health Research scientific steering committee (SSC) 
based in Kisumu, the Nairobi scientific SSC, and the KEMRI ethics review committee also 
based in Nairobi. Due to CDC's involvement I also had to apply for ethics approval from the 
Institutional Review Board based at CDC's main offices in Atlanta. In the UK I had to obtain 
approval from the London School of Hygiene and Tropical Medicine Ethics Committee. The 
latter was straightforward and took less than 2 months. The former approval processes 
were more complicated and took significantly longer than anticipated (May 2007-October 
2008). In part this was due to coordinating revisions across two committees which both 
applied extensive review, and in part it was due to the political violence which occurred 
following the Kenyan Presidential election in December 2007. A positive consequence of 
the delay in obtaining ethics approval was that it gave me the opportunity to familiarise 
myself with my place of study and become immersed in the KEMRI/CDC 'trial community'. I 
was also able to use this time to start learning both Kiswahili and Dholuo. 
During my scoping visit to KEMRI/CDC in February 2007 it became apparent that, apart from 
my PhD, I could provide technical assistance to the HIV research branch. I have professional 
training in clinical vaccine research and the HIV research branch director was looking for 
someone to mentor regulatory staff and the PAVE trial management team during 
preparations for the PAVE HIV vaccine trial. Hence I moved to Kisumu in June 2007 and was 
employed as a clinical trials consultant. The remit of my duties was to oversee the protocol 
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submission to relevant ethics and regulatory authorities, to work with the investigators in 
preparing the site and to establish a competent team to run the trial. My job description did 
not cover any of the CE activities for the HIV vaccine trial. These were planned and 
coordinated by behavioural researchers with the support of community FWs. Hence I was 
not directly involved in any of the activities which were planned to be the focus of my PhD 
fieldwork. Furthermore following consultation with the HIV research branch chief we agreed 
that I would lay aside my consultant duties once I received ethical approval for my research 
and commenced active fieldwork. 
Balancing the role of a clinical trials consultant and PhD student was not without challenges, 
however combining these roles also provided me with unique insights into the workings of 
the KEMRI/CDC research programme. Essentially for the period I was employed as a clinical 
trials consultant, from June 2007 to September 2008, I assumed the role of an 'observing 
participant'. I assumed certain responsibilities and gained access to areas and situations that 
would otherwise have been out of bounds for me as PhD student. The way I would balance 
and perform these two roles was explained to the PAVE trial staff and others, such as the 
CAB. Valid concerns were voiced by colleagues about my 'positionality' and whether I would 
be able to maintain objectivity in my PhD research, given my professional involvement in 
the HIV vaccine trial. We discussed their concerns and I reiterated that I would not continue 
in the role of a consultant once I commenced my PhD fieldwork. Some of these tensions 
revealed underlying and understandable resentment about the opportunity I had been 
given as an international researcher to combine work with PhD studies. Pursuing higher 
education is highly valued at KEMRI/CDC and I was also earning a good salary as an external 
technical consultant. These types of reactions are to be expected during the 'getting in' 
stage of any project. People were curious and wanted to understand my motives for being 
at KEMRI/CDC and my reasons for studying a particular phenomenon. In my case there were 
also some concerns that I might be critical about PAVE related CE activities and that my PhD 
fieldwork may involve an evaluation of staff members' performance and effectiveness. The 
main factors which helped to redress these concerns were time, building trust and 
establishing good relationships with KEMRI/CDC staff and others who formed part of the 
KEMRI/CDC'trial community' e. g. CAB members. I also presented my PhD research plans on 
repeated occasions at KEMRI/CDC seminars to open the floor to questions about my study. 
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About 4 months into my work as a clinical trials consultant a series of events occurred which 
led to the initial postponement of the PAVE vaccine trial, and its ultimate abandonment in 
spring 2008. Interim results from a multi-site HIV vaccine trial being conducted in the US and 
in South Africa, called STEP, indicated that the trial vaccine being tested in STEP did not 
prevent HIV and might be associated with increased risk of HIV acquisition in men with pre- 
existing adenovirus 5 immunity, and in uncircumcised men (Steinbrook, 2007). It was 
concluded that this was due to the inclusion of an adenovirus vector in the STEP vaccine 
construct. The PAVE HIV trial vaccine, which was going to be tested in Kisumu and 
elsewhere, also included an adenovirus vector. Hence after further review of the STEP trial 
results and high level meetings between PAVE primary investigators and vaccine developers 
the PAVE trial was abandoned. This course of events resulted in intense discussions at our 
site during the period when it was not clear whether PAVE would proceed or not. At one 
point CDC colleagues in Atlanta suggested that we should undertake some community 
consultation aimed at assessing willingness to participate in the planned PAVE trial. Part of 
the rationale was to facilitate the inclusion of lay perspectives in decision-making about the 
continuation or abandonment of the proposed HIV vaccine trial. Whilst this rationale was 
welcomed by the PAVE trial vaccine team, hesitations were also voiced about the utility of a 
questionnaire to assess community members' willingness to participate in PAVE. Up until 
that point community members had not yet been informed about the proposed PAVE 
vaccine trial. The CAB had been involved in trial preparations but CE activities with the 
broader community had not yet commenced. Questions were raised about whether 
questionnaire respondents would be able to comment adequately on the issues at hand, 
and how this data would be used to inform international high level decision-making. These 
considerations had implications for the practice of CE in vaccine research, and I applied a 
critical incident analysis to explore these in detail. The results of my analysis were presented 
in poster at the AIDS Vaccine Conference in South Africa in October 2008 (Appendix I, Doc. 
4). This was one way I used the experiential knowledge gained as an 'observing participant'. 
The exposure I gained also provided me with a broader perspective of the KEMRI/CDC 
research programme, and deeper insights into the complexities of applying federal 
regulations and international ethical guidelines at community level. 
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The abandonment of the PAVE trial meant that I needed to find new case studies for my 
PhD fieldwork and amend my research protocol accordingly. I discussed options with my 
PhD supervisor and senior researchers at KEMRI/CDC. As a result I was given permission to 
study an ongoing RVT and a planned MVT. 
'Staying in': October 2008 - December 2009 
In September 2008 I obtained ethics approval to commence my 'formal' fieldwork. I ceased 
working as a clinical trials consultant and focussed full time on my ethnographic fieldwork. 
Hence I changed my vantage point and moved from being an observer participant to 
becoming a participant observer. The RVT was managed by a team of researchers based in 
the International Emerging Infections Programme Research Branch and the MVT by a team 
of researchers based in the Malaria Research Branch. I had not worked for either of these 
while I was a clinical trials consultant and while the staff knew me they had not associated 
with me professionally. The fact that they knew me worked to my advantage in that I did 
not have to explain myself in the same way I had had to during my time in the HIV Research 
Branch. I was a familiar face and knew the terrain and the people who could help me with 
the logistics of my fieldwork. This foreknowledge and the quality of my relationships greatly 
facilitated this stage of 'staying in' and allowed me to undertake my research less 
conspicuously than if I had only newly arrived at KEMRI/CDC. 
The location of my fieldwork also shifted at this stage from the city to the country. The RVT 
and the MVT both took place in Karemo Division (see chapter 1), a rural area north east of 
Kisumu. I rented a small office in one of the buildings used by demographic surveillance staff 
in Siaya, the main town in Karemo Division. I recruited two research assistants to serve as 
cultural brokers, language teachers, transcribers and translators. These research assistants 
had had no prior involvement in health research and were resident in the area where the 
vaccine trials were taking place. One (AS) was a mother in her early 20s who had a 
professional background in HIV counselling and testing; the other (RO) was a young man 
who had recently graduated from secondary school and was skilled in computer technology. 
These research assistants joined me at the beginning of December 2008 when I started 
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mapping out the terrain in which I conducted fieldwork more closely. To navigate the terrain 
I hired a car and wherever possible I stayed overnight in Karemo Division. My main 
residence was in Kisumu where my children were at school, hence I moved back and forth 
between Kisumu and Karemo during the course of my fieldwork. Some of my fieldwork also 
took place at the KEMRI/CDC field station in Kisian, which is closer to Kisumu. 
In October and November 2008 I focused on observing the final stages of RVT participant 
recruitment, meeting the CAB and introducing myself to community leaders such as the 
District Commissioner (DC). My meeting with the DC was important in terms of establishing 
the premise of my research and my association with KEMRI/CDC. He was interested in my 
topic of enquiry and thought that it was good that my research was funded separately from 
KEMRI/CDC. In all my introductions with potential interviewees and other community 
members I was careful to stress, that whilst I was collaborating with KEMRI/CDC, I was a 
student from a university in England, and my fieldwork was funded by a charitable trust 
which supports research. I also reiterated this point on other occasions e. g. when I obtained 
informed consent from interviewees. However it is possible that community members who 
were not directly involved in the research - and even some who were interviewed 
in the 
study - did not make this distinction. in fact on one occasion I was phoned by the 
father of a 
MVT participant several days after I had been to his home with one of my research 
assistants to interview him and his wife. His daughter was sick and he was asking me for 
advice on what to do. I stated that he really needed to contact the MVT team and advised 
him to take her to Siaya District Hospital (SDH) as soon as possible. He said he would and I 
then alerted the on-call trial clinician to expect them. To a certain extent such mixed 
understandings about my persona by community members were inevitable by virtue of my 
colour and position. However I do not believe this detracted significantly from the value of 
the information which was shared with me by participants. Mixed understandings were not 
evident amongst community leaders, hospital staff, community intermediaries or research 
staff. 
At the start of December 2009 my research assistants and I conducted a mapping exercise of 
Karemo Division. Karemo Division is divided into four locations which are administered by 
governmental chiefs and their assistants. These locations are of relevance to the KEMRI/CDC 
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research programmes since they form an easy way to organise VRs and CAB members. We 
arranged to meet the chiefs from these locations at particular times and also invited CAB 
members from each area to join us at either at the chief's office or a health centre. Each 
chief provided us with an overview of his area, the geography, the population, and 
residents' economic activities, the main challenges faced in these communities and the 
major landmarks. One chief also drove with us around the parameters of his location. CAB 
members provided us with information relating to their activities for KEMRI/CDC and 
described community members' perceptions of the research programme. These mapping 
visits were very useful in orientating us to the individual locations and making contacts with 
community leaders. 
Broadly speaking my fieldwork during the 'staying-in' stage followed the sequence of CE 
activities associated with the RVT and the MVT. In Appendix I Doc. 5I outline all of these CE 
events chronologically. In the early stages of this period I accompanied the community 
liaison officer for the vaccine trials (CLVT) on CE events and travelled with her in a 
KEMRI/CDC vehicle. As I became more familiar with the environment and started to 
undertake additional research activities such as interviews, I drove with a research assistant 
to different events. We were made aware of CE activities by the CLVT and were always 
welcome to attend public forums. On a few occasions the CLVT wanted to meet CAB 
members on her own; but overall we were given very good access to CE events and also to 
trials-related activities taking place at SDH and the peripheral health centres. Wherever 
possible I attended all of the CE activities listed in Appendix I Doc. 5 from October 2009 
onwards. When I could not attend I sent one of my research assistants and asked them to 
compile field notes about the event they observed. I kept field notes of all events and 
tended to keep these as a form of diary during the course of my fieldwork. In this way I 
captured more than just particular activities. For some specific CE events and for consent 
processes we also used observation tools (Appendix I, Doc. 6) which I developed with 
colleagues from another research institute in Kenya who were also involved in the MVT. We 
used these tools to collate comparative data about CE in the MVT at two different trial sites 
in Kenya. Our findings were presented orally at a conference in Liverpool in 2010 (Chantler 
et al., 2010) (see Appendix I, Doc. 7. for the abstract). 
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During this stage of fieldwork I interacted with and interviewed senior KEMRI/CDC 
scientists, community liaison and communication officers, vaccine trial staff (clinicians and 
FWs), VRs tasked with helping KEMRI/CDC make connections at community level and CAB 
members who were delegated responsibilities for local representation. At the sites where 
the trials were taking place i made connections with and interviewed district administrators, 
a senior leader of the county council, chiefs and assistant chiefs, a church pastor, health 
professionals and health facility committee members responsible for the clinics and 
hospitals hosting the vaccine trials, and community members whom I met during vaccine 
trial-related CE events. I observed events targeted at parents of potential vaccine trial 
participants and accompanied parents during informed consent processes for the trial. 
Where possible with the support of my research assistants I conducted follow-up interviews 
with these parents in their homes. 
In terms of data collection my research assistants (RO and AS) were responsible for 
accompanying me during interviews and observations, interpreting where necessary, and 
transcribing and translating interviews and FGDs discussions. I conducted all of the 
interviews with KEMRI/CDC staff by myself since English was the primary language used in 
these interviews. Interviews held with VRs, CAB members and community leaders such as 
the DC and chiefs were also primarily held in English although interviewees occasionally 
used Dholou or Kiswahili to illustrate certain points. Interviews with parents of RVT and MVT 
participants and some community members were conducted in Dholuo. I attended most of 
these interviews and either RO or AS would interpret for me, otherwise the interview would 
be conducted in Dholou by RO or AS and translated following transcription. My aural 
understanding of Dholuo increased significantly during the course of my fieldwork and 
could follow the content of interviews in Dholou but found it more difficult to communicate 
in spoken Dholuo. I could initiate conversations and cover certain subject areas but was not 
able to facilitate an interview or focus group discussion in Dholuo. Working with a team of 
local research assistants helped me significantly in this regard and also allowed me to learn 
more about the local culture and environment. 
As is customary in ethnographic research I undertook some initial analysis of the data while I 
was still involved in fieldwork. This helped me to revisit issues that came up during 
observations and interviews and to explore emerging questions. One topic area which 
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repeatedly arose was paternal hesitancy and occasional resistance to the participation of 
children in vaccine trials. In order to explore this topic area in more depth I recruited an 
additional research assistant. This research assistant (P0) was originally trained as a nurse 
and had experience of working in health research and was currently enrolled in Masters 
level study in community health and development at Maseno University near Kisumu. He 
originated from Nyanza, was of Luo ethnicity and was married with one child. The latter was 
of particular relevance to the sub-study we developed for him to undertake for the 
requirements of his Masters studies. The main aim of this study was explore fathers' 
understanding and experience of health research and their views concerning the 
participation of children in vaccine research. 
My fieldwork drew to a close in December 2009 and before I left Kenya I presented some 
initial findings for discussion with research staff at KEMRI/CDC. This was a useful exercise 
and led to constructive exchanges and a draft manuscript which I wrote with some input 
from collaborators from KEMRI/CDC during the 'Pulling back'stage of my fieldwork. 
'Pulling back': January 2010 - ongoing 
I refer to this stage as 'Pulling back' rather than 'getting out' as it has involved leaving and 
returning; returning both physically for short field visits and intellectually through 
immersion in my data. I have been based in my home town, oxford, during this stage and 
have had access to the Oxford University libraries. These have provided a space to think, 
read and consider my material and related literature. At first I concentrated on sorting, 
checking and organising my data and then I proceeded with an in-depth analysis. Alongside 
this analysis I started to think about the organisation of my thesis and how to present my 
data. I started writing the findings chapters and worked on a few abstracts and a 
manuscript. Writing the findings chapters was an intense and lengthy process and it became 
evident that I had a wealth of information to convey. The breadth of my data provides a 
wide angle lens on the practice of CE and omitting any would have detracted from the full 
picture I was seeking to capture. 
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In June and September 2010 and in April 2011 I returned to KEMRI/CDC for short trips of 
between 1-3 weeks. During these visits I worked with PO on the Fathers Study data, visited 
the places where I had conducted my fieldwork and verified and discussed some of my 
interim findings during presentations with KEMRI/CDC staff, CAB members and a few SDH 
staff members. I also participated in workshops with wider audiences. Such activities and 
ongoing communication with manuscript co-authors from KEMRI/CDC enabled me to hone 
my writing and present a valid critique which portrays the challenges encountered in CE 
transparently and constructively. 
It has been very important for me to find a space away from my field of enquiry to reflect 
carefully on my work and findings. I needed to draw away from the immediacy and the 
politics of the field and reflect on my experiences from a critical distance. This helped me to 
distil my arguments and theory and express these in a measured and authentic manner. My 
subject area is sensitive and my findings have implications for the KEMRI/CDC research 
programme; hence I have chosen to involve key people at KEMRI/CDC in some of my 
publications. This has been a valuable exercise as it has given us the opportunity to think 
through complex issues which are affecting practice and to consider together ways of 
addressing these. It is also a challenging process and has required me to state my case 
clearly and ensure that my arguments are cogent, constructive and measured. The writing 
of this thesis has been both instrumental in this and partly shaped by this, and it will form 
the basis of future publications. 
Data Analysis 
The scope and nature of my research questions and study objectives meant that I could be 
flexible and iterative in my fieldwork. One of the key advantages of adopting an 
ethnographic approach and committing a period of 2 years to my fieldwork was that it 
allowed my interviews and informal conversations to be grounded within the realities I 
observed. I was able to follow up on observed events in interviews and discussions which 
allowed me to explore different peoples' perspectives of these. This triangulation of what I 
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saw for myself with what people said is evident in the presentation of my findings where I 
use descriptions of social situations to add depth to interview data 
My primary collected data comprised of observational field notes, interview transcripts, 
study participants' demographic information and source documents including KEMRI/CDC 
publications and standard operating procedures. The interviews and FGDs were recorded 
digitally and subsequently downloaded to a computer programme and transcribed (and 
where necessary translated) into Word files. I checked all the interview transcriptions for 
accuracy by listening to the digital recordings and cross-checking them with the transcripts. 
I highlighted areas which needed additional attention or were not audible and asked my 
research assistants to look at these again. Transcripts were stored on password-protected 
computers and participants' demographic information, data backups, paper copies of the 
transcripts and field notes were kept in locked cabinets when they are not being used. 
Access to these materials was limited to the research team. 
Data collection and analysis occur concurrently or in alternating sequences in qualitative 
research which allows interim findings to inform the ongoing research process. The analysis 
which took place during my fieldwork was iterative and involved me talking about the data 
with my research assistants and collaborators, recording reflections in my field notes and 
discussing particular issues with my supervisors. Particular issues or questions which arose 
during interviews or observations informed my subsequent fieldwork. For example I began 
to look much more closely at CE with health facilities as the result of a FGD with hospital 
staff. 
I started a more systematic analysis of the data towards the end of the 'staying in' stage of 
my research. By this point most of my interviews had been transcribed, checked and 
corrected so I was able to import them into a qualitative data software programme (NVivo). 
I also imported my field notes which I had copied electronically and source documents e. g. 
CAB members' reports and standard operating procedures relating to CE. Storing my data in 
one places allowed me to organise them and commence a systematic analysis. I used a 
thematic approach for analysing my interview data (Green and Thorogood, 2004 p. 177). 
This approach involves the following steps: familiarising oneself with the data; initial coding, 
developing a coding framework; applying this framework to the rest of the data; looking for 
75 
cross-cutting themes; and revising the framework where necessary. I also took care to 
embed my findings in the contextual data contained in field notes and other source 
documents. My overall aim was to generate an explanatory and descriptive analysis which 
would allow me to draw meaningful and accurate theoretical and practical conclusions. 
Conclusion 
This chapter has presented a detailed account of my fieldwork and an overview of the 
methodology, data collection methods and the approach to analysis I applied in writing up 
this thesis. While appropriate given my ethnographic study methodology, in part I also 
chose to provide a very detailed portrayal of my fieldwork in order to allow readers to judge 
and consider critically for themselves how my presence and position may have influenced 
and facilitated my research. 
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Chapter 4: 
The History of Community Relations at KEMRI/CDC 
'Right from the beginning, the community engagement was there. I think it's 
stepped up but 1 don't think there was ever a time thatyou know, like a study was 
done and n- one, because you know could not imagine, you could never really do 
that, you have got to talk to somebody [yeah]. So you talk to the chiefs and you have 
a community meeting, then you might meet with the DHMT (District Health 
Management Team) at the hospital... ' 
Senior American Scientist, RS 14 
Introduction 
In this chapter I trace the history of community relations at KEMRI/CDC. To construct the 
story of community relations at KEMRI/CDC I reviewed published papers from the 1980s to 
date which contained some description of how trials were implemented at district and 
community level, and corresponded with three of the authors by email, and held a 
telephone interview with one of these. In addition I drew on my field notes and talked in 
person and by email to six researchers who had been attached to KEMRI/CDC for 5 years or 
longer. These discussions provided important insights and illustrated the risk of projecting 
contemporary concepts such as 'community engagement' onto past practices; hence in this 
chapter I apply the broader term 'community relations' in order to capture the full range of 
interactions between researchers and the community. 
In chapter 3I argued that the genesis of the concept 'community engagement' in 
international health research can be traced back only to the mid to late 1990s. KEMRI/CDC 
was founded in 1979; hence it can be problematic to apply the term CE to past interactions 
between KEMRI/CDC researchers and the community even if some of those activities are 
also associated with current practice. In the above-cited quotation a senior American 
scientist focuses on the initial stages in community relations, which require researchers to 
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follow inherent and established social and cultural etiquette and official protocol. These 
community entry stages are arguably fundamental prerequisites. However they do not 
encompass all aspects of community relations and are not equivalent to CE. In this historical 
narrative I will present other facets of community relations and identify precursors to the 
way in which CE is currently framed at KEMRI/CDC. 
Historical Narrative of Community Relations at KEMRI/CDC 
In the immediate area where I carried out ethnographic field work, trials on health 
interventions that will be applied on a community-wide basis (community-based trials) are 
relatively new phenomena. Most of the research conducted in Karemo Division during the 
1980s and 1990s took place within the paediatric and maternity wards and the outpatients 
clinics at Siaya District Hospital (SDH). These observational studies evaluated paediatric and 
maternal mortality related to malaria, anaemia and HIV, assessed blood transfusion 
practices and validated an algorithm for integrated management of childhood illnesses 
(Lackritz et al., 1997, Perkins et al., 1997, Zucker et al., 1994). The validation of the algorithm 
included a comparison of the performance of a minimally trained health worker and a 
trained paediatrician, who, in contrast to the health worker, had access to laboratory and 
radiological support. In terms of contact with study participants' home and community 
environment Lackritz (1997) acknowledges 'J. Ochieng for effectively conducting the follow- 
up in unmapped, unmarked. remote areas' but makes no further reference to this aspect of 
his longitudinal evaluation of severe anaemia in children. To conduct these studies 
researchers collaborated most closely with their official counterparts from the Ministry of 
Health which included members of the District Health and Management Team (DHMT), the 
hospital medical superintendent, the district medical officer and the hospital staff. This 
official collaboration is one of the fundamental prerequisites which have been particularly 
prominent throughout the history of KEMRI/CDC. To explore other facets of community 
relations I will draw on experiences from community-based trials and related projects that 
took place in the rural areas of Asembo and Gem which lie adjacent to Karemo (see Map 2). 
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Saradidi Community Health and Development Programme 
The Saradidi community health and development programme was initiated by a church 
congregation in 1979 (Kaseje and Sempebwa, 1989). Its origin was a development 
education programme run by the Anglican diocese of Maseno South. This course provided 
participants with the impetus to become involved in health and development activities. 
They mobilised the community and accessed funds from the Anglican church to set up a 
health and development programme. To strengthen this programme community leaders 
invited outside health and development professionals to assist them in the process of 
defining their problems and identifying ways to solve them as a community. Kaseje and 
Sempebwa (1989) stress that `the role of outsiders was to facilitate the process'. They 
describe how the community developed its own support structure and health programme 
by drawing on internal and external resources. The support structure comprised a 
management board, whose members included teachers, village elders, chiefs and church 
members, and village health committees who were responsible for health activities taking 
place in their respective villages. The emphasis on community participation in the Saradidi 
programme reflected core ideals conveyed in the WHO Alma Ata Declaration on Primary 
Health Care (World Health Organisation, 1978). 
Primary Health Care... requires and promotes maximum community and individual self- 
reliance and participation in the planning, organization, operation and control of primary 
health care, making fullest use of local, national and other available resources; and to this 
end develops through appropriate education the ability of communities to participate... ' 
In the Alma Ata Declaration primary health care (PHC) was presented as a matter of social 
justice, which would enable all people to achieve a good level of health and live socially and 
economically productive lives. It was viewed as an integral part of health-care systems 
which merited increased levels of funding and technical support. Much emphasis was placed 
on responding to the expressed healthcare needs of communities and strengthening pre- 
existing health-care solutions, such as traditional birth attendants. 
One of the health priorities identified by community members in Saradidi was for people to 
be trained in matters of health in order to teach and assist others and to serve as 'agents of 
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change'. In response a village health helper curriculum was devised based on the problems 
and needs of the community, and a trainer was provided by the Department of Community 
Health of the University of Nairobi. This link was facilitated by Dr. Kaseje who originated 
from Saradidi and who was working as an epidemiology lecturer within that Department. 
Dr. Kaseje also collaborated closely with other health institutes including researchers 
attached to KEMRI/CDC. A professional relationship between him and an American 
physician was of particular note both for the development of the Saradidi programme and 
the future work of KEMRI/CDC in Nyanza province. 
In the early 1980s Dr. Spencer, a physician in his late twenties, moved to Kenya to work with 
KEMRI/CDC. Motivated by personal interest he visited the Department of Community 
Health in order to learn more about their teaching programme and research. This visit 
resulted in Dr. Spencer being offered an honorary appointment by the University of Nairobi. 
He shared a lectureship with Dr. Kaseje which allowed them both to pursue research 
interests within the Saradidi programme. Their role in this programme was to provide 
technical support for a malaria control project. As part of this work Dr. Spencer and Dr. 
Kaseje identified research gaps which they discussed with the Saradidi programme's 
management board. Because the management board were keen to know whether their 
activities had resulted in improvements to health, for example a decrease in infant 
mortality, they were convinced of the need for research. 
With the support of the management board and KEMRI/CDC Dr. Spencer and Dr. Kaseje 
built up a research team. This included laboratory technicians, entomologists, statisticians 
and social scientists. Research activities were supported by WHO and mainly aimed at 
evaluating the effectiveness and impact of malaria control strategies, and assessing the 
sensitivity of malaria to different drug regimes. Individual research projects had to be 
approved by the management board and the purpose of research activities was also 
discussed in community forums and meetings with parents where studies involved school 
children (Spencer et al., 1983). Researchers were accountable to the Saradidi management 
board and the board reserved the right to stop any research study if concerns arose. This 
occurred in a trial trying to establish the relationship between salt intake and hypertension. 
Board members were not convinced of the relevance of this trial for local health priorities, 
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and community members expressed anxiety about trial procedures which included taking a 
salt tablet. 
The main purpose of research activities at this time was to strengthen and improve services 
provided by the Saradidi health and development programme. This programme was 
significantly shaped by the Alma Ata philosophy of community participation. The influence 
of this philosophy and 'bottom-up' approaches to development can also be traced in the 
following excerpt from Dr. Spencer's curriculum vitae (Spencer, 2011). 
`.. the main focus of my time in Kenya was in the Saradidi Rural Health Development 
Program, a research, teaching and service program based at Saradidi a community of about 
50000 people in western Kenya, on the shores of Lake Victoria near Kisumu. Mentored by 
Dr. Dan Kaseje, the Kenyan senior project leader, I worked with him to train a network of 
community health volunteers that would provide medical and preventive services directly to 
the people living in their village.... We worked in full partnership with the people of Saradidi 
who maintained control of the program throughout'. 
Dr. Spencer's references to his 'menlorship by a Kenyan senior project leader' and the way 
the project `worked in full partnership with local people, who maintained control of the 
program 'are significant. To a certain extent they justify his position; but more critically they 
shed light on underpinning aspirations about the nature and function of collaboration at 
that point in time. It is also important to remember that research activities and related 
protocols did not drive the agenda but played a supportive role in achieving the overall goal 
of improved health for local residents. Indeed the success of this locally-initiated health and 
development programme has been attributed to community members maintaining 
responsibility for the direction of the programme (Kaseje and Sempebwa, 1989). 
The material presented in this section is based on my review of relevant literature and 
related documents. More importantly, it is informed by an interview that I conducted with 
Dr. Kaseje about the development of the programme and subsequent integration of 
research activities. Whilst these sources provided me with valuable insights I cannot be sure 
whether recollections contained in documents or shared with me verbally adequately 
reflect the reality at the time. Despite this limitation it is evident that community-driven 
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healthcare, and to a certain extent community-controlled research were conceived of being 
the ideal at this point in time. 
Expansion of the KEMRI/CDC Research Programme 
The growth of externally-funded research on the epidemiology, entomology, and 
immunology of malaria during the 1990s (Bloland et al., 1999, Phillips-Howard et al., 2003, 
Ter Kuile et al., 2003) precipitated a gradual shift in the locus of control in the conduct of 
KEMRI/CDC studies. KEMRI/CDC developed extensive research infrastructures in Western 
Kenya including central office and laboratory facilities on the outskirts of Kisumu. The 
impetus for studies no longer arose from direct interaction with community-based health 
programmes but reflected an 'internationally defined' research agenda. National and 
expatriate researchers aspiring to contribute to scientific progress became increasingly 
accountable to external sponsors and host communities no longer played a dominant role in 
overseeing research activities. More broadly, community-led health and development 
initiatives were no longer seen as the ideal or the norm. 
Local involvement in research was mainly limited to the recruitment of traditional birth 
attendants (nyamreche) and other community health workers to assist with a wide range of 
clinical tasks on a casual basis. These tasks included obtaining blood samples and smears, 
performing malaria tests, measuring temperatures and administering oral anti-malaria 
medication. The trend of delegating specific research tasks to community health workers is 
exemplified in a large community-based randomised control trial of insecticide-treated bed 
nets that took place from 1996-1999. This trial covered a vast area of 500km2 which 
included 79 villages in Asembo and 142 in Gem and encompassed a total population of 
125,000 (Phillips-Howard et al., 2003). Over 300 nyamreche were enlisted as casual 
employees to be a grassroots link between project staff and village residents. Some of them 
were promoted to more senior positions within an established network of local supervisors. 
Nyamreche were involved in educational activities such as composing songs and were 
trained to obtain household consent, complete basic demographic questionnaires and dip 
the intervention nets at regular intervals. They were paid daily or half-daily rates of Ksh 100 
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(approx US $ 1.30 at the time) or 50 respectively; the Ksh 50 rate was generally reserved for 
composing educational songs, attending barazas (open community meetings facilitated by 
administrative chiefs) or weekly nyamreche meetings. In my email correspondence with 
Phillips-Howard (2010) she elaborates further on employment-related benefits and captures 
KEMRI/CDC's main motivation for working with local nyamreche at that point in time. 
'... We also supplied them with their own gumboots, umbrellas far rainy season. Quite a few 
also had bicycles if they had some distance to travel. Interestingly at one point they requested 
a uniform, but after long discussions between them and the office in the end this did not 
happen -I think they felt they wanted to stand out as different from community, but our take 
on it was that it was because they were part of the community that they did so well in their 
work, and were trusted by the community'. 
The nature of the involvement of village members in health and research tasks is of interest 
in this 1990s narrative of community relations. Informed by the ideals of community 
participation village health helpers had been viewed as 'agents of change' in the 1980s 
Saradidi self-help health programme. But as the KEMRI/CDC research programme expanded 
increasing attention was paid to their role in facilitating research as those who were 
'trusted' by other community members. The nature of tasks delegated to them also changed 
as a growing body of contracted field workers took over more technical responsibilities. In 
essence we see younger, more qualified community members becoming part of the 
KEMRI/CDC workforce whereas most of the community health workers and nyamreche 
continued to be affiliated to research studies on a casual basis. Of note here are inherent 
distinctions in status between nyamreche and field workers. Nyamreche are usually older 
women whose age, experience and child-bearing afford them much respect at community 
level. Field workers in contrast are secondary school leavers who gain employment by virtue 
of their academic qualifications rather than their positions within the local community. 
Community Relations made Visible in the Biomedical Literature 
An article which describes the development of the infrastructure for the insecticide-treated 
bed net (ITN) trial contains several sections about community mobilization and educational 
activities. The way in which community processes are made visible by Philips-Howard et al 
(2003) is significant since reports on biomedical research do not usually include much detail 
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relating to these aspects of research preparations. Partly the rationale can be understood 
given the high profile of this trial in terms of the national malaria control agenda and the 
fact that it involved whole communities rather than individuals. It is also of interest, that 
whilst Phillips-Howard et al (2003) do not refer to ethical requirements their article 
coincides with the emergence of the concept of CE in literature about the ethics of 
international health research. 
Phillips-Howard et al. (2003) relate how community mobilisation commenced with meetings 
with government officials (district officers, chiefs, and assistant chiefs) to explain the 
purpose of the bed net study. Subsequently, barazas were conducted in each of the 33 sub- 
locations in Asembo and Gem to allow villagers to ask questions about the proposed trial. 
These meetings were attended by several hundred adults who were thought to represent a 
substantial proportion of adult villagers. Local language and English leaflets describing the 
project were distributed and researchers responded to questions about net ownership and 
use, the possibility of employment with the project, and details of malaria transmission, 
prevention, and treatment. These meetings are described as being a way of obtaining 
authorization from those present for the trial to be conducted in their sub-locations. 
Having obtained community approval, the authors describe how voluntary village ITN trial 
committees were established to assist with communicating information about the trial. A 
volunteer from each village was also elected to represent their village at the randomisation 
lottery. At this public lottery the village representatives chose a sealed envelope from a 
basket containing hand-written tickets. Each ticket determined whether a village received 
the trial intervention or not. This public lottery was witnessed by national and local officials, 
who had been invited to the public launch of the bed net trial. At this stage community 
mobilisation had a primarily educational focus. School children participated in drawing and 
poetry competitions, nyamreche wrote songs about the study and local actors were trained 
in participatory educational theatre (PET). Songs and skits were performed at public 
meetings, schools and traditional functions and PET actors visited all of the villages at least 
once prior to net distribution. The following quote from Philips-Howard (2010) provides 
insights into the relationships between researchers and nyamreche and stresses the 
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iterative nature of these educational elements, which at that stage did not require formal 
ethical review. 
'Interesting question about ethics. for the songs - no, they did not each go 
back to ethics as it 
was an iterative and unique process - each sector of ce group developed songs and we even 
had a competition where the nyamrerwa (nymareche) from the sector office were awarded a 
prize. for their winning song (a kanga each I believe). They often make songs which were 
sung-independently of our involvement-at local barazas, so the ones they created for the 
project were considered more a strengthening of their traditional role in the community than 
a 'research' component. A couple of the songs we heard as early versions had to be amended 
because they were more like 'odes to CDC'... we love you Dr (X) you are so strong; Dr (P) is 
so beautiful (ha)... After discussing with them the rationale for the songs was to help provide 
understanding to the community about malaria and care of sick children (e. g. go to clinic 
early if child sick), and looking after the bed net properly, they 'upgraded' their songs! ' 
The published account (Phillips-Howard et al., 2003) of the development of the ITN trial site 
refers to fundamental prerequisites in community relations i. e. the approval by official 
leaders. However it also describes how researchers sought to foster a much broader 
community involvement by the use of participatory techniques. The nature and size of the 
trial and the fact that it was not part of an existing health project meant that researchers 
had to pay closer attention to how to galvanise public support. Another point of interest to 
this historical trajectory is that locally-developed and sometimes impromptu educational 
components did not require the same level of ethical review which is currently mandated by 
institutional review boards at CDC. 
Development of a Health and Demographic Surveillance System 
Building on the infrastructure created by the ITN bed net trial, KEMRI/CDC started to 
develop a health and demographic surveillance system (HDSS) in 2001. The aim was to 
transition from holding a periodic census to continuous demographic surveillance using 
tools developed by other surveillance sites in developing countries. To achieve this goal a 
Ghanaian researcher, Dr. Adazu, who had worked at one of the first surveillance units in 
Africa (Navronogo HDSS, Ghana) was initially hired as a consultant and later appointed as 
the Chief of the KEMRI/CDC HDSS. The Navrongo HDSS had been a founding member of 
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INDEPTH (The International Network for the Demographic Evaluation of Populations and 
Their Health in Developing Countries), a strategic international network of field sites 
conducting demographic surveillance in developing countries. Dr. Adazu's experience 
facilitated KEMRI/CDC's entrance into INDEPTH and helped to strengthen KEMRI/CDC's 
position as one of the leading players in the arena of international collaborative health 
research. 
The appointment of an African scientist to this senior position of leadership was viewed very 
positively by KEMRI/CDC staff and national and international collaborators, and Dr. Adazu's 
work ethic and strong leadership gained him a lot of respect. He developed clearly defined 
operating procedures and demanded very high standards from his team; any field staff 
members caught falsifying data were fired without recourse. Interestingly the broader 
community generally accepted this zero tolerance approach, and after his unexpected death 
in January 2009 a district health stakeholders' meeting was interrupted to hold a minute's 
silence in his memory. 
The idea of the HDSS was first presented to community leaders and local residents in 
Asembo and Gem during the dissemination of results from the bed net trial. This was 
followed by ongoing community-based discussions to explain the purpose of the HDSS and 
its implications for participating households. In terms of implementation the next step in 
developing the HDSS was to use a satellite-enabled global positioning system to map all of 
the houses, villages and towns within the specified surveillance area. Initially this included 
only the areas where the bed net trial took place, Asembo and Gem. Subsequently the HDSS 
area was extended to incorporate Karemo division in 2007. After the mapping exercise field 
workers visited the household heads to explain the purpose of the HDSS and obtain their 
consent to be included in the surveillance system. Households who agreed to become part 
of the HDSS were given a unique location code which was painted on each house (see photo 
5). These codes consist of symbols and numbers to identify the village, compound and the 
house (V stands for village). 
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HDSS Household Location Code Marked on the Door of a House 
(Acknowledgement: G. Jones) 
Individual residents in turn were allocated a permanent identification number composed of 
this location code plus a three-digit individual number. Households who withheld consent 
were not included in the surveillance system although they still appear in annual updates of 
satellite maps. Earlier in this chapter I cited Lackritz's (1997) acknowledgment of 'J. 
Ochieng's contribution to effectively conducting the follow-up (in a longitudinal evaluation of 
severe anaemic children) in unmapped, unmarked, remote areas'. The advanced mapping 
process outlined above contrasts with Lackritz's description of follow-up. In the HDSS 
uncharted territories became mapped and were recorded with advanced technology. 
Today the KEMRI/CDC HDSS includes a total of 385 villages across Asembo, Gem and 
Karemo; in Karemo alone this amounts to 19,000 households. Surveillance is conducted 
every four months through house-to-house interviews conducted by local field workers who 
are trained to collect demographic, health and socio-economic data. The information thus 
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obtained is supplemented by regular reporting of births and deaths by VRs. A VR is an 
individual selected by the community members to support the implementation of 
KEMRI/CDC projects and studies. I will expand on VRs role and conditions in chapter 7. 
At KEMRI/CDC the HDSS is viewed as the backbone of the research programme and 
presented as a key asset in reports and funding applications. Conducting trials within 
demographic surveillance areas can augment the scientific credibility of findings and is 
viewed favourably by regulators. Maintaining a HDSS requires long term commitment and 
significant investment, which can be difficult to attract since sponsors are more interested 
in funding health interventions. The main purposes of the HDSS are to facilitate the 
evaluation of future population-based public health interventions, generate hypotheses and 
help address the causes of morbidity and mortality (Adazu et al., 2005). Whilst these 
outputs are very important from a research perspective they provide no immediate benefit 
for households who are requested to provide sensitive information about family members' 
health and socio-economic conditions on a regular basis. A chief from Karemo recalls how 
community members initially responded to the idea of a HDSS in the following interview 
excerpt. 
'... the part of properties is what brought contentions because those people asked, why do you 
want to know my radio, why do you want to know my animal, do you want to steal my 
animals? People asked a lot of questions there, but they were told that one was purposely, f or 
the recording and knowing whether you are improving in lifestyle or not. So they were also 
convinced and from there we rolled it down to the sub-locations mobilizations and then from 
there they (KEMRI/CDC) told as they were going to employ some of our children to do the 
work of interviewing they will not get people from outside because they (the community) 
don '1 want people from outside to know their secrets [laughter]. 
Chief and CAB Member, CR 05 
Community members were suspicious about researchers' intentions-for example police 
living in urban quarters associated health surveillance activities with spying. Many people 
were reluctant to disclose information about their assets and economic status and some 
wondered what they would receive in return. A CAB member from Karemo noted in a 
monthly report dated May 30th 2008, that 'villagers are worried about why the CDC keeps 
on asking what they possess at the moment, after which no contribution is made' This 
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perceived lack of exchange led some to complain to VRs that you are guining. from our 
name but we are left poor' (VRs, CR 28). The 'you' in such remarks relates to anyone 
involved in the research programme. Repeated home visits and unrelenting questioning led 
to fatigue and resulted in 'villagers hiding from the field worker, they were fed up with all 
the questions they were asking, and yet people are hungry. ' (CAB member report, dated 8th 
April2008). According to a male development worker in his twenties more feedback on the 
rationale for demographic health surveillance was required. To press this home he posed 
the following rhetorical question during an interview with one of my research assistants. 
'... imagine a situation Mr. Peter [mmm], where somebody comes and interviews you at 
your home there, you have how many cows, and he goes like that, without telling you his or 
her intention with your cows. You will question, you get, you will remain with some 
questions, as he goes [yeah], you remain with some questions [yeah, yeah]. ' 
Community Member, CM 03 
Such responses focused attention on the need to address community concerns in a more 
formal manner. Significant material and financial investments had been allocated to setting 
up the HDSS and researchers realised that they could not afford to jeopardise its success by 
neglecting such matters. 
Formalising Community Liaison Activities 
The development of the HDSS in 2001 and an associated increase in community-based 
studies seeking to address public health questions in the fields of malaria, HIV and 
schistosomiasis precipitated the need to formalise and prioritise community relations. An 
existing Luo-speaking Kenyan employee, with a degree in Zoology, was appointed to the 
position of Community Studies Head. The Community Studies Head had an office at the 
main research facility in Kisian but spent most of his time in the field. His primary role was 
to ensure the continued support of community and political leaders and make certain that 
the public were informed about on-going projects and their results. He was also responsible 
for supporting the implementation of studies, supervising those in charge of information, 
education and communication activities and managing VRs. As part of his job he established 
the first KEMRI/CDC CAB in 2003 to assist with preparations for a baseline cross-sectional 
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survey of sexually-transmitted infections among individuals aged 13-34 living in the Asembo 
area (Amornkul et al., 2009). CAB members were asked to provide researchers with specific 
feedback about the wording and cultural acceptability of a sexual risk behaviour 
questionnaire, to relay community concerns and to comment on questions of assent and 
consent. Following this pattern CABs at KEMRI/CDC tended initially to be set up to serve 
specific studies. But as they became more established they later broadened out to include 
other studies. The broader model has some advantages in terms of synergising efforts and 
maximising information. However it can also limit the level of input CAB members can 
contribute to individual studies. The modalities involved in setting up a CAB, selecting CAB 
members, defining their roles, remit and accountability will be described in more detail in 
chapters 5&8. 
At the start of 2004 researchers conducting biomedical trials in the Asembo area became 
the subject of negative press reports, which claimed that they were tricking community 
members into joining studies and using them as 'guinea pigs'. This type of reporting on 
research is a common phenomenon in East Africa and reoccurs on a regular basis. The main 
article in question in this instance was published by the East African Standard (Big Issue 
Team, 2004) (Appendix II, Doc. 1). The journalists were critical of the government's failure to 
investigate claims that Walter Reed, a research unit of the United States Army, was 
subjecting community members to unethical research procedures. Their article included 
photographs of research participants, who asserted that they had been lured into research 
by the promise of free food and financial benefits without being told about the real 
implications of the research. According to a project officer who was working with Walter 
Reed at the time there were no records of the main complainant ever having taken part in 
the study cited in the article. Routine reports conducted by external study monitors also did 
not substantiate the article's claims. After further investigation by Walter Reed it was 
determined that those cited in the article were influenced by a disgruntled former employee 
whose contract had not been extended. This conclusion has become the widely accepted 
narrative used by researchers to explain this incident. 
Of note in terms of this episode in the historical narrative is that local residents do not 
always differentiate between research groups. Furthermore both CDC and Walter Reed are 
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American research units that work in collaboration with KEMRI. Hence, while KEMRI/CDC 
was not directly implicated in these events the incident drew attention to the need to 
rethink the way in which community relations were organised across the research 
programme. 
By the middle of 2004 the Community Studies Head left this position to coordinate a large 
malaria drug trial in Asembo. Therefore KEMRI/CDC advertised for a new community liaison 
officer (CLO) to be primarily responsible for coordinating community relationships in all of 
the study areas. The idea was to narrow the remit of this type of position so that the officer 
would not have any direct responsibilities for studies. The CLO's main duties were to 
strengthen community relations, oversee the work of VRs, be a point person for CABs and to 
support study coordinators in their interactions with local communities. A male Kenyan of 
Luo origin with a background in secondary school education in Kenya and the UK was 
appointed as CLO in 2005. Shortly after he took up this position the American leadership at 
KEMRI/CDC changed. The previous senior scientist, who is a clinician with expertise in 
malaria, returned to CDC's main offices in Atlanta, and a female epidemiologist with a 
science doctorate took over in September 2005. The scope of the KEMRI/CDC research 
programme had grown substantially in the five years prior to her appointment. Previously 
malaria research and demographic surveillance had been the main foci of activities at 
KEMRI/CDC; however the portfolio had expanded to included HIV research in 2001, 
international emerging infectious diseases (IEIP) in 2004, and Tuberculosis in 2004. When 
the new senior CDC scientist arrived the KEMRI/CDC programme was organised into 5 
research branches: Malaria, HDSS, HIV, IEIP and Tuberculosis. Each branch had a scientific 
lead and therefore, unlike previous CDC leaders, she did not have to balance leadership and 
management responsibilities with providing detailed oversight of individual studies. 
According to an American investigator this allowed her 'to lake a global look at the program 
and address deficiencies' (RS, 13). Of pressing priority in this respect was the need to 
support the work of the CLO, and to identify ways of responding to increasing demands for 
accountability at community and district levels. 
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'Um, so Matthew (CLO) was actually hired right before I came and he was hired because 
there were issues and everybody, felt they needed a centralized community person so I don't 
know all the pieces before I came, but certainly the like heavy dutiness of it, and like 
Matthew's constant meeting with everyone has and was only really started when I got here 
and has only increased year by year like where we learn, oh we need to include the city 
council chairman and so now we need that meeting, and we need to include the teachers and 
we need to include these opinion leaders and those people we have to do a courtesy call to 
the DC (District Commissioner), all that has been like in the last couple of years of learning 
who feels like we are not totally including them. I think that generally the relations are much 
improved like Linus (previous CDC director) said to me that he thought, you know, because 
he was here before that, that relationships in the community were very much improved and 
also it's been an education process for the community of who KEMRI/CDC is and all the 
research. I mean ten years ago things were brand new in some communities so a lot of it has 
just been getting used to KEMRI/CDC, not necessarily any of the efforts we have made. ' 
Senior American Scientist, RS 14 
This excerpt from an interview with the CDC director suggests that encounters between 
researchers and the lay public are now characterised by mutual learning and familiarisation; 
researchers become skilled at negotiating obligations and community members are exposed 
to and get used to the technicalities and benefits of research. It also makes several explicit 
statements about the direction of inclusion and agent of inclusion. In this excerpt the CDC 
director repeatedly says that 'we' need to do such-and-such in order for different groups to 
feel included. This suggests that KEMRI/CDC has become the agent of inclusion and that 
community liaison activities are directed from the research institute to the community. 
However as I will expand on in chapter 9 community leaders - 'gatekeepers' - have also 
started to demand more accountability from KEMRI/CDC and other research institutes and 
non-governmental organisations working in Siaya District. 
In continuing conversations it was very apparent that the CDC leadership places much 
confidence in information dissemination as a means of smoothing the path of research and 
overcoming hostility. This was the rationale for developing a communications team under 
the leadership of a female Kenyan graduate communications specialist who was appointed 
in October 2007. Over the past three years this team has produced a wide range of 
publications (see chapter 5 for more detail) and worked with field staff and scientists to help 
them communicate more effectively with local and national stakeholders, including the 
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media. The following quotation aptly illustrates the drive to produce written materials 
which can reach everyone. 
.... we have the brochures we have that community newsletter, we haven't had very many 
issues yet but um the idea of that is that you know, half in Luo and half in English, I mean it 
is both in Luo and in English. To really give and like just flood the community because the 
thing that most worries me is that you somehow you reach this set of people and you never 
reach this set of people whether it is the men, whether it is just the people who are working, 
and then you find from them that they think that they have never been reached, and that we 
have never reached them and so they give this impression that somehow we are not 
communicating, you know, so there is a disconnect because we don't somehow reach 
everybody. We reach probably some people all the time [yeah] and then probably another 
group of people never and so if we do more of the written materials it seems to me that if you 
just have it in every household, somehow you are communicating, you know, more. ' 
Senior American Scientist, RS 14 
The underlying questions about communication, inclusion and disconnection articulated in 
these interview excerpts have a significant bearing on KEMRI/CDC's current approach to CE. 
They also resonate with a recurrent theme in this chapter, namely the influence of 'the 
exercise and experience of control in the conduct of research' on the practice of community 
relations. 
Growing Presence and Visibility of KEMRI/CDC 
The growth in research activities, in particular community-based studies, the development 
of the HDSS and the increased employment of local residents have all resulted in 
KEMRI/CDC becoming more visible at community level. The majority of employees are 
Kenyan and many originate from the areas where research is taking place. In fact in order to 
qualify for some positions applicants have to be local residents. This is the case for FWs who 
support the day to day running of trials. These positions are very sought after at community 
level and the application process is very competitive. Applicants need to have completed 
secondary school and achieved at least aC grade in their final examinations. Positions are 
advertised on notice boards at chief's offices, clinics and hospitals. These notice boards 
were erected by KEMRI/CDC in response to requests for more transparency about 
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employment practices and opportunities. The notice boards are used to advertise a range 
of employment positions not just those available at KEMRI/CDC. 
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Notice Boards at Chiefs Camps in Siaya District 
(Acknowledgement: G. Jones) 
Employment opportunities are scarce in the rural communities where KEMRI/CDC works. 
Hence many people and in particular school leavers aspire to work with KEMRI/CDC. In fact 
job applications, short-listing and interviews represent another form of CE; one which is 
characterised by aspiration, imaginations of opportunities and in many cases 
disappointment. 
FWs are employed on annually renewable contracts and undertake a range of duties. These 
include home follow-up of participants, data and sample collection, recruitment and 
consent activities and any other work delegated to them by fieldwork supervisors and study 
coordinators. To complete their duties FWs move from place to place by motorbike or 
bicycle making them very visible. They also mix socially with their local community which 
serves to increase awareness of KEMRI/CDC. A case in point is a traditional healer, who first 
learnt about KEMRI/CDC when a fieldworker came to him for help in a personal matter 
unrelated to physical health. 
94 
Photos 6&7: 
While there is no official career structure for FWs some have benefited from further internal 
training and gone on to become study coordinators and investigators in their own right. 
Whilst it is a general policy to employ local residents as FWs they usually do not operate in 
their immediate home areas. Questions of confidentiality have led to FWs being stationed in 
adjacent areas where they are less well known. From a community perspective it is very 
important that young people from local areas are not disadvantaged in terms of 
employment possibilities. Community members voice a strong preference for FWs to 
identify themselves as coming from the area, to be native Dholuo speakers and to 
understand the local environment and cultural context. 
The way in which KEMRI/CDC has become part of the fabric of the community has fostered 
community relations in a positive manner, although as noted earlier in this chapter 
discontent amongst local staff can have negative repercussions. Overall however a strong 
local presence does seem to have served to familiarise people with the idea of research; a 
notion which I will explore further in subsequent chapters. 
Discussion of the Main Themes 
Two core themes arising from this chapter are the experience and exercise of control in the 
conduct of research, and the 'direction' of interactions between researchers and 
communities. Who is responsible for community relations, who initiates relations, who 
includes whom and why, who manages ensuing communications and what is the nature of 
this conversation, is it one or bi-directional? 
Looking historically we first encounter control in the social and cultural etiquette and official 
protocol international and national researchers have to observe in order to gain access and 
obtain permission to conduct trials. Whilst this implies that district authorities and 
community leaders command significant control it is also important to remember that 
researchers possess significant leverage since trials are generally well resourced and more 
often initiated and directed by researchers. In Saradidi these questions did not feature to 
the same extent since, in keeping with the participatory ethos of the health and 
development programme, the locus of control already lay with local residents. International 
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researchers were invited by community leaders to support the programme and they worked 
in close partnership with national mentors. Research was viewed as a core component of 
the health projects and the primary aim of research activities was to help the programme to 
achieve its goal of improved health for local residents. The fact that research operated 
within a locally developed and managed infrastructure helped to address any potential 
barriers or perceptions of disconnect between researchers and the public. The direction of 
interactions was two-way and researchers were accountable to the local programme board. 
A gradual shift occurred in the 1990s when KEMRI/CDC started to conduct large externally- 
funded trials which prioritised research outcomes rather than the delivery of healthcare. 
These trials required a different type of infrastructure and no longer operated within or 
alongside rural health projects. The intensification of research and the development of the 
HDSS directly affected how control was exercised. Pre-existing nyamreche or community 
health workers became facilitators of research rather than agents of change and 
communities became hosts rather than co-initiators of research. This, coupled with the 
advanced technology associated with clinical trials, expatriate leadership and the CDC logo 
on a fleet of vehicles fuelled the perception within communities of research emanating from 
'elsewhere'. 
The research agenda was now mainly driven by scientists based at the expanding research 
facilities on the outskirts of Kisumu. These scientists worked closely with local field workers; 
however they were primarily accountable to external sponsors, ethics committees and 
regulators. This meant that community members living in the areas where studies were 
taking place were no longer actively involved in initial or ongoing decision-making about 
research. This disconnection resulted in incidences of community resistance, a form of 
passive control, and contributed to rumours which have been described as a symptom of a 
potentially problematic relationship between community and researchers (Geissler and 
Pool, 2006b). Researchers recognised that they had to start to do more than just observe 
inherent 'community entry' protocols in order to secure ongoing community acceptance 
and meet recruitment targets. To this end existing and new staff were delegated specific 
responsibilities for strengthening community relations, managing VRs and developing new 
ways of involving community members in discussions about research. 
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Thus within the period of 30 years the KEMRI/CDC research programme in Nyanza Province 
has evolved from early involvement in local community-led health programmes into a global 
enterprise. Moreover, while science was an intrinsic part of the Saradidi community health 
and development programme from 1979 to 1989 currently the scientific component is more 
externally applied and therefore separate from the community. This disjuncture is explicitly 
evident in community members' initial responses and recurring misgivings about the HDSS. 
The notion of community has also changed. Whereas once the community was a resource or 
the source of change, now it is portrayed as a potential problem and a crucial partner. 
In practice this gradual but marked evolution has meant that researchers have had to learn 
how to make a place for science in settings where encounters between scientists and their 
lay and professional public is overlaid by differential access to resources, technologies and 
expertise. This too has driven the need to focus even more attention on CE. Comparing the 
structure of community relations between 1979 and not, it is evident that CE today is very 
different. Because of the external origin of both studies and the science involved, CE today is 
much more about researchers reaching out to communities rather that the two meeting as 
partners on an equal footing. 
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Chapter 5: 
The Framing of Community Engagement at KEMRI/CDC 
'The community are those that seek our services, those whom our activities affect out there 
in the field, and even where our infrastructure is situated, and the people 
we interface with on a daily basis as we do our work' 
Senior Kenyan Scientist 
Introduction 
This chapter examines how community engagement (CE) is framed and organised at 
KEMRI/CDC. To do this I firstly provide an overview of the organisation of CE, conduct a 
review of the terms of practice, give an account of the personnel involved and outline the 
main methods used in CE. Secondly I consider how researchers' cultural and social 
conceptions and assumptions about the local community shape CE and serve to demarcate 
a boundary between the practice of research and the place where research is conducted. 
The empirical data for this chapter are drawn from a wide range of sources including 
interviews and informal conversations with researchers, VRs, CAB members and community 
members, observation recorded in my field notes and source documents. My fieldwork 
primarily focussed on the rotavirus vaccine trial (RVT) and the malaria vaccine trial (MVT) so 
most of the social situations I use to illustrate points relate to these trials. However during 
the course of my fieldwork I also gained insights into core issues of relevance to the practice 
of CE which apply across the KEMRI/CDC programme. These pertain to the distinction made 
by KEMRI/CDC personnel between the research community and the community where 
health research takes place, and the understanding of CE as a mode of interaction between 
these communities. 
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In terms of sequencing, this chapter complements the historical review narrated in chapter 
3. Specifically it seeks to describe how researchers are currently engaging the 'community' 
in projects which promise access to medical technologies, such as childhood vaccines which 
could, if proven effective, reduce mortality and morbidity against prevalent diseases. It also 
explores some of the drivers for CE and some of the challenges and complexities 
encountered in CE. Not least amongst these are defining the practice of CE, and delineating 
what constitutes the 'community', and accounting for the norms and values of this 
community. 
Organisational Construction of Community Engagement 
In this section I explore the main terms of practice which are applied at KEMRI/CDC to 
describe the 'community' and community relations. I also consider the relationship between 
ethics and CE from the perspective of researchers. Then I provide an overview of the 
personnel involved in CE and their respective roles. Finally I outline the range of strategies 
which are used at KEMRI/CDC to engage defined groups within the community. 
Terms of Practice Applied in Community Relations 
Several terms are used to describe community relations in the KEMRI/CDC setting: 
'community liaison', 'community entry' and more recently 'community engagement'. A 
standard operating procedure (SOP) drafted in 2010 by the community liaison officer (CLO) 
with the support of quality assurance officers and others actively involved in community 
relations provides some insights into the subtle differences in how these terms are applied 
(see Appendix II, Doc. 2). The term 'community liaison' appears in titles and job descriptions, 
and it conveys a notion of structure and organisation; for example there is a community 
liaison officer and a community liaison office. The term 'community entry' on the other hand 
is synonymous with the steps taken by researchers to negotiate access and obtain 
permission to conduct research in specific communities. The CE SOP suggests that 
'community entry lays the foundations for ongoing partnerships with key respected 
persons who represent the needs, concerns and wishes of the targeted community. The 
document goes on to emphasise the importance of continuing dialogue with these partners 
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in order to 'maintain community engagement prior to and during the course of a study: 
Hence in contrast with 'community entry; 'community engagement' is understood to 
represent longer term and more participatory interactions between researchers, community 
leaders and community members. 
The CE SOP provides less insight into how the concept of 'community' is understood and 
defined at KEMRI/CDC. It uses the terms 'the targeted community' and 'research 
community'and lists individuals and groups of people who live in or have a link to the areas 
where trials are conducted. To reflect further on this I have synthesised the main points 
from KEMRI/CDC personnel's definitions and interpretations of 'community' and related 
'community engagement'. 
Two central ideas were communicated about what constitutes a 'community': firstly the 
'community' is the 'place where we do this work'; and secondly the 'community' represents 
the 'people we interface with in the course of our work'. Who these people are varies 
depending on the interviewees' positions and frame of duties. For example an American 
trial investigator described how for her the 'community goes on and on' (RS 13) from trial 
participants, their families, those who live around them, right up to those responsible for 
national malaria control. In contrast those responsible for data collection in the field applied 
a tighter frame. 
'Ok, me when I just hear of the community the first thing that comes in to my mind is the 
people that I visit or that the community interviewer visits, the people that I keep on 
knocking on their doors, compounds day in day out to solicit for information irrespective 
of the source exactly, so they are just the villagers, exactly. 
Male Fieldworker, RS 07 
Staff members' thinking about 'community' was characterised by a differentiation between 
researchers and the general community. This distinction featured less amongst staff living in 
the areas where research was taking place, but even they described how the tools of their 
trade, bicycles and motorbikes, and their duties set them apart from their local community. 
Researchers based in clinics and hospital facilities and those responsible for collaborating 
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with Ministry of Health (MOH) counterparts also distinguished between the MOH 
community and the local community. 
'I guess 1 just think of it, I don't know, the place where we do this, so Siaya, you know, then I 
guess I think of it as the Ministry of Health community, I guess / think of it in those two 
ways. Sort of the [so you see kind of almost different communities out there? ], yeah, so 
when I think about who needs to know, you know it is the local community around the 
area where we are going to do it, it is the hospital community, it is the Ministry of Health 
community, then it is like the KEMRI/CDC community, people have to be informed, [and 
the government administration would that come under the local community? ], yeah I 
guess I would, like the chiefs and all that I would put under the local community. ' 
Senior American Scientist, RS 14 
The above quotation captures explicitly the strong undertone of 'those who need to know, 
an undertone which shaped many staff members' interpretations of 'community' and 
related 'community engagement'. The 'community' constitutes those who need to know 
about KEMRI/CDC research programme; those who participate or seek our services, those 
who live where we work, community leaders and official collaborators and who shape public 
opinion. 
Whilst the CE SOP (Appendix II, Doc. 2) does not explicitly define the term 'community, ' it 
includes a chart which differentiates between three main channels which should be used to 
facilitate 'community entry' during preparations for KEMRI/CDC studies. In this chart 
individuals and groups are categorized under three headings: 'Provincial Administration', 
'MOH and other Partners', and 'General Public'. The latter is used as a term to denote 
everyone else who lives in the area where KEMRI/CDC research is taking place. Conceptually 
this chart represents how the 'community' is imagined as constituting distinct groups. It 
contains a comprehensive list of individuals and groups but no further elaboration on how 
interactions with stakeholders from these channels should be framed. This may be because 
it can be difficult to convey practical and tacit knowledge in formal documents. This 
omission also serves to emphasize that documentation provides an incomplete picture of 
the practice of 'community engagement' or the understanding of 'community', which are 
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significantly influenced by the personalities, backgrounds and expectations of the primary 
Oayers both within KEMRI/CDC and outside. 
'(heKenyan staff member responsible for 'community liaison' in the RVT and MVT depicts 
community engagement' as a 'learning process' - an art rather than a science. Each trial has 
different features therefore it is difficult to apply a single model across the research 
programme. The approach to CE also has to be adapted in response to questions raised at 
community level, or bottlenecks experienced in the course of different trials. She described 
these as 'opportunities'to evaluate practice and commented on the difficulties of conveying 
experiential knowledge in SOPs and guidelines. 
'But I think the more positive thing, the positive things about it, you see like, it's also like a 
learning process we really don't have like everything on paper, so such opportunities also 
make you think like what should we do better [laughter] [yeah]. ' 
Female CL VT, RS 11 
In our interview the Community Liaison for Vaccine Trials (CLVT) employed the metaphor of 
a 'tool box' of methods which can be used to engage the community. She distinguished 
between a core strategy which applied conventional tools, such as barazas (open 
community meetings facilitated by administrative chiefs), engaging opinion leaders and 
working with VRs and CAB members; and an evolving strategy which was responsive to 
concerns raised in the course of trials and helped to devise new methods. 
V would confidently say that before, the strategy that we had was more like engaging the 
opinion leaders, the barazas the CAB and the VRs, but I think like also like having a 
problem or a concern raised in the community would also make you think of another 
strategy (to use) to turn out... a good example like was using the churches to pass the 
information across. That didn't come up until we had an experience in Ng'iya, then 
realizing like maybe fathers are not willing to participate or are not willing to have their 
children participate in the studies then you again think like how do we get these fathers, 
then the boda-boda issue came up. Then it also depends on the targeted group for example 
like Tuberculosis if think about it, the adolescent cohort, then you would think of involving 
schools, but you think of maybe Rota virus, malaria that the age group is young, then you 
think of maybe involving women groups so I think it also like depends on the study 
orientation. " 
Female CL VT, RS 11 
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In essence 'community engagement' is understood to be the process of 'a research 
community interacting with another community: Researchers assume responsibility for 
ensuring that community members know who they are, what they are doing and what 
involvement in research entails. The emphasis is on communication, sharing information, 
encouraging participation, gaining support and fostering a sense of community ownership 
or responsibility for the research programme. 'Community engagement' is also viewed as a 
means of dialogue and exchange which can help shape how research is conducted and 
address community concerns. A few people also talked about how 'community engagement' 
can provide a forum for discussing mutual benefits and the ways in which research can 
contribute to community development. 
The Relationship between CE and Ethics 
KEMRI/CDC staff members' interpretations of ethics included reference to externally 
applied ethics constructs, such as Good Clinical Practice (GCP) (International Conference on 
Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human 
Use, 1996a)4, professional codes of conduct and personal and community values premised 
on cultural norms and practices. GCP compliance was understood to drive the conduct of 
research with its emphasis on quality, safety, documentation and demonstrating respect for 
participants' rights. KEMRI/CDC personnel viewed GCP as something researchers have to 
abide by which is not of direct relevance to CE. In fact a case was made for ethics training to 
branch out and include more deliberation about the norms and values of researched 
communities. 
'.... the training we receive is basically... on how to do proper documentation, how to do 
good informed consent, how to fill out case report forms, report SAE's you know safety 
procedures and all that... But for me I would think ethics needs to go beyond that because 
there is that aspect of ethics in GCP which is good but now there is, you know, normative 
you know whatever, normative values of people which is also an ethical issue that needs 
also some kind of training which kind of has been neglected in the training, because, 
because the training that is done is just purely GCP. ' 
Male Fieldworker, RS 02 
4 Good clinical practice is a set of internationally recognised ethical and scientific quality requirements which 
must be observed for designing, conducting, recording and reporting clinical trials that involve the 
participation of human subjects. 
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The exchange of information between researchers and community members associated 
with CE was presented as a way of learning how to best apply a research protocol within a 
given community. GCP focuses on compliance with international standards whereas CE 
promotes an understanding of what is acceptable in the cultural context of operation and 
where conflicts may arise. Acceptability was talked about in terms of people's dignity and 
respect for their personal and community norms and values. Importance was also placed on 
transparency about the intentions and purpose of research and the need to account for 
community members' sphere of experience and related understanding. 
Synopsis of Terms 
This overview of the terms presents 'community engagement' as the way in which 
researchers interact with the researched community in order to raise awareness about their 
work and be responsive to issues which arise in the course of trials. CE helps researchers 
learn how to apply research protocols with due consideration of cultural norms and values. 
The use of the term 'community engagement' at KEMRI/CDC over the last 5 years reflects 
the perceived need to strengthen relationships and form partnerships with people who 
represent the communities where research is taking place. Chapter 3 described the shift 
from 'community entry' to 'community engagement' in more detail and underlined its 
significance for the ongoing success of the KEMRI/CDC research programme. Researchers 
believe that they have to be proactive about reaching out to 'those who need to know' and 
have tasked individuals with specific responsibility to ensure that CE is core to the 
KEMRI/CDC research programme. 
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Personnel: Roles & Relationships 
Here I provide an overview of all those involved in CE at KEMRI/CDC. In chapter 5I will 
expand on the perspectives and experiences of key personnel in order to shed light on 
pertinent questions, challenges and opportunities encountered in the practice of CE. My 
objective here is to depict the organisational structure and the different means of CE 
applied at KEMRI/CDC. 
Figure 2 below depicts the primary players involved in CE at KEMRI/CDC and illustrates their 
respective interrelationships. Table 2 below provides an overview of the qualifications 
required for paid positions and outlines the related working conditions. Whilst overall 
responsibility for the coordination of CE lies with the CLO (highlighted in yellow) it is evident 
that many others play a significant role in shaping community interactions. Particularly 
important are FWs who collect data at community level and those who have been delegated 
study-specific community liaison duties by their line managers. The support, vision and 
visibility of the KEMRI Centre for Global Health Research (CGHR) Director and the CDC 
Director also influence practice, as do decisions taken by research branch chiefs, principal 
investigators and study coordinators about trial logistics, the involvement of local 
collaborators and the recruitment and follow-up of participants. The recently formed 
communications team also supports CE by providing materials which can be used to 
facilitate information exchange at community level. To quote a senior American scientist (RS 
14) '... everyone plays a role, but the CLO most formally' 
Figure 2 includes village VRs and CABs since they play an active role in facilitating the 
KEMRI/CDC research programme. Their respective shapes and lines of relationship with 
personnel at KEMRI/CDC are marked in green to differentiate the more informal nature of 
these relationships from the formal lines of accountability which exist between members of 
staff. I provide some detail about VRs and CABs when I outline the main means of CE applied 
at KEMRI/CDC, but I will expand more fully on their roles in chapters 7 and 8. 
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Table 2: Working Conditions & Stipulated Qualifications for Paid jobs at KEMRI/CDC 
Positions Qualifications Required Working Conditions 
CDC Director PhD or similar, publications Housing, Diplomatic Passport, 5 
track record, direct hire from year renewable contract 
USA 
CDC Senior Scientists MD, PhD or similar, Housing, Diplomatic Passports 
(including branch directors) publications track record, Renewable contracts 
Direct hire from USA 
KEMRI Director PhD or similar, good Long term contract, 
publications track record, government position, security 
extensive experience and pension 
KEMRI Senior Scientists Masters or PhD, publications Salary determined by 
(including brand directors) record, relevant professional qualifications & length of 
and technical experience service, government positions, 
pension 
International Scientists Depends on the job, Contracts are negotiated, some 
qualifications, professional are paid as consultants 
expertise which is not readily 
available in country 
Technical Middle Management: Bachelors degree, or a relevant Annual renewable contract 
Study Coordinators medical or nursing Salary scale determined by 
Fieldwork Coordinators qualification, professional level of qualifications and 
Clinicians with management expertise and experience length of service, pension 
duties contributions are payable at 
Regulatory Staff the end of the year 
Quality control staff in the field 
Community liaison leads for 
trials 
Behavioural or Social Scientists 
Clinical Research Staff working Nationally recognised nursing Annual renewable contract 
in the field, at clinics and or medical qualification, Salary scale determined by 
hospitals where the trial are professional experience and qualifications and length of 
taking place expertise. service, pension contributions 
are payable at the end of the 
year, no fixed pension or job 
security 
Fieldworkers Form 4 Leavers with good Yearly renewable contracts 
grades (Last year in secondary Locally competitive salary 
school), resident in area where 
research taking place, speak 
Dholuo 
Village Reporters Resident in area where Casual staff paid set hourly or 
research taking place, daily rates for delegated tasks 
respected locally, able to read and meetings 
and write (in English), basic 
knowledge in public health, 
willing and ready to work 
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Means of Engagement 
Here I describe the different means of engagement which are used by KEMRI/CDC personnel 
to interact with the 3 community channels cited in the CE SOP. These are the 'Provincial 
Administration', the 'MOH and other Partners', and the 'General Public' (i. e. applied as a 
container for everyone else). The nature and format of interactions between respective 
representatives will be expanded on in more detail in subsequent chapters. 
1. Provincial Administration 
The provincial administration channel ranges from the Provincial Commissioner down to 
chiefs and village elders. At senior level collaboration mainly consists of official 
communiques and occasional formal meetings between KEMRI/CDC directors and the head 
of the provincial administration. Previously interactions at district level mainly targeted 
chiefs. More recently increased attention has been paid to improving communication 
between the district officials and KEMRI/CDC staff operating in their areas. The CLO now 
provides the district commissioner (DC) with monthly updates and attends relevant district 
level meetings. Chiefs are still viewed as important gatekeepers and accordingly receive 
training about some trials and attend an annual meeting at the main KEMRI/CDC offices. 
2. Ministry of Health and other Partners 
This channel includes the provincial and district directors of medical services and public 
health, the district health management team (DHMT), health facility committees and non- 
governmental and community-based organisations that provide health services. 
Collaboration with high level government officials is mainly the premise of the KEMRI/CDC 
directors and senior investigators and comprises formal meetings to draft memoranda of 
understanding. These types of agreements are also drawn up between health facility 
committees and KEMRI/CDC with the assistance of trial managers. Researchers also meet 
regularly with the DHMT, and collaborators who provide significant clinical oversight are 
sometimes included as co-investigators on research protocols. Relationships between 
research and regular staff members within clinical settings are less formal and are 
influenced by lines of accountability, communication, work load, organisational culture, and 
access to resources. At district level researchers are required to attend quarterly health 
stakeholder forums which are chaired by the DC and organised by representatives from the 
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ministries of medical services and public health and sanitation. These forums aim to 
strengthen accountability and improve communication between community leaders, 
government and non-government health service providers. They were introduced in 2008 
as a governmental initiative to seek to respond to and coordinate the growth of non- 
governmental organisations and research groups active in the district. 
3. General Public 
The term 'General Public' is used in the CE SOP as a way of capturing everyone who lives in 
the places where research is being conducted. It refers to the constituents of the 'local 
community' and indeed this may be a more apt term for what is meant here. For the 
purpose of this outline I will differentiate between CE activities which target parents of 
potential participants and those which target the whole local community. I also provide a 
brief outline of the role of two key community intermediaries - VRs and CAB members - in 
these kinds of interactions. 
I. Village Reporters 
Designated village members have been involved in the implementation of research since the 
start of the KEMRI/CDC collaboration in 1979. They have been particularly valued as a 
means of creating inroads for researchers because they are trusted by other community 
members. The term 'village reporters' was applied to this group when the Health 
Demographic Surveillance System (HDSS) was established in 2001. A VR is essentially an 
individual selected by the community members after meeting specified criteria ('be 
respected members of the community, be able to read and write in English, have a basic 
knowledge of public health, be willing and ready to work) to support the implementation 
of KEMRI/CDC projects and studies. They are casual employees who perform delegated 
duties for the HDSS and 'are engaged by projects on a need basis' (VR SOP-Appendix II, Doc 
3). VRs are viewed as central to CE and work closely with community liaison staff and 
facilitate information exchange about KEMRI/CDC projects at household and village level. 
They are described by the CLO as 'the interface of KEMRI/CDC at village level' and are 
expected to represent the work of KEMRI/CDC in their villages. Whether this equates with a 
more anthropological understanding of 'embodiment' is debatable since to all intents and 
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purposes VR's immediate bond is to their home and their land. However they carry their 
material symbols of belonging to KEMRI/CDC proudly. 
Photo 8: Informal Discussion after a VR Meeting 
II. Community Advisory Boards 
CABs are a more recent form of community representation at KEMRI/CDC. The first CAB was 
set up in 2004 and now there are 4 CABs functioning in the main areas where KEMRI/CDC 
conducts research (Kisumu, Asembo, Gem and Karemo). CAB members are nominated by 
community members and represent a broad cross-section of the local population. Their 
mandate is to foster partnership between KEMRI/CDC research teams and the local 
communities participating in KEMRI/CDC conducted studies to benefit advancement of 
research and the community'. They are asked to advise researchers on how to approach 
certain issues and to provide them with feedback about communities' views and 
understanding of research. They are not supposed to mobilise communities for participation 
but rather to act as a resource body within their locations. This involves facilitating 
connections and organising exchanges between community-based organisations and 
community liaison staff. CABs meet quarterly and their agenda generally includes updates 
on KEMRI/CDC activities, overviews of new trials and feedback from CAB members about 
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community perspectives. These meetings are attended by study coordinators or field 
supervisors for the HDSS which means that there is limited interaction between CAB 
members and FWs. Indeed there is limited opportunity for VRs and CAB members to meet in 
a formal capacity. As a result they tend to work in isolation and not know much about each 
Photo 9: The Kisumu CAB (mainly serves the HIV Research Branch) 
Activities targeted at the general public or'local community' 
These activities involve presenting information about KEMRI/CDC research at community 
forums. Meetings can be open to all (as is the case of barazas) or can be restricted to 
members of specific groups or professions. The nature of the meeting determines the 
content of the presentation and the seniority of staff who attend. 
" Barazas organised, called and chaired by chiefs and assistant chiefs 
" Village gatherings organised by village elders 
" Presentations at church services and meetings 
" Talks/oral presentations at community-based organisations & women's groups meetings 
" Formal presentations at forums for head teachers, opinion leaders and local politicians 
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others' duties and responsibilities as regards CE. 
Chief's and assistant chief's barazas were the primary venues for public contact between 
community members and representatives from KEMRI/CDC. Barazas are open community 
meetings which are facilitated by a chief or an assistant chief and are attended by village 
elders and other community members. Barazas are the forum used by chiefs to disseminate 
information at community level. This information can refer to governmental policies, 
security, development initiatives or other local affairs. With the chief's permission 
individuals and representatives from various organisations or government offices can also 
used barazas as a means of publicizing their work, events, projects or communicating 
specific messages. Barazas are mainly held in the morning hours and mainly attract older 
women and men and some young mothers and children. Younger men are sometimes 
present on the periphery standing by their bicycles or motorbikes. 
Barazas take place outside a chief's offices or in a central place within a certain location. 
These places usually have benches, otherwise chairs are either bought from the chief's 
office or people bring their own. Women sit in groups apart from the men, and younger 
women mainly sit on the ground on lessor (colourful pieces of material which women tie 
over their clothes). I usually tried to sit with the women but more often I would be asked to 
sit at the front, facing the meeting, on chairs reserved for the chiefs and visitors. On one 
occasions when I did sit with the women one of my male research assistants refused to sit 
with me; according to cultural norms he could not sit with the women on the ground. He 
could stand at the back near the women but could not sit with them on the ground. 
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Photo 11 & 12: Chiefs Baraza in Siaya Town, May 2009 
Activities targeted at parents/guardians of potential participants 
These activities involve more intimate discussions with parents and in particular mothers. 
They include oral presentations and follow-up discussions with individual mothers at health 
clinics, village meetings arranged by VRs and village elders, and home visits conducted by 
FWs and VRs. 
RE 
Photo 12: CLVT talking about the MVT before it started with a women's group 
Photo 13: Targeted meeting with mothers to boost recruitment after start of MVT 
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Cultural & Social Construction of the Community 
Here I consider how the way in which the 'community' is imagined, talked about and 
experienced by researchers demarcates a boundary between the practice of research and 
the place where research is conducted. Earlier in this chapter we learnt that a distinction is 
made by KEMRI/CDC staff between the local community where research takes place and the 
research community. This distinction prevails despite the fact that the majority of 
KEMRI/CDC's workforce originates from the local communities in which research is 
conducted. By joining KEMRI/CDC, local researchers obtain access into a new community 
and the exposure they gain from this, the tools of their trade, bicycles and motorbikes, and 
their duties set them apart from their local communities. This immersion into the world of 
science and local researchers' association with a modern project and a powerful 
organisation alters the way they think about the places where research is conducted. The 
community becomes framed as a place awash with 'cultural' beliefs and practices which are 
considered to be contrary to the exercise and goals of bio-medical research. Researchers 
cite stories about the use of traditional herbal remedies in the context of a trial, and 
suspicions and related rumours about study procedures which involve taking blood from 
research participants, as examples in case. 
International and local researchers acknowledged the need to respect community norms 
and practices and some suggested that more attention should be paid to understanding 
these in the practice of CE. At the same time this willingness to engage difference did not 
reduce their experience of a wide gap and potential contradiction between local culture and 
science. 
'Of course we have the GCP ethics, ok, you know that specify' the responsibility of the researchers 
towards the research, the researched community, there is that part of which is commonly known. 
But there is also something that we call normative, the norms and the morals of the society I mean 
of dealing with the people, like respecting their cultural beliefs and systems which at times could be 
conflicting to the interests of research... ' 
Male FW, RS 02 
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Despite this conscious emphasis on respect for different woridviews and experiences it was 
also apparent that researchers viewed rumours, which often arose as a community 
response to trials, as weird misunderstandings or reinterpretations of their work (see 
chapter 9 for a detailed discussion and analysis of these and other community responses). 
From the researchers' perspective, the strangeness of some rumours, in particular those 
relating to blood, demarcated the distance between research and community, and 
constituted the community as an 'other' which CE has to work on. This 'other' was also 
sometimes construed as potentially dangerous; for example FWs talked about themselves 
being at risk because of rumours and associated hostility. They argued that they should go 
into the field in pairs or groups because of the dangers of enraged fathers or superstitious 
natives, and research staff required to live in the community claimed risk allowance. These 
points serve to illustrate that the community is seen as something which is out there, quite 
strange and potentially dangerous which has to be brought into contact with science by the 
means of CE. 
Another prevailing view of the community, closely related to accounts of 'irrational' rumours, is 
that people out there do not understand what researchers are trying to achieve; they are 
not enlightened and have a limited knowledge of science. This helps to explain the 
emphasis placed on information exchange in CE at KEMRI/CDC. Researchers felt compelled 
to explain science to community members in order to overcome popular suspicions about 
the purpose of research and particular trial procedures. To try to bring the community on 
board and counteract rumours about the withdrawal and use of blood in research, 
researchers employed series of interventions. These included blood demonstrations, talks 
by mothers who had taken part in research before and research facility and laboratory visits 
for chiefs and CAB members. 
Blood demonstrations were facilitated by community liaison team members with occasional 
assistance from clinical trial staff, and they took place during chiefs' and assistant chiefs' 
barazas. In a demonstration I observed the community liaison team members used a bottle 
of red-coloured water to portray the normal volume of blood found in infants. She then 
contrasted this with the amount of blood withdrawn from infants during study visits by 
extracting 2mls of the red-coloured water from the bottle. In her commentary she 
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transmitted other facts about blood collection and used humour and interactive methods to 
engage her audience. In essence the demonstration explained the scientific process of 
venepuncture with some reference to the reasons for taking and testing the blood. As such 
it helped to clarify certain issues. On rare occasions however the blood demonstrations also 
led to further speculation when some onlookers thought the CLVT was using human blood 
in her demonstration. 
Another intervention used to address blood rumours in public meetings was to invite 
previous research participants to talk about their experiences. This idea was proposed 
during discussions between researchers about problems that the RVT team were facing in 
the field. The principal investigator (PI) of the Kisumu infant Breastfeeding Study, a trial 
seeking to reduce maternal-to-infant transmission of HIV, suggested that participants from 
his trial may be willing to help. During the course of this trial some of the mothers taking 
part had formed a support group and a few had become active peer supporters. The Pi's 
suggestion was discussed with these mothers and several agreed to support the RVT team in 
their efforts to address community concerns about blood. These mothers were from Kisumu 
so they travelled with the CLVT to prearranged meetings where they shared their 
experiences and helped to answer questions posed by community members. According to 
the CLVT their contribution was very valuable and offered a more personal, accessible and 
credible perspective than that given by researchers. 
The CAB also represented a way of overcoming boundaries and suspicions about 
researchers' intentions. CAB members helped researchers respond to concerns by alerting 
them to issues being raised in their communities, arranging forums for discussions and 
providing advice on who should address specific questions or rumours and how. CAB 
members and local chiefs were also given the opportunity to visit research facilities and 
laboratories. One of the main aims of these visits was to give chiefs and CABs the 
opportunity to see what happened with blood samples collected as part of trials. The hope 
was that they would then take this information back to the communities to help allay fears 
about what is being done to the blood. This intervention aimed at reducing the sense of 
distance and disconnect between the research enterprise and the local communities. 
Whether these interventions did achieve a rapprochement is another question which is 
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central to this thesis. It is also a question which depends on how rumours and related 
speculations about research are understood. An extensive literature documents the history, 
genesis and meaning of blood rumours in relation to medical research and other 
interventions which represent an intrusion into African society (White, 1993, White, 1995, 
White, 2000, Fairhead et al., 2006b, Geissler, 2005, Geissler and Pool, 2006a, Vaughn, 1991). 
White (1993,2000,1995) draws connections between blood-stealing stories and the 
political and economic exploitation which occurred during colonial and post-colonial rule in 
East Africa. Drawing on this work Geissler and Pool (2006a) suggest that the 'blood stealing' 
idiom is a popular means of debating medical research and related political-economic 
exploitation. They describe how popular concerns about blood are a common response to 
medical research across the African continent, and how emerging rumours draw on local 
interpretations about the flow of resources and the cultural value attributed to blood. Seen 
in this way, rather than simply being misinterpretations of reality, rumours can embody a 
deeper popular critique of the distribution of the benefits of science and the boundaries 
which control resources in global health research. If this is the case then interventions 
which only elucidate practical aspects of the withdrawal and use of blood in research will 
not address underlying concerns about the exchange of value and unequal benefits. This 
observation is important to the framing and practice of CE at KEMRI/CDC, since it suggests 
that core questions which arise in response to bio-medical research are not always 
adequately discussed or dealt with in CE. The primary focus of CE in its current format is to 
redress practical misunderstandings communicated in popular critique rather than consider 
sufficiently the socio-economic context within which such criticisms are voiced. 
Discussion of the Main Themes 
The current framing of CE at KEMRI/CDC suggests that CE is about researchers reaching out 
to the community where trials take place, principally by conveying information and teaching 
laypeople about science. The local community is in CE presented as separate from the 
KEMRI/CDC community and in this formulation 'community' comprises: those who need to 
know about the research programme; those who participate in or seek services from this 
programme; those who live where research is taking place; and community leaders and 
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official collaborators who shape public opinion. Much emphasis is placed on information 
exchange, transparency about the purpose of research and reaching as many people as 
possible. Other potentially important aspects such as employment, health service provision 
and infrastructure-building are less emphasised. KEMRI/CDC personnel are tasked with 
fostering good community relationships, and particular personnel are delegated direct 
responsibility for communication, collaborating with community leaders, and forming 
representative bodies, which can help researchers to apply protocols with reference to 
community norms and values. 
CE is conceived of as being both a learning process and something that has to be planned 
carefully to mitigate possible discontent and the potential influence of cultural idioms and 
related blood rumours. These rumours influence researchers' thinking about the local 
community and further entrench boundaries and demarcations already drawn between the 
KEMRI/CDC community and the place where trials take place. Rumours are in and of 
themselves indicative of a boundary between researchers and the community and they 
have implications for how CE is framed and practiced. In chapter 3 we saw how the 
resurgence of rumour and related negative media reporting in 2004 resulted in the 
appointment of a CLO. In this chapter we have seen how rumour is conceived of as a threat 
to the research programme which must be dealt with in CE. Particular interventions are 
developed to overcome concerns about the withdrawal and use of blood in research. But 
whether these practical interventions achieve their purpose is questionable, since they 
emphasise practical points and arguably do not pay the necessary attention to deeper 
underlying concerns about unequal exchanges. 
From the present organisation of community liaison at KEMRI/CDC CE appears to be 
conceived of mainly as a tool to achieve smooth operation of trials and to counter negative 
rumours and opposition; the principal means to this end are thought to be information, 
knowledge and increased familiarity with science. 
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Chapter 6: 
KEMRI/CDC Staff Perspectives on Community Engagement 
'... it was just winning their trust, and being honest with them, who you are, 
whatyou are doing, I am part ofyou we can all work as a team, 
we are here to help your children... ' 
Community Liaison for Vaccine Trials, RS 11 
Introduction 
This chapter considers how CE is practised and socially constructed at KEMRI/CDC. To do 
this I will recount the experiences of five groups of key personnel who operate at different 
levels of the research programme. These synopses will facilitate an analysis of the social 
construction of CE and shed light on important challenges and tensions encountered in the 
practice of CE. The empirical data for this chapter were drawn from a series of interviews 
with 19 researchers, informal conversations with KEMRI/CDC personnel and observations 
recorded in my field notes. In places I also draw on interviews with community 
intermediaries to illustrate particular realities. 
This chapter demonstrates that the definition and application of the terms 'community' and 
'CE' are fluid and are influenced greatly by individuals' spheres of activity and 
responsibilities. There is significant pressure to present the research programme in a 
positive light and to manage community relations in the best possible manner in order to 
achieve this end. This does not negate a participatory ethos; however, it raises questions 
about the overall aims and drivers for CE. 
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Social Construction of Community Engagement 
The following five synopses draw on the experience and thinking of different levels of 
personnel at KEMRI/CDC who are involved in CE. The aim is to facilitate a more in-depth 
understanding of the social construction of CE at KEMRI/CDC. I chose to focus on groups 
operating at different levels of the KEMRI/CDC hierarchy (see Figure 2, chapter 4) in order to 
capture a full breadth of perspectives. 
Level 1: 
Senior Scientists: 'The Face of the Research' 
The KEMRI/CDC public health and research collaboration programme in Nyanza province 
operates under the official umbrella of the KEMRI Centre for Global Health Research 
(CGHR). Physically the KEMRI-CGHR main office is based within a secure compound on the 
outskirts of Kisumu. This compound is walled and one has to pass through two gates 
manned by security guards to access it. Many different buildings are located within this 
compound; the KEMRI-CGHR main office is on the right as one passes through the second 
gate, the KEMRI/CDC main offices and scientific wing are housed next to these offices in a 
substantially larger and more modern building. 
Apart from the KEMRI/CDC programme it is important to remember that the KEMRI-CGHR 
hosts many other research programmes with international and national universities, the 
Wellcome Trust and World Health Organisation. The KEMRI/CDC programme is by far the 
largest collaboration in terms of personnel and funding and is managed by a senior 
American scientist employed by CDC. A senior Kenyan scientist is the Principal Investigator 
(PI) of research conducted as part of this collaborative agreement (CoAg) which is funded 
mainly from a budget provided by CDC. Within the CoAg system an accounts department 
manages funds, and all expenses must be approved by the highest ranking KEMRI-CGHR 
scientist. KEMRI-CGHR is the official employer of all national and some international staff. 
The role of CDC and other partners is to provide technical support in the implementation 
and management of research programmes are endorsed by KEMRI-CGHR. In practice the 
lines of accountability are less clearly defined and, in terms of access to resources, the 
relationship between KEMRI-CGHR and CDC is unequal. The KEMRI-CGHR offices within the 
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Kisian compound are less pristine, their internet system not as reliable as that provided for 
staff working for KEMRI/CDC and there are very few KEMRI-CGHR vehicles. Such 
differentials tend not to be voiced or discussed openly between collaborators although they 
are of significance to the partnership. 
The character and workings of the KEMRI/CDC collaboration are very important since they 
have a direct impact on the public perception of research programmes. They also have a 
bearing on how the senior scientists collaborate with colleagues and partners in the Ministry 
of Medical Services and Ministry of Public Health and Sanitation, the public administration, 
the political fraternity and other research bodies and non-governmental organisations 
working in public health. 
Senior scientists' main responsibilities in relation to CE include ensuring that research 
programmes are endorsed by the relevant national and provincial level government, 
medical and public health officials. This requires them to follow unwritten but established 
protocols and to meet and communicate regularly with these bodies and officials about 
ongoing research and planned projects. The leading scientists from CDC and KEMRI-CGHR 
concur about the importance of communicating the purpose of KEMRI/CDC programmes 
and activities in well-defined and clear messages. However there is limited discussion about 
how to present the face of the research' in a manner which reflects the nature of the 
collaboration as accurately as possible. Essentially it can appear that there is no joint agreed 
agenda on CE, and it is not always clear who has overall responsibility for the KEMRI/CDC 
research programme. 
At community level there is little doubt that CDC rather than KEMRI is perceived to be the 
fiace of the research'. This can be attributed to its higher visibility and perceived status. For 
example one chief described KEMRI as 'a place where research is done' and another 
explained that it was not until CDC came that the impact of research was felt at community 
level. It was only then that people became aware of the purposes and benefits of research; 
before it had been out of their sight. 
'It has been here for a long time and you know KEMRI being a government body it couldn't 
expand largely in the way the CDC now is working I don't know whether it was 
limited 
because of funds problem, or maybe personnel, yeah, because they were there before, but 
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we could not hear them in a wide way, the way we are now getting the CDC people coming 
and meeting people, interacting with our community'. 
Male Chief, CR 41 
Administrative leaders are aware that KEMRI is part of this expansion. The general public 
however tends to have a different perspective as a chief who is also a CAB member in 
Karemo Division shared with me. He explained that 'when you talk about KEMRI/CDC 
people like taking the last one CDC' so I asked him to tell me what they say about CDC. 
`What they say, is that the CDC is involving about treatment, and also what (has helped) 
most is that like CDC, when it came in operation in the village, most of the school leavers 
were really involved in employment, so that one also raised people's knowing the activities, 
people scrambling for the jobs. You know, the job opportunities are less, so they see that 
CDC has assisted the community by employing their children and that is a reality. And 
that's what they feel good about CDC. They don't talk about KEMRI employing but they 
talk about CDC employing, because KEMRI is silent somehow to them, you know, when the 
CDC start coming to the ground they say KEMRI/CDC but the last word people grab is 
CDC. 
Male Chief & CAB Member, CR 5 
This quotation suggests that community members pay more attention to CDC than KEMRI. 
Both social and physical factors contribute to this, for example the status conferred by 
employment with an international programme and the observation by a CAB member that 
'most vehicles that run around here are written CDC' (vehicles used in the field at the time 
of my fieldwork only displayed the CDC logo-this changed in 2011/12 and now most vehicles 
display a KEMRI/CDC logo). In relation to KEMRI it is rare for a staff member to introduce 
himself or herself as a KEMRI/CDC employee. Instead they tend to say 7 am with CDC'. A 
district official also pointed out to me that the origin of the funding and the nationality of 
senior technical personnel help to explain why awareness of CDC is more pronounced at 
community level and why people tend to view research as something foreign. 
On the ground CDC is also often mistaken for a non-governmental organisation due to the 
free treatment and good care provided to trial participants and its programmatic work in 
supporting HIV care and treatment across Nyanza Province. Through the Global AIDS 
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Programme, which is financed by the US Government, CDC provides anti-retroviral drugs, 
funding, training and supervision of support centre staff. Another factor which contributes 
to these perceptions is that senior KEMRI-CGHR scientists do not attend health stakeholder 
meetings or other formal public functions as often as do senior CDC scientists. The 
following quotation illustrates the importance that one of the senior CDC scientists placed 
on being known by people based in the communities where research is taking place. 
'But also, for example, at the chiefs' day when that chief said this is doctor "do you know" 
whatever, which was you know kind of funny but to me the message there, to me what 
liked was that he knew me [uhum] and that meant that what he was saying was that he 
knew me I had been out there. ' 
Senior American Scientist, RS 14 
The scientist was recollecting the time when a chief publicly referred to her as, 'Dr. Do you 
know, at an annual chiefs' day which took place at the KEMRI/CDC main offices. By using 
this turn of phrase the chief was alluding to the fact that this scientist frequently challenges 
people at public meetings to take an HIV test in order to know their status - i. e. do you know 
your HIV status? He made this remark in a positive manner and it was evident that he 
valued the scientists' interaction and presence at public forums. It does not necessarily 
follow that chiefs and other community leaders expect the same level of interaction from 
the KEMRI- CGHR leadership. In fact even though the highest ranking scientist is not as well 
known in person at district level he possesses inherent status by virtue of his governmental 
position. Nevertheless the differentials in interaction do contribute to the general 
perception that CDC is the face of the research' rather than KEMRI. 
From KEMRI's perspective this has repercussions since its senior staff members believe that 
if CE is done the right way the studies will be owned by 'them' and the 'community'. The 
KEMRI-CGHR leadership also voiced some hesitation about CDC's intensive interactions with 
community leaders because it can lead to expectations which extend beyond KEMRI's 
mandate. Of particular interest is what is meant by 'we' and 'them', how collaborators refer 
to joint endeavours, and who takes credit for outcomes or shoulders responsibility for 
failure. So whilst there is general support for forums which encourage discussion and 
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disseminate results there are questions about how CE might more accurately reflect the 
nature of the collaboration and the face of the research : This synopsis suggests that the 
practice of CE implicitly communicates something about the social organisation of science 
rather than just the nature and purpose of science. 
Level 2: 
Community Liaison Staff: 'Relationships, Marketing and Image' 
A Kenyan community liaison officer (CLO) coordinates community interactions across the 6 
geographic areas where KEMRI/CDC undertakes research in Nyanza province. His 
responsibilities include overseeing the work of the VRs, working with CABs, attending 
barazas and stakeholder events, and meeting regularly with government officials and local 
politicians in order to update them on the KEMRI/CDC research programme. In addition he 
facilitates the annual chiefs' day at the KEMRI/CDC field station during which chiefs receive 
updates on KEMRI/CDC activities, interact with senior researchers and visit research 
facilities and laboratories. As the central resource person he organises crosscutting events 
which are not limited to individual trials and works closely with principal investigators, 
project managers, study coordinators and other staff in planning trial-related CE activities. 
The CLO's main remit is to represent the broader programme. Consequently he is less 
involved in the implementation of trial-specific CE activities which tend to be facilitated by 
study coordinators, field supervisors or other designated team members. In the RVT a 
female member of the study team was assigned these duties. An American project manager 
reasoned that her status as a 'mama' and her background in teaching home economics 
allowed her 'to come alongside mothers easily'. I refer to this person as the 'Community 
Liaison for Vaccine Trials' (CLVT) since she continued to be responsible for CE in the MVT. 
The CLVT was actively involved in establishing a CAB for the RVT, and as a result she has 
developed a close working relationship with members of this CAB, which now serves all 
studies taking place in Karemo. Her other duties include creating awareness about the trials 
at community level, liaising closely with VRs who disseminate information at household 
level and maintaining good relations with chiefs and other community leaders. In the RVT 
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the CLVT also conducted home visits to address concerns which had arisen within the 
household or to follow-up infants who had defaulted from HIV care and treatment services 
or needed nutritional support 
The CLO and the CLVT present themselves as alternative public intermediaries between the 
community and the research institution. The nature of their interactions differs in significant 
ways. Broadly speaking the CLO represents KEMRI/CDC at a political level whereas the CLVT 
has closer contact with the general public and focuses on individual trials. These differences 
in roles may help to explain why one emphasises the importance of promoting a positive 
image, while the other stressed the value of rapport and gaining community members' 
trust. The CLO was keen to present how KEMRI/CDC is making a difference on the ground. 
For example, he described an initiative by which funds are set aside to demonstrate 
KEMRI/CDC's commitment to social responsibility. He likened this initiative to charitable 
activities undertaken by large commercial enterprises - thus introducing a marketing logic to 
the practice of CE. In practice many of these social responsibility activities rely on 
KEMRI/CDC staff contributing financially to support school outreach events e. g. in the form 
of prizes for drawing competitions. By contrast the CLO tended to stress that presentation 
the CLVT focused much more on establishing relationships which encouraged mutual 
understanding and joint reasoning. 
'Ok, my role basically is to promote the organization's positive image at community level, 
to generate community support and acceptance for our activities. I also play the role of 
being the spokesperson for the organization at community level. If projects have issues that 
they want to be disseminated in the community, I go down with the message properly 
packed that befits that particular audience, target audience, if there are issues arising from 
the communities like some legitimate concerns, their views, their feelings, their 
discomforts, their compliments about our activities, I also capture this and report back to 
the KEMRI/CDC management team. So I interface between the community and the 
organization, if there are issues or rumours, falsehoods, propaganda that also might 
emanate from our activities I have a plan, a rapid plan, response plan we mobilize our 
team on the ground and put the facts as they are, normally there are issues that the 
community, you know, issues of employment that keeps on recurring, issues of blood, you 
know so we go ahead and de-stigmatize. ' 
Male CLO, RS 01 
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'.... like you get to know your audience best and then from there you can judge how do I 
need to address these people, how long should I need to talk to them, so like lowering 
yourself to their standard in the sense that you don't really make them feel like you are this 
level and they are this level, but like we can all reason together and work together [so not 
like you were the graduate] of course like fine I am from KEMRI/CDC but when I come to 
the community we are all at the same level so I think just [is that a matter of how you 
speak to them or is it a matter of attitude? ] Ok, it's how you speak to them plus attitude, 
then time consciousness is one things I also really try as much as I can, because I realize 
like you tell them for example like I want to talk to you people at maybe 9am and you 
arrive there at 11, it is also respecting their time, respecting them, then I think slowly you 
build trust and you work very well with them. ' 
Female CL VT, RS 11 
The gender and personal strengths of the CLO and the CLVT played an important role in the 
division of their duties and the ways in which they approached their work. The CLO's gender 
and credentials allowed him to negotiate political and official forums with relative ease. On 
the other hand his position, responsibilities and gender all limited the level of interaction he 
had with community members, in particular mothers of trial participants. The CLVT in 
contrast was more able to come alongside the latter but had to put more effort into gaining 
the respect of local leaders. When presenting at barazas she found herself having to provide 
details on her marital status in order to establish her credentials. Over time, she believed she 
had succeeded in developing a good working relationship with chiefs and other local leaders. 
In terms of challenges relating to CE, both interviewees referred to different types of 
pressures that they experienced in the course of their work. The CLO described some of the 
problems he faced in trying to maintain regular contact and positive relationships with a 
growing number of stakeholders. Traditionally chiefs have been the primary focus of 
interaction. However the expansion of the KEMRI/CDC programme has resulted in increased 
demands for inclusion and accountability. For the CLVT 'the main challenge maybe to use 
one word, is at times the pressure you get from the community [pressure] pressure'. In this 
interview she was mainly talking about demands brought to her by VRs. The VRs were 
disgruntled about their limited involvement in the MVT and were saying you know the 
community liaison yes, she's refused to pay us'. In fact, although she found herself having to 
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manage VRs' complaints, the decisions about their involvement had not been her 
responsibility. Moreover she had been keen to engage their help in recruitment and was 
apprehensive that their non-involvement and possible indifference could have a negative 
impact on the trial. 
In my fieldwork it was evident that both the CLO and the CLVT attributed much value to CE 
as a means of promoting dialogue. Questions arose however about whether CE activities 
always succeed in providing equal opportunity for expression. The following quotation 
illustrates how the researchers' perspective can be prioritised even when the purported aim 
is to encourage involvement. 
'Community engagement simply means community involvement [which means? ] which 
means dialogue, meaningful, ongoing dialogue with the community. I am talking, you 
know, engagement means the research community talking freely, without fear of reprisal 
or intimidation, with the community, telling the community why they must be researched, 
how they will be researched, timelines, the outcome, the likely outcome, their benefits, you 
know, the risks involved, you know, and then the feedback process, so you engage, you are 
with the community, you work with the community. ' 
Male CLO, RS 01 
The above quotation frames CE as virtually a one-way street for the flow of information 
from researchers to the community. By contrast the CLVT repeatedly stressed that CE is not 
just a one-off event but an ongoing process which allows one to draw on different sources 
to learn about community concerns. She illustrated the latter by describing how the RVT 
team became aware of community misunderstandings about the travel reimbursement 
given to trial participants' mothers. The participants themselves expressed some misgivings, 
the VRs and CAB members recounted circulating suspicions about this payment and even 
health professionals at the clinics began to question the purpose of reimbursement. People 
simply were not used to being paid to attend a health centre. As a result they became 
suspicious about researchers' motives, particularly in relation to the collection of body fluids 
(blood and stool). The CLVT used this example to illustrate the variability that can exist 
between what is ethical and what is culturally acceptable. So, whilst travel reimbursement is 
generally considered to be an acceptable practice within a research ethics framework, in the 
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specific community where the trial was taking place it was not viewed as culturally 
acceptable. From this scenario we learn how CE can serve as vehicle for voicing and 
discussing diverse perspectives, promoting mutual understanding and familiarising 
community members with research practices. 
Level 3: 
Communications Team: 'Making benefits explicit' 
In October 2007 KEMRI/CDC appointed a Kenyan communications officer (CO) to strengthen 
internal and external communication across all research programmes. Initially she worked 
alongside an American communication specialist who had been sent from the CDC offices in 
Atlanta to support the development of this work. She was also joined by an American 
publications officer based at KEMRI/CDC who produced materials for the intranet and 
scientific posters. Since 2007 this communications team (CT) expanded to include a media 
specialist, a web designer, an administrative assistant and a series of interns. When it comes 
to CE the communications team and community liaison personnel are viewed by KEMRI/CDC 
as working together to achieve the same aim, albeit by different and complementary 
means. The latter prioritises face-to-face dialogue while the former uses various written, 
visual or oral media in order to facilitate information exchange. 
The CT's main strategy is to produce a wide range of publications including newsletters, 
informational leaflets, photographs and film clips to be used in CE activities. The 
publications are edited and mainly written by members of the CT although contributions 
from other members of staff are encouraged. In addition to this work the CT also supports 
community events such as the annual chiefs' day, dissemination of results meetings, and 
activities organised to mark World Malaria, World AIDS and World Tuberculosis days. 
Where the CT becomes more involved in face-to-face interactions is in media relations. Over 
recent years the CDC field station director had placed significant emphasis on promoting 
constructive relationships between KEMRI/CDC and the local and national media. The CO 
has been responsible for developing a more proactive stance. This has involved developing 
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closer relationships with journalists, providing the press with up-to-date and timely 
information about KEMRI/CDC programmes and helping staff respond to press enquiries. 
The CT runs regular media training for senior staff members and some research 
collaborators. This training is aimed at helping participants to manage media attention, 
communicate clear and well defined messages effectively and present themselves and their 
work in a positive light. 
In relation to community liaison the CO described her main role as facilitating information 
exchange by presenting science in a way that is accessible to lay people. She viewed CE as a 
process of interacting with the community, whereby they learn more about our 
programmes and are encouraged to participate, and we receive feedback about our work". 
The CO placed particular emphasis on the feedback angle and thought that more should be 
done to strengthen this aspect of CE. One of her American CT colleagues presented a 
slightly different interpretation of CE. He explained that CDC has an agenda when it is going 
into a community and therefore it has to think about how best to accommodate the 
community in order for the community to accommodate it. Implicit in this framing of CE is 
the question of benefits which the CO also commented on extensively in terms of how to 
communicate the purpose of science effectively. She argued that people need to see and 
understand how trials and demographic surveillance can make a difference to their daily 
experience. In the following quotation the CO contrasted a vaccine trial with a development 
project in order to illustrate how research can be experienced as something that is done to 
you, rather than something you participate in and reap benefits from. The sense of being 
removed from the purpose and outcome of research can lead to suspicion therefore you 
need to be explicit about potential benefits. 
'... another question that usually sort of comes up is maybe a lot of people, the community 
members don't understand at the end of the day how a vaccine trial is going to benefit 
them, you know, they are used to probably someone coming and having a development 
programme in their area where they can all develop within, where they can all participate 
in, you know, and see results within a few months, but this is a trial that going to take say 
three years, like for example the malaria vaccine trial, and after that it will take much 
longer for them to actually determine whether the vaccine was successful, you know, etc, 
etc, so you know, a lot of them have this mentality sort of that we are actually just helping 
these people do their work, you know, so they don't have that, actually that is one of the 
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problems that I saw when I first came in into this place. People are involved in our work, 
but they don't get how, you know, so it's like this 'so what' question, you know, I am 
involved in this study. So you come to, even our other activities for example, DSS where you 
come into my house and ask me questions, 'so what, you know. So we've been trying to sort 
of tell people that once, when you are going to talk to the community, make sure you 
mention how it is going to benefit them at the end of the day. It may look a bit far off but 
make sure you do, you know tell them thatyou are going be part of thisgreat thing that is 
going to get this, mightget this vaccine that will help millions of children, you know, things 
like that. So we sort of try and answer that question that way, but at the end of the day, 
you know, there is always that question lingering [so what? J yeah, so what? ' 
CT Member, RS 06 
The latter part of this quotation expresses the CO's commitment to communicating the 
human angle of science. She argued that in order to capture public interest one must show 
how scientific knowledge will benefit both the individuals involved and society in general. 
Hence in addition to making science understandable it was vital in her view to demonstrate 
how research can help improve people's lives. 
'I am making like for example, a brochure just needs maybe four sentences about the 
particular trial, and maybe a magazine would need like a full page or two pages. l come 
and work on it and I try as much as possible to relate it to the human angle, because if 
someone doesn't understand how they are benefitting from the knowledge of this 
particular study, then, they would not take much interest in it. So / know sometimes 
scientists would you know be really, you know, sort of strong on the science part but so I 
try to humanize it. ' 
CT Member, RS 06 
Review of a Community Newsletter 
In order to explore how the CT put into practice its commitment to making the benefits of 
research more explicit I reviewed an issue of a publication which is distributed quarterly at 
community level (Appendix II, Doc. 4). The publication is called the 'Dound Oganda' which 
means the 'Voice of the People', and it is referred to as 'A Newsletter for the KEMRI/CDC 
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Community'. The use of the term 'the KEMRI/CDC Community' is noteworthy in view of 
previous interpretations of community, cited earlier in this chapter, which tended to draw a 
line between the community wherein research takes place and the researchers who 
conduct it. 
The issue that I reviewed contains four short articles which appear both in Dholuo and 
English. Whilst my critique concentrates on the article about the RVT it is important to note 
that every article in this newsletter contains an explicit or implicit reference to benefits: 
teenage girls receive free sanitary towels as part of KEMRI/CDC's community social 
responsibility programme; pregnant women are offered hope in efforts to prevent malaria; 
and a long-serving Kenyan employee uses training he has received from CDC to make a 
difference in his home area. The discourse is purposeful and communicates a clear 
underlying message about KEMRI/CDC's positive contributions to the communities in which 
it conducts research. 
The article about the results of the RVT also focuses attention on what KEMRI/CDC has 
achieved, but with less emphasis on local benefits. The main message is that this 'incredible 
trial' has shown that the rotavirus vaccine could help to save the lives of thousands of 
children in Africa. Public support for this trial is demonstrated by the high turnout of 
participants ('hundreds of mothers and children') and community leaders at dissemination 
events. The fact that community leaders voiced concerns about the distribution of benefits 
at these events is not mentioned; nor does the article contain any vote of thanks to the 
participants and the local community. The article also assumes quite a high level of 
understanding of technical terms such as placebo, although it does explain what rotavirus is 
and how it can affect children. 
This issue of the 'Dound Oganda' is an example of how publications are used to present the 
work of KEMRI/CDC in a positive light. The choice of name is interesting since clearly the 
newsletter is not written by community members but by Kenyan staff working for 
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KEMRI/CDC. The use of colour photos and glossy paper communicates implicit messages 
about the status and wealth of the organisation. So whilst the publication succeeds at 
making benefits explicit by the use of stories to which local people can relate, it also draws 
attention to differentials in access to resources. Some stories can leave readers with 
questions about the distribution of benefits e. g. whether a long serving employee should 
have had the opportunity to attend a longer training course. 
Level 4: 
Trial Investigators: 'Control and critical awareness' 
Trial investigators are involved in making strategic decisions about how to approach CE in 
individual trials. To quote a senior American investigator, 'we came up together with ideas 
of how to involve, how to reach these people, what are the routes, and what are we going 
to say' (RS 13). Investigators described CE as a process of making sure that people have 
accurate information about a study, having staff out there to address questions 
immediately, meeting recruitment goals and encouraging community involvement. An 
American trial manager expanded on this by stating that CE was 'an attempt to give as 
much information about who you are, whatyou are there for, and the implications of what 
you are doing' (RS, 03). From his perspective communicating who you are is important in 
establishing trust and ensuring that participants understand that 'we are working on their 
behalf, more than on the behalf of the manufacturer'. This investigator who had lived in 
Kenya for over 5 years described CE as 'morally the right thing to do in an environment 
where education levels are low', and he placed particular value on forums which encourage 
critical thinking. 
'And being able to address a broader group of people where questions are generated that 
the subjects themselves may not think of brings some added benefit to the client, or 
possible client. Especially in this environment where education levels vary so much, 
sometimes you need have some level of education to ask an educated question. ' 
Male American Trial Manager, RS 03 
Interestingly there were subtle differences in the CE approach adopted by the MVT and RVT. 
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This was particularly evident in relation to the involvement of VRs. The RVT used VRs to help 
them spread the word about the study, provide feedback on community perceptions and 
remind participants about their appointments. The MVT team members however were not 
convinced that VRs should play a pro-active role in telling community members about the 
study. Unlike the RVT team they chose instead to use a leaflet to help disseminate 
information. Moreover the investigators doubted whether VRs even had the capacity to 
explain fully the content of this brochure. So they employed more FWs from the local area 
to help identify participants, sit with them and explain the process. The VRs were informed 
about the MVT as part of their regular meetings but they were not given extra training or 
delegated specific duties. This resulted in disaffection and raised questions about whether 
some VRs were misrepresenting the MVT at community level. For the trial manager this 
scenario highlighted the importance of the need to tread carefully with the community and 
the VRs when it comes to research. 
In terms of capturing and forming public opinion a senior MVT team member expressed 
concerns about the capacity of the CAB which had been established by the RVT. He was 
doubtful about how well it represented or infiltrated the community and called for a more 
strategic involvement of other leaders who could influence public opinion, such as church 
ministers and teachers. His reasoning is explicit in the following quotation. 
All we need from them is to understand what we do, because people go to them to seek 
information and as long as they do not understand what we do, then, they may notgive the 
right information and when the wrong information is out there, it influences a lot of 
communities' perceptions and even attitudes towards our work. ' 
Male Kenyan Trial Investigator, RS 04 
Questions relating to the accuracy, flow and use of information are of particular significance 
in this context. Researchers' attempts to control the exchange of information are evident in 
carefully edited and pre-scripted messages, in their choice of collaborators and in their 
reluctance to use certain forums as means of reaching potential participants. The following 
social situation illustrates the latter in particular. 
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Plans for a Launch 
With the active support of the trial sponsors' community liaison staff, the MVT and other 
senior staff had started to organise a launch to coincide with the start of the MVT. Its main 
aim was to reach the community where the trial was going to take place, provide 
information about malaria and explain the purpose of the vaccine trial. A senior scientist (RS 
13) was keen to encourage an informal ambience with activities for children, quizzes for 
adults and short presentations about key messages. She was keen to invite a broad cross- 
section of the community and recognised the importance of involving community leaders. 
Where she became reluctant was when she heard about plans to give local politicians the 
opportunity to speak at this event. She was worried about what they would say and how the 
community would react: 'I don't know how the community will respond but I don't want 
them to feel like I am going to be in this because my MP told me to be in this, when and I 
don't know what the MP is going to say...: She sought to argue against the involvement of 
politicians but Kenyan members of the organising team explained that 'once you put up a 
bouncy castle and a quiz show and then people will come, when people come and the MP 
isn't invited, they say it's like having a dinner party in your own home but you weren't 
invited'. So they tried to think about how they could prevent this event from descending 
into a political forum. The suggestion was made to invite a senior representative from the 
national governmental division of malaria control to chair the launch. The idea was that he 
could guide other speakers on the content of their presentations or even just formally 
introduce `the mayor and this person, this person, this person so they don't have to get up 
and say anything'. In the end, after several meetings and quite a lot of deliberation, plans 
for the launch were shelved and other more traditional and less potentially problematic 
forums were used instead to inform people about the start of the trial. 
The 'launch' social situation illustrates clearly researchers' hesitancy about CE-related 
situations that they feel unable to control or manage. In this example there was a real fear 
about what the politicians would say and how community members might have responded. 
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Whilst this is perhaps a more extreme example in reticence it serves to highlight some very 
important questions about impartiality. These questions also apply when it comes to the 
involvement of other community leaders and intermediaries. The benefits of involvement 
have to be weighed against the possibility that CAB members and other leaders could 
become co-opted and use their positions to influence others unduly. Investigators expressed 
concerns about this possible misuse of authority (although in other places they also stressed 
the importance of gaining community acceptance for research). 
'I want people to know about the study and choose the study because they want be in the 
study, and I am very concerned about having anything, where it is as though someone who 
is a figure of authority is saying, be in the study. ' 
Female American Trial Investigator, RS 13 
This suggests that among the main challenges facing those who make decisions about the 
application of CE are how best to manage, balance and resolve intrinsic tensions that arise, 
particularly relating to encouraging critical awareness, maintaining control, and reaching 
recruitment targets. 
Level 5: 
Fieldworkers: 'We are part of this community' 
Those responsible for data collection in the field stressed the importance of 'attachment' in 
community relations, and described their role as trying to bridge the gap between 
researchers and community. FWs from the local area described how they used their 
position as 'people of the community'to complement and strengthen CE efforts. Those from 
other parts of Kenya in contrast had to demonstrate an affinity with the local community in 
order to gain trust and be heard. 
'We went out, and like sensitization, as much as the community liaison officer was going 
around, but we were taking ourselves as now the people of the community, now talking 
about the same, but not by convincing them, just information [ok]. 
Male Fieldworker, RS 10 
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'I think it is, it, it, it resonates with the people because most people want to feel that they 
are part ofyou or you are one of them, you know, especially in this country you know when 
you go in and try and emphasize that you know I am not a stranger, this is who I am, this 
where I come from, I am part of you, you know, they tend to want to identify with you, so 
the more the people identify with you the better, the easier you will find it to communicate' 
Male Fieldworker, RS 02 
In the second quotation above the field supervisor stresses the importance of persuading 
the local community that you are not a stranger but one of them. According to local staff it 
is especially important to establish one's family credentials before one visits community 
members' homes or speaks at public forums. The more easily people can identify with you 
the less likely it is that they will view you with suspicion. 
.. and most of us also come from that community so you talk of the son of whom is the one 
who is coming you see [so they knew you or they knew your family? ] yeah, so they say if the 
son of whatever and he is always a good man then this is a good thing [okj he is not a 
stranger, but when you come with strangers to talk to the community they feel like there is 
something fishy, yeah. ' 
Male Fieldworker, RS 10 
Strangers were defined as those who could not demonstrate any 'attachment' to the local 
community, either by birth, residency, having attended school in the area, or by having an 
interest in and an understanding of the area. 'Attachment' was also measured in terms of 
how people approached the community, whether they were courteous and respectful and 
whether they worked closely with local people. This notion of 'attachment' is very important 
in relation to CE and KEMRI/CDC activities because of the prevalent tendency to view 
research as something foreign. The following quotation illustrates the significance of 
'attachment' in a very poignant manner. 
'Ok, there are some lines that we try to bridge [uhum] that is what I would say because, 
actually like when we went in part of the reason why most of these rumours came up it 
was because the community as Karemo, as Karemo community was now suspicious of us, 
as the CDC people going into them to research with them, so because of that, there tends to 
be that line now between them as a community and us as researchers. But it's our work as 
researchers going there to try and bridge that you know and persuade them that we have 
not come here for your harm, we have come here for, for, for your good. There is nothing 
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dangerous about us we are part ofyou, we are part of this community, you know, and um 
there is a concept we always have to emphasize when we go out that we are not strangers 
even when Igo to barazas, you know, 1 try to tell them that, you know, I am working for 
CDCyes, but that I am a Kenyan. And even when Igo down to Siaya, I am your neighbour 
from Kisii, you know, across, so I am one of you and I wouldn't come here to harm you, 
even if I am working for CDC but 1 wouldn't agree to certain things that would harm you 
because I belong to you know, I am part ofyou. ' 
Male Fieldworker, RS 02 
Clearly the ability to demonstrate attachment plays a vital and central role in facilitating 
research and overcoming barriers. By definition however attachment results in certain 
obligations which have to be negotiated. Most often this responsibility falls on the shoulders 
of FWs who build up close relationships with the families they visit over the course of a 
vaccine trial. They find themselves having to address expectations and explain KEMRI/CDC 
policies, which are not always well defined. Let us consider the example of a FW who 
accompanied a clinical officer to the home of a deceased trial participant in order to 
conduct a verbal autopsy. 
7 went there and the people came, the father was there and the mother and everybody 
else. So I was introduced to other people, these are, he is from CDC, from CDC, they are the 
people who took our baby, who were taking care of our baby. So it came out nicely that we 
had, we were taking care of the baby, and so 1 told them, yeah, we were taking care of the 
baby, the baby's health. And now because we had the baby and the baby had died we need 
to know exactly what happened, because there is a report we had to do and all that. And 
you see after that I was asked, so now what do you do? There are expenses we have had, 
what is the project doing with the expenses we have had when organizing for the burial 
arrangements, is there anything you can do? / had to tell them we really don't do much 
unless the baby died at the facility then we could do that [pay the bills at the health 
facility? ] yes at the facility but not at home. See they don't understand they feel that is 
quite inhuman, it's quite unlike our culture you just walk into our compound and all you 
want is information, and you walk away the baby had died, a real challenge. ' 
Male Fieldworker, RS 08 
The FW felt very uncomfortable about this scenario. Culturally and socially he empathised 
with the family but he also had to follow standard operating procedures. In such situations 
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FWs frequently find themselves reaching into their own pockets since '... our Luo tribe take 
it that if you go and somebody is having some problem, whatever you have just leave it 
there, a gift. ' (RS, 10) This sense of obligation can be contrary to research regulations and 
operating procedures but FWs' personal attachment to the local community compels them 
to respond. 
'Yeah we are not supposed in fact it is out of our protocol but you are also a human being 
(laughter). You are not supposed to do it, but it forcesyou. You get children they have not 
eaten from the other day and the mother went to the hospital and didn't come back. She 
didn't tell anybody that she was admitted they just got it that somebody told them that 
their mother is in Siaya. They don't have anything, you go there to get something, you 
leave them like that? No, you cannot. ' 
Male Fieldworker, RS 10 
FWs tend to view these types of contributions as a community responsibility that they 
assume and therefore they usually do not report this to their supervisors. Supervisors and 
clinical investigators are however aware of these difficulties and indeed encounter similar 
challenges in their own work. Frequently they find themselves assuming responsibilities 
beyond those stipulated in research protocols. For example, they go out of their way to 
provide nutritional supplementation for undernourished participants, and proactively follow 
up participants who have defaulted from HIV care and treatment services. Close 
engagement with communities and participants' families in this context requires all involved 
to negotiate boundaries of practice in a manner compatible with their personal moral codes 
and with reference to cultural norms and practices. 
Discussion of the Main Themes 
The character of the KEMRI/CDC collaboration and power dynamics as between 
representatives from the two organizations, and within the two organizations, influence the 
public perception of the research programme and relationships with external partners. 
Promoting a positive image, giving careful attention to the content of information shared 
with the media and general public, and demonstrating 'attachment' to the local community 
are core features of the CE approach at KEMRI/CDC. A marketing logic pervades the 
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practice of CE and much emphasis is placed upon drawing attention to the benefits of 
research and seeking to appear close to the community. 
It is evident that all levels of personnel have to grapple with and resolve, insofar as they can, 
certain tensions in the practice of CE. There is the tension of approaching partnership with a 
specific agenda which can result in unequal relations and restrict lines of accountability. 
Lines of accountability are also at the heart of tensions that exist between the desire to 
encourage critical awareness about research amongst members of the general public and 
the need to achieve recruitment targets and meet sponsors' demands. Researchers are keen 
to control the dissemination of accurate information about trials and are concerned about 
the need to minimise any undue influence of potential participants by community leaders. 
Before summing up, I would like to revisit the point relating to concerns about the 'face of 
the research' and the way in which the KEMRI/CDC collaboration is represented and 
understood at community level. This point is closely related to observations about the role 
of 'attachment' in the conduct of an international research programme. In chapter 4 we 
learnt that community members typically view research as 'foreign'. This perception can be 
reinforced by the presence of international staff and by national field staff who place more 
emphasis on CDC than KEMRI/CDC. On the other hand both community leaders and 
community members highly value official and personal interaction with international 
researchers. It is evident then that the extension of courtesy on behalf of expatriate 
researchers and 'being known' by community leaders both facilitate the smooth running of 
international research programmes. 
In chapter 4 we learnt how KEMRI/CDC rapidly grew into a global enterprise; here we have 
seen how this has resulted in the organisation and practice of science being set apart from 
the local community. This has propelled the need to engage, involve and reach as many 
people as possible in order to address any sentiments of disconnection. Researchers have 
also worked carefully at trying to demonstrate 'attachment' both by the employment of 
local staff and by creating inroads with community intermediaries. They have used these 
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connections in order to promote identification, trust, acceptance, understanding and 
communication. It is also important to highlight that disconnection and close engagement 
can coexist; so whilst the exercise of science is on one level demarcated from common 
experience it also reaches closely into people's lives. Community members develop close 
relationships with KEMRI/CDC personnel, and parents refer to their children as 'being with 
CDC'. In a context characterised by socio-economic constraints this 'attachment' implies 
responsibility and raises expectations for material assistance which researchers have to 
negotiate in the practice of CE. 
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Chapter 7: 
Village Reporters' Perspectives on Community Engagement 
'CDC/KEMRI, they network with the community through VRs, because we get the 
information from them, and then we bring to the villagers, and we get them information 
from the villagers to them. So we are the bridge between CDC and community because 
what they say in the community, we take to them and then what they want to do with the 
community, it is us to take it to the community. ' 
Female VR, CR 39 
Introduction 
In this chapter I present VRs' perspectives on community engagement (CE). First I describe 
who these people are, how they are selected and outline their official roles and remit. Then 
I explore how these relate to and compare with their personal experiences and the 
challenges they face in their work. Two groups of people act as intermediaries between 
KEMRI/CDC and the communities in which research takes place: VRs, and CAB members. In 
some respects both groups share a similar brief. However their status in terms of 
remuneration and who they are accountable to in carrying out their duties differs. VRs are a 
hybrid since they are not in the strictest sense volunteers, but nor are they 'contracted 
KEMRI/CDC employees'. They are casual staff who represent their villages, submit reports to 
KEMRI/CDC supervisors and receive payments for delegated tasks and meeting attendance. 
CAB members' brief is to foster partnership between the KEMRI/CDC research team and the 
local communities. They receive sitting allowances for meetings but are not answerable to 
KEMRI/CDC line managers in the same manner as VRs. it is also important to note that VRs 
have a longer history of involvement at KEMRI/CDC than CAB members who are part of 
more recent developments in the evolving way in which the organisation relates to the 
community. 
This chapter focuses on the perspectives of VRs and draws on empirical data from a series of 
interviews and a group discussion with 9 VRs. These interviews took place between May and 
October 2009 at a time when the RVT was coming to an end and the MVT starting up. VRs 
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were invited to take part in an interview during a meeting held for all VRs. One of the 
demographic surveillance team members introduced me to a representative group of VRs 
drawn from all the areas where the vaccine trials were operating. With the support of my 
research assistants I explained the purpose of my study to this group of VRs and asked 
whether they would be willing to participate in a series of interviews and whether I could 
join them on some of their home visits. All of the VRs we spoke to agreed to participate and 
we made appointments to visit them in their villages. This chapter is informed by the 
interviews held with this group of 6 female and 3 male VRs. it is also informed by 
observations made during household visits with these VRs and regular meetings between 
KEMRI/CDC personnel and groups of VRs. I also reviewed pertinent conversations and 
interviews with researchers and consulted secondary sources such as KEMRI/CDC figures 
and standard operating procedures relating to VRs. 
At this juncture I include a brief review of relevant literature which informed my analytical 
thinking for this chapter and the following chapter which discusses CAB members' 
perspectives on CE. Some of this literature has been cited in chapter 1 however here I look 
at it with a particular focus on questions of relational ethics. 
Review of Relevant Literature 
Community involvement in promoting and sustaining health was championed in the 
Declaration of Alma Ata on Primary Health Care (World Health Organisation, 1978). This 
Declaration stated: 'the people have the right and duty to participate individually and 
collectively in the planning and implementation of their health-care'. Community 
participation and self-reliance were stressed as being invaluable to achieving sustainable 
development. The Alma Ata recommendations were widely adopted in developing countries 
by policymakers, health professionals, funders and communities, and implemented to 
differing degrees with varying success (Oyaya and Rifkin, 2003, Rohde et al., 1993). 
The involvement of community members under various names such as 'village health 
helpers' or 'community health workers' was integral to Alma Ata and subsequent initiatives 
in developing countries prioritised the training and equipping of health volunteers. 
Despite a 
move away from community-led health programmes during the late 1980s there 
is now a 
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renewed focus on the involvement of such volunteers. The Kenyan MOH, for example, 
launched a strategy for the delivery of essential health services to the community in 2006 
which is premised on the involvement of community owned resource people (Ministry of 
Health, 2006). 
Community engagement and collaboration at community level 
Community-based volunteers also play a significant role in health research in developing 
countries, where they act as intermediaries between lay people and scientists. The 
involvement of community intermediaries reflects the increased attention paid to CE as 
means of protecting communities (Benatar and Singer, 2000, Benatar and Singer, 2010, 
Emanuel et al., 2004). In a framework developed by Emmanuel et al. (2004), collaborative 
partnerships between researchers, health policymakers and the community are conceived 
as being a way of ensuring that research is ethical. In practice, CE is defined as 'a process of 
working collaboratively with relevant partners, who share common goals and interests' 
(Tindana et al., 2007). 
An ethics based on relationships, attachment and familiarity 
Respectful relationships are core to the Emanuel et al. (2004) framework and their detailed 
reference to benchmarks for measuring good practice has initiated broader discussion about 
ethics and community. Overreliance on formal guidance, principles and a related 'tick box' 
mentality can stifle ethical reflection. Accordingly, Geissler et al. (2008) argue that 'research 
ethics should make space to unfold ethical relations ; relations which either pre-exist or 
which develop in the implementation of public health trials. Drawing on ethnographic 
research into interactions between FWs and villages hosting vaccine research, they highlight 
the importance of attachment and familiarity versus detachment. Whilst attachment made 
it difficult for FWs to uphold certain trial restrictions (e. g. medication being available only to 
trial participants), the formation of social bonds allowed FWs' interactions to 
be guided by 
their 'ethical impulse' or moral compass. Geissler et al. (2008) argue that in order to achieve 
a correct balance, ethical guidance should be complemented by considerations arising out 
of interactions characterised by trust. 
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Trust, the social context and the role of CIs 
Trust is a relational notion which describes a voluntary relationship between two or more 
people (inter-personal trust) or between a person and an institution (institutional trust) 
(Gilson, 2003). Molyneux and colleagues demonstrate its importance with particular 
reference to consent and community perceptions of research (Molyneux et al., 2005a, 
Molyneux et al., 2005b). Their work emphasises the need to understand the social context 
and ensure that research teams incorporate both technical and inter-personal competence. 
The latter may be achieved by employing community-based assistants who are known and 
trusted by local residents (Gikonyo et al., 2008). In international public health research such 
employees are often referred to as FWs. Their wide-ranging duties mainly relate to data 
collection, recruitment and consenting participants. FWs are usually secondary school 
leavers seeking opportunities to develop skills and obtain training and work experience. 
They are employed on renewable contracts and serve as cultural brokers for researchers 
who do not come from the trial area. 
FWs are not the only type of community intermediary common in the implementation of 
international health research. As noted above, community or village health workers play a 
role, as do 'peer recruiters' and more advisory interlocutors such as CAB members. Whilst 
the advantages of CIs are evident some attention has been drawn to ethical considerations. 
Simon & Mosavel's (2010) concern is the potential for 'vertical exploitation' of Cis. They 
argue that this occurs when outside researchers exploit community intermediaries social 
connections with local community members to promote research. Specific reference is 
made to recruitment practices, but 'vertical exploitation' also covers potentially unfair 
employment practices. 'Horizontal exploitation', by contrast, is described as occurring when 
community intermediaries exploit their partnerships with outside researchers to gain power 
and influence within their communities (Landy and Sharp, 2010). These dual ethical 
concerns demonstrate that power relations have to be taken seriously and thought about 
carefully in the conduct of research and related CE. 
In this chapter I explore the experiences of VRs who support research conducted 
by the 
Kenya Medical Research Institute in collaboration with KEMRI/CDC. VRs' perspectives are of 
144 
interest since they reside permanently in the villages in which they work, and so must 
balance kinship, cultural and professional boundaries. Unlike FWs, they are casual workers 
and not contracted employees; consequently they are not so closely accountable to 
researchers. VRs are comparable to other casual employees engaged as Cis in similar 
settings in the developing world. This provides additional justification for documenting their 
experiences and considering their practical, ethical and theoretical implications. 
Institutional Framing of the Role of Village Reporters at KEMRI/CDC 
... we also have a system, a VR system, they are very resourceful, we use them to capture 
the feelings at the community, at every village level. ' 
CLO, CR 01 
Since KEMRI's establishment in 1979, and inspired by contemporary ideals of Alma Ata, 
village volunteers have played a vital role in its activities. In the Saradidi Community Health 
and Development Programme 'village health helpers' acted as agents of change to promote 
health development through community-initiated projects (Kaseje and Sempebwa, 1989). 
However, as KEMRI's portfolio expanded, trials began to be conducted separately from 
community-led projects. In collaboration with CDC, KEMRI developed extensive research 
infrastructures in western Kenya. This collaboration is formally referred to as the 
KEMRI/CDC Research and Public Health Collaboration and it accounts for a substantial part 
of the KEMRI research programme. In the areas where we conducted our field work 
community members often referred to this collaboration simply as 'CDC'. 
With the expansion of the research programme a clear demarcation became apparent 
between the practice and social organisation of science, and regular health services and 
community activities. Alongside this, the role of village volunteers within KEMRI/CDC 
evolved from being agents of change to becoming community intermediaries and facilitators 
of research. Their involvement was formalised with the establishment of a health and 
demographic surveillance system (HDSS) in 2001. They became referred to as 'VRs', and 
standard operating procedures (SOPs) were developed by KEMRI/CDC to define their role. 
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According to one of these SOPs (Text Box 2), VRs represent the 'interface' between the 
community and KEMRI/CDC staff. Hence the nature of their work is bi-directional and 
challenges can arise in their interactions with community members and researchers. The 
term 'interface' takes for granted that there is a gap between the practice of science and 
community experience. VRs are seen as those who can cross this boundary and create 
inroads which will facilitate research implementation. They can also provide insights about 
the nature of this boundary and its implications for practice. 
Text Box 2: Definition of Village Reporter 
'A Village Reporter (VR) is an individual selected by the community members after 
meeting specified criteria, to support the implementation of KEMRI/CDC projects and 
studies. This individual is the interface between the community and the KEMRI/CDC 
staff. The VR will support all KEMRI/CDC projects in the designated geographic area. 
The support offered by VRs is an essential and valued component to the success of our 
work. The village reporters are not permanent employees. They are engaged by 
projects on a need basis and are paid centrally according to how many days/hours 
they work. ' 
Standard Operating Procedure No 11, version 1St November2011 
In this SOP VRs' duties are described as falling broadly into three areas: 1) capturing data on 
births and deaths for the HDSS; 2) mobilising the community; and 3) serving as a community 
resource. VRs primary responsibility is the notification of births and deaths at weekly zonal 
meetings with HDSS supervisors. However they also play an important role in mobilising the 
community which includes raising awareness about the work of KEMRI/CDC and providing 
researchers with feedback on community concerns, misconceptions or rumours. Some 
projects also train VRs to support trial-specific education efforts at village and household 
levels. VRs are viewed as a resource both for the community and for researchers; they are 
encouraged to participate in health education activities and researchers rely on them to 
facilitate community entry. In addition to these core duties some trials have trained VRs to 
assist with technical responsibilities such as reading Tuberculosis skin tests. 
People interested in becoming VRs are nominated by their villages according to criteria 
provided by KEMRI/CDC. Their selection is endorsed by village elders and administrative 
chiefs, 'because it is now again upon us to identify good people for the CDC to 
be VRs' 
(Assistant Chief, 56). VRs' main responsibilities are to record births and deaths for the HDSS 
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and provide this data at weekly meetings. Trials also involve VRs in mobilisation, identifying 
and following up participants. VRs are primarily accountable to the senior KEMRI/CDC 
community liaison officer, but they also report to HDSS field supervisors, trial supervisors 
and trial-specific community liaison staff. Formalisation of the role of VRs in 2001 led to 
changes in the range and type of people engaged. Earlier trials mainly involved nyamreche 
(traditional birth attendants) who were typically older women who had benefitted from 
additional training from governmental and non-governmental organisations. The new 
selection procedures resulted in a broader representation across age, and to a certain 
extent, gender. 
Currently there are 414 VRs working in the health and demographic surveillance area; 171 
(131 women, 40 men) of these are based in the area where this study was conducted. In 
Siaya town, the urban centre in Karemo, some VRs represent designated areas where they 
either live or where they can establish contacts. VRs receive regular payments for allocated 
duties which are administered by financial officers within the human resources department 
at KEMRI/CDC. They receive Ksh705 for the notification of a birth or a death and Ksh 300 for 
attending weekly meetings. For other activities they are paid an hourly rate of Ksh 40 if they 
work less than 4 hours per day and a daily rate of Ksh 320 if they work longer. Project 
leaders have to sign VR's time cards which the VRs submit to the community liaison officer 
(CLO) by the 20th of each month in order to receive their payments by the end of each 
month. These payments are transferred into a bank account which KEMRI/CDC recently 
opened for each VR. I was given access to payment information for VRs based in Karemo for 
January, February and March 2011 which suggests that on average VRs earn approximately 
2100 Ksh (US $ 28 )a month. The most one VR claimed for one time period was Ksh 7450 
(US $ 99) and the least Ksh 1570 (US $ 21). This is comparable with information given to one 
of my research assistant by a few of the VRs we interviewed. They stated that the minimum 
a VR can earn per month is approximately Ksh 1400 (4x 300) plus some additional payments 
for demographic reports) and the maximum Ksh 4000 (4x 300) plus payments for reports 
and other duties). The average monthly income was estimated at about Ksh 2500 (US $ 33). 
For the VR who makes approximately Ksh 4000 a month this is a substantial addition to the 
Ksh 2000 he can earn from farming his land and selling milk. 
s At the time of my fieldwork the US $/Ksh conversion rate was 75 Ksh to US $ 1. 
147 
This helps to explain why these types of semi-voluntary positions with fixed payment rates 
are very sought after in communities where there are limited formal employment 
opportunities. VRs conduct their duties alongside other activities; many volunteer for other 
organisations and most are small-scale farmers. They belong to a growing social group who 
seek out as many informal employment positions as possible to make a living and support 
their families. Their average income is equivalent to that of a labourer or watchman working 
full time in the city of Kisumu and represents a substantial addition to their other earnings - 
in particular as it does not involve relocation. 
In addition to VRs monthly payments a special one-off allowance of Ksh 2000 (US $ 27) is 
given to the families of VRs who die to help them buy a coffin (the cost of a coffin at the 
time I conducted my fieldwork ranged from Ksh 5000-20000 (US $ 67-267) according to one 
of my local research assistants). The history of this allowance can be traced back to the time 
when the insecticide-treated bed nets trial was coming to an end and the HDSS was being 
set up. The prevalence of HIV in the demographic surveillance area and limited treatment 
options contributed to an increase in deaths amongst KEMRI/CDC personnel and VRs at that 
time. In solidarity KEMRI/CDC personnel - including international researchers - paid 
something out of their own pockets to help the families of the deceased. Funerals are 
significant occasions for the Luo and it is a cultural norm for kin, friends and patrons to 
contribute funds towards funeral costs and family welfare by means of an organised 
'harambee' (let's pull together) collection prior to the event or an informal whip-round (hat) 
at the funeral. This informal expression of solidarity and the close connections between 
field staff and senior researchers led to a sense of obligation to formalise a set allowance for 
the families of deceased VRs. Today this allowance is viewed as somewhat anomalous both 
by KEMRI/CDC staff and some VRs who would prefer to receive other support to meet 
current medical expenses. However it is important to recall that this allowance was 
authorized at a time when there was limited access to antiretroviral therapy, a significant 
consideration given the heightened prevalence of HIV in the areas where VRs reside. 
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Village Reporters' Perspectives 
In this section I synthesize VRs' perspectives on their role and the challenges and 
opportunities they encounter in their work. At the outset it is important to state that in 
contrast to VRs working in some of the original places of KEMRI/CDC activity the VRs I 
observed and spoke to are relatively new to KEMRI/CDC. They became involved in the 
KEMRI/CDC research programme in 2006/7 when the HDSS system was extended to Karemo 
division. The programme in Karemo has however grown significantly since 2006 and most of 
the VRs based in this division have supported a wide range of activities, observational 
studies, malaria surveillance, HIV home-based care and testing and vaccine trials. We must 
also remember that VRs live in impoverished areas and they are keen to secure work to 
support their families. They are employed as casual labourers and their position can be 
viewed as vulnerable. Even so, while they all spoke openly about challenges they face in 
their work they also stressed its' positive aspects. 
VRs include a wide range of people, from those who are young and ambitious, to mothers 
with young children, middle-aged and older community members. Amongst the younger 
contingent, personal circumstances have usually meant that they were not able to pursue 
further education and better employment opportunities. In general VRs' association with 
KEMRI/CDC affords them recognition, a regular income and some opportunity for self- 
development, which I will comment on in more detail below. At the same time they 
confront limitations due to their lack of formal qualifications, the casual nature of their 
employment, trial requirements and researchers' perceptions of their capacity. VRs are 
particularly sensitive to the value placed on their role by individual trials. They gauge this 
from the level of interaction between themselves and members of the project team, the 
training received and the level of responsibility and nature of tasks assigned to them. In the 
following five sections I explore their perspectives on becoming a VR, their role, the nature 
of their work, their view of CE and the challenges they face in. being a VR. 
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Becoming a Village Reporter 
'We were like five people and people queued behind us, that is the way we were elected, 
not nominated really, but elected by the community'. 
Male VR, CR 32 
The announcement that KEMRI/CDC wanted each village in Karemo Division to select a 
person who could serve as a 'go between' was made at chiefs' barazas in 2006, a few 
months before the HDSS started conducting surveillance activities in this area. The 
response to the announcement was very positive and in some instances the selection 
process took place during the same baraza. The chiefs had alerted community members 
that something important was going to be discussed and hence attendance at these 
particular meetings was high. Members of different villages asked to go aside in groups in 
order to reach consensus about who should represent their village. In other instances chiefs 
called for elections to take place at village level and in some cases this led to very heated 
campaigns. 
'We call the elections in each and every village [ok, right, ] and the election was very hot 
[mmm] you know they believe they will be paid [right], like the other place we had to 
repeat it twice [right] mmm. Sometimes we used to call the community liaison officer and 
the team to oversee the elections [right, because] because there was a campaign like, just 
like a MP (Member of Parliament). ' 
Chief & CAB Member, CR 25 
As the above quotation indicates chiefs and KEMRI/CDC personnel played an integral role in 
the selection of VRs. Chiefs were keen that 'good people' be identified and were not so 
concerned about selection criteria while members of the HDSS needed to make sure that 
elected VRs had the capacity to complete designated duties. The latter was established 
during short interviews and a seminar held to teach potential VRs about the HDSS and their 
potential role and responsibilities. Despite this official involvement in their selection all of 
the VRs to whom I spoke were very keen to stress that they had been elected by members 
of their villages. 
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'There were some jobs that we were supposed to do in the village and therefore, the village 
elder was not supposed to choose his person. it is the villagers who knew whoever can 
work for them very well. ' 
Female VR, CR 39 
When I asked interviewees why they had been interested in becoming a VR they cited 
several key reasons. These included the possibility of financial remuneration, the 
opportunity for self-improvement (e. g. to learn more about health) and the desire to make a 
difference at community level. Election earns VRs significant respect at community level, 
and improves their status both financially and socially. VRs understood that KEMRI/CDC had 
come to help improve health conditions and many of them had either worked as community 
health workers already or been involved in health education as members of drama groups. 
Out of the 6 women I interviewed all were mothers and most were married, two had trained 
as community health workers with non-governmental health organisations and one of these 
was a traditional birth attendant. The youngest of the women was very active in her 
community and also worked as an assistant at her local chief's office. She expressed 
ambitions of becoming a chief or gaining political standing. Out of the three men, two were 
young married men with young children and the other was retired. The younger men were 
very active and vocal members of their respective VR groups. One in particular was keen to 
draw attention to VRs working conditions and the need to raise their payments and increase 
their allowances. 
'Yeah, at first, I was interested in employment because I was just working like a peasant 
farmer... and when I heard about how they used to pay people, I decided that I should go, 
and secondly, I wanted to do something for my community that can create impact [mmm], 
mainly on health issues and [mmm] social related issues [ok]. 
Male VR, CR 32 
'I was much interested to be one of them, yeah. I thought that they could make somebody 
know more about health of the people around, and I knew that they are dealing with 
health. They want to control the diseases that are disturbing the people around. ' 
Female VR, CR 27 
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Before becoming VRs my interviewees had only a limited understanding of the nature of 
KEMRI/CDC's work and tended to associate it with the prevention of malaria and 
distribution of bed nets. A couple of them knew that KEMRI was the research arm of the 
Ministry of Health (MOH) but the others were less aware of the research angle of the 
KEMRI/CDC programme. What they had heard at or via barazas and seen in adverts posted 
at chiefs' camps is that KEMRI/CDC was offering a range of employment opportunities. 
Some even applied to become FWs however they were not successful due to a lack of 
schooling or low grades. This did not put them off and since they were keen to be part of 
KEMRI/CDC they expressed an interest in becoming VRs and sought to gain their villagers' 
support and nomination. This notion of being one of them or part of KEMRI/CDC is of 
interest and something we will continue to explore it through the course of this chapter and 
the thesis. 
Village Reporters' Role 
I work as a mouthpiece of CDC in my village and a mouthpiece of my village to CDC, 
[so you see in both ways] yah, I speak to my village, I speak for my village 
and I speak for CDC [ok]yeah. 
Male VR, CR 32 
VRs describe themselves as the 'baseline' (which is an interesting use of a research term), 
those who collect data and form a vital link between KEMRI/CDC and the local community. 
The above quotation suggests that they understand their role as being a spokesperson both 
for their village and for KEMRI/CDC. In practice this involves an exchange which prioritises 
explaining the purpose of research and addressing related community concerns. As part of 
this process VRs are required to account for the work of KEMRI/CDC and can be called upon 
to act as arbiters. The term 'your people' in the following quotation underlines the strength 
of the association of VRs with KEMRI/CDC. 
'You may see sometimes that a fieldworker comes to a certain home [mmm], they refuse 
him and then send someone to me, that those people, your people came here and / chased 
them away, come and explain to me what they wanted 
Male VR, CR 32 
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When it comes to explaining research VRs stress the importance of making sure that 
villagers understand the main aims of different projects, the voluntary nature of trial 
participation and the potential benefits of research. They try to clarify that the purpose of 
health research is to prevent and address the causes of disease and they describe the 
benefits as being closely aligned to these aims. This helps them to counter expectations 
which can extend beyond the remit of research projects - e. g. when in the process of 
collecting mortality data they are frequently asked whether KEMRI/CDC can contribute to 
funeral costs. I will return to explore pick up on this challenge and expectation below. 
VRs are expected to mobilise the community and share information about studies. However 
there is some uncertainty as to whether 'mobilisation' is the same as recruitment or 
whether it is just about raising awareness and encouraging people to find out more. 
'Mobilisation' is a term used in formal documents (e. g. the VR SOP) and it is also used 
frequently by researchers in conversations or descriptions of CE activities. It is however a 
term, which is difficult to define in practice and is used variedly by different people and 
groups. In one trial taking place at the time of my field work VRs were asked to identify 
potential participants and take FWs to their compounds. In this instance VRs clearly played a 
significant and direct role in the recruitment of participants. In the RVT VRs were asked to 
tell mothers with newborns about the study and to advise them to go to their local health 
facility if they wanted to find out more. By contrast the MVT researchers were much more 
hesitant about involving VRs in the distribution of information about the trial and had 
doubts about their capacity to explain the content of a recruitment brochure. There are thus 
clear differences in the way in which individual trials interpret mobilisation and how they 
involve VRs in awareness-raising and recruitment. 
VRs themselves are more definite about what mobilisation means and view encouraging 
people to participate in trials as an integral part of their work. They also describe how their 
close relationship with villagers means that they are particularly well placed to do this. 
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'They take part because they know us, they know that they will get free treatment. 
Secondly, the child, the child will be monitored throughout the time the child is enrolled, so 
that is why they. Secondly they see, thirdly they see that if the person within the 
community, if the VR has just informed them about the research going on, they say, no this 
is a good thing [if they hear it from you? ]. Yeah, this is a good thing not a bad thing 
(because they trust you or? ). Yeah, they trust us and they know that the kind of work we 
are doing is a good work. So they say no, I have to enter. ' 
Male VR, CR 38 
In some instances VRs can be quite proactive about promoting research and may well use 
their own personal experience to offset rumours and underline their perception of the 
benefits of research participation. This is of concern especially since, whilst VRs do state 
that participation is voluntary, they seem not to lend much weight to the disadvantages and 
potential risks of taking part in vaccine or other trials. 
'1 welcome all the research now, I only tell the people in my village the good that I have 
seen in being in the study, so I tell the villagers that if you might think that your child 
might be sold6, then even ours are in the study, so and so child is also in the study, so it is 
something that has been brought to help us but not to harm us. ' 
Female VR, CR 29 
The above quotation and observations raise questions about the impartiality of VRs and 
their capacity to speak on behalf of their respective villages in view of their close association 
with KEMRI/CDC. To further illustrate this, the following quotation describes aptly how VRs 
frequently find themselves in a position of having to defend the work of KEMRI/CDC, which 
can make it difficult for them to remain objective or to present a fully accurate and unbiased 
picture to their communities. 
'... these people need VR who can answer them correctly... but ifyou are weak they can push 
you towards the wall and you cannot know how to answer them (they can give you a hard 
time) but we don't want to tarnish the work of CDC down we want to uplift it and make it 
different with other organizations? ' 
Male VR, CR 38 
6 Such concerns were raised at community level regarding the trials. I have mentioned such concerns 
in 
chapter 4 and will talk more about them in chapter 9. 
Some non-governmental organisations have a negative reputation in these communities. They are 
described 
as briefcase organisations because they come and go, are not committed to the local community and there is a 
lack of transparency about how funds are used. 
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Such 'concerns with impartiality' are my own personal reflections and relate to my 
interpretation of bio-ethics. They are not concerns which were raised directly by VRs 
themselves or other community leaders. Indeed community leaders spoke very positively 
about the work of VRs, noting that VRs play an invaluable role in addressing questions at 
household level. Most researchers also stressed that VRs are recruited because they are 
respected village members and the main premise of their work is to support KEMRI/CDC 
activities. A few however expressed hesitation about VRs competency and how VRs could 
use their position as a means of undue influence. 
The Nature of their Work 
'To some extent we are working for KEMRI/CDC as volunteers and we are serving our 
community, the bigger percentage is just to serve the community. ' 
Male VR, CR 32 
VRs described the nature of their activities as 'partly volunteering and partly working'. This 
is of interest since according to official documents they are hired or engaged by projects to 
perform specific tasks. This would suggest that they are employed on a casual basis and are 
therefore not volunteers. The informal nature of their work and the inherent value attached 
to volunteerism in the field of health and development however leads them to describe the 
job they do as 'partly voluntary'. Whilst VRs maintain that the payments they receive do not 
adequately reflect their efforts they are very careful to stress their willingness to work and 
their commitment to selflessness. VRs inhabit what Brown (2011) describes as the 'grey 
area that exists between voluntarism and paid labour' and they understand that selflessness 
affords respectability which opens up opportunities for financial gain and self development. 
Despite some dissatisfaction with their working conditions it is important to draw attention 
to the value that VRs place on their association with KEMRI/CDC. It has earned them 
respect at community level and improved their status both financially and in terms of social 
relations. They view their work as an income-generation opportunity which has provided 
them with a level of exposure which they would not otherwise have obtained. Exposure in 
this instance means the experience they gain and the new things they witness by being 
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connected to KEMRI/CDC in terms of training, public relations, meeting people and 
accessing resources. 
'The best thing of being a VR, the best of all being, you know, now I might say they are, 
even though it's a voluntary service but 1 see that it's not voluntary because now, at the 
beginning, I didn't know where the bank was, even though I knew where it was, but I 
happened not to have entered in [eeh], our leader, the community liaison officer, had made 
efforts, we are now having the ATM cards that I could have not got if it was not for the 
being a VR. Another thing is that I might talk to a white person like you which I might not 
talk to if not being a VR [mmm], another thing is that I am now known everywhere by all 
tribes [eeh] and I know how to interact with the people, I know how to make my PR (public 
relations) to be better [mmm] than, I know how to better it[mmm, ok] yeah. ' 
Female VR, CR30 
The status that VRs gain from association with CDC is further illustrated in the following 
quotation from a CAB member. This interview excerpt also provides some insight as to why 
more emphasis is placed on CDC rather than KEMRI. 
'You see people, in fact KEMRI's name has died a natural death within the villages it is CDC 
that helps. Yeah, she is from CDC, you see we have the VRs [yeah], and you see, most 
vehicles that run around here are written CDC, and the VRs, you see eh we have very 
learned women, those actually they reached, they have finished their basic education, they 
got married, they have been staying in the village for so long, you see, the VRs most of them 
are women [yeah]. Then when CDC came, CDC recognized their importance, a woman who 
can read and write, and therefore, they were contracted to do some worthy work within 
their villages. So what do they do? They want people to know that they are really 
connected with CDC and therefore they scrap away the word KEMRI and remain with CDC, 
and therefore, everything is C, CDC. So anything that is happening within the village is C, 
CDC not even KEMRL' 
Female CAB Member, CR 02 
With the above-cited benefits in mind the VRs I spoke to were keen to be given more work 
by KEMRI/CDC. At the same time they also called for a review of their working conditions, 
stating that since they first started as VRs there had not been a 'salary' increment. Some of 
them spoke more specifically about the relationship between remuneration, motivation and 
the response to research at village level. 
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'So first, I think when the, the CDC/KEMRI wants to change the whole thing and to affect 
[mmm], the village positively in a big way, [mmm] or in a good way, they need to adjust 
that payment for the VRs so that we may be motivated [mmm], yah, because the cost of life 
is going high, and when we started we were being given 290 shillings. But when you 
compare the price of sugar when we were starting, it was 45 a kilogram, today its 90 
[mmm], such things also can maybe interfere with some little things in the research. ' 
Male VR, CR 32 
Similarly, but from a slightly different angle, another VR talked about how people were 
surprised that even though she is working with KEMRI/CDC she cannot pay school fees. She 
thought that KEMRI/CDC should take the problems that VRs face into careful consideration, 
especially since they rely so heavily on VRs as community intermediaries. To quote; 
'without VRs, in fact you can't go through without VRs, because we are the grassroots' 
(Female VR, CR 29). 
These quotations also suggest that questions of pay and working conditions can rightly or 
wrongly have a direct knock-on effect on community members' views of research and VRs' 
relationships with researchers. Indeed these quotes stress VRs unique positioning and 
leverage and convey the need for researchers to recognize, acknowledge and appropriately 
reward their influence. 
Village Reporters' View of Community Engagement 
'... CDCgoes straight to the community, and in villages and in houses. ' 
Female VR, CR 29 
According to the VRs I spoke to KEMRI/CDC engaged very closely with local communities; 
meeting people not only at barazas but also in their villages and homes. The VRs viewed 
their own role as central to the practice of CE and drew upon historical and contemporary 
examples to illustrate this. From a historical perspective they argued that their employment 
at the start of the research programme facilitated community acceptance and made people 
feel that 'the work that is going to be done here is part of the community'. Even several 
years into the programme they differentiated clearly between the advantages of their 
approach in contrast to that of field workers. 
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'Yeah, the approach to the community [yah], there is a little difference [mmm] yah, 
because some [yah], use the VRs to create the awareness or to mobilize or to tell people 
about the project [eeh], but some come individually. They come, the projects, the staff, 
project staff [yah, yah], they come themselves [ok], so there is some little difference 
because you are a villager and you are VR [mmm], so if you take the message to them 
[mmm], somehow they understand it better [mmm], and feel part of it [mmm], and it is 
different from, if the staff, project staffs, they come by themselves. ' 
Female VR, CR 29 
In VRs' self perception, they believe that their value lies in their close attachment to the 
village; they are trusted and can therefore 'open the way' for others. The reasons why they 
are nominated to be VRs are more difficult to discern and may not always be because they 
are trusted. It may, for example, have more to do with respect and familial and cultural 
obligations. VRs may not necessarily be people in whom others would always confide in. 
However they do seem to enjoy a certain standing in their villages which could be due to 
various factors e. g. their age, marital status, assets, religious affiliation, strength of 
character and ability to influence others. 
VRs repeatedly stressed the value of their close attachment by referring to scenarios when 
their absence had made villagers uncomfortable and in some cases resulted in FWs being 
chased from compounds. They thought that KEMRI/CDC should adopt an approach which 
encouraged much closer collaboration between project staff and VRs in order to overcome 
suspicion and encourage trial participation. 
In line with sentiments expressed in the previous paragraph VRs tended to define 
'community' as those living and working together in close proximity. They equated this with 
their village and the people who shared something in common with them, for example a 
school, a health facility or a water point. Some also drew attention to the importance of 
communication, shared goals, mutual support and positive interaction when they talked 
about the nature of community. This close-knit understanding of community explains in 
part the heavy emphasis that VRs place on their role as the pathway for KEMRI/CDC in terms 
of CE. 
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Challenges Faced by Village Reporters 
'.. when 1 enter a home they think! have some gift to give them they say thatyou have to 
bring us something that is the main challenge... when you enter any home they know 
thatyou carry something for them. ' 
Male VR, CR 28 
The main challenges encountered by VRs in the course of their work can be summarised 
under two broad themes: negotiating working relationships; and managing community 
expectations. I will consider each in turn. 
As noted in chapter 5 in the recent past different KEMRI/CDC projects have chosen very 
varied approaches to CE, trial recruitment and participant follow-up. These have involved 
VRs to varying degrees and resulted in VRs comparing and giving preference to certain 
projects above others. By this I mean that they put extra effort into studies which involve 
them more than other studies do. They talked more positively about the former category of 
studies in conversations and interviews. This preference is partly related to remuneration 
but importantly it also has something to do with the value that VRs perceive to be attributed 
to them by particular projects. 
'Ok, the real issue is that with the KEMRI/CDC is like we have so many projects [yeah, 
yeah], and the way they pay their people is different [ok]. Like now you can see that the 
Tuberculosis project [mmm], is like is making use of so many funds like a, once you are 
taken to the training, you are given refreshments [oh, yah], and again the type of, the 
number of days that they give you [mmm], are long. Now you will find the malaria people 
[mmm], they take you to the training [yah], there is no refreshments that you are given 
[mmm], and the number of days for mobilization that you are given is less [ok], so that's 
why they were complaining. ' 
Female VR, CR 30 
When a project fails to engage VRs' services or simply expects them to undertake additional 
duties alongside their regular HDSS activities without additional payment, they feel sidelined 
and undervalued. This heightens their awareness of the unpredictability of their role and 
related benefits. As a result they are less inclined to support such a project which can have 
negative repercussions on the general community response. Whilst it is trial investigators' 
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prerogative to determine how they will involve VRs based on protocol requirements and 
related plans for CE and recruitment VRs can be active in seeking more involvement. They 
also try to negotiate better working conditions by putting pressure on those who supervise 
them most directly such as trial-specific liaison staff. However they find it more difficult to 
voice their complaints in person to the community liaison officer (CLO) both for fear of 
losing their job and the nature of his response. 
Unvoiced discontent can lead to a lack of motivation which is observed by trial staff and 
communicated to the CLO. When this happened in the MVT the CLO called for a general 
meeting of all VRs working across several zones. The size of the gathering was perceived as a 
barrier to communication by some VRs. However a few did stand up to complain about their 
lack of involvement in the MVT. The CLO responded by stating that projects can use their 
own discretion on how and whether they want to engage the services of VRs. VRs should 
accept this and not work against these projects but remember that they represent the 
whole research programme and are paid centrally by KEMRI/CDC. When I spoke to some of 
the VRs after this meeting they were not completely satisfied with his response and wanted 
the CLO to discuss these issues in more depth with them in smaller zonal meetings. 
The other main challenge that VRs face is how to manage peoples' expectations in the 
course of their work. To a certain extent some of the expectations the VRs encounter are 
the result of community members likening the KEMRI/CDC programme to that of a non- 
governmental organisation and comparing what they receive from it with what other non- 
governmental organisations provide. They do not see the point of so many questions during 
surveillance visits and think that they should be paid for their time or at least given a token 
of appreciation. 
'... but Cls when they come, they just ask questions and go, [yeah] ask questions and go. So 
the villagers came to me and ask me, why don't you give people things [mmm], because 
these, your people just come and ask so many questions and they go without giving 
anything [right]. ' 
Male VR, CR 32 
To elaborate more poignantly on the problems which VRs can face in negotiating 
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expectations one VR told me a story about an occasion when he met with a group of 
researchers in his village. There were two 'wazungus' (a term used to denote white people) 
and a Kenyan and after they asked him for directions to a particular compound they invited 
him to accompany them on the visit. They were conducting a malaria parasitaemia survey 
and needed to collect some blood samples from this household which had been selected at 
random. The following are the VR's recollections of this visit: 
'When they arrived there was only one mama who was very old, ninety something years 
old and she didn't have something to eat, she didn't have something to wear, she was old 
desperate and poor and the same time she was sick. What they did, they just took blood, 
and she was staying with her grandson, so after taking blood, she was given some 
medicine. Was it medicine? I think some tablets. Again we went to look for her grandchild 
who was working, trying to train as a carpenter, next to the prison, so we brought him 
back, asked him some questions, also we took blood from his finger tips and we went away 
with those wazungu. So people were asking me, the state of that woman, could we just 
even just give her ten shillings or fifty shillings, and we have walked with two wazungu 
and someone who is senior in CDC, we just take blood from this woman, we know she 
anaemic, she don't have something to eat, she is desperate and poor, you just take blood 
and go away thatyou are doing research on malaria. Is it normal surely, if a muzungu (a 
white person) can come to a house like that, that house was pathetic, a grass thatched 
house that is leaking. So l had a lot of hard time after that because that woman was too 
old, too poor, too desperate and was living in a compound alone. That grandson used to 
come at night and go out at dawn, so they asked me why don't you even just give one 
hundred shillings to that woman for a kilo of sugar, of unga (flour). ' 
Male VR, CR 32 
In this instance the VR's close proximity to the household made the situation all the more 
difficult for him to deal with. He could not just get up and leave, he had to face questions 
from other community members. Moreover when he got home the mama was waiting for 
him expecting something in return. Dipping into one's own pocket to support a neighbour is 
a cultural norm and social expectation (Shipton, 2007). In Luo communities giving, exchange 
and entrustment are associated with being a 'good' person. 
Faced with such situations VRs often find themselves having to defend the work of 
KEMRI/CDC whilst also reaching into their own pockets to respond to need. To a certain 
extent they view the latter as their neighbourly responsibility, particularly when it comes to 
cultural norms such as funeral contributions. On the other hand these kinds of scenarios 
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highlight the practical and ethical difficulties VRs can face in remaining sufficiently impartial 
whilst responding appropriately to evident need. These difficulties are compounded by the 
fact that there is no budget apportioned by KEMRI/CDC to deal with such scenarios and 
indeed it could be difficult to institute such support fairly. On the other hand the lack of 
such provision contradicts embedded cultural norms and obligations. It underlines the 
difficulties in negotiating expectations which arise as a research programme expands and 
crosses boundaries of relationships and obligation. 
Discussion of the Main Themes 
VRs belong to a social group who seek out as many informal or formal employment 
positions as possible in order to make a living and support their families. They are careful to 
stress their commitment to selfless community service since it augments their respectability 
at community level and opens up opportunities for financial gain, exposure and self- 
development. They value the status they gain from association with KEMRI/CDC and are 
keen to work even if they view their contribution as 'partly volunteering and partly 
working 
VRs stress their unique approach and invaluable role in CE and trial implementation. How 
they describe these is reminiscent of concepts presented in the literature on relational 
ethics (Gikonyo et al., 2008, Molyneux et al., 2005a, Geissler et al., 2008). VRs value their 
work with KEMRI/CDC and hold the trust of many people in the places where they live and 
work. But, as this chapter has shown, challenges can arise from trust, attachment and 
relationships with researchers which must be recognised, understood, and properly 
addressed in order to realise the full positive potential of community intermediaries such as 
VRs. 
VRs are referred to as a means of capturing community feeling by the CLO. In addition to 
undertaking set data collection tasks for researchers they are also expected to support the 
work of KEMRI/CDC in their villages and feed back any potential concerns about the 
programme to researchers. This suggests that although they are nominated by fellow 
villagers as village representatives, the premise of VRs' role is not about community 
advocacy but the facilitation of the research programme. In practice this means that VRs 
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have become closely aligned with KEMRI/CDC and have to balance competing allegiances. It 
also raises questions about the potential for misuse of trust, close relationships, and undue 
influence in promoting trials. However, such challenges can cut both ways. For example my 
findings show that low morale can affect how VRs relay information about trials within their 
communities. VRs who feel dissatisfied over their involvement in specific trials can be 
passive towards, or even influence opinion negatively against, such trials. Partly, this 
phenomenon stems from their remuneration system (according to work done); partly, it 
depends on how far VRs feel that their contribution is appropriately recognised and 
appreciated. This is a different form of misuse of power relations than those already 
described by Simon and Mosavel (2010) and Tandy and Sharp (2010). VRs in this case are 
controlling their social networks and making it more difficult for researchers to benefit from 
them. 
Managing villagers' expectations of concrete assistance is a further challenge related to the 
concept of attachment. VRs' physical, familial and cultural proximity to trial participants 
places them in a difficult position of having to negotiate implicit and explicit expectations of 
help in a cultural setting in which sharing and mutuality remain cherished - if not necessarily 
obeyed - moral imperatives (Prince and Geissler, 2010). Their relationships as clan members, 
friends or neighbours require them to respond personally, and to explain why KEMRI-CGHR 
and CDC cannot provide help with more basic needs such as clothing and food. Interestingly, 
in giving such explanations, VRs talk about how help could be construed as 'coercive', 
paraphrasing the concerns with 'undue inducement' voiced by ethics guidelines, to which 
they were exposed during initial training and orientation. 
The challenges identified in this chapter warrant more in-depth examination than I have 
been able to give them here, including further dialogue with Cis such as VRs on how to 
address the challenges they face in practice. The fact that they face these challenges may 
also mean that they are doing a good job and are engaging both with their communities and 
the KEMRI/CDC research programme at a deep level. They are people who care about the 
issues and problems which arise in the implementation of research at community level. 
Even though more research would provide greater insights the findings and analysis 
presented here have both practical and theoretical implications. 
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On a practical level, closer working relationships between FWs and VRs should be fostered 
at KEMRI/CDC, coupled with greater communication between trial teams and VRs regarding 
the design of CE strategies. Clarifying the nature and ambit of VRs' involvement, and their 
rights and lines of communication, are also necessary; not least, to ensure that the value of 
the 'VR system' outweighs its potential disadvantages. Theoretically, we need to consider 
how to deal with the more problematic aspects of relational ethics in the context of CE - 
especially questions of undue influence and cultural and familial insider-obligations in the 
context of CE. To ensure continuity of good relationships between CIs and researchers it is 
also essential to develop our thinking further about how to manage both vertical and 
horizontal power relations in the conduct of trials. 
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Chapter 8: 
Community Advisory Board Members' Perspectives on CE 
'What I know the, when you want to be with the community, your entry point will be the 
village elders, through the assistant chief or chief And then even the unlearned ones, when 
they hear something like research, they will always go to somebody who is a bit 
enlightened to ask, we hear that this is coming, is itgood? So me 1 know the communities 
will always look for an influential person, within the community, in their locality. ' 
Female CAB Member, CR 07 
Introduction 
This chapter is very closely connected with the previous chapter since it relates the 
experiences of another community intermediary associated with KEMRI/CDC. Hence the 
literature review at the start of chapter 7 about community involvement and relational 
ethics is also of relevance here. A key difference between CAB members and VRs however is 
the fact that CAB members are volunteers in the strictest sense. They do not receive 
remuneration for their activities and their role is primarily advisory rather than being 
enlisted to promote research inroads into villages. 
In this context it is important to remember that the terms 'volunteer' and 'partnership' can 
deflect attention away from the hierarchy and dependency which can underlie 
relationships, particularly relationships which are characterised by differential access to 
knowledge and resources. The use of the term 'volunteer' suggests that CAB members are 
free agents when in fact their autonomy is tempered by the fact that the CABs are set up 
and coordinated by KEMRI/CDC. This configuration suggests that researchers can exert 
some control over bodies set up to represent community voices. Nevertheless community 
members were and are very keen to become CAB members and gain access to KEMRI/CDC. 
To present the institutional framing and personal perspectives of CAB members I draw on 
extensive field work carried out with the Kisumu and Karemo CAB at KEMRI/CDC from June 
2007 until December 2009. During this period I attended numerous meetings convened for 
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both CABs, accompanied them on visits to other research institutes and to KEMRI/CDC 
facilities both within SDH and at the main KEMRI/CDC field station at Kisian. I visited CAB 
members in their homes and joined meetings they organised for the person responsible for 
community liaison for the RVT and MVT. In addition 1 spent a lot of time with this staff 
member in her preparations for and her interactions with CAB members. I also reviewed 
relevant documents which outline the role and function of the CAB and was able to read 
and analyse CAB members' reports on their activities. Finally I conducted two focus group 
discussions and 7 semi structured interviews with Karemo CAB members. 
A key finding which emerges from this chapter is the concept of 'positioning' and how it 
applies to CAB members. Positioning enhances status, it provides access to new information 
and it can facilitate the implementation of research. Simultaneously it challenges notions of 
allegiance and accountability, and raises questions about how respect, influence and trust 
shape community opinions about research. 
Institutional Framing of CABs at KEMRI/CDC 
CABs are a fairly recent form of community representation at KEMRI/CDC. The first CAB was 
set up in 2004 and now there are 4 CABs functioning in the main areas where KEMRI/CDC 
conducts research: Asembo, Gem, Karemo and Kisumu. The Kisumu CAB mainly supports 
HIV-related research taking place in urban and semi-urban communities. To date only the 
Karemo CAB has collaborated with KEMRI/CDC in the implementation of vaccine trials. 
Historically CABs at KEMRI/CDC have tended to be established to support preparations for 
and the implementation of specific trials. This was the case in Karemo where the CAB was 
set up by the RVT team several months prior to the start of the trial. 
'Well, you know this was one of the first vaccine trials that CDC here has done and looking 
at the ways to work with the community, to make sure that we didn't violate anybody's 
rights or, to know that we are approaching in a way that the community would be 
responsive to, ok And of course if we were doing something that results, maybe something 
that the community would take offence of, ok, we wanted to avoid those issues and of 
course yeah, it seems like a good idea in general to have representatives in the community 
giving you feedback. ' 
Male American Trial Manager, RS 03 
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In the planning stages the American trial manager and field coordinator sought advice from 
other research groups at KEMRI/CDC who had experience in running a CAB. They searched 
the literature on CABs and discussed how to proceed with the community liaison officer 
(CLO). They chose a model which would facilitate a broad representation of the Karemo 
population. They explained their intentions to the four Karemo administrative chiefs and 
asked them to organise barazas, which would provide a platform for sharing information 
about the RVT and identifying potential CAB members by means of a community-led 
nomination process. I attended one of these barazas during my first field trip in February 
2007 and appended field notes describe this nomination process (Appendix I, Doc. 3). My 
observations reveal how researchers sought to control this initial encounter with the local 
community. 
KEMRI/CDC CABs generally have a membership of 16-24 with a fairly equal gender balance, 
although the elected chairman is usually a man and the secretary a woman. CAB members 
elect their own committee which includes a chairman and a secretary, and sometimes an 
organising secretary and a treasurer. The purpose of a CAB depends in part on why it was 
formed and purposes can vary at different time points. The first CAB was set up in Asembo 
and was initially formed in order to provide researchers with feedback on questions to be 
used in a survey on sexual behaviours. Progressively however a more generic CAB model 
evolved with the objectives of serving as: a means of community entry; a way of gaining 
input on aspects of study development and implementation; a way of hearing about 
community concerns; a means to respond to concerns; and a platform for sharing and 
disseminating information. 
The schedule for CAB meetings changed from monthly to quarterly half way through 2008. 
This decision was taken centrally to reduce costs in view of broader funding concerns. 
Quarterly meetings are paid for by KEMRI/CDC base funding and it costs approximately Ksh 
20000 (£150) to hold a meeting. The change in schedule has resulted in packed agendas and 
limited opportunity for discussion and questions. To obtain more specific feedback some 
researchers organise additional CAB meetings which they pay for separately. Although the 
cost of these meetings is relatively negligible in terms of trial budgets it is a significant 
amount in the local context and can be difficult to justify under central funding agreements. 
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The mission statement of the Karemo CAB as cited in a CAB member appointment letter is 
'to foster partnership between KEMRI/CDC research team and the local communities 
participating in KEMRI/CDC conducted studies to benefit advancement of research and 
the community'. This statement implies that benefits to both the community and the 
research are expected as a result of this collaboration. The appointment letter is an official 
document which refers to the role of a CAB member as 'a job' but makes it clear that this 
appointment is not salaried. The only remuneration CAB members receive is a 
sitting/transport allowance of KES 400 to attend meetings. CAB members certify that they 
accept these terms and the letter is countersigned by the CDC Director. Appended is a copy 
of an appointment letter since it lists the CAB functions and CAB members' responsibilities 
in detail (Appendix 11, Doc. 5). In short CAB members are expected to 'serve as the ears and 
voice of the community and study participants and help researchers ensure that 
community members at all levels are involved in the research process and that cultural 
differences are respected'. They are required to 'serve as a resource, attend meetings and 
training and demonstrate commitment to developing an understanding of issues where 
they may have little expertise. 
The groups mainly represented in CABs at KEMRI/CDC are: women's groups, boda boda 
(cycle transporters) syndicates, church leaders, retired teachers, business leaders, 
community health workers or nyamrechwe, community-based organisations, youth groups, 
disabled groups, opinion leaders and health workers. In regard to this idiosyncratic 
membership it is not clear why these groups are prioritised over others. Of interest also is 
the fact that the Kisumu CAB includes representatives from HIV advocacy groups and the 
Muslim community. 
CAB members' backgrounds, life experience, social class and educational and professional 
achievements vary but they are required to have a working knowledge of English. CAB 
meetings are held in English and CAB members are sometimes asked to compile brief 
written reports on their activities and community feedback. CAB members enjoy vested or 
commanded respect of the designated groups and communities they represent. They are 
those who either: hold an official position (i. e. chiefs); whose knowledge, experience and 
age is respected; whose association with a faith group gives them moral standing; or whose 
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activities promote local investment and social good. They are viewed as opinion leaders 
with differing spheres of influence. The following definition for an opinion leader was given 
to me by a chief from Karemo, who is also a CAB member: 'This is somebody whom the 
community has faith in, seek for advice from him at their highest point of need after which 
they get to believe what he/she says concerning matters of development in the 
community: (CR, 05) 
CAB members receive regular training about the role of CABs, trials and related procedures 
and research ethics. Training materials are mainly sourced from collaborators at the CDC 
offices in Atlanta. CAB members also visit the research facilities at the KEMRI/CDC field 
station and the research clinics and laboratories based at their local health facilities and 
hospitals. The Kisumu CAB has also visited another CAB at the US Army Walter Reed 
Research Station in Kericho, and joint meetings between different KEMRI/CDC CABs have 
taken place. 
A spirited discussion about internal power relations within the CAB occurred at a joint 
meeting between the Kisumu and Karemo CABs. To situate this discussion it is important to 
point out some differences between these CABs. The Kisumu CAB represents a city, mainly 
deals with HIV research and has been in place since 2004/5. In contrast the Karemo CAB, 
which was established in 2007, deals with a broader programme of research activities and 
its members mainly come from rural areas although a few live in Siaya, the main town in 
Karemo. 
At their joint meeting one to the Kisumu CAB members questioned the appointment of 
chiefs as chairmen for the Karemo CAB. He argued that in rural setting chiefs carry a lot of 
official weight which could compromise their ability to serve in this capacity. He explained 
that teachers could not chair school management committees and called for an official 
policy on who can chair CABs. In response both Karemo CAB members and the community 
liaison officer (CLO) stressed that it was CAB members' decision to appoint chiefs as 
chairmen. The Karemo CAB members stated that they were appointed by virtue of their 
personal leadership skills and not because they were chiefs. Another Kisumu CAB member 
did not think this was a major issue as long as the election of chiefs to the position of 
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chairmen constituted a unanimous decision by all CAB members. This incident led to some 
reflection about questions of autonomy, authority and leadership, leading one Karemo CAB 
member to remark that 'to a certain extent the spirit of chieftain is retained and as a CAB 
we are at the pilot stages of our work'. 
Different Conceptualisations of CAB mandates 
As outlined above the CAB model applied at KEMRI/CDC is geographic, institutional, 
collaborative and advisory. CAB members represent different groups from defined 
geographic areas in which KEMRI/CDC is conducting research. The model is institutional 
since, to all intents and purposes, the CAB is hosted and financed by the institution. It is 
collaborative since it aims to foster closer partnership between KEMRI/CDC and the local 
communities in order to advance research whilst simultaneously benefiting the community. 
Finally is advisory since CAB members are required to advise researchers in the 
development and implementation of recruitment and retention strategies, and serve as a 
resource to the CLO and research teams. 
Despite the collaborative ethos of this model the impetus for setting up and resourcing CABs 
originated from researchers. This raises questions about the independence of these boards. 
It could be argued that paying volunteers an allowance engenders or implies a certain level 
of control or governance. In other words CAB members become more accountable to 
KEMRI/CDC than to the community. Such concerns have been voiced within the HIV 
research branch of KEMRI/CDC. Staff members responsible for community liaison within this 
branch have been keen to enhance the Kisumu CAB's neutrality in order to increase the 
CAB's credibility in discharging its mandate, to encourage it to function more independently, 
and to reduce overreliance on institutional support. The latter is welcome from a budgetary 
perspective since it can be difficult for KEMRI/CDC to secure funds for CE activities which are 
not directly related to trial recruitment. 
In 2007 HIV research branch staff members suggested that the Kisumu CAB should register 
itself as a community based organisation, and KEMRI/CDC offered to support this process. 
The vision engendered was of an autonomous CAB which could apply for 
funds and 
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eventually be able to support itself thereby gaining more credibility as a representative 
body. The following comment made during an email exchange between myself and a 
Kenyan member of the HIV research branch illustrates some of the rationale behind this 
move 
'They say in Africa that you cannot bite the hand that feeds you. Given that the primary 
objective of this CAB was to be like the eyes of the community in research activities, do we 
expect them to reprimand, or even question the researcher if they are hosted by the 
research institutions, given refreshments, lunch and transport reimbursement for their 
meetings amongst other indirect benefits? ' 
Whilst Kisumu CAB members were enthusiastic about this vision they also expressed 
reservations about assuming long term responsibility for running costs, calling and 
managing meetings. Some CAB members ran community based organisations, but they 
mainly attracted funding for charitable projects rather than for advocacy activities related to 
research. 
At the height of these discussions about autonomy in 2007 a French HIV activist visited the 
HIV research branch in Kisumu. She was travelling on behalf of the non-governmental 
organisation 'Sida Action', which is a contested group within the world of HIV advocacy (de 
Cenival, 2008). The purpose of her visit to Kisumu was to stimulate support for a more far- 
reaching change in the purpose and organisation of CABS. With the permission of the HIV 
research branch chief she met the members of the Kisumu CAB to find out more about their 
role and responsibilities and to communicate Sid Action's broader vision of establishing 
community-based ethics forums. She explained that these forums should be autonomous 
advocacy groups which could hold researchers accountable. She argued that this kind of 
forum would be more productive than having several smaller CABs hosted by research 
organisations. She urged the CAB to talk to members of other CABs based in Kisumu about 
developing such a forum. During their discussions she also asked the CAB members about 
peer recruitment strategies employed by other research groups working in the Kisumu area. 
The CAB members were willing to discuss related ethical concerns; however they also 
exercised restraint in their answers and were evidently uncomfortable about criticising 
other research groups. At the end of their meeting the HIV activist handed out business 
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cards and told CAB members that if they were interested in developing a community ethics 
forum they could apply for funding from Sida Action and other HIV advocacy groups. 
Whilst the idea presented by the HIV activist reflected some of the concerns raised by 
KEMRI/CDC staff about the independence of CABs hosted by research organisations, it 
represented a more audacious vision of community advocacy and political activism. In 
essence two new conceptualisations of a CAB or a community representative body were 
being proposed. The first involved the existing CAB registering itself as an autonomous body 
with the city council, which would enable it to apply for funding for its activities and 
enhance its impartiality. Collaboration with KEMRI/CDC would still remain a strong feature 
of its purpose but the basis for collaboration would become more equal. Essentially the CAB 
would take on more leadership in this CE exercise. The second conceptualisation was of an 
independent politically orientated and activist community ethics forum which could demand 
closer accountability from any researchers working within a stated geographic location. This 
would require existing CABs to amalgamate, sever direct links with research institutions and 
formulate a new mandate. 
In practice it has been very difficult for the Kisumu CAB members to realise either of these 
proposed ways of increasing their autonomy. Endeavours to pursue registration as a 
community based organisation were met by a lot of governmental red tape and currently 
they are considering registering as a society. A society is a professional body whereas a 
community based organisation mainly deals with problems affecting people in a specific 
geographic area. Community based organisations generally have broader mandates, attract 
more funds and have more scope to take action. 
To date the CAB has not pursued the idea of amalgamating with other CABs to establish a 
more activist forum, and as far as I am aware there has been no further communication 
from the HIV activist about this proposal. The HIV research branch has also started to 
pursue more research activities in rural areas (Asembo/Gem/Karemo) as opposed to Kisumu 
which has resulted in reduced engagement with the Kisumu CAB. These questions about 
autonomy and the positioning of CABs remain of relevance at KEMRI/CDC even if it is 
unclear how to resolve them. 
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Karemo CAB Members' Perspectives 
As indicated in the quotation cited at the start of this chapter CAB members are usually 
people who command or enjoy a certain level and manner of respect at community level. 
They describe themselves as people to whom community members normally turn for advice 
or guidance in relation to questions of personal or public importance. The reasons people 
turn to them are varied and include seeking reassurance, wanting the benefit of a different 
and possibly more 'enlightened' perspective, wanting to know the range of opinion on 
certain issues, and looking for resources and connections. The notion that some people are 
more enlightened than others is very common in the rural areas where i undertook my field 
work. Those considered to being enlightened are those who have benefited from a good 
education and may have spent some time away from the locality for the purpose of work or 
study. This term was also frequently used by people of a higher standing to distinguish 
themselves from subsistence farmers and petty traders. CAB members may be considered 
to be enlightened and they definitely possess a certain status which can be attributed to 
their age, education, position, business skills and/or inherent leadership qualities. 
With regard to this notion of status it is important to think carefully about why people are 
respected. Is it due to their social standing; is it because they are a recognised authority 
(which may not necessarily be assumed to be benevolent); or is it because they are known 
to be people who make things happen and are not afraid of voicing their opinions? Or are 
certain people respected and trusted on the basis of personal ties or kinship relations? The 
reasons why individual CAB members are respected within their respective groups and 
communities vary and some CAB members may engender more respect than others, simply 
because they hold recognised positions - e. g. administrative chiefs. Some CAB members may 
also not command the respect of all members of their communities - e. g. youth leaders may 
not always be fully respected by their elders. 
The Karemo CAB encompasses a wide range of people including retired teachers, a blind 
advocate for disabled people, two chiefs, and representatives from boda boda syndicates, 
youth groups, traders, churches, community based organisations, and women's groups. 
These people share in common the ability to communicate freely and confidently with 
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KEMRI/CDC staff. They are also willing and able to set time aside for this voluntary work, 
and whilst not all of them are financially secure such constraints do not hinder them from 
being involved in the CAB. They are motivated by a desire for increased public access to 
treatment and health services, and value the opportunity to learn more about health, 
research and the way KEMRI/CDC works. One CAB member talked about his interest in the 
dialogue between the community and KEMRI/CDC and the way this can change perceptions 
about research. In the following three sections I will present CAB members' perspectives on 
their nomination, their role in CE and the questions they are asked. 
Becoming a CAB Member 
'It was about 2007 there, I think around February or March of thatyear. There was some 
mobilization that came from the office of the chief that the KEMRI/CDC wanted groups of 
people [mmm]. So we went [mm], and we found the CDC team there and they told us 
actually what they wanted to do [mmm]. So they wanted us to be in our respective groups 
[m m], so we were classified according to the groups that were there for example the 
women's groups, the community based organisations [mm], the boda boda traders or the 
bicycle transporters, the retired teachers and so forth. So, we were told now to have 
representatives from each group, there was a nomination from each group [mmm], then 
later on, there was an interview carried by the CDC and from that interview, I mean up to 
the nomination, we were about fourteen or so people [mmm], then we were called for the 
interview and finally I think they came out with six or seven people who qualified [mmm]. 
So that way we became CAB members [from Siaya town], yeah, that is from Siaya. ' 
Male CAB Member, CR 06 
This quotation describes the CAB nomination process which took place at barazas across the 
four main locations in Karemo in 2007. Chiefs were asked to alert community members in 
advance that KEMRI/CDC was looking for community representatives from different groups 
within the locality. When people heard this they were keen to come and find out more; 
according to one CAB member some even thought this might equate to an employment 
opportunity. At the barazas a team from KEMRI/CDC introduced the RVT and then explained 
that they wanted to form a CAB and what this meant. The nomination process was a fairly 
informal affair which took place in small groups and was decided by a show of hands. The 
names of those nominated by their peers were then passed on via the chiefs to the 
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KEMRI/CDC team during the same baraza. In some instances groups nominated people who 
were not actually present at the baraza. In these cases the chief checked with the individual 
in question and then passed on their details to KEMRI/CDC. The CAB members I spoke to 
were proud of having being nominated and viewed it as an honour that was in part due to 
their good public relations. One CAB member said she faced stiff competition and was glad 
that she made it, while another stated with satisfaction that 'it was not easy to get here'. 
The nomination process was also described as a ticket to an interview something they won 
and were very proud of, something that provided them the opportunity to gain access to 
KEMRI/CDC. 
'So that one gave us a ticket to interview [eeh], then for those of us who won the ticket, you 
were given a date [ok], for the interview at the chiefs camp [right] yah. So at the chief 
camp is where we were told, do you know that CAB will be voluntary [eeh], and do you 
accept to do voluntary work [eeh], as per now what are you doing for a living because we 
don't want to interfere with whatever you are doing because this will be a free thing. ' 
Female CAB Member, CR 08 
[Interestingly in chapter 10 this concept of gaining access recurs when mothers of RVT 
participants ask if they can be give a gate pass into the MVT which was about to start. These 
mothers wanted to continue their association with KEMRI/CDC and to continue to benefit 
from the larger project. ] 
It was evident that even though the work of CABs is voluntary those nominated were keen 
to be accepted as CAB members. The interviews were conducted by the female Kenyan 
community liaison for the vaccine trials and a female American study coordinator for the 
RVT. They took place at the four chief's camps across Karemo division. CAB members 
described these interviews as informal discussions in which KEMRI/CDC representatives 
sought to ascertain whether nominees understood the purpose of the CAB and would be 
suited to this role. Those who passed the interviews successfully took part in training on the 
function of the CAB, the conditions and responsibilities of membership and the RVT. Initially 
the selected CAB members mainly supported the RVT, but later their role expanded to 
providing input on other studies. 
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'Yes, you see us, first um we knew about the rotavirus, we thought our CAB was made to be 
for the rota virus project... we were trained on the Rotatec (the vaccine), the Rota virus and 
we were also told the targetgroup of the study and then we thought that it was only a CAB 
for the Rotatec, the Rotavirus. Then, later on we came to learn that it was a whole 
community CAB, where anything, any project, any study that would come through CDC 
would pass through. ' 
Female CAB Member, CR 02 
CAB members conveyed a considerable measure of self confidence and described 
themselves as leaders to whom others listen and come to for advice. One female CAB 
member (CR 8), who is also a local councillor, described herself as 'exposed' meaning that 
she was not inhibited about speaking out in front of authority and strangers. She was 
literate, but more importantly had life experience and knowledge partly gained from having 
lived in Nairobi. Therefore she was not impeded by cultural norms which can hinder women 
from voicing their opinions. 
Whilst CAB members were assured of their status within their own communities it was also 
apparent that their association with KEMRI/CDC changed how people viewed them and 
raised certain expectations. Although they continued to be viewed as valued sources of 
information people also thought they were earning a lot and would refer to KEMRI/CDC as 
'this, your people', asking them tongue-in-cheek, 'what do you think about these your cars? ' 
Overall however CAB members' status and pre-existing relationships enabled them to listen 
to concerns, provide information and allay anxieties. 
'Our area, and of course you see, the good thing was that the people who were actually 
elected and finally selected to become CAB members are actually people who people listen 
to [mmm] within the community. I sit here people want to ask me questions. People are 
desperate they really want to believe me, it helped a lot. They come along and really want 
to verify whether what they are hearing, what's said, is true or false. So, I just make the 
record straight and once they go out, they are satisfied, yeah. ' 
Female CAB Member, CR 02 
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CAB Members' Role in Community Engagement 
'How will you work without people? You are working in their area and you are working 
alone, if they'll just stand and look atyou and after all when you leave they'll come closer 
to see whatyou are doing there and maybe spoil it. lfyou don't involve them even ifyou 
put water there they will not come and use that water, so they have to be involved. ' 
Female CAB Member, CR 44 
Understandings of community engagement terminology 
In the early stages of my field work I asked CAB members to define the terms 'community', 
'community engagement' and 'ethics'. On an arranged day in November 2008 I invited them 
to a meeting at which I provided an overview of my study with opportunity to ask questions. 
Towards the end of this session I gave them each a piece of paper and asked them to write 
down what they understood the three terms to mean. Their interpretations of 'community' 
were very similar and placed emphasis on the following characteristics people who lived 
together, shared a geographical space, had common interests and goals, shared the same 
history and culture, had common beliefs and values, worked together and shared common 
resources. 
The notion of commonality was very strong in these definitions and only one CAB member 
introduced the idea of difference within her definition. She said: 'a community is a group of 
people living together with different tribes, culture and ethics'. Of note is that this person 
lives in Siaya Town which has a more diverse population than most of the villages across 
Karemo. It includes people who have moved to the area from other parts of Kenya in the 
pursuit of work or who have been transferred to Siaya as policemen or health professionals. 
CAB members' definitions of CE in this meeting were more varied and tended to stress the 
importance of involving everyone in the community to achieve a mutually beneficial goal 
(see Text Box 3). Participation and understanding were seen to be central to this activity. 
Only one definition focussed solely on communicating research messages; the others 
encapsulated a much broader agenda which in some ways was more closely aligned with 
community development. 
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In subsequent interviews CAB members continued to equate CE with community 
involvement and participation, which are terms that are used widely in the development 
literature. CAB members seemed to draw on these ideas of team work and coming together 
to achieve a specific goal in their reflections on CE. They warned that if you do not involve 
people you could end up by spoiling your project. This is graphically illustrated in the 
quotation at the start of this section. However they also used these terms with specific 
reference to research by explaining how important it was for everyone to know about the 
research. For example one CAB member who is also a chief talked about how those with 
more formal education can help their neighbours understand the purpose of research and 
what it will involve for their children. 
When it came to explaining 'ethics' CAB members referred to two aspects of ethics: the 
guidelines that govern research which they had been introduced to as CAB members; and 
'chike' (cultural rules) which represent behavioural norms for the way you should live and 
relate to one another. The fact that there is no specific word for the term 'ethics' in Dholuo 
partly explains these broad interpretations; on the other hand even in English 'ethics' can be 
interpreted variously depending on one's perspective and purpose. In the field of research 
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ethics increasing attention has also been paid to the importance of accounting for and 
respecting cultural beliefs in the implementation of trials. Interestingly this aspiration is also 
evident in one of the CAB member's definitions of 'Ethics': 'It is harmonising the beliefs of a 
community or an individual with the guidelines of any research or any other institution 
undertaking anything involving them or him/her: This suggests that CAB members are 
right to have a broad view of ethics and they should help researchers think about how trials 
interact with cultural and social beliefs. 
Positioning: Providing safe passage 
CAB members, like VRs, also viewed their role as central to the practice of CE. They thought 
it would be difficult for researchers to operate without their support and argued that trials 
need to 'pass through the CAB' before they commence. One of my interviewees stated that 
the CAB provided trials with a 'safe landing' in a community which might otherwise be 
resistant to research. In the following quotation he described how KEMRI/CDC tapped into a 
pre-existing system of consultation and used this to its advantage. 
'You know in our place here, there is a lot of politics [mmm], and they wanted to involve 
CAB so that when they come, and more so that they are coming to do the research. They 
wanted to have a safe landing [mmm], so that the CAB people, like we call them opinion 
leaders, when the community run. You know when you are staying in a village like this, we 
normally have people which the community regards so much [mmm], if they have a 
problem, they run to them, they ask them, oh we've heard of this and that, are you aware 
of this? And then if that person talks negatively about that thing, [mmm] they will just 
automatically reject it [right]. But if they find the person is with that idea and then 
convince them, they now believe, so they have the people they believe on [ok]. Some people, 
these people are being found at the churches [yeah], the community, you know maybe 
somebody who is, who is more than, normally get in touch with the people and then help 
them some other assistance. You find those kind of people are the people who are normally 
being elected at the schools as the chairmen [yeah, I see], they are normally elected on the 
activities which they, so they regard them so much [mmm]. That's why when the 
KEMRI/CDC came here, and interviewed them, and involved them, now when they hear 
about the things, they run to those people and then they get the answers. ' 
Male CAB Member & Chief, CR 25 
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Despite significant advantages this also raises questions about using trust as a lever for 
promoting community acceptance of research. CAB members did not comment specifically 
on this although they repeatedly stressed that their role did not involve convincing people 
to take part. Whether their association with KEMRI/CDC in and of itself did serve to allay the 
anxieties of those who turned to them for advice is, however, an open question. 
Positioning: Balancing allegiances 
People were fearing that these are NGO's that were just coming here to cheat, cheat 
people... but me I was very firm and even talked it out at the chiefs Baraza. I said that CDC 
has worked in the area I come from [mmm], me I am "Nya Sembo"[a lady from Asembo] 
and CDC has worked at our place [mmm], and people were given free nets [mmm], and 
they said bye to mosquitoes [mmm]. So it has nothing to do with the conning people 
[eehJ... there were a lot of rumours, but still / stood firm telling them that CDC has done a 
lot from even where / come from 
Female CAB Member, CR 08 
The notion of standing firm expressed in this quotation is of interest as it suggests that CAB 
members take positive action to promote the work of KEMRI/CDC. It describes how 
association with KEMRI/CDC can result in a CAB member's balance of allegiance shifting 
from the community more towards the research institution. In this quotation the 
interviewee draws on her past experience and current dealings with KEMRI/CDC to refute 
rumours or questions about KEMRI/CDC's intentions. In the interview she talked about how 
her mother had been a VR with KEMRI/CDC in Asembo in the early 1990s and how as a 
family they had benefited from the Saradidi community health and development project. 
This went some way towards explaining why she felt so positive about KEMRI/CDC. In terms 
of her prior understanding and experience of KEMRI/CDC she was atypical. She was not 
atypical however when it came to how CAB members viewed their responsibility of 
presenting KEMRI/CDC in a way that would help to overcome suspicion and promote 
acceptance. Similar ambitions were evident amongst VRs who were keen to present 
KEMRI/CDC as being different from organisations which prioritise self gain over community 
benefit. 
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CAB members take 'being' with CDC very seriously; it has become important to their identity 
and positioning. They are happy to be associated with CDC and the modernist project of 
health research and can be zealous in their support of KEMRI/CDC. They are keen to defend 
modern and what they perceive to be good values. They do not want to revert to the old 
ways but want to be associated with the new, and they seek to encourage KEMRI/CDC to 
extend their influence and do more to contribute to their communities. Hence although 
some CAB members do offer critique overall they are more vocal about the need to extend 
research and related health services. With regards to critique it is also important to consider 
whether critical thinking or questioning of recognised bodies is common or well-developed 
in rural Kenya. The education system does not teach problem-solving skills and students are 
encouraged to respect authority and follow instructions. Whilst this does not always quell 
initiative and ambition it can foster undue deference to strong leaders, powerful bodies or 
those who are perceived to be 'enlightened'. 
Positioning: Role and inherent ambiguities 
When CAB members explain their role they tend to repeat certain figures of speech and 
terminology which were used in their training to illustrate the purpose of the CAB. These 
terms are 'the eyes and the ears' or the 'eyes and the voice' and 'the bridge between 
researchers and the community'. In the following paragraphs I trace different applications 
and interpretations of these terms and seek to covey some of the ambiguity which 
surrounds the role played by CAB members. On the next page I cite the terminology as given 
in the CAB appointment letter (Appendix II, Doc. 5) and CAB training materials (Appendix II, 
Doc. 6) on the left side and on the right I present an extended interview excerpt to illustrate 
and contrast how this terminology is applied in practice. I then reflect on the contrasts and 
ambiguities revealed therein. 
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CAB Terminology as cited in 
KEMR//CDC Documents 
'CAB members serve as the ears and 
the voice of the community and study 
participants. ' 
'CAB members will listen to the 
concerns of the community, with 
regard to CDC and the research 
project. ' 
'CAB members will inform the 
research team of the concerns. ' 
'The members of the CAB and the 
research team will work together to 
come up with possible solutions for 
the problems. ' 
'The main reasons for having a CAB 
are to build a bridge between the 
community and the research staff.. 
and to serve as the voice of local 
questions and concerns throughout a 
given study. ' 
'The CAB functions as the primary link 
between the community and the study 
research team. ' 
'The CAB is responsible for 
disseminating study information to 
the community. ' 
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Discrepancies are evident in how the figurative term 'ears and voice' is described in the 
KEMRI/CDC materials and how it is interpreted in practice by the CAB member cited on the 
previous page. Officially this term is used to illustrate CAB members' responsibility to listen 
to what community members are saying about research and to relay any concerns to 
researchers. But the interviewee adds a slightly different slant to this by claiming that CAB 
members are 'an ear or eye of KEMRI/CDC'. Implicitly this interpretation changes how CAB 
members are positioned in regard to the community and KEMRI/CDC. It suggests a more 
proactive role than just communicating community concerns and thinking about solutions. 
Indeed the CAB member presents herself as part of the solution. She attends seminars run 
by researchers and then she goes down to her people and talks to them about this research 
(in fact she says that she is told to do this by those running the seminars). She helps to 
bridge the gap between the village and the researchers, she shares information and she 
encourages people to come to the clinics where the research is taking place. If we review all 
the responsibilities assigned to CAB members one could argue that this is a valid 
interpretation since, after all, they are asked to disseminate information about studies at 
community level. What is not specifically spelt out however is whether this is to raise 
awareness and canvass opinion or whether it is to encourage participation, and how one 
differs one from the other. Other CAB members understood their responsibilities for 
communication as entailing being the ear for both the community and the researchers. They 
describe themselves as go betweens, those who are positioned between the community 
and researchers and who relay information from one to another. 
'I attend the meetings the CAB meetings I get the information of what CDC want to do 
come back to the people and tell them what is going to happen and if they have any 
questions 1 take back to the meeting and we write in reports whatever we hear we write in 
our reports and we take to the meetings (okay). I was like an ear for the CDC in the 
community and an ear to the community in the CDC meetings. ' 
Female CAB Member, CR 44 
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'... as a CAB member, mostly I am here to, I am here just as an eye of the KEMRI/CDC or I 
am here to link the two people together. I am between them, if there is a problem in our 
area, I will take it to the KEMRI/CDC when we meet. I will give them the problem or 
anything that is ought to be done, we will share the ideas together to help the, any 
situation... So I am there to help the community, if there is any problem, I raise it up. I 
make the communication become cheaper between KEMRI/CDC and the community' 
Female CAB Member, CR 04 
This positioning is however not always comfortable and ambiguities relating to their role 
were also expressed by other CAB members. Many were unclear about their role, what they 
should do and how open they should be about their activities. One person even described 
their activities as slightly clandestine. 
'CAB members you know they should be just like a spy, somebodygetting something from a 
project or getting the views of the people against or pro the project and then you give a 
direct link to the researcher that should be the main work of a CAB member. ' 
Male CAB member & Chief, Area 2, CR 05 
This quote essentially describes CAB members' responsibility of informing researchers about 
community concerns. CAB members were not asked by researchers to act as spies but they 
were also asked not to be too zealous in their representation of KEMRI/CDC. The turn of 
phrase chosen by CR 05 does however communicate some negative associations with 
working undercover and disclosing sensitive information to outsiders. What is interesting is 
that this person is well known at community level and his links to KEMRI/CDC were not 
concealed. He was also very proactive about organising public forums for researchers to 
respond to particular community concerns when they arose. Nevertheless the sub-text 
suggests that operating as a go-between for researchers and community members is not 
always comfortable. CAB members can be unsure about how to position themselves and 
whether or not to 'expose' themselves: i. e. whether to tell other people that they were 
acting as CAB members. Of note is that the use of the word 'exposure' here is different than 
its use as a way of describing how attachment with KEMRI/CDC provides CAB members or 
VRs with new experiences, or how living elsewhere can increase one's understanding of the 
world. 
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'Ok, in after the first meeting we were not told to expose ourselves, yeah, so the community 
didn't know what we are doing... so they can just talk and you get what is in their hearts or 
what they are feeling so when this rota virus was introduced they could talk; me I can't 
take my child they are going to misuse my child, me I can't take my child for research I 
don't know what will happen after 2 years or 3 years. So they can talk and you get the 
information because they don't know you are connected with the CDC and that's how we 
were getting the information and taking to the CDC on the meeting day. So it was 
somehow an advantage being private because now they can say it openly. ' 
Female CAB Member, CR 16, FGD 
Questions about exposure and positioning stimulated an animated debate in a focus group 
in which CAB members talked about how they should present themselves at meetings, and 
whether they should speak out as CAB members or just put forth their opinions as 
community members. The discussion also raised questions about what they should or 
should not do as CAB members. Focus group participants explained that initially they were 
constrained in terms of what researchers wanted them to say or do. Researchers were 
hesitant about their ability to answer questions about the research and therefore only 
wanted them to pass on the information given to them. As the trial progressed researchers 
did engage their help to organise forums but their role was to facilitate information 
exchange and not to speak in public forums on their own or convince or encourage people 
to take part in research. Some of the CAB members expressed frustration about a desire to 
be more actively involved in promoting KEMRI/CDC. 
This exchange touched on what it means to mobilise the community. Whilst CAB members' 
mandate does not officially cite mobilisation as one of their responsibilities, CAB members 
equated disseminating information and assisting in education activities with mobilisation. 
The following excerpts present two differing interpretations of mobilisation. 
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Excerpt (Female CAB member, Area 1, CR 2): What is Mobilisation? 
CR 2: Normally when we get to the CAB meeting, there are normally sessions where 
each location comes with their issues, their concerns and then they are written on 
the wall, wallpaper or newsprint, then they are discussed by everybody. Then we 
go to, ok we get a way forward, we make suggestions, and even if it means now 
the KEMRI/CDC, whoever, they must go back to the community. Then we help 
mobilize, that is the way through, the way out, the only way out, we help mobilise 
and they come back again as a team, we go now again to the community. 
When you talk about mobilising as a CAB member, what do you mean? 
2: It was like now, if it is my group, our members like the community based 
organisation, they may have issues that I may not be able to answer. If I make a 
report there, we make a work plan and we got that on Saturday, they will come to 
SWYND (name of community based organisation), and meet with the SWYND 
members to clarify those concerns that I took from there. 
I: So in that sense, it is not that you were mobilising the people to take part in the 
study, you are just creating opportunityfor people to talk? 
CR Z: Exactly. You see with this kind of study the way we were trained, you just give 
people information, you get them, you talk about it, you are conduits... 
Excerpt from Field Notes, written after a first meeting with some CAB members 
from an urban area in January 2009: 
What is Mobilisation? 
The second question was about the role of a CAB member. The typical answer was cited: 
'CAB members are a bridge between the community and CDC' 
Again I probed further on this later, and asked them in particular what activities they 
get involved in. The term 'mobilisation' was mentioned and I asked them to explain what 
this meant. The boda boda representative said it 'involved convincing people to take 
part in the study and the others agreed with this definition. I checked this again 
with them but they definitely viewed this as part of their role. The disabled group 
representative talked about the fact that they are told things in CAB meetings that now 
need to be shared with others; they are channels of information. 
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There is a fine line between when sharing information becomes recruiting, encouraging or 
even convincing people to take part in trials. Even though most CAB members stated clearly 
that they were not supposed to mobilise people in the sense of recruitment, many of them 
did talk about encouraging people to take part in trials during interviews and focus group 
discussions. 
Positioning: Changing people's thinking about research 
One CAB member explained how the dialogue between researchers, CAB members and 
community members helped to change the way people think about research. He explained 
that 'the question of research was polluted people feared research in the past and thought 
that the risks were very high and that researchers were out to gain from you' He and 
others described how interaction with KEMRI/CDC both through CAB members and in 
observing research taking place in the community resulted in a change in people's thinking. 
Community members became accustomed to research because of what they saw happening 
and their interchanges with CAB members, VRs and KEMRI/CDC. 
CAB members primarily focussed on their role in information exchange and spoke less about 
how they advised researchers and even less about bringing community priorities for 
research to the table. Only one CAB member mentioned the latter and it is important to 
clarify that this person was an active advocate for disabled people's rights. He ran his own 
community based organisation, was very articulate and thought carefully about broader 
issues for example support for indigenous research at a national level. He proposed that 
space should be allocated to bringing community ideas and research priorities to the table. 
He referred to health problems which were affecting local people and for which they would 
like to see a solution, questions relating to learning disabilities and other diseases. His 
stance was that CAB members and other community representatives could be and should 
be more active in forming the research agenda. Others differed and questioned their own 
and community members' capacity to shape the research agenda and advise researchers on 
technical issues. 
'How will they know what they want to be researched on, they are not researchers they 
don't know what is happening, like now the swine flu, would they know if they are not 
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told? So I don't see the community deciding on some research that they want to do, but if 
there is, they should say it, they should go to KEMRI or CDC, they make this research done 
here. ' 
Female CAB Member, CR 44 
The content of this section suggests that community members are becoming more familiar 
with the practice of research and less sceptical about the intentions of research. At the 
same time research remains a sphere which is led by experts and which community 
members and even CAB members do not feel equipped to influence directly. 
Positioning: Relationships with others and questions posed to CAB members 
In contrast to VRs CAB members are less involved at household level, and do not encounter 
the same kinds of requests for assistance. Community expectations are not directed at them 
as individuals; however they are asked to encourage KEMRI/CDC to do more. Occasionally 
someone will ask them to buy them a soda since they are 'working'for CDC, but overall they 
do not encounter or need to balance the same obligations as VRs or FWs in the execution of 
their duties. 
CAB members argued for closer interaction with FWs and VRs and thought that this will 
strengthen CE. Some of them already worked closely with VRs from their area but most had 
limited contact with FWs. If rectified they believed that closer contact would help them 
address community questions. They could also link up FWs with people raising specific 
concerns which would help to reduce speculation and improve community relations. 
Initially the questions people posed to CAB members focused on the nature of KEMRI//CDC 
activities. They wanted to know what to expect, and why KEMRI/CDC prioritised research 
and did not address more concrete needs. 
'The difficulty is that the people wanted to know what the CDC will actually do to them. 
There were a lot of questions, so we take the information from the community, we link 
them with the, give them to, to the CDC. But like now the people are, you see the people are 
aware of the activities, they were asking the people are they going to build our schools 
[ok], are they going to provide us with food when we are hungry, those kind of questions. ' 
Male CAB Member & Chief, CR 25 
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Questions were most pressing in the early stages of the RVT, and waned off later. However 
as the following interview excerpt indicates some questions do not go away and form the 
basis of suggestion, storytelling and debate at community level. Storytelling was defined by 
one CAB member as a form of sharing information in an entertaining fashion. The following 
quotation describes this practice and outlines problems that CAB members can face when 
they seek to set the story straight. 
Interview Excerpt, Female CAB Member, Area 1, CR 02: Storytelling 
'Yeah, even in South Alego, we have the shopping centres where they can do read 
newspapers they can listen to their radios. But, even here within Township here, where 
you feel that it is not reserve, there are places where they don't listen to radios, they 
don't read newspapers. So it is very true a few people to go to those shopping centres to 
read and listen. But you see, around here, people around here are storytellers, they want 
to go back and give information that will make people laugh, because if people don't 
laugh, then there is nothing you have said and therefore, they will add a little salt, they 
will add a little sugar and then it will tell something very terrible even if it was good. 
That is actually what happens. So when somebody writes somewhere that somewhere in 
either in, either in Sudan, I don't know whether it is Sudan or Nigeria or somewhere, 
where I think some people went to do some research and um somehow the research 
made the orphans and children turn to be H/V positive and then they were chucked out 
of the area. That is what people are going down into the villages to say. Just like it 
happened there, that is what is going to happen here. So people would want to listen to 
such kind of horrid stories, you know, because they are about what they want to listen 
[Entertainment? ] It is kind of, it is entertainment now. So you know the kind of message 
deliverer will strive to entertain this people even if he has to lie and make things bad 
and bad and bad. So you know ifyou have such kind of people in the village, and you are 
X (a CAB member), you want to go with facts, then you see you are in trouble because 
you will be dull. They keep on asking questions like you see, they take our blood but the 
syringe they use has been contaminated with the H/V vi, virus. So we found out that it 
was not really even blood, it was the matter of the syringe being contaminated, yeah. So, 
we had to like eh convince them like eh how can the syringe be contaminated because 
the syringe is filled in front of you. Yeah, go and ask the people who are actually 
participating, were the syringes filled in front of them or the syringe came already 
opened. Then slowly by slowly they listened and of course they were waiting to see 
whether today or tomorrow, a child wasgoing to die because the child maybe was under 
that study but they saw none, yeah they saw none. ' 
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In the above social situation the CAB member found herself having to infiltrate popular 
banter in order to try to put the other side of the story across. In her interview she talked 
about how she met with storytellers in person to discuss the repercussions of their stories 
and to emphasise that KEMRI was a government organisation. As a result some of them 
changed their stories saying that they had been misinformed but this is now the truth. 
CAB members are asked a wide range of questions by different people and some are 
approached directly by community leaders. For example, an Anglican clergyman sought 
reassurance that parents understood that trial participation is voluntary. CAB members can 
seek the support of the CLO and trial staff when questions pertain to technical issues, 
concerns about blood and requests for additional support such as medical camps and 
malaria prevention. 
Text Box 4: Types of Questions CAB members are asked 
'Yah, the question that has really refused to go away is this issue of blood but I would say that it 
our culture. People simply fear blood, yah. In our culture, you don't just kill, people fear 
blood, so 
even if somebody sees a little drop of blood [mmm], they feel that that should not 
happen. And 
also, I think from other myths... ' 
At first they were asking were, where we were taking their children, where the people who are in 
the study take their children and they also ask if there is something, there is any profit? ' 
And then they will ask you how comes that every now and again the KEMR/ is 
here, the World 
Vision is here, what is, what is their interest in our Karemo? ' 
Why this research, what is happening, why should we take our children for Rota virus and 
whatever? Why do they want children, they take blood of children what are going to do with the 
children? We understand they want to take these children to America? You know even when there 
was nini (what) this family planning earlier, people thought that they were going to make them 
sterile so even when this Rota came they were suspicious and they wanted to know why this Rota 
virus? Children have been having diarrhoea they are being treated, why is this nini now coining 
up, why do we need the vaccine, where had they taken it from? 
'How come so and so has a child, the same age with the, that other lady. They 
both went to 
hospital to register ok to participate in the study, so and so's child was taken, so and so 
's child was 
left, why [laughter] yeah? ' 
'People are asking about what, they want are nets, when are we getting nets, why 
did these people 
get nets and we did not get? That home got a net, that home did not get a net, why? 
' 
'Now they ask; why is it only for the women and the children and not for the old men? 
' 
'When are they starting? ' 
190 
The sequencing of the questions in Text Box 4 shows how, gradually, people's attention is 
drawn more towards the benefits of trial participation. In a bid to negotiate trials to their 
advantage concerns turn to focus on exclusion rather than inclusion. This shift requires CAB 
members to explain why one child may be accepted for the study and another not and why 
recruitment may be limited to certain ages and have a finite number. More broadly this shift 
also charges those responsible for CE with the difficult task of addressing the boundaries 
which control resource distribution and research participation. 
Discussion of the Main Themes 
CAB members presented themselves as a pre-existing network of community leaders whose 
opinions are highly valued by community members. By tapping into this resource CAB 
members felt that KEMRI/CDC has been able to gain significant insights which have helped 
smooth the passage of research. At the same time CAB members' reflections about their 
contributions also raise questions about whether their links with researchers have affected 
both how people view them and their ability to provide independent advice. Here again we 
encounter the double-edged sword of trust; on the one hand it facilitates positive rapport, 
on the other it may lead to undue influence. A fundamental question is: can 'trust' be an 
appropriate lever to use when seeking to promote community acceptance of research? We 
also have to remember that trust and respect can be invested into people for different 
reasons and respect does not equate with trust. One may respect someone because they 
occupy a position of authority but you may not trust them as an associate or friend. 
CAB members highly value their association with KEMRI/CDC. They were proud to be 
nominated by their peers, to pass the interview and to gain access into a modern and 
progressive project. They described themselves as go-betweens, those who are positioned 
between the community and researchers and who relay information from one to another. 
CAB members' positioning emerged as a key theme in this chapter, which cut across many 
different aspects of their experiences. CAB members' positioning enhanced their status, it 
facilitated research, and it helped researchers appreciate contextual issues and address 
local concerns. At the same time it created challenges regarding CAB members' allegiance 
and the execution of their role. Significant confusion over the scope of CAB members' role 
was evident with CAB members occasionally having to take partisan action in order to 
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represent KEMRI/CDC's work accurately. However in other instances they were unsure 
about how much are they allowed to say and whether they should 'expose' themselves as 
CAB members or behave more like 'spies'. Some of these questions were resolved as the 
CAB became more established and members became more confident about what they could 
do, and when they should seek input from researchers. Other questions however continue 
to linger, particularly those relating to 'mobilisation' and trial participation. What is the 
difference between telling people about research, gathering them to find out more and 
recruitment? In practice there are subtle differences in how different CAB members 
interpret their role, with some being more proactive than others when it comes to 
encouraging community members to participate in trials. The confusion that exists over the 
scope of the CAB role is not helped by the use of figurative terms such as the 'eyes and ears. 
In the first part of this chapter I recounted two new and different conceptualisations of a 
CAB. Both of these seek to increase the autonomy of such bodies and make them more 
accountable to the community. Neither of these models represents current practice at 
KEMRI/CDC even in the Kisumu CAB which is being encouraged to register itself as an 
independent body. The Karemo CAB was set up as one way to help prepare the community 
for vaccine research and ensure that participants' rights are protected. This CAB retains 
strong links to KEMRI/CDC and in essence CAB members function as recipient and conveyers 
of information and community feedback. Very few CAB members have embraced the role of 
community advocates and whilst they feel free to question the purpose of research they 
tend to do this from a position of support rather than a position of neutrality. 
The value that CAB members attribute to their association with KEMR1-CDC, and the way 
they position themselves as those who travel across the notional boundary between the 
community and KEMRI/CDC, is reminiscent of patron-client or client-patron relations. Ideas 
of patronage or patrimonialism are inspired by Max Weber's distinction between systems 
based on impersonal rational bureaucracy bound by law, and family-like personal systems of 
redistribution to dependents (Reynolds Whyte et at., Forthcoming). In African societies the 
dominant form of political accountability is not rational universalistic bureaucratic rule, but 
personalistic patron-client ties (Chabal and Daloz, 1999). In patrimonial systems material 
resources both derive from and are converted into interdependencies among people. What 
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matters is 'having people' - patrons and clients - and nurturing connections, which provide 
access to opportunities and resources, and enable you to fulfil your obligations to your kin, 
clan tribe or ethnic group (Smith, 2003). Patron-client relations are essentially ways of 
structuring exchanges between unequal parties and they are characterised by expectations 
and obligations for both parties (Reynolds Whyte et al., Forthcoming). Let us return to the 
CAB to illustrate: KEMRI/CDC as the imagined patron expects CAB members to stand with 
them and obliges them to foster partnership between the research organisation and the 
local community. In return CAB members, as clients or associates, receive allowances, 
training, connections and access into a circuit of knowledge about research activities, 
peripheral job opportunities and other developments. Becoming part of KEMRI/CDC in turn 
means that CAB members assume certain patrimonial responsibilities, which involve trying 
to bring about an equitable redistribution of research benefits in their respective 
communities. The importance attributed to nurturing connections in patrimonial societies 
also sheds light on why CAB members are cautious about voicing critiques about research. 
Their hesitancy about assuming the role of community advocates is likely to be related to 
fears about severing potential opportunities for self and community development. 
Nonetheless CAB members' input is clearly of value and has helped researchers to be more 
sensitive to contextual concerns when it comes to implementing vaccine trials. Their advice 
does not necessarily change the course of trials but it helps to bring community concerns to 
light and to address them. In relation to ethics therefore their role is more about preparing 
the ground although they themselves also talk about the importance of harmonizing local 
culture and beliefs of the community with ethics guidelines. Currently it would be fair to 
state that CABs help raise awareness of research, but do not necessarily stimulate objective 
or critical discussion about research. The place and importance of critical awareness in CE is 
however still up for debate and may require new models of CE in which community 
representatives' occupy a less divided or ambiguous position. What is evident is that the 
increase in research taking place in Karemo, and related CE including forming the CAB, has 
contributed to a change in the community's thinking about research. This will be illustrated 
in more depth in chapter 10. For now however it is fair to say that increasingly people are 
attracted to the benefits of research and the boundaries which control access to such 
benefit 
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Chapter 9: 
Gatekeepers' Perspectives on Community Engagement 
'... most of my people still ha ve got faith in the administration, the chief and his team, 
whenever we tell them something they say that is the right thing [so as long as you 
support? ] They trust, but when I say that it is bad they turn the world against you. ' 
Male Chief, CR 5 
Introduction 
In this chapter I present the perspectives of 'gatekeepers' from the government-appointed 
district administration and the elected county council on the way in which KEMRI/CDC 
engages with the local community. I refer to these people as 'gatekeepers' since they have 
formal power to grant or restrict access to particular locations8. Gatekeepers' perspectives 
are influenced by many factors. Accordingly I begin by providing some background 
information on their official positions and roles, their relationships with the citizenry and 
why they matter in terms of CE. I also outline how KEMRI/CDC engaged gatekeepers from 
Karemo during preparations for community-based research, in particular the RVT. 
To illustrate gatekeepers' perspectives on CE I then draw on observations from my 
fieldwork, reports of meetings, and a series of interviews undertaken with the District 
Commissioner (DC), and a leader from the county council, 4 chiefs and 1 assistant chief. To 
reflect inherent differences between the roles of various gatekeepers I differentiate 
between the perspectives of senior officials and those of lower levels of administrative 
chiefs who interact more closely with the local community. The data used for this analysis 
were collected between October 2008 and December 2009, which was 2-3 years into the 
establishment of a community-based research programme in Karemo. At this stage several 
rounds of demographic surveillance had been completed, the RVT had reached its' 
recruitment target, Tuberculosis prevalence cohort studies had commenced and 
preparations for the MVT were underway. 
8 These powers have been delegated to district administrators since colonial times. 
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Who are these Gatekeepers & Why do they Matter? 
According to Holloway and Wheeler (2002 p. 47) 'gatekeepers' represent those who have 
the power to grant or withhold access to the setting in which one wants to conduct 
research. For KEMRI/CDC these people comprise those who hold positions of leadership 
within the government administration, the political leadership and the ministries of public 
health and medical services. In this chapter I focus on the first two groups with specific 
reference to officials from the district administration and elected representatives from the 
county council. I will turn my attention to gatekeepers from the ministries of health in 
chapter 10. 
District Administration 
At the time of my fieldwork the highest ranking official at district level within the national 
administration was the district commissioner (DC). The DC is appointed by the Kenyan 
president and directly accountable to the provincial commissioner. In turn the DC supervises 
district officers (DOs) who are in charge of district sub-divisions, chiefs who are responsible 
for locations within these divisions and assistant chiefs who represent sub-locations. 
Historically the district administration has been the main body responsible for ensuring that 
government policies are applied at district level and that law and order is upheld. Under the 
new constitution some of these responsibilities are being transferred to local authorities 
such as municipal and rural county councils. Hence in the future it will be difficult to 
differentiate between the roles of the district administration and the local authority. A core 
distinction which will remain, however is that administrative officers are permanent public 
service employees, whereas council officers (such as the mayor, chairman of the council and 
councillors) are elected for terms office under a political mandate. For the purpose of this 
thesis it is unnecessary to comprehend the intricacies of gatekeepers' official duties 
however it is important to understand why these officials matter when it comes to the 
implementation of research. 
Senior district officials such as the DC and DOs hold judicial powers and are charged with 
coordinating government activities across a district. This includes overseeing the work of 
non-governmental organisations and research groups who contribute to local development. 
Representatives from such groups are required to inform the DC and relevant DOs of their 
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work plans and obtain their approval (this is usually a verbal approval following the written 
submission or oral communication of work plans). Historically this community entry function 
was the main role played by senior gatekeepers played in terms of research. Once their 
approval was obtained researchers tended to collaborate more closely with chiefs in the 
implementation of research. However under the coalition government formed in 2008 
there has been a greater push to enhance accountability and improve communication 
between the district administration, the ministries of health and other organisations 
working in the district. As a part of this drive a quarterly health stakeholders' meeting 
chaired by the DC and run in partnership with district health officials has been instigated. 
Any health-related organisations are required to attend this forum and provide detailed 
updates on their work. 
As suggested above chiefs have historically played a crucial role in the implementation of 
research programmes. Chiefs are the face of the government at community level and are 
delegated certain legal authorities by the state which enable them to enforce the law, settle 
disputes and administer government policies. In addition - and in contrast to the DC and the 
Dos - chiefs originate from the communities they administer; hence they have strong family 
and clan connections. They are well known and command the respect needed in order to 
settle disputes and mobilise community members to attend barazas and other government 
activities. In essence they are intermediaries between the state and the people and their 
authority and judgement carries considerable weight on the ground. This is one of the main 
reasons why so much emphasis is placed by researchers on the involvement of chiefs in the 
implementation of community-based research. 
The position of 'chief was first instituted by the British during their colonial rule of African 
territories (Lonsdale, 1964). In order to save costs and to benefit from the perceived 
authority of indigenous leaders British colonial administrators created a system of indirect 
rule. They appointed Africans as local agents of colonial rule and delegated to them 
responsibility for translating orders, collecting tax revenues and enforcing law. This 
imposed chieftainship did not however generally reflect inherent leadership structures and 
colonialists tended to create artificial territorial boundaries. According to Berry (1992) 
colonial administrators failed to recognise that African societies were not divided into neatly 
bounded, mutually exclusive, stable cultural and political systems, but were instead 
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dynamic, changing communities, whose boundaries were fluid and ambiguous and whose 
members were often engaged in multiple contests for power and resources. This meant that 
community responses to externally appointed chiefs could be ambiguous and chiefs had to 
exercise strong leadership in order to discharge their duties. 
Over time the chief became an established part of the Kenyan government administration 
and chiefs continued in office even after independence from colonial rule in 1963. Chiefs 
today are state functionaries who wear uniforms which resemble those of soldiers and 
whose main purpose is to apply government policy down the chain at community level. 
" ,ý 
nil'. 
Photo 14: Administrative Chiefs in their Official Uniforms 
Their charter of service (Appendix II, Doc. 7) cites the following duties: To enforce the law; 
to prevent, manage and resolve social, political and other conflicts; to operate community 
policing; to enable harmonious co-existence of communities; and to hold interactive public 
barazas (open community meetings). As suggested above their work is primarily about 
applying government processes down the chain of command, and whilst their charter 
requires them to interact with and obtain feedback from the populace emphasis is placed 
on achieving cooperation. Hence chiefs tend to focus on communicating down the chain of 
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command rather than relaying community opinions to their superiors. This is of relevance to 
chief's involvement in CE in health research. When examining chiefs' current involvement it 
is also important to consider their past involvement. Graboyes (2010) provides some 
insights into this in her review of historical sources and oral accounts about the practice of 
medical research in East Africa in the 1950s. She describes how colonial medical researchers 
used chiefs to spread news about research, which was frequently misrepresented as 
treatment rather than research. With government support researchers expected the chief 
to explain the research to his people, overcome suspicion and achieve cooperation. Minimal 
guidance was provided on how chiefs should achieve these aims by researchers, who 
tended to turn a blind eye to any tricky tactics. For example, Graboyes (2010) cites evidence 
that chiefs ordered people to take part in research and issued fines to those unwilling to 
participate. Whilst chiefs do not exact the same level of authority in CE today it is important 
to be aware of this history in since people do not forget the past which can continue to 
shape current perceptions and responses to biomedical research in subtle ways. 
Elected Representatives 
Over the course of my fieldwork relationships between researches and elected leaders from 
the county council gained more momentum. in part this closer engagement occurred in 
tandem with the increased status and powers attributed to local authorities under the new 
constitution. In part it was also just a result of the growth of KEMRI/CDC activities at 
community level. Traditionally county council leaders and councillors, who represent 
different wards at community level, have interacted minimally with researchers. In fact, as 
discussed in chapter 6, researchers have been hesitant about involving politicians (i. e. 
elected representatives) in their activities. They are wary of their motivations and do not 
want community members to be unduly influenced by those who hold significant influence 
over public opinion. The fact that some politicians from neighbouring areas spoke out 
against research during a period of negative media coverage in 2004 (see chapter 3) served 
to increase researchers' reticence to engage this group (Big Issue Team, 2004). In addition 
and possibly more significantly the scope of the role played by councillors at district level 
has been unclear, and their terms of office transient. However as described in the next 
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section representatives of the local authority have begun to demand closer collaboration 
with KEMRI/CDC. Researchers have started to respond to this request in order both to 
increase understanding of the goals of their programme and to minimise any negative 
repercussions which could ensue from the non-involvement of political gatekeepers. 
It is clear even from this short review that gatekeepers play diverse roles in terms of CE 
depending on their position and influence. There are those who provide official approval 
and those whose support is indispensible when it comes to rolling out programmes at 
community level. It is also evident that involving gatekeepers is not just about facilitating 
entrance but more importantly about retaining support over time. The range of gatekeepers 
has also evolved with KEMRI/CDC now being required to collaborate with a broader 
spectrum of community leaders including those who hold political office. 
The Involvement of Gatekeepers in Community-based Research 
When the decision was made to extend the health and demographic surveillance system 
(HDSS) into Karemo division in 2006 senior representatives from KEMRI/CDC met with the 
then DC from Siaya District to discuss and agree on these plans. With his approval 
subsequent meetings were held with the DO and chiefs from this division. At these meetings 
the purpose of the HDSS was presented and possible benefits and disadvantages outlined. 
The chiefs and the DO voiced their support for the planned programme and helped raised 
awareness at community level. The chiefs were particularly active in mobilising community 
members to attend barazas where they could learn more about the HDSS from a team from 
KEMRI/CDC. They were also involved in helping researchers to recruit VRs to assist in 
surveillance activities. 
During preparations for the RVT chiefs and the DO from Karemo were invited to attend an 
'Educational Seminar on Clinical Trials, Rotavirus, immunization and other causes of 
Diarrhoea' held in seminar rooms at a hotel in Siaya. This seminar was led by the study 
coordinator, project manager and community liaison lead for the RVT. Chiefs were given an 
overview of the trial protocol and ask to comment on ways to inform and engage the 
community about the proposed research. As part of this consultation chiefs were also asked 
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to organise a series of barazas at which researchers could discuss the trial with community 
members. This pattern of community interaction is KEMRI/CDC's primary strategy for 
disseminating information and responding to questions about research at community level. 
To further strengthen relationships with chiefs KEMRI/CDC has instituted an annual chiefs' 
day at the field station near Kisumu. The aim of this event is to orientate chiefs to the 
broader research portfolio and provide them with the opportunity to meet senior 
investigators and visit research facilities and laboratories. It is also hoped that as a result of 
these days and other interactions chiefs will assume the role of ambassadors for 
KEMRI/CDC. 
'... we have this annual chiefs' day here at the campus... we would like them to sort of be our 
ambassadors out there so that when they go and meet someone who is a bit worried about 
us taking some blood samples, then they can clarify for them exactly what we use it for... ' 
CT Member, RS 06 
The following social situation describes one of these days which occurred during the course 
of my fieldwork. 
Social Situation: 4th Annual Chiefs' Day 
The 4th annual chiefs' day was held in July 2009 and attended by over 200 chiefs and 
assistant chiefs. The chiefs travelled to the field station by public transport and were given 
special permission to pass the 2 security gates which guard access to the KEMRI/CDC offices. 
They had to provide identification and their names were verified and checked off from a list 
compiled by clerical staff at KEMRI/CDC. On arrival attendees were welcomed with tea and 
donuts and given the opportunity to peruse information stands set up by different research 
branches within KEMRI/CDC. 'People of high calibre are gathered' prayed one of the chiefs 
at the opening of the formal programme thereby affirming their position and conveying 
their honour at being invited to this event. The acting KEMRI Director welcomed them 
warm-heartedly to an environment where science takes place and where KEMRI 
collaborates with a wide range of groups including CDC. He explained that KEMRI's mandate 
is to look for ways of improving health and whilst this used to be all about doing research 
'on' communities, it is now about doing research 'with' communities. He sought 
confirmation from the audience who responded with an animated: 'Yes'. 
Following on the CDC Director announced the recent launch of the MVT describing it as a 
momentous occasion which may mean that your children or your children's children will not 
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experience or know malaria in the same way as you do. She declared that KEMRI/CDC is at 
the cutting edge of scientific discovery and stressed chiefs' and their communities' 
contribution to this by citing the employment of 200 people from the local community over 
the past year. Throughout the CDC Director's presentation and interactions she employed a 
variety of metaphors to communicate a central idea about the role of chiefs with regards to 
the research programme: Chiefs are the 'eyes of the community', 'our windows' and 'the 
people who tell us what is going right or wrong'. She encouraged constructive criticism and 
urged chiefs to keep KEMRI/CDC informed about community concerns and questions. 
Both directors' presentations were followed by short contributions from Kenyan research 
branch scientists and a question time. According to the training officer a shift in the subject 
of questions was apparent, from an emphasis on employment issues to an interest in 
science and health-related action and policy. He commended the chief's for this and 
pronounced that this was 'the best chiefs' day so far'. To conclude the formal programme 
one of the chiefs offered a vote of thanks. He said that 'down there when you mention 
KEMRI/CDC death is being, chased away and ifyou mention it 10 times a day you get more 
life. He then rallied all of the participants to join hands and chant quoting the US President 
Obama, who is of Kenyan patrilinage: 'Together we can' (Photo 15). 
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After lunch chiefs from the same areas 
gathered together and were reimbursed for 
their travel expenses by the community liaison 
officer (CLO) and his assistants. They were also 
presented with a 'Partnership Award' (Photo 
16) by KEMRI/CDC personnel working in their 
areas of jurisdiction. Finally photos were taken 
before the chiefs embarked on their return 
journeys. 
/ 
Annual chiefs' days are unique in the way they open up a space which is not usually 
accessible to members of the general public or community leadership. Chiefs are welcomed 
in cordially, interact directly with senior researchers, and are exposed to the materiality of 
research i. e. the modern buildings, the well-equipped laboratories and the well-maintained 
landscape. Friendship is extended in the sharing of food and drink and gratitude expressed 
in formal presentations by researchers. The chiefs enjoy the pleasure of being 
'in' which 
underscores their desire to be involved with a powerful organisation. The analysis presented 
in this chapter and elsewhere in the thesis indicates that strong emotions such as, 
desire, 
fear and anger can characterise encounters and non-encounters with KEMRI/CDC. In the 
above social situation the recognition afforded to chiefs heightens their 
desire to represent 
a modern project 'down there'. In contrast later in this chapter anger about non- 
involvement is expressed by senior gatekeepers, and chiefs relate common community 
fears 
about the research programme. In chapter 10 fear emerges differently when parents 
express anxiety about the consequences of no longer 'being with CDC' when the 
RVT ends. 
At the end of the aforementioned annual chiefs' day the CDC Director informed attendees 
about plans to alternate the target audience for such events in future. The chiefs' day would 
take place every other year from now on with a biennial day for members of the district 
administration and elected representatives occurring in the intervening year. Although the 
Director did not expand on the reasons for this, these will become self-evident in the 
following section. The chiefs did not react especially to this announcement and those with 
whom I had closer contact were aware of senior gatekeepers' desire 
for closer involvement 
with KEMRI/CDC. 
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The Perspectives of Senior Gatekeepers at District Level 
To present the perspectives of senior gatekeepers I draw on interviews with the DC and the 
chairman of the county council and observations of events which involved them and other 
appointed or elected leaders. To set the scene I start by providing a resume of a meeting 
which took place between the DC and senior representatives from KEMRI/CDC. The 
substance and circumstances of this meeting are critical to understanding key issues which 
shape the perspectives of senior gatekeepers. 
Social Situation: A Meeting called by the District Commissioner 
On Monday 27th October 2008 I was invited to join an impromptu meeting with the Siaya 
DC. The meeting had been called in response to complaints about the KEMRI/CDC research 
programme voiced during a district health stakeholders' forum the previous week. The 
KEMRI/CDC community liaison officer (CLO) had attempted to address grievances at the 
forum but the DC requested follow up in person with KEMRI/CDC directors and those who 
were leading research studies in Siaya. Recognising the urgency of this request the 
KEMRI/CDC leadership immediately dispatched a team of 12 (13 including myself) in 4 cars 
to meet with the DC in his offices at the District Headquarters in Siaya town. The team 
included a senior representative from KEMRI Centre for Global Health Research (CGHR), the 
CDC Director, the head of the HDSS, the CLO, the communications officer, a research doctor 
based at Siaya District Hospital (SDH), the coordinator for the Global Aids Programme 
(which supports district HIV care and treatment services), the study coordinators for the 
MVT and the Tuberculosis adolescent cohort study, a representative from the enteric 
research group, the HDSS special projects officer and the person responsible for community 
liaison in the RVT and MVT. I travelled in the same vehicle as some of the team and the 
tone and content of conversation conveyed the anxiety felt about potential repercussions. 
The head of the HDSS commented that it was well within the DC's jurisdiction to either close 
or hamper the KEMRI/CDC research programme. 
On arrival at the headquarters the team was admitted into the DC's office fairly quickly 
although it was clear that both the DC and his secretary were taken aback by the size of the 
delegation. The DC complained that there were too many people but still sent for more 
chairs to cater for everyone. We sat in chairs in a semi-circle around the DC's large desk with 
the CDC Director and the KEMRI CGHR representative to his right and left. Following 
introductions it was agreed that the main agenda was to discuss stakeholders' 
dissatisfaction about the way in which KEMRI/CDC was working on the ground and to 
consider how to move forward. 
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The DC started the discussion by drawing attention to a plaque which recorded the start 
date of his mandate as October 2007. He lamented the lack interaction between KEMRI/CDC 
and himself since he took up office and pointed out that prior to this meeting no one from 
KEMRI/CDC had even been to pay him a courtesy visit. From his perspective there was 
`something missing in communication'. Related to communication he elaborated that 
people expected more transparency and a greater level of participation in decision-making 
in the current political climate. The predominantly Luo local population felt that since they 
were now in government (following the formation of the coalition government under a 
power sharing agreement between the parties of Mwai Kibaki and Raila Odinga) they should 
have a greater say about what happens in their community. Local and district leaders 
wanted to know more about how KEMRI/CDC operates and the DC stated that now was the 
time to address this demand. At this point the CDC Director interjected to state that she was 
happy to do anything and outlined how KEMRI/CDC already interacts with stakeholders with 
particular emphasis on regular meetings with the District Health Management Team 
(DHMT). The DC responded by saying that this information was not reaching his offices and 
that he had heard that Ministry of Health staff feel there was something missing in the way 
KEMRI/CDC communicates. This perturbed the CDC director who stressed that both she and 
senior researchers meet frequently with the District Medical Officer (DMO), especially in the 
run up of a new trial, and that they always send a representative to DHMT meetings. The 
CLO in turn remarked that he had not been invited to recent administration meetings to 
which the DC replied he should just get in touch and take part. 
The meeting then moved on to concerns raised by district officers about the lack of links 
between KEMRI/CDC and local universities. The DC urged those present to facilitate closer 
collaboration and commended a cotton growing project, run jointly by the Kenya 
Agricultural Research Institute with Moi University in Eldoret. This led to a discussion about 
'zoning' which related to complaints about KEMRI/CDC's perceived reluctance to allow 
other organizations to operate in areas where they conduct research. The DC advised 
KEMRI/CDC to team up with a wider range of stakeholders in order to prevent further 
speculation. In relation to collaboration he expressed scepticism about concentrating 
activities at the level of sub-locations and questioned chiefs' capacity to address broader 
concerns. In his opinion researchers should work more closely with district officers who 
supervise chiefs and who had felt sidelined. He used the following phrase to stress the 
importance of extending involvement: '... remember that those who are left out make noise 
but ifyou involve them they can help correct public perceptions 
When the DC started to talk about the need for more public forums at which 
misunderstandings about research could be aired those present were quick to update him 
on planned events, and the CDC Director invited him to KEMRI/CDC's first results 
dissemination meeting scheduled for November. The DC welcomed this invitation but also 
encouraged KEMRI/CDC to do more about sharing research findings at district and 
community level. The head of the HDSS agreed and acknowledged that the HDSS had 
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previously only supplied chiefs and not other district officials with copies of their annual 
report. The DC appreciated this response and went on to call for the department that 
handles the community to be strengthened and reiterated earlier points about developing 
partnerships and improving communication. Pointing out that one tends to see the same 
faces at barazas he stressed the need to use a wider range of forums and channels including 
vernacular radio stations and newspapers. He also thought it would be a good idea for 
KEMRI/CDC to distribute a community newsletter issued in Dholuo and English. The head of 
the HDSS picked up on the essence of the DC's argument and concurred that KEMRI/CDC 
needed a new communication strategy: yes' replied the DC, 'one which emphasises 
dialogue'. 
In the closing stages of the meeting the DC raised questions about KEMRI/CDC's mandate; 
he stated that there was a lot of confusion about this on the ground, with people tending to 
associate CDC with non-governmental and KEMRI with governmental activities. He called for 
these perceptions to be corrected and the nature and remit of KEMRI/CDC collaboration to 
be communicated clearly to everyone. In terms of the remit of operations he raised a 
concern that had been put to him about infrastructural development. He asked for 
KEMRI/CDC to invest in more permanent structures rather than just bringing in containers. 
The CDC director explained that US government funds cannot be used for buildings, which 
meant that they had to apply for other funds to restore existing structures or erect new 
buildings, as was the case of plans for a new centre at SDH. The DC thanked her for this 
clarification, and stated that this was exactly the type of information that should be shared 
at the newly instituted quarterly district health stakeholder meetings. He explained that the 
aim of these forums was to avoid replication and encourage transparency: 'in the past some 
organisations would run away with money, so we need to make sure that people are 
accountable'. 
The style of the exchange in this meeting was very formal to start off with and gradually 
lightened up as the KEMRI/CDC delegation acknowledged and responded to the DC's 
complaints and concerns. By the end of the meeting the DC summed up with some words of 
appreciation and counsel by saying: 'this is a good starting point-but remember if you 
work in isolation you will have people fighting againstyou'. 
The circumstances and content of this meeting raises several questions and provide us with 
unique insights into officials' views of the KEMRI/CDC programme at a specific point in time. 
The DC had been appointed in October 2007 and although KEMRI/CDC had interacted with 
his predecessor there had been no formal exchange with him prior to this meeting. This 
omission added weight to criticisms voiced by other stakeholders and resulted in the DC 
requesting a formal meeting with senior representatives from KEMRI/CDC. KEMRI/CDC 
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acted without delay and sent a very large delegation which included the CDC Director and 
senior staff from different programmes. The quick response, size and nature of the 
delegation communicated several important points: first KEMRI/CDC's fear of possible 
repercussions; secondly their commitment to addressing complaints; and thirdly the 
magnitude and influence of the research organisation. Regarding the latter it is interesting 
to note how the DC maintained control of the meeting even though he was initially taken 
aback by the size of the delegation. 
The DC's above-described critique of the KEMRI/CDC programme comprised 4 main 
arguments which emphasised the need for closer interaction and improved communication. 
First he argued that the recent change in the political environment had resulted in an 
increased demand for transparency and consultation at community level. Local residents 
wanted to have more say about programmes taking place in their communities. Secondly 
community leaders were also keen for international organisations to form connections with 
local universities and groups with similar interests. He described how other organisations 
felt excluded by KEMRI/CDC. He criticized the use of zoning tactics and encouraged closer 
collaboration with other health stakeholders. Thirdly the DC questioned KEMRI/CDC's 
primary focus on chiefs when it came to facilitating both community entrance and the 
ongoing implementation of research programmes. He argued for closer working relations 
with more senior officials and drew attention to the pitfalls of not involving them. Fourthly 
he made a strong case for increased accountability at district and community level by 
stressing both the need for improved communication with his office and more public forums 
to discuss and provide feedback on research. In the Kenyan context it is important to 
remember that these sorts of demands implicitly communicate an appeal for access to and 
the sharing of resources and fringe benefits. 
This meeting led to some changes in how KEMRI/CDC approaches CE in Karemo division. 
Most significantly the CLO started to visit the DC on a monthly basis to provide him with 
regular updates on the research programmes. Care was also taken to involve the DC in 
special events such as the visit of a media team from the USA and a meeting between RVT 
investigators, sponsors and community representatives. Over time increasing emphasis was 
also placed on interacting more closely with leaders from the political fraternity and others 
who influence public opinion at community level. Several 'opinion leaders" meetings were 
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organised which were attended by local councillors, the Siaya mayor, the chairman of the 
county council, youth representatives and clerks from the local member of parliament's 
office. Whilst this broader application of CE served to improve community relations it also 
raised questions about the research agenda, its remit and application. 
Central Themes 
Three central themes emerge from an analysis of interviews with the DC and the chair of the 
county council and related observations. I have labelled these themes as follows: 
'Detachment and involvement', 'Questioning the agenda: Research as an affair for the poor', 
and 'Relationships and obligations'. Each is examined in turn below. 
Detachment & Involvement 
'... we just see KEMRI vehicles running up and down doing research. ' 
Male County Council Leader, CR 57 
This symbolic analogy was repeatedly used by interviewees and others in informal 
conversations to portray anger about feeling detached from the KEMRI/CDC programme. 
Interestingly the DC used this analogy both to argue for closer collaboration and to draw 
attention to changing relationships on the ground. At the meeting described above he 
complained that 'research should not be a matter of driving up & down and going back to 
office' (CR, 31). Six months later he then recounted how one particular incident -a 
KEMRI/CDC vehicle stopping to help at the scene of a road traffic accident - had had a 
positive impact of people's perceptions of the research programme. The humane 
intervention of KEMRI/CDC staff travelling in this vehicle demonstrated attachment rather 
than detachment. 
Detachment was viewed negatively by the DC and a leader of the council who both warned 
about possible repercussions of not involving local leaders and those higher up in the official 
hierarchy 
'... because if they sideline the political leadership they might get it rough because we are 
mobilisers and with our support they can go a mile more than where they have gone 
but if 
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they don't work with us hand in hand then it might not help them much, but we had 
agreed in principle that they will be contacting us calling us in meetings, then we know 
what they are doing so that we also support them. ' 
Male County Council Leader, CR 57 
Both argued that the active involvement of leaders can help prepare communities for 
research and extend the ambit of the programme. Their underlying motivations for closer 
involvement differed slightly; for example the DC was engaged in postgraduate study in the 
field of community health. Therefore he was keen to help correct misperceptions about 
trials and promote the dissemination of accurate information. He also requested more 
feedback on research findings and how these would benefit the local community. Whilst 
elected representatives were also interested in both the short term and long terms benefits 
of research their main motivation lay elsewhere. They hoped that collaboration with 
KEMRI/CDC, or to quote a county council leader, 'becoming part and parcel of KEMRI/CDC' 
(CR 57) would help secure support for community programmes. 
Hence when the mayor and a leader from the county council were invited to the KEMRI/CDC 
offices they presented a proposal for a jigger control programme to the CDC Director. They 
also discussed other forms of support e. g. building matatu (bus) stop shelters which could 
be used to post health messages and raise awareness of KEMRI/CDC. These proposals 
indicated that community leaders are keen for KEMRI/CDC to extend their mandate and to 
offer other assistance apart from research. Indeed at the groundbreaking of the 
construction site for a new research centre at SDH, which was also going to house improved 
HIV care and support services, the DC thanked KEMRI/CDC for all the support they had given 
the community of late. He stressed that the community really appreciated the way that 
KEMRI/CDC was moving beyond their mandate of research. At the same event he also 
congratulated researchers for improving their communication strategy and urged 'that now 
we are linking up - let's keep it that way' (CR, 31). 
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Questioning the Agenda: 'Research as an Affair for the Poor' 
But may I ask why did KEMRI choose Kenya and particularly Siaya? / know for this vaccine 
trial (malaria vaccine trial) hmm why did they chose Siaya, because of the low population 
the lower 'nini' [/ mean] the lower income, so that people would accept? 
Male County Council Leader, CR 57 
Certain apprehensions and some scepticism about the KEMRI/CDC research programme 
became apparent in discussions with leaders from the political fraternity and during 
meetings with opinion leaders. For example the chairman of the county council expressed 
reservations about 'the research being done on children as opposed to when we were 
young they were done on either, either guinea pigs or done on rats' He also questioned 
researchers' motivation for undertaking trials in an area where economic deprivation was 
widespread. Equally he felt it was pitiable to conduct research in health facilities which were 
unable to provide patients with basic essentials such as bed nets to prevent malaria. With 
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these statements he asserted his authority and responsibility for speaking up when things 
are not done properly. His criticism about the lack of basic essentials of health facilities was 
directed both at government health officials and researchers. More importantly his 
observations raised critical questions regarding the ethics of conducting research in 
resource-limited settings. 
The DC also commented on these dilemmas and explained how underlying poverty and the 
lack of government resources meant that 'people expect that KEMRI/CDC should give more 
support to these communities than what they are doing currently' (CR 31). He reasoned 
that it was very difficult to apply a research agenda without attending to other pressing 
health issues. This observation was reiterated in opinion leaders' requests for help with 
other disease prevention programmes such as de-worming and jigger eradication, and their 
questions about the demarcation of space for research activities in busy health facilities. 
They argued that any space sectioned off for research within the paediatric ward at SDH 
should be made available to general patients when the ward was congested. 
At the heart of these questions lie concerns about the equitable distribution of benefits 
both for those participating in trials and those hosting trials; how will trial participants 
benefit from the profits that manufacturing companies make from new vaccines, and how 
can we ensure that local communities prosper from the research enterprise in terms of 
employment, infrastructural development and commercial opportunities? 
Both the chair of the council and the DC associated research participation with poverty. This 
view was also expressed by some fathers whom we interviewed separately in a sub study 
and substantiated by the experience of VRs based in urban areas. 
'! would believe these people, the vaccine trials you are doing on ordinary 'mwananchi' 
[ordinary citizen] child yeah ordinary 'mwananchi' [ordinary citizen] child you are not 
doing it on somebody like Onynago's child, I have been to the hospital I see these people 
going to villages in the villages in ordinary homes, and I will put a challenge to you, tell me 
which prominent home have you carried the research? ' 
Male County Council Leader, CR 57 
This quotation suggests that apart from the 'stigma of exploitation' (Big Issue Team, 2004) 
widely associated with research there is also an additional 'stigma' attached to taking part in 
research-namely that if you take part in research you must be poor. The quotation also 
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claims that researchers do not target those who are better off. In regards to the latter claim 
both the DC and a leader from the county council argued that KEMRI/CDC needed to engage 
with a broader section of society including those from the middle classes. They stressed that 
research should not be perceived as 'an affair for the poor' (CR, 57) and that it was 
important to include children from wealthier backgrounds in order to achieve a more 
representative sample of the population. They also thought that middle class parents could 
serve as effective spokespersons to promote the work of KEMRI/CDC. 
The 'stigma' attached to research participation is however not just a result of researchers 
targeting particular population groups over others. Those with financial means take pride in 
being able to pay for their children's health-care and are more sceptical about the possible 
outcomes of trials and researchers' motivations. These attitudes were communicated very 
clearly in the undertone of my interview with a leader from the county council. Whilst he 
advocated for more engagement with the middle classes he also remained doubtful about 
the research programme and in particular the involvement of children in trials. 
Relationship & Obligation: Demonstrating Solidarity 
This theme is very closely linked to what I have presented above and relays explicit demands 
for solidarity in a partnership characterised by actual and perceived differences in access to 
resources. It also relates directly to discussions about patronage, expectation and obligation 
which were touched on in the summary of the previous chapter. 
A week after the meeting between the DC and senior representatives from KEMRI/CDC 
described above I witnessed the following social situation which underscores how 
relationships and obligations are closely entwined. This social situation took place during a 
community meeting held at one of the health facilities hosting KEMRI/CDC trials. Kogelo 
Dispensary is located near the centre of a dispersed village within large grounds owned by 
the local community. At the time of the meeting a police station was also being erected 
within these grounds, co-financed by community fundraising and a local government grant. 
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Photo18: Kogelo Health Dispensary 
Social Situation: A Request for Support and Solidarity 
It was the 3`d of November a day before the 2008 US presidential election which would 
determine whether Barack Obama succeeded in becoming the first black American 
president. A large crowd was expected to assemble within the grounds of the health facility 
which was just 1km from Obama's ancestral home. The local community had planned a 
schedule of events to mark the occasion including prayer meetings, drama, dance, speeches 
and the overnight screening of the election results. Provincial and national dignitaries had 
been invited and journalists from across the world were beginning to arrive at Kogelo. The 
local community and Kenyans in general greatly anticipated the possible election of a black 
American president of Kenyan patrilinage. 
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Photo 19: 
A man from Kogelo touching a portrait of Obama painted by a local artist 
To prepare for these events the DC, local chiefs, the Luo elder Riaga Ogol and his entourage, 
the Siaya mayor, the chairman of the county council and other political representatives, the 
police chief and other police officers, community leaders, health facility staff, community 
health workers and other community members had assembled for a public meeting. The 
KEMRI/CDC CLO and communications officer (CO) were also present in order to be available 
to speak to journalists about trials taking place at Kogelo. The main agenda for this public 
meeting which was held under a marquee decorated with Kenyan flags was to discuss the 
proposed schedule of events and confirm security arrangements. 
As part of a broader discussion the DC referred to the need for KEMRI/CDC to strengthen 
linkages across the local community. He claimed that people were not sure what was going 
on and as an example he asked the chairman of the council what he knew. The chairman 
said that all he knew was that it had something to do with malaria and children. There was 
some laughter about this, but was clear that the DC was trying to drive home a particular 
point about the need for closer collaboration with senior officials. During the course of the 
DC's address he requested financial contributions to buy water and fuel for a generator. In 
between speeches from other dignitaries he called the CLO over to ask whether KEMRI/CDC 
could commit KSh 10,000 towards the purchase of drinking water for attendees. The CLO 
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tried to contact the CDC Director but he could not reach her. Being put on the spot in this 
way the CLO found himself having to agree to this request since refusal would have 
undermined burgeoning relationships with the district administration. There was also 
something larger at hand here in regard to the connection between the local community 
and the US. This connection facilitated the acceptance of Kenyan/American research 
collaboration and helped to form a tangible attachment between research staff and local 
residents. For example Kenyan and American personnel visited President Barack Obama's 
grandmother regularly and in turn she opened new research facilities and cut the ribbon at 
the start of the Kisumu World AIDS Day Marathon. 
This social situation demonstrates clearly that relationships in this context carry with them 
certain obligations. In this instance solidarity was exacted in a very direct manner but 
obligations can also be communicated in a more subtle manner by both parties. As 
relationships develop between researchers and the community co-dependencies can evolve 
which can both facilitate and complicate partnerships particularly when it comes to 
negotiating expectations. In the above scenario the purchase of water for a political function 
could not be justified under budget restrictions; therefore senior researchers made personal 
donations in order to honour the promised contribution. This type of resort is however not 
sustainable, feasible or judicious when it comes to responding to other expectations for 
material help. 
Subtle Differences between Senior Gatekeepers' Perspectives 
In the process of my analysis some differences in perspectives between the DC and a leader 
of the council and other elected representatives became apparent. Both groups related a 
similar experience of initial detachment however overall the DC was much more positive 
about the research programme. In contrast the county council leader maintained a more 
critical distance and his associates' primary concern was to ensure that KEMRI/CDC made a 
significant contribution to the local economy. This is evidence of the patrimonial system 
which undergirds the Kenyan political system. As a patron the county council leader was 
keen to facilitate and demand benefits for his electorate. He was sceptical about the long 
term benefits of vaccine research. By contrast, the DC believed these trials would make a 
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significant contribution to the wellbeing of mankind. Pertinent to these differences in 
perspectives are the nature of these gatekeepers roles and lines of accountability, and the 
fact that political leaders mainly originate from the local community whereas senior district 
administrators are posted to the area by the government. In terms of accountability the 
district administration represents the state while members of the political fraternity 
represent themselves as the voice of their constituents. 
Where their views converged was regarding the importance of consultation and the 
involvement of leaders at every level of the district. Both the DC and the chair of the council 
also expressed concern about the association of participation in research with poverty and 
urged researchers to engage with a broader spectrum of society, including those who are 
better educated and more financially solvent. 
In his interviews the DC talked a lot about the value of community consent in this context. 
He explained how economically and educationally disadvantaged people were reassured if 
recognised community leaders approved of research. Whilst he acknowledged the problems 
this could pose in terms of undue influence he balanced this against other advantages, such 
as promoting a broader public discussion about trials and gaining insights into local and 
cultural beliefs. He believed that the former supported comprehension of research 
procedures when it came to obtaining individual informed consent. The chair of the council 
was more concerned about broader ethical questions which arise when one conducts 
research in resource-limited settings. While the DC agreed that it was very difficult to apply 
an exclusive research mandate in these settings he also thought that KEMRI/CDC was 
beginning to extend the boundaries of its mandate. To exemplify he referred to the planned 
clinical research centre which would house improved HIV patient support services and 
intervention of KEMRI/CDC staff at the scene of a road traffic accident. From his perspective 
these demonstrations of 'attachment'to the local community were fundamental to success 
of the research programme. 
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The Perspectives of Chiefs 
To present the perspectives of chiefs I draw on 5 interviews with chiefs from Karemo where 
I was based and observations of interactions during events which involved these and other 
chiefs. The chiefs whom I interviewed defined the term 'community' as a group of people 
living in a demarcated geographical area and associated 'CE' with community involvement 
and sharing of information. They believed that as many people as possible should know 
about the research programme in order to promote understanding and counter negative 
feedback. In terms of their involvement in CE chiefs described 3 overlapping aspects: 
facilitating community entrance; brokering community understanding; and negotiating 
community acceptance. They also associated involvement with KEMRI/CDC with 
opportunities for development. Hence I explore these factors in 4 interrelated sections. 
Facilitating Community Entrance 
KEMRI/CDC is portrayed by chiefs as having followed due process when it presented their 
plans to extend the HDSS to Karemo in 2006/7. They met with the DC in office at that point 
and had a formal meeting with the DOs and chiefs during which they explained the aims, 
scope and potential benefits of the HDSS and future trials. Members of the administration 
were persuaded of the advantages and helped researchers to inform the broader 
community. They mobilized community members and organised barazas where researchers 
presented their plans. In interviews chiefs stressed the benefits of collaborating with 
KEMRI/CDC in terms of improvement to local health facilities, employment and training of 
local residents. As the research programme grew a common pattern of community 
entrance evolved: 'they called the chiefs to a workshop, they called the opinion leaders to 
the same, they had a big baraza and then we rolled it down to the sub-locations' (Male 
Chief, CR, 42). Chiefs described their role as both authorizing and facilitating research. They 
argued that their support and approval were crucial since community members place a lot 
of faith in administrators and trust their judgement. 
.... you know people believe in administrators [right], yeah, anything coming, at least they 
want to get a hint from administrators' 
Male Assistant Chief, CR 56 
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Respect for the judgement and capacity of chiefs was evident in CAB members' 
appointment of chiefs as chairmen for the alternating CAB in Karemo. To what extent this 
respect is attributed to the office of chief rather than the person is open for debate, and I 
was party to conversations in which both negative and positive pronouncements were made 
about different chief's performances of their duties. Literature informed by similar research 
in Kenya also suggests that whilst community members respect the opinions of chiefs, they 
are keen to make autonomous individual or household decisions about participation in 
research (Molyneux et al., 2005b). 
Brokering Community Understanding 
'People were called and talked to and everything was just explained to them... ' 
Male Chief, CR 25 
As an extension to their role in facilitating community entrance chiefs assumed some 
responsibility for brokering understanding about the work of KEMRI/CDC at community 
level. They assembled people and talked to them about the purpose of the research 
programme. Public meetings such as chiefs' barazas were portrayed as ideal forums for 
presenting information about the KEMRI/CDC research programme. Barazas represent the 
main forum for the dissemination of information at community level. They are also the 
places where state policy is defined and where disputes between residents are settled. 
Essentially they are the place where the representatives of the state interact with 'civil 
society' to discuss state policy, consider how new projects are applied in their given 
community (or public sphere) and where concerns can be voiced publicly. The latter was 
considered particularly important in relation to discussing and addressing rumours about 
research openly. 
'Until your people (researchers) came out in public and attended chiefs barazas and 
assistant chiefs' barazas, talking with them (community members) telling them why the 
blood is being taken and even the quantity is when they now become feeling free. ' 
Male Chief, CR 42 
Brokering understanding is not a straightforward task and chiefs recounted how community 
members were initially very apprehensive about research activities. 
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At first you know some of them were afraid of this, it was not even easy to get them and 
talk to them, some even if we wanted to go and visit their homes, like now we are here, the 
time when they saw the VR going round to release this, some used to even lock their houses 
and disappear [they were scared? ] eh (yes) they were scared they came on pole pole (little 
by little) after sensitization. ' 
Male Chief, CR 42 
According to chiefs community members' fears were fuelled by 'propaganda' spread by 
people with a political agenda. One chief was particularly adamant about this stating that 
those circulating rumours had no basis for their claims and were unwilling to defend them 
publicly (i. e. at barazas). In contrast chiefs were officials with an invested authority who had 
access to accurate information which they communicated openly. 
'... you know these people who propaganda, they are people who don't have a base, because 
the chief has got a base because he has got office if hegoes there you get him. Whatever he 
tells people has got some weight, the assistant chief also has got a base because he has got 
place where ifyou go you get him there so either at a baraza ifyou attend so ifyou just say 
that we have some people are just trying to mislead people around saying one, two three 
and with us we went to a seminar on such a such day up to this day and here is the 
document saying that that one is being done like this and that, you see, and that person 
trying to mislead people, where is he? Let him just come and explain his also now here, you 
see, he doesn't come to the baraza, he doesn't have something to produce, we brought that 
one out, it is rumours. ' 
Male Chief, CR 17 
The above quotation communicates something about the use of official status to counteract 
rumours. This was also conveyed in phrases such as '.. people changed because we 
penetrated everywhere in this location to tell them the truth. ' These observations raise 
important questions about the appropriate use of state authority in CE and the impartiality 
of chiefs in regard to supporting a modernising project which could benefit their areas. 
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Negotiating Community Acceptance 
'... the community must accept it before it is being started. ' 
Male Chief, CR 25 
Community acceptance of research was viewed by chiefs as essential to ensure that people 
who want to participate in trials feel free to do so. One chief argued that unless the majority 
agree about the value of research those who want to participate in trials are at risk of being 
disregarded or victimised by other community members. His stance conveys more of a 
consultative approach to negotiating acceptant in contrast to the zeal relayed at the end of 
the previous paragraph. 
'So the community must first of all accept it [mmm] and agree to participate [mmm] eeh 
(yes), [the whole community? ] eeh (yes), because if you find, maybe the community have 
accepted then the fewget interested, if the community accepted it, is when they participate 
[right]. Even if everybody don't participate, but the one participating is not disregarded 
[right], you know if the community reject it and then maybe few people now try to 
participate, they hate them [right] they will victimize them [they will give them a 
problem], so first of all the community must accept [mmm]. ' 
Male Chief, CR 25 
To attain acceptance of research, this chief explained, that you must first convince the 
community. It is not enough for a chief to stake his support for the research - he must build 
consensus. He described how this involved chiefs and CAB members sitting down with 
community members to discuss the benefits and disadvantages of research. These 
discussions took place at church meetings, chiefs' barazas, village elders' meetings, 
anywhere where a group of people could be gathered. According to the chief his role was to 
bring a proposal to the table in a way which allowed everyone to voice their opinions freely. 
The public nature of this discussion and who said what clearly played a crucial role in terms 
of building consensus. 
'And then people will see if so and so is saying the research is good, I think this thing is 
good, and even if there is somebody who is against it, he will be afraid, he will be silent 
about it, because I know even now not everybody will be for the research, some people are 
against it, they cannot take their children there, butyou know they are silent because most 
of our people were for it, [mmm, the majority support it? ] the majority support it. So once 
the majority support this something, it will be easier to sail through. ' 
Male Chief, CR 25 
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The quotation above describes how the opinions of certain people can shape general 
responses to research. Whilst the chief did not specifically state who these people were he 
had previously underlined the role of CAB members in achieving consensus about research. 
Opportunity for Development 
'They (community members) are still begging that the research is good, 
but they still need a lot of assistance' 
Male Chief, CR 42 
Chiefs are responsible for overseeing development activities and it was evident that they 
viewed research as an opportunity to boost such activities in their locations. They also 
actively advocated for local community members not to be disadvantaged when it came to 
employment and training. To this end they persuaded KEMRI/CDC to erect notice boards at 
every chief's camp so that job advertisements could be displayed locally. In terms of 
development chiefs were keen for trials to be based in health facilities in their areas both 
because of short term infrastructural improvements and to increase the likelihood of 
benefitting from longer term research outcomes. They frequently requested KEMRI/CDC to 
extend to its programmes to other health facilities across their area so that more people 
could benefit. Overall KEMRI/CDC was viewed as filling gaps which were not adequately 
provided for by the government. As outlined below KEMRI/CDC's intervention was highly 
valued when it forestalled the need for community members to fund development projects. 
Wow even CDC, at the moment, our people is seeing it as a good body, because you see that 
maternity wing. That maternity wing was started by community members through 
harambee (community collection of funds), yeah, they built it up to, even doing roofing. 
Now they were left with plastering and putting doors, and windows and painting and the 
whatever. Now we went for the so called LATTIF (local government funds) [ok], we waited 
for money for more than four years, until we forgot about it. Now when the research 
CDC/KEMRI, that research of rota virus came, they wanted at least a place where they can 
place their equipments and stationeries. They took that wing, the whole building, in fact it 
is the CDC/KEMRI that constructed that building up to the level you are seeing now, then 
they took some rooms. [They shared the building? ] Yeah, so our people started 
having a 
feeling that in fact CDC has helped the community because after failinggetting money from 
LATTIF, in fact we had a plan to go back to the members of the public 
[right] for the 
maternity wing to be completed. So in other words, CDC/KEMRI rescued us 
from involving 
members of the public. ' 
Male Assistant Chief, CR 56 
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Apart from seeking to maximise potential community benefits arising from their 
collaboration with KEMRI/CDC chiefs also related how they had to mitigate community 
expectations. From the outset these expectations were high especially since CDC, as an 
international organisation, was considered to have access to considerable resources. 
Community members wanted to know '... what CDC will actually do to them... are they going 
to build our school, are they going to provide us with food when we are hungry? ' Over time 
people became more used to the practice of research and instead of looking simply for 
broader benefits they started to question the inclusion criteria. They argued that all age 
groups, not just mothers and children, suffered from diseases like malaria; hence 
KEMRI/CDC should make more effort to include others in their programmes. As a result 
chiefs found themselves having to mitigate expectations whilst also advocating for 
KEMRI/CDC to extend its mandate and increase local benefits. 
Discussion of the Main Themes 
This chapter relates a story of material engagements which have material implications. 
Senior gatekeepers in particular highlighted the complexity of applying a modern well- 
resourced project in an environment characterised by economic constraints. They 
challenged the research organisation to complement their research agenda with a mandate 
which pays increased attention to solidarity. They were concerned about the equitable 
distribution of research benefits and the widespread association of trial participation with 
poverty. Senior gatekeepers' perspectives communicate something about what Comaroff 
and Comaroff (1999, page 3) refer to as a neo-communal ethic which is characterised by 
civic or populist strivings for a moral community and social being at a time when a triumphal 
neo-liberalism calls into question the very existence of society and civic responsibility. 
Senior gatekeepers implied that partnership and collaboration between researchers and the 
local community must account for moral concerns, foster a sense of mutuality and result in 
concrete material contributions. Senior gatekeepers and local chiefs were ready and willing 
to contribute to this partnership on this basis. 
221 
'Becoming part and parcel of KEMRI/CDC' was presented as a way of benefitting 
gatekeepers' communities and augmenting their personal standing as senior officials, 
politicians and community leaders. Essentially senior administrators, elected 
representatives and chiefs alike communicated, albeit using different words and means, the 
aspiration to be associated with a powerful institution. Collaboration became more 
desirable for senior gatekeepers as the research programme grew and opportunities for 
learning, connections and material support became more evident. Whilst this suggests some 
imbalance in the basis of collaboration between KEMRI/CDC and senior gatekeepers, these 
officials also readily asserted their authority and stressed their indispensability in the 
application of the research programme. They demanded a constructive mutually beneficial 
partnership based on recognition and ongoing involvement of senior officials beyond initial 
approval processes. Senior gatekeepers' conception of collaboration in fact reflects their 
implicitly acknowledged patrimonial responsibilities which required them to nurture 
connections which provide access to opportunities and resources, and seek to fairly 
redistribute these resources fairly to their clients or people. 
This chapter indicates that it is vital to pay due attention to state bodies in CE and to 
appreciate the civic commitment of gatekeepers in CE. Chiefs also stressed the public 
deference invested in the state, a respect for hierarchy that seems to override underlying 
questions about the state's capacity and reliability. State bodies are also increasingly 
demanding accountability and cooperation between government, non-government and 
international organisations. In regard to the KEMRI/CDC research programme this meant 
that senior officials did not only want to know about the rationale for research, they wanted 
more direct involvement in it and more transparency about material benefits. Accordingly 
increased interactions between researchers and senior gatekeepers, and concrete 
demonstrations of attachment and solidarity (e. g. trial staff stopping to help at the scene of 
accidents, funding for research and clinical infrastructures at SDH) led to the abating of 
residual hostilities. This resulted in a more positive discourse about the KEMRI/CDC at 
district level meetings and public functions. 
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The chiefs' story in this chapter differs significantly from that of other more senior 
gatekeepers. In part this is due to the closer attention played to this group by KEMRI/CDC 
historically. Their strategic dual position, as 'instruments of the state at community level' 
and people who wield significant kinship influence, has always been recognised. Effectively 
chiefs facilitate an interesting interplay between state, community and a modernist project. 
Chiefs' barazas provide spheres for civic discussion, participatory consensus-building and 
mediation about research related concerns. At the same time chiefs clearly do not represent 
disinterested parties in this process. They like their senior colleagues are keen for their areas 
to benefit from opportunities for development associated with research. This is not 
surprising in places where a lack of resources and related insecurity encourage 
opportunism. This opportunism is described by Johnson-Hanks (2006) as the fluid quest for 
possible connections which could lead to economic opportunity, exchange and mutual help, 
or ties to a responsive patron. 
Chiefs also enjoy the sense of being 'in' with a modernist and powerful organisation. Whilst 
this serves to facilitate research it also raises questions about how to balance the notion and 
consequences of 'being in' with a healthy critical distance in CE. Overall chiefs associate CE 
with sharing information, brokering understanding, mediating acceptance and promoting 
development. Senior gatekeepers expect more and this needs to be appreciated. My 
analysis suggests that researchers need to be willing to engage materially and work more 
closely with gatekeepers to address overriding moral questions of social justice. 
Synthesis of VRs', CAB Members' & Gatekeepers' Perspectives 
This chapter brings to a close the examination of community intermediaries' and community 
leaders' experiences and perspectives on CE. Hence it is an opportune moment to consider 
the similarities and differences which emerge from chapters 6,7 and 8. 
It is immediately apparent that these groups share certain desires in common even if they 
communicate these differently. Essentially all of them want to be connected with 
KEMRI/CDC and expect personal opportunities and community assistance to ensue from this 
association. Patrimonial responsibilities add weight to their need to gain access to a 
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Powerful organisation and work for the distribution of material and social benefits to their 
kin, communities and electorate. Both VRs and senior gatekeepers expressed anger when 
they felt disconnected from KEMRI/CDC and emphasised the need for KEMRI/CDC to 
demonstrate attachment at community level. Senior gatekeepers also warned researchers 
against working in isolation and encouraged them to foster partnerships with local 
government bodies, academic institutes and other organisations working in the same area. 
CE was viewed as having material implications by gatekeepers. Senior gatekeepers argued 
that one cannot apply a research agenda without accounting for inadequate health services 
and the poverty of most trial participants. For them the material expression of solidarity 
was central to CE and provided the basis for ongoing collaboration. They believed that the 
KEMRI/CDC mandate should be broader than merely research in the given socio-economic 
context. Chiefs also voiced similar opinions but in a much more subtle manner which was 
characterised by collaboration and opportunism. They simply wanted to ensure that their 
areas of jurisdiction were in the best possible place to reap the benefits of a modernising 
project. For VRs, CE also had material implications which were experienced in a more direct 
and personal manner; their connections with KEMRI/CDC meant that they had to negotiate 
and occasionally respond to villagers' expectations for material assistance. 
The bases of the partnership between researchers VRs, CAB members and gatekeepers 
differ significantly. VRs and CAB members are much more closely aligned to KEMRI/CDC. In 
fact one could argue that although VRs represent and are nominated by fellow villagers they 
are answerable to researchers. CAB members are on paper more independent. However in 
practice they have assumed the role of patrons rather than advocates. In this context it is 
also important to remember the terms 'volunteer' and 'partnership' can deflect from the 
hierarchy and dependency which can underlie relationships, particularly relationships which 
are characterised by differential access to knowledge and resources. Senior gatekeepers in 
this respect are more equal with researchers and are keen to assert the authority that they 
can wield in terms of providing approval for research. 
Although there are evident differences in the roles played by different community 
intermediaries and leaders in CE, the questions which arise from their involvement are 
similar. Those questions concern the more problematic aspects of relational ethics and 
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maintaining critical distance between community leaders, intermediaries and researchers. 
Where trust is employed as a means of mediation there is more potential for undue 
influence and where patrimonial responsibility undergirds the desire for connections 
community intermediaries are less likely to act as community advocates and community 
leaders may be less able to hold researchers accountable. These points have serious 
implications for the practice of CE and its association with improving ethical practice in 
research. 
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Chapter 10: 
Diverse & Changing Community Responses to Vaccine Trials 
'Now different people have different opinion, like with those staying in rural areas, they 
were just saying that these white people and these people that are talking in English, we 
don't know them, we don't know where they came from. They just come here and suck our 
blood, we don't know them and we don't want to talk to them, the police they are saying 
that we are terrorists you see [ok]. The, the nurses who are supposed to help us health 
wise on health education are saying that these people are, are paid a lot of money and they 
still need some money from us. They don't want to pay us, it's like they are paid a lot of 
money and they don't want to help us, now different tribes, different people 
have different opinions. ' 
Female VR, CR 30 
'Yeah people around here are quite positive, they are now used to research 
Female CAB Member, CR 44 
Introduction 
This chapter is to presents the many diverse and changing community responses to the 
vaccine trials. As we will see these responses were wide-ranging, reflecting people's fears 
and suspicions as well as their interest in the research programme and their growing 
aspirations and expectations about what KEMRI/CDC could achieve in their communities. In 
my analysis I differentiate between Initial concerns, some of which draw on latent cultural 
idioms, and those which Emerged as a result of closer interaction with the KEMRI/CDC 
research programme. 
The data presented in this chapter came from a broad range of sources including interviews 
with VRs, CAB members, community liaison team members, FWs, community members and 
parents of RVT and MVT participants. The interviews with parents informed the bulk of my 
analysis with the other interviews providing additional insights. In addition to these 
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interviews 1 also contextualised my analysis by drawing on field notes of CE activities. 
Examples of such activities included talks given by the community liaison officer for the 
vaccine trials (CLVT) at public forums including chiefs' and assistant chiefs' barazas, women's 
group meetings, RVT participant meetings, HIV support group meetings and savings 
associations meetings. My research assistants and I participated in a large number of such 
events; for example, we observed 22 CE activities in the run-up to the launch of the MVT. 
We also accompanied parents during the trial consent and enrolment process and observed 
certain clinical procedures. 
Concerns that arise during the course of biomedical research are often referred to as 
'rumours' both in the literature and in practice. At KEMRI/CDC researchers and community 
intermediaries use the term 'rumour' to denote popular concerns which they believe do not 
accurately reflect the 'truth' of their actions or intentions. The term 'rumour' carries 
connotations of hearsay and gossip. But such synonymous use of the terms 'rumour' and 
'concern' can be misleading since some concerns expressed by community members do not 
share the characteristics of hearsay or gossip. Examples include concerns voiced about 
potential and medically-recognised vaccine side-effects and questions raised about 
differentials in care-giving between research participants and routine clinic attendees or 
hospital in-patients. Arguably then a distinction ought to be made between 'rumours' and 
'concerns' without simply dismissing popular interpretations of research. Whilst these may 
seem unfounded from a biomedical perspective they can convey subtle and important 
critiques about the practice of research particularly relating to questions of fairness and the 
equitable distribution of benefits. 
Over time, and as a result of closer interactions with and observations of the KEMRI/CDC 
research programmes, initial community fears and suspicions subsided. People became 
more used to the trials and a relationship of trust was established between research staff 
and community members. Experience and familiarisation created space for dialogue and 
allowed community members to voice their expectations and concerns more openly. 
Variations in responses were however still apparent particularly amongst fathers and certain 
sections of the urban population. 
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This chapter is organised into five sections: the first looks at initial responses and refers 
mainly to the RVT; the second relates parents' experiences of their children's participation 
in the RVT; the third traces changes in community members' responses to the KEMRI/CDC 
research programme; the fourth explores questions of decision-making about children's trial 
participation; and the final section summarises the key themes and questions which arise 
from this chapter. 
Initial Responses 
Initial responses to the RVT were diverse and depended very much on community members' 
perspective, background, profession, gender and experience. There were those who were 
interested and keen to find out what trial participation would involve; those who preferred 
to sit back and see what happened; those who were inherently suspicious about 
researchers' motivations; and those who felt excluded and expressed some hostility about 
the research programme. 
In this review of initial responses it is important to state from the outset that, despite mixed 
reactions to the RVT, the research team managed to achieve its recruitment targets and 
completed the trial successfully. Many mothers were very keen to enrol their children in the 
RVT even if they harboured fears about the vaccine and study procedures involving the 
withdrawal of blood. Others were also interested but preferred to wait and see how the first 
participants fared before enrolling their children in the study. Many of these mothers 
signed up their children at a later stage, or regretted their missed opportunity to join the 
RVT. 
At the same time researchers' motivations and reasons for conducting trials in Karemo were 
questioned by community members, in particular men and urban middle class residents. 
The provision of transport reimbursement and free treatment gave rise to speculations 
about hidden agendas, and rumours circulated about researchers' intentions to abduct trial 
participants. 
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Why this research, what is happening, why should we take our children for Rota virus and 
whatever, why do they want children.... children have been having diarrhoea... why is this 
nini (thing) now coming up, why do we need the vaccine, where had they taken it from? 
Female CAB member, CR 44 
'Yeah, when, like in Rota, there was, I think transport reimbursement [mmm], so when 
some people heard about it, they say oh, why are these people [mmm], they treat us free of 
charge, they do things free of charge and again, they give us money, what is happening 
here, there must be a hidden agenda. Why do they give us money? ' 
Male VR, CR 32 
Such inherent distrust is not something which is restricted to research or even KEMRI/CDC. 
A general scepticism about the intentions of outsiders including government agencies, non- 
governmental organisations, missionaries and anyone who cannot demonstrate strong 
attachment to the local community is prevalent across Karemo division. 
'... and then they will ask you how come that every now and again the KEMRI is here, the 
World Vision is here, what is, what is their interest in our Karemo? ' 
Female CAB Member, CR 07 
In part this scepticism can be explained by the fact that this area, along with most of Nyanza 
Province, was politically marginalised, as the main seat of the opposition, from the time of 
independence until more recently. This meant that the population felt excluded from 
political processes and related developments. It also fuelled misapprehensions about 
governmental initiatives, such as vaccine campaigns, which were alleged to be ways of 
curbing reproduction and decreasing votes for the opposition. Following a change in 
government in 2008, which has resulted in greater political representation for the local 
population, people are now very keen to be involved in projects taking place in their 
communities. They do not respond favourably to non-involvement especially if they feel 
excluded from potential benefits. This was the case for health professionals cited in the 
quotation at the start of the chapter. It was also the case for fathers of trial participants 
who felt sidelined in the trial consent process and threatened by FWs coming to their homes 
to ask questions about their children or their livelihood. 
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Overall two main areas of concerns were initially relayed by community members about the 
KEMRI/CDC research programme, namely anxieties about the trial vaccine, and conjecture 
about the withdrawal and use of blood in trials. 
Vaccine-Related Concerns 
'The vaccine will, especially with boys, it will make them to be impotent [ok], yeah, then 
some of the kids will die before they reach year one [right], some of them will just be 
retarded so they had all these issues. Some of the kids will be taken to the US [at the end of 
the study? ] at the end of the, I think no they didn't even say at the end of the study, like you 
enrol then after some time they will take those kids to the US. [Yeah, I heard that they were 
worried about the FWs coming on the motor bikes and picking the kids and going? ]. Then 
those vehicles (KEMR//CDC vehicles? ), yes, they have red number plates, but much of the 
issues were just to do with blood and bad things about baby boys [that is interesting, why 
baby boys? ], you see like in terms of like they won't grow to be really full men so ! think 
that worried them a lot. ' 
Female CL VT, RS 11 
The above quotation reveals concerns relayed to community liaison personnel about the 
rotavirus vaccine. It is difficult to measure whether concerns were specific to this trial 
vaccine or reflected more general discomfort with any new vaccine intervention. Fewer 
concerns were, however, raised about the vaccines used in the MVT; although this could be 
explained by the disease burden that malaria represents at community level. Malaria is a 
recognised health problem which affects everyone whereas very few people had ever heard 
of rotavirus before the RVT trial started. 
In general the mothers, fathers, guardians or other family members of participating infants 
expressed support for the Kenyan Expanded Immunisation Programme (KEPI). They 
confirmed verbally that their children had received all the routine vaccines offered in KEPI 
and few reported doubts or negative experiences. 
Parents' main fear about the RVT was that their children may die or be harmed mentally or 
physically if they were given the trial vaccine. According to those who enrolled their children 
this was one of the main reasons why other parents did not do so. This type of fear was also 
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relayed in some of my interviews with researchers and community members. Parents and 
community members also harboured anxiety about whether the trial vaccine would affect 
recipients' fertility. 
Aside from these fears associated with a new vaccine, an element of uncertainty about the 
nature of the rotavirus vaccine was evident. One mother of a participating child told me that 
some parents were not sure if their children were being given a vaccine or a medicine. In 
part this might have something to do with the translation of terms; in part this could also be 
explained by the fact that the rotavirus vaccine was an oral preparation. Infants were given 
several drops and as such it resembled both the Vitamin K drops and the polio vaccine given 
to children under the age of one as part of their routine healthcare. 
... in Luo it seems to have mixed many things so some people term it as medicine and some 
people term it as chanjo (vaccine in Swahili)... 
(Mother of RP 07) 
The fact that the RVT and MVT took place in regular public health facilities mitigated some 
of the parents' vaccine-related concerns. The trial vaccines were given within a familiar 
context; a context more closely aligned to what Streefland (1999) would describe as 'routine 
vaccination' in contrast to 'campaign vaccination'. Research nurses also gave RVT 
participants their regular vaccines and sometimes helped the general nurses administer 
regular KEPI vaccines to non-participating infants. These factors are likely to have 
normalised the trial vaccination experience since 'routine vaccination' has historically been 
less subject to controversy. 
Over the course of my fieldwork, two government-initiated vaccination campaigns took 
place in Karemo. The first was a tetanus vaccination campaign directed at women of child- 
bearing age and the second a measles vaccination campaign. I heard about the tetanus 
campaign from parents of RVT participants, community members and chiefs. Most of the 
RVT participants' mothers whom we interviewed had received the jab at vaccination posts. 
However some of the community members we spoke to had avoided it. For example an 
older mother told us she could not get there, it was too far away, however her daughter-in- 
law challenged her and said '... no that was not the reason. You were more worried about 
231 
circulating talk' (CM 05). Rumour suggested that the tetanus vaccine was a type of 'family 
planning' that might even affect future children's fertility. 
'Some people don't want to go like, you know some people say, why is the vaccine justgiven 
to ladies and women, why not men, so some people thought it was a family planning 
(laughter) and refused to go, yah. They don't understand why is just given to girls and 
women, why not men, yah. And with me, I just went. There was one I was given when I was 
also still in school, ' 
Mother of RP 02 
The district public health nurse reported that this measles vaccination which took place in 
August 2009 was much more successful than a campaign held in 2006. In 2006 considerable 
scepticism about governmental intentions had been expressed, so this time the campaign 
team worked hard at mobilising the population and involving key community stakeholders. 
Even so parents of MVT participants related how historic concerns about vaccines continued 
to deter some people. 
'Some are saying that they are for hurting the children; for example when we were going 
for measles vaccination, a mother said that these are government drugs that are meant to 
hurt children. So we asked her how it would hurt the children. She told us there was a time 
Moi government produced a vaccine and took it to Kikuyu land to make the male child 
impotent. So we told her that was her opinion and we would continue taking our children 
and if the government can do such a thing, then it is them who would lose. So we took our 
children and others refused. ' 
Mother of MP 04 
Blood Rumours 
The initial stages of the RVT were characterised by speculations about researchers' motives 
which were primarily communicated by the means of blood rumours. Blood rumours also 
emerged at the start of the MVT albeit to a lesser extent. This is of interest since the MVT 
participants were required to provide more blood samples than RVT participants. In fact 
apart from providing pin prick drops of blood for HIV testing only a sub-group of RVT 
participants had to provide venous blood samples. In the following paragraphs I explore the 
ways in which blood rumours emerged in the RVT and try to understand the underlying 
meaning of these rumours. I will not comment on the origin or history of these rumours 
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here as this is documented extensively in the literature to which I have referred in chapters 
2 and 5 (Geissler, 2005, Geissler and Pool, 2006a, Fairhead et al., 2006b, White, 1993, 
White, 1995, White, 2000, Vaughn, 1991). 
According to VRs conjecture about a surreptitious blood trade; 'ohangla remo; which 
benefitting white researchers was widespread at community level during the RVT. Within 
this context of suspected exchanges of value, certain study procedures, such as travel 
reimbursement, home follow-up and the provision of free medication and treatment 
provoked concerns about hidden agendas. 
'... they said the study staff is transfusing blood from their kids and they collect it together, 
they sell them to the wazungu (the white man), at sometime they used to see wazungu 
who were working with the CDC, mmm, so they said ah, this a muzungu (white person) 
business 
Male VR, CR 32 
And he (a father speaking to the field supervisor) told me that since he has been young, 
there was no time when somebody came to remind him to take his kid to the hospital, / 
mean [ok] which hospital is this where you are reminded to take your kid to the hospital 
and you are paid 120 shillings, and they get blood? Something has to be going on... ' 
Male FW, RS 09 
'Then also free medication was also a very strong rumour I remember yeah, why do you 
give free things yet we should be paying? So like you may think you are helping butyou are 
causing more trouble, yeah, even the free medication was really an issue... all these benefits 
why? You must be having hidden agendas' 
Female CL VT, RS 11 
People were not used to receiving benefits or being paid for going to the health centre and 
wondered why participants were being given money - it could only be for blood'. Even 
amongst parents of participants travel reimbursement evoked varied interpretations with 
some viewing it not only as a payment for travel expenses, but also a payment for blood. 
Indeed the CLVT was told by parents of MVT participants that '... the money they get 
for 
transport reimbursement is not enough it is not enough for the blood that is being taken... ' 
Similar sentiments were also expressed at barazas and relayed to research staff by VRs. 
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These responses suggest that questions about the fairness of the exchange between 
participants and researchers were being debated at community level. Such questions and 
sentiments were also communicated by the means of rumour and speculation. 
'Ok, rumours ok I can remember like the rumours like we would withdraw almost you 
know goro goro is 2kg of blood (laughter) from the child that blood that they would 
withdraw is taken to the US they sell it and in the long run theygain and us we don'tgain. ' 
Female CL VT, RS 11 
This excerpt describes a rumour which, if taken at face value, could just be written off as 
improbable and false. However, when examined more closely it communicates a significant 
underlying message about the equitable distribution of research benefits. This is an example 
of how rumour can serve as a tool or idiom for popular expression of scepticism. 
Other fears about blood were also the subject of much discussion at community level, for 
example the amount of blood taken and its subsequent use. Rumours frequently 
exaggerated the volume of blood withdrawn from infants and parents of participants found 
it difficult to judge whether the amount taken was indeed excessive. Venepuncture was 
frequently experienced as a stressful and painful event, which only served to heighten 
anxieties and increase fears about potential negative repercussions. 
'People are, because being that you explain to them even three times, people believe that 
blood is very less in the body and being that it is taken and this blood is what the child is 
using [mmm], maybe even the way people are feeding with a lot of difficulty, sometimes 
the child only took porridge, still they are going to take blood, how will this affect my child, 
that is the fear they have, and also this disease of, they ask that perhaps they might be 
testing for HIV in hiding. ' 
Female VR, CR 39 
For researchers ascertaining participants' HIV status was a critical factor in evaluating the 
efficacy of the rotavirus vaccine. The investigators were seeking to establish whether the 
vaccine produced an adequate antibody response in HIV+ infants and whether it prevented 
rotavirus-related diarrhoea in this sub-group. Hence all participants, both infants and their 
mothers, were offered an HIV test as part of the trial. Mothers were informed about this 
during their first visit to the research clinic and were given the option to consent or withhold 
234 
consent for HIV testing. The consent process was viewed by researchers and community 
representatives (such as chiefs and the district commissioner) as an important opportunity 
to provide detailed information, discuss parental concerns and ensure that parents or 
guardians understood all aspects of both the trial and the HIV testing. A separate consent 
form was used to document their decisions regarding HIV testing. The importance 
attributed by researchers to elaborating on the purpose of HIV testing and obtaining 
participants' consent for this separately is underlined by the fears expressed in both in the 
quotations above and below. 
'Some people were saying that they were taking blood, maybe they are going to put, I don't 
know how they are going to put the virus (HIV) there and bring the result, the baby is 
positive. That's why some people decided not take part in the study. ' 
Mother of RP 02 
At the time of the RVT, HIV was still highly stigmatised at community level with conspiracies 
about its origin and transmission persisting in some places. In the interview excerpt above a 
mother talks about how some people conjectured that the researchers were intentionally 
infecting infant trial participants with HIV. 
Contrasts were drawn by parents and community members between the use of blood in 
research and in routine health-care. Venepuncture as part of routine care was viewed as 
necessary to identify the cause of illness and people were reassured by the fact that they 
were given the results of their blood tests there and then. Venepuncture in research 
however raised suspicions since participants were not given the results straight away and 
blood was analysed at laboratories located away from the research site. 
'Eh (yes) what are they going to do with my blood, because in the hospital my blood is 
taken the test is done and then the result is there we finish. But here they don't see that? ) 
Eh (yes) for example you take my blood here you have to take it to the 
laboratory and then 
the results will be later, that is the difference that I think they see. ' 
Female VR, CR 29 
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Even though the reasons for taking and shipping samples to other places for testing were 
outlined during the consent process, participants still tended to express unease about the 
use of blood in research. They suspected that additional tests (particularly those related to 
HIV) were being done without their knowledge. Some were also influenced by popular 
suspicions that drew links between the use of blood in research and its use in witchcraft. 
The latter mainly emerged because people were not sure about where the blood was being 
taken and what was being done with it. One mother told me that people from her village 
believed that researchers could use the blood in the 'wrong way' and cause the death of a 
child. This mother's child had actually passed away during the trial (although she did not 
attribute this death to witchcraft). 
Blood rumours are very persistent in this setting and the fear of blood being taken can 
provoke emphatic expressions of resistance. 
'When we go to visit another home the mother told us that I don't want CDC/KEMRI near 
me because I live here, alone in the bush, I don't want people who will come in the night 
and slaughter me because 1 am alone, because I have heard that CDC/KEMRI are after the 
blood... ' 
Female VR, CR29 
The community liaison officer (RS 01) explained this type of response by reflecting on the 
value of blood: '... blood in our community is precious, it is considered as 'life: If you spill 
somebody's blood, that's probably killing or just slashing somebody [harming them], that 
is an abomination, that's very, very serious because blood is associated with life, because 
normally people see that when you don't have blood, you die: Similarly a CAB member also 
stressed the value of blood with a particular emphasis on fear and how it can contribute to 
the persistence and intractability of rumours. 
'Yeah, the question that has really refused to go away is this issue of blood. I would say 
that in our culture people simply fear blood, yeah. In our culture, you don't just kill, people 
fear blood so even if somebody sees a little drop of blood (mmm) they feel that that should 
not happen. ' 
Female CAB Member, CR 02 
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Negotiating Rumours as a Parent of a Trial Participant 
I know the benefits I don't listen to what people say. ' 
Mother of RP 02 
Here I explore how parents of trial participants negotiated rumours and negative 'talk' 
about the vaccine trials. Their primary response was to remember the benefits they 
experienced as part of the vaccine trials and ignore what people were saying. To explore 
parents' responses and related negotiations in more detail I describe, below, two social 
situations which occurred during the course of two families' involvement with the RVT. 
Social Situation 1: `1 had tasted the goodness of KEMRI in the past' 
One of the mothers I interviewed told me how when she first enrolled her baby into the RVT 
a close relative had tried to stop her. This relative had also enrolled her baby into the trial 
but subsequently the infant had passed away. The grieving mother blamed the trial for her 
baby's death and was therefore seeking to block her kin and change her mind about 
allowing her child to take part. My interviewee told me that she insisted that she wanted 
her baby to participate in the trial and did not let her relative put her off. She was also not 
worried about the rumour, which started circulating after her relative's child died. People 
were spreading fear about the trial by saying that 'CDC is killing children'. The main reason 
my interviewee remained positive was the confidence she had in KEMRI. She understood 
that KEMRI was collaborating with CDC in this trial and she had benefitted from the help of 
KEMRI in the past. In 1998 one of her older children was very sick and it was KEMRI staff 
that had cured her child and prevented her from dying: 7 just went to the hospital and the 
KEMRI department are the people who assisted me when the child was already quiet as if 
she is dead'. At that time KEMRI had been helping to improve the children's ward at Siaya 
District Hospital (SDH) and some of the KEMRI staff were based in the ward. They had 
helped her sick child even though she was not taking part in any research. The mother's 
decision to enrol her younger child in the RVT was a direct result of this experience: '... 1 had 
tasted the goodness of KEMRI in the past'. 
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This mother went on to tell me how the same relative who tried to put her off from 
enrolling her baby in the trial now comes running when she sees her coming from the 
hospital with drugs. She asks her to give her part of the dose given to her by KEMRI/CDC for 
one of her own children who is sick. Her relative has not necessarily changed her mind 
about the trial but she is keen to access and experience medical benefits, if only second- 
hand. 
Social Situation 2: They took care of her well.. and used to visit me frequently' 
This case scenario draws on the experiences of seven family members from one homestead 
(a conglomeration of houses within one distinct compound which constitutes a household). 
This household included the head of the household who was the grandfather, his wife, 
married and unmarried sons, daughters, daughters-in-law and their children. The oldest 
daughter-in-law's first child had taken part in the RVT but had passed away during the trial. 
Despite this she still spoke favourably of the trial and in fact none of the family members I 
spoke to seemed to apportion any blame to the trial. The grandmother said: 'when 
KEMRI/CDC took her grandchild they took care of her well and when the kid was admitted 
in Siaya, when she used to go there, she would see they were trying to take care, and when 
the kid passed away they still came back to visit so she is ok with that' The mother of the 
deceased participant herself said: 7 have been with KEMRI/CDC and they used to visit me 
frequently and even if the kid is sick then when I took the kid to the hospital they used to 
treat the child for free, so that is why 1 have prayed for them to come again 
This family told me that people in their village were more sceptical about the trial and some 
even surmised that children died because KEMRI/CDC were doing bad things with the blood 
they collected: 'They use it in a wrong way, witchcraft or something, and that's why the 
kids die. ' Thus when their child died villagers 'didn't talk about research they were saying 
that the kid has been bewitched : In fact when the child was sick their neighbours had told 
the child's mother to take her to a traditional healer to have her treated for a condition 
called 'sihoho'. According to local legend 'sihoho' is associated with bewitching and 
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therefore it does not respond to western medicine, even though some of the symptoms 
include an extended abdomen, stomach pain and diarrhoea. There is a particular sound that 
is associated with 'sihoho' when one taps the abdomen. When the mother heard this noise 
she decided to take her baby to a traditional healer. This lady prayed over the baby and 
then made a cut into the infant's belly, sucked the surrounding skin, and removed some 
human hair, a fruit called onunga and some small meat bones from the baby's abdomen. 
When the mother saw this she believed that her baby had indeed been bewitched. After 
that the baby got well but then the problem returned. Since they thought that 'sihoho' 
sometimes comes with malaria the baby's family decided to take the child to the research 
clinic for malaria treatment. After the child had been examined at the clinic she was 
immediately referred to the children's ward at SDH. The KEMRI/CDC staff on the ward 
treated her baby but she did not recover and died in hospital. 
The mother spoke very lucidly and openly about this experience and did not seem to hold 
any grudges against KEMRI/CDC for what had happened to her child. The experience had 
not turned her against research and both she and other family members spoke favourably 
about the home visits performed as part of the vaccine trials and the care given by 
KEMRI/CDC staff. 
The above social situations raise some important points and they share a common thread. In 
both cases the protagonists spoke favourably of research and in particular the care and the 
follow-up they had experienced. The mother in the first social situation cited a very 
significant event in her life which had left a lasting impression on her. The trust she had 
gained from the help extended to her by KEMRI in the past gave her the confidence to 
remain single-minded about her child's participation in the RVT. The family in the second 
case scenario found themselves overwhelmed by questions about the genesis of their child's 
sickness and suspicions about bewitching; so much so that they delayed going to the 
research facility. But they themselves never questioned whether the trial might have 
contributed to their misfortune. They retained a positive view of KEMRI/CDC and the 
mother of the deceased child told me that she would not hesitate to enrol other children in 
research. In contrast the relative whose child died in the first case scenario was reticent and 
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apportioned some blame for her misfortune to KEMRI/CDC. Notwithstanding that, however, 
she was still keen to access benefits of KEMRI/CDC care-giving, if only from a distance. These 
case scenarios helpfully demonstrate that people can have varied emotional responses 
both when they first encounter medical research and also when something negative occurs 
which is (rightly or wrongly) attributed to trial participation, by certain people. Peoples' 
responses are not always based on scientific reason; they can be influenced by a wide range 
of factors including personality, peer and family relationships and past experience. 
Experiences of Trial Participation: 'Being with 'KEMRI/CDC' 
"KEMRI/CDC takes children and takes care of them" 
Household Head of RP 11 
"KEMRI/CDC always take good care of the children when they are sick, they give them 
proper attention and treat them properly, that's why I am always grateful for 
KEMRI/CDC... They diagnose the child properly, and know the exact disease or problem 
that is affecting the child. " 
Grandmother of RP 09 
Parents and guardians of trial participants came to associate being 'under KEMRI/CDC' with 
receiving 'proper medical care'. For them this care constituted; accurate diagnoses, good 
medicines, close monitoring, active assistance, referral to specialists, and good 
communication between families and medical staff. They highly valued the art of care- 
giving and the technical expertise available in trials and contrasted this favourably with care 
offered by routine healthcare providers, e. g. governmental services. Treatment provided by 
KEMRI/CDC was described as efficient, 'people are treated faster and in an orderly fashion' 
(MVT 01), attentive, 'the doctors were giving the children much attention' (RVT 08), 
dedicated, 'they take effort to make sure the child will get well', thorough, 'they do the 
follow up properly and do not desert you' (RP, 07), and respectful 'the relationship with the 
mothers was also good (RP, 08)'. 
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Parents' experience of care-giving resolved any lingering fears they may have harboured at 
the start of the RVT. When they spoke about the study they mainly remembered the good 
things and were fearful of returning to routine health services when the RVT concluded. 
... in Rota they take the child sickness into their hands and they treat the child properly and 
accordingly but when you go to the government side you find out that most children die in 
the line when they have just been taken to the hospital because they are not treated on 
time... 
Mother of RP 09 
Of relevance here is the fact that the parents whom I interviewed remembered being told 
about the benefits of the RVT but did not remember much about the trial vaccine except 
that it would help prevent diarrhoea. They talked a lot about the care and the security the 
RVT offered and did not mention risks of side-effects related to the administration of a trial 
vaccine. When I probed about this some family members did have questions about the 
safety of the vaccine and how it was tested. However this area of concern was not conveyed 
unless I introduced the topic. So whilst parents were fearful about the vaccine at the start of 
the study their experience of participation seemed to erase these fears from their 
memories. 
Differences in care-giving were also observed by others, notably parents whose children 
were receiving medical care in the same health facilities as trial participants. 
'I saw a difference there were wards that were for KEMRI/CDC, there you see they attend 
to the kids after every short time, they test the child and then the second person has 
reached they look at the kid, after every 30 minutes you see someone coming with the kids 
file asking questions that is very different from where we were the other side. If one 
person goes round in the morning at 9 and the other one will come at noon and the other 
at 3 in the night only but CDC they look at these people after every short time... Those who 
we were with this side said that they wish there kids were also in the study with the CDC, it 
could have been very good. ' 
Female CM, 07 
The ethical implications of these observed differences in care-giving will be explored 
in more 
detail in chapter 11. Here I would like to focus on the sentiment expressed in the 
last 
sentence, a sentiment which is also communicated in the following quotation. 
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'Mmm, to me like now what is happening at the District Hospital here for example eeh, if a 
child has been attacked with malaria [mmm], you will find a mother praying in her heart 
that why don't the KEMRI/CDC take my child [mmm]. Why, because they, you see they now 
have the belief and it is true the way KEMRI/CDC is handling the patient is quite different 
from the Ministry of Health and that is sure, even me 1 have witnessed this one at the 
hospital [mmm]. So you find that now every expectant woman, every woman with a little 
child would always want just attention from the KEMRI/CDC [mmm] yeah. ' 
Male CAB Member, CR 06 
These quotations suggest that community members' responses to research shifted and that 
trial participation became more desirable. Mothers were keen for their children to benefit 
from the care provided by KEMRI/CDC. At the same time they worried about what would 
happen when the trial came to an end, or if their child was not eligible for participation. 
Ending Trials: "The promise of the new" 
In the months leading up to the end of the RVT the CLVT organised several participant 
feedback meetings. Their purpose was to inform parents and guardians of participants 
about the end date of the RVT, to outline final arrangements, respond to outstanding 
questions or concerns and to extend a vote of thanks. The meetings took place in the 
grounds of the health facilities which had hosted the RVT and on average 60-80 people, 
mainly mothers, attended each gathering. One meeting took place in a church next to the 
health centre but the others were all held in the open air. Parents sat on benches or on the 
ground in a semi-circle facing the representatives from the RVT team. These 
representatives included FWs and clinical researchers based at the respective health facility, 
the CLVT and a senior member of the RVT team. Each meeting followed a similar agenda: 
introductions and vote of thanks, an overview of the final arrangements, a synopsis of new 
trials due to start, an open discussion, a final summary, refreshments and the provision of 
travel reimbursement for attendees. 
The atmosphere at these meetings was animated and when given the floor parents stood up 
spontaneously to tell their stories. These stories were presented as testimonies of their 
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gratitude for the care and medical attention participants received during the trial. 
Occasionally stories included references to concerns or hostilities parents had overcome in 
order to take part but overall these testimonies were positive and celebratory in nature. 
'I was initially concerned about my child taking part in this trial. However with time, I 
realized that my child was receiving better care and the trial staff were concerned about 
the welfare of the child. I am therefore veiy thankful I would like to encourage my fellow 
parents to allow their children to participate in future research studies of this nature 
without fear of anything. For the aim of this people is to see that children grow up healthy. ' 
Comment by a father of a RVT participant at a feedback meeting 
Testimonies frequently culminated in requests for KEMRI/CDC to include RVT participants in 
any new trials: 'Can we get a gate pass into the next study? ' It was evident that parents 
were very concerned about what would happen once the study was over; how could they 
ensure that their children would continue to receive good health-care? Some were worried 
about the reception they would receive at routine health facilities and many were 
concerned about how they would pay for medicines and in-patient care. 
"We had become like family with staff working for this study and we were being given V. LP 
treatment every time we brought our children for treatment. We now don't know what 
will happen to us when we have to take our children to the MOH doctors... " 
Quote from parent of R VT participant during a meeting 
The RVT trial team had always gone the extra mile to make sure that participants received 
the medical care they required. In some instances they had even done more that the trial 
protocol stipulated. They accessed nutritional supplements for undernourished participants 
and took positive action when HIV+ participants defaulted from routine patient care and 
support services. A clinical office was placed in the patient support centre at the SDH which 
resulted in trial participants accessing essential care more quickly. In this way the 
researchers removed some of the obstacles parents can face when seeking to access health- 
care for their children. The dilemma for parents now was how to sustain access to good 
health-care. 
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For parents one obvious solution was to remain attached to the KEMRI/CDC programme. 
Hence they were keen to find out more about the new trials which were due to start. They 
asked about the selection criteria and wanted to know whether children who had taken part 
in the RVT could enrol. The CLVT stressed that this depended on their age, and whilst she 
would like them to continue to benefit from research she was also keen for parents to 
understand that they were under no obligation to enrol their children in another trial. 
Picking up on the aspirations of parents another member of the RVT team used a religious 
allegory to describe how the RVT had to go away but a helper(s) was coming. The new trials 
were likened to the Holy Spirit which was given to believers after Jesus had ascended to 
heaven. This promise of something new made it easier for researchers to negotiate 
dilemmas which emerged at the end of the RVT. The continuation of the research 
programme allowed KEMRI/CDC to demonstrate its ongoing commitment to improving 
health conditions in participants' communities. 
Changing Responses to the KEMRI/CDC Research Programme 
Above I noted how community members' responses to research shifted due to their 
experience of care in the RVT. Trial participation became more desirable and community 
members' responses evolved as they started to interact more closely with KEMRI/CDC. 
Whilst some concerns resurfaced at particular time points (e. g. blood concerns at the start 
of the MVT) people's attention became increasingly drawn to the benefits of participation. 
Their experience of the RVT and later the MVT served to allay prior suspicions about 
KEMRI/CDC, and strengthened relationships and trust between research staff, participants 
and community members. 
'This change of heart, what brought it, was that when something is new not most people 
agree with it, unless they have seen how it works, but now that CDC has come and has 
worked in Karemo and those who were in the study have seen the benefits of being in the 
study, so those who refused get the sense and see that what they had refused was really 
good and so they have joined, because if a child has been taken in the study she is well 
treated and taken care of, so it encourages those who had refused that this was something 
that was good. ' 
Female VR, CR 29 
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CAB members recounted how many of those who had spread rumours about KEMRI/CDC 
changed their views and enrolled their children in vaccine trials. CAB members credited this 
change in thinking to two main things: 1) the good they could see in the programme; and 2) 
the dissemination of information about the programme. Researchers, VRs and even parents 
of trial participants concurred, and the latter believed that KEMRI/CDC would have no 
difficulties in enrolling future vaccine trails participants. According to interviewees from all 
these groups community members had recognised that children who were enrolled in trials 
were well looked after and did not have to pay for their care. They had also noted that fears 
about potential harm which could result from trial participation were not realised. They saw 
that the programme was good and what they saw was confirmed by what they heard from 
respected leaders in their communities. Parents of participants also talked about how they 
came to accept trial procedures as normal practice and were no longer as fearful about 
venepuncture or the administration of new vaccines. 
Whilst my interviewees concurred that community members had become more positive 
about research this did not mean that they were fully convinced. Indeed one CAB member 
(CR, 08) described her community as '50/50'. What she meant by this was that even though 
people in her community were beginning to appreciate KEMRI/CDC's work, they were still 
unsure about enrolling their children in trials. I will return to this point in the section on 
recruitment, consent and decision-making about trial participation below. 
Responses to Preparations for the MVT 
Here I describe community responses to information shared by KEMRI/CDC at public forums 
like chiefs' barazas. Information was mainly communicated by means of oral presentations 
and occasionally backed up by written leaflets. Oral presentations were based on a slide 
print-out of a Power-Point presentation (Appendix II, Doc. 8) developed by the CLVT and the 
MVT study coordinator. The presentation was checked for accuracy by the principal 
investigator for the MVT. The print-out was used by the CLVT as a guide in terms of what 
she needed to cover in her oral presentations. In the early meetings she followed the script 
quite carefully but as she mastered the content she referred to the print-out less often and 
also encouraged greater interaction from the audience. The CLVT was fluent in Dholuo and 
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able to translate the content of the information linguistically and conceptually as she spoke 
(the print out was not translated). When a technical term did not exist in the local language 
she used words from Kiswahili or English, e. g. 'chanjo' (vaccine) or 'placebo', but apart from 
this community interactions were conducted in Dholuo. 
When addressing public forums the CLVT would usually focus specifically on transmitting 
defined messages about the trial, and then open up the forum for discussion. Occasionally 
she would adopt a different approach whereby, instead of starting with the messages about 
the MVT, she asked those present what they knew about KEMRI/CDC. This was the case at a 
baraza which took place several weeks after the start of the MVT where she was told that 
KEMRI/CDC are 'the people who write on peoples' doors, 'the people who treat Malaria, 
and 'the people who take blood from children'. These responses provide us with an 
indication about the level of understanding and experience present amongst the general 
public at that stage. The definitions were not all negative; they simply encapsulated what 
community members perceived to be the core aspects of KEMRI/CDC's work. To explore 
these issues further we documented all the questions which community members asked the 
CLVT during barazas and other meetings presentations. I list these questions under subject 
areas in Text Box 5. 
My classification of questions reveals that community concerns had become more focused 
on questions of exclusion and benefits rather than fears about what research participation 
may involve. Whist questions did arise about certain study procedures (in particular 
venepuncture) people were more interested in finding out how to access the trial. Older 
community members expressed misgivings about their exclusion from research programmes 
and others also wanted the benefits of research to extend beyond those directly 
participating. Earlier we saw that the practice of reimbursement was initially received with 
scepticism and fear of hidden agendas. Several years on people now were asking openly 
how much reimbursement would be given, and they even questioned whether 
it was 
sufficient in certain instances. 
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Text Box 5: Types of Questions Asked at Public Forums between Jan-Sept2009 
Benefits 
Will everyone receive free health-care? 
If the child is big and not in the age-group and is sick with malaria can they also treat her? 
Sometimes you can find a mother has a child who is sick for some time, can they also help us? 
Can you also help the lives of adults as well? 
Children who will be born after the malaria study is finished, what will be done about them? 
Accessing the trial/Issues relating to exclusion 
What about children who are not in that age bracket? 
Why only 1800 children? 
Can a child of 2 years join the malaria vaccine trial? 
Can kids from Gem (neighbouring division to Karemo) take part? 
Only 4 stations (clinics where trial taking place) are identified and people are coming from 
far, how come 
Mulaha (local clinic closest to place where baraza is taking place) is not included? 
Why does KEMRI/CDC take only healthy babies and not sick ones for their studies? 
Why do we take only fat and healthy babies? 
What if you child had been in another study, can they still be enrolled? 
You only take younger children; do you take those above 10 years? 
Why the study is not considering all children below five years to be enrolled in the study yet there are medical 
campaigns for all children less than five years? 
Are children who participated in Rotavirus study having a chance to join the malaria study? 
Are you planning to conduct malaria research on adults because they are also affected 
by Malaria? 
Why are we doing research on children only and not on adults? 
What about the old their antibodies have also gone down how will they be helped? 
Practical & Logistical Issues 
When will the children be taken for the study? 
If the number exceeds 1800 of enrolment, what will they do? 
How many people know where the KEMRI/CDC offices are? 
Where else in Kenya is this study being conducted? 
When a child is in the study, will they still get the KEPI vaccines and where will this be given? 
If a child is sick with an illness apart from malaria, do they still treat the children? 
Reimbursement 
What amount will be given as reimbursement? 
How much is the reimbursement? Is it whether you come from far of near or is it a flat rate? 
If the child gets sick in the night and you don't have money, how will the reimbursement 
help? 
In case the baby is sick at night and treated at Ngiya HC, will they get a reimbursement? 
Study Procedures 
What is the time span for withdrawing blood 5 times in the study? 
What if one leaves after getting one dose only? 
If there is excessive fever swelling at the injection site what can be done? 
What site is the blood taken from? 
Scientific Issues 
Why is it that only female mosquitoes transmit malaria and not males? 
The people doing TB research can they also do Asthma research? 
Is there a way CDC can finish mosquitoes since malaria is a disease that 
disturbs a lot in the community? 
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From my broader observations of barazas it was apparent that attendees responded 
differently to information which had a direct impact on their livelihood. For example, people 
were more animated during presentations about a seed exchange programme than they 
were during the CLVT's talk about the MVT. They were interested in the MVT but it was 
aimed at young children and most of the attendees at that baraza were older and did not 
have eligible children. Their primary concerns were for programmes which could improve 
their lives and at that particular baraza, some complained that older members of the 
community were not given insecticide-treated bed nets by KEMRI/CDC. 
There were also notable differences in responses to the trials as between rural and urban 
areas. This was apparent in higher enrolment rates in rural areas and in some of the 
attitudes communicated by those who would describe themselves as better off than 
'ordinary citizens'. Preliminary findings from a sub-study involving fathers suggest that 
participation in trials is widely associated with poverty. However some of the material 
related to this is contradictory and requires a more in-depth analysis. For example, some 
fathers stated that parents who faced economic constraints were more likely to enrol their 
children in trials in order to reduce healthcare-related expenses. Similarly those with means 
did not want to be connected with research since it was perceived to be 'an affair for the 
poor'. Giving a different perspective on this question a father who was interviewed by one 
of my research assistants talked about how some parents were embarrassed to associate 
with researchers and take their children to the clinic. 
'No it's just something like inferiority complex of human being, being thatyou are poor you 
don't have even a good cloth to put on you can't mingle with these people like people of the 
research that most... like there is a lady who told me that she find it hard to be with CDC 
staffs is because ladies who come to do interviews; the was one who embarrassed her with 
the husband because she came in a three quarter trouser. And according to Alego customs, 
a lady should not put on a tightfitting trouser. ' 
Father of MVT Participant 
This quotation raises some important socio-economic and cultural considerations and 
reveals how dress can be a barrier in more ways than one. The questions of poverty, access 
to health- care and decision-making about participation in trials are poignant in the setting 
where I conducted my fieldwork. On the one hand there is the rural population, who have 
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become very positive about research; 'they were seeing it as their personal saviour' (Male 
FW, RS 07). On the other hand there is a mainly urban group of people who go to private 
health facilities and do not find out about research which could benefit their children. The 
disengagement of urban residents, in particular those who may describe themselves as 
middle class, was discussed by researchers, but a solution was not found. 
In this section we have seen how community members' focus shifted increasingly to the 
benefits of participation in research. Changes in community responses to research were also 
characterised by increased expectations for material assistance at community level. 
KEMRI/CDC, and in particular CDC, is seen to be a wealthy international organisation. 
Therefore community members called on CDC to work tirelessly in their communities. 
Discouraged by the state of government services and health facilities and encouraged by 
infrastructural improvements made by the KEMRI/CDC research programme community 
members started to believe that 'CDC are the ones to bring change in the community' 
(Excerpt from a report by a CAB Member, April 2008)'. 
Recruitment, Consent & Decision-making about Trial Participation 
Recruitment activities for the MVT overlapped with CE events aimed at increasing public 
awareness of the trial and included other more targeted activities which were mainly aimed 
at mothers with young children. The fact that recruitment and consent activities involved 
very few fathers had important consequences which are discussed later. Recruitment 
activities included the distribution of leaflets about the study to households by FWs, 
displaying posters about the trial (See pictures below) and village-based meetings for 
mothers run by the CLVT, which were organised by village elders. VRs were also asked to let 
people in their villages know about the trial and a Tuberculosis trial taking place in Karemo 
also referred potential participants to the MVT. 
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Photos 20 & 21: Posters about the MVT on a shop next to the entrance of SDH 
Mothers who signed up their children for the trials told us that they found out about the 
MVT from their friends, neighbours, VRs, barazas, health facilities (in particular maternal 
child health (MCH) clinics); churches and from other groups to which they belonged. In 
Siaya town a lot of the mothers first heard about the MVT at the MCH clinic at SDH. Indeed 
this clinic was the main focus of initial recruitment activities. A few weeks before the start 
of the MVT the CLVT visited the MCH clinic and talked to several mothers about the trial. 
She took down the details of those interested in participating and contacted them with an 
appointment when the start date was confirmed. A FW was also delegated to approaching 
mothers at the MCH during the first months of the MVT. 
Photo 22 & 23: Maternal Child Health Clinic, SDH 
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The Consent Process 
One of the first mothers to give consent for her child to participate in the MVT was 
approached at the MCH at SDH by the CLVT. She returned on the first day of the MVT and 
took part in a consent conversation with another mother which was facilitated by a clinical 
officer (CO) in the presence of the principal investigator and me. The CO established a good 
rapport with the mothers and proceeded to read the consent form, stopping intermittently 
to clarify certain aspects and check comprehension. The elder of the two mothers 
interjected questions from time to time but the younger mother, who was a single parent of 
18 years of age, followed proceedings quietly. When I interviewed this mother at a later 
date she admitted that she had been very nervous about the process. 
'I was not comfortable because I didn't know what they are going to do next. For the first 
time somebody is telling you there is something new here which has just come.... Then that 
one makes me to be worried, the first time for my child' 
Mother of MP 01 
The consent process went very smoothly and, at the end of the conversation with both 
mothers, each completed a comprehension test on their own with a CO. The test was aimed 
at making sure that they had understood the key points of the MVT and what participation 
would involve. Where there were gaps in understanding the COs went over these points 
again. Despite this it was evident that this process had evoked fear in the mother I 
interviewed, a fear that was possibly exacerbated by the fact that she was amongst the first 
to consent for her child to participate in the MVT. 
I also interviewed the other mother who took part in this first consent. Her perspective was 
slightly different. Whilst she too was also worried about being one of the first to participate 
she talked more about how her thinking evolved and changed during the course of the 
consent process. 
'For the first time when I met them in the hospital I got doctors hurrying up, they are 
arranging some of the things and I got this mother, Mama Martine, I started asking what 
are this for, are we the only people to be treated? She told me we 
don't know they have 
said the others are coming, we don't know if the others are coming and as time passes 
by 
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we were the only people sitting. Thereafter we were taken the two of us to the consenting 
room and when we had started to be explained about this some of the things I had seen at 
the back of my brain, this thing I am not going to do. As the doctor started explaining 
there are some of the things I was thinking of, and it made me not to decide even not to 
take part because they had told us the three injection they are random, they are not the 
same, after they had told us that they are not the same. Now I asked myself now what if my 
child will be given this one and my child fall sick and the other one given this and it 
succeeds?.. But sometimes I look over myself and say that if the three injections they knew 
what they are doing, let me assume they knew what they are doing... Then as time goes by 
I have even said let the child be taken, he is in the hands of the people who are experts, -l 
am not an expert and / came to comfort myself that everything that we have in this world 
is from God... ' 
Mother of MP 02 
In the MVT consent was initially only obtained from parents or guardians by clinical staff. 
However as the trial workload increased FWs were also delegated responsibility for consent. 
Most people were consented in groups of 2-12 and the consent form was mainly read by 
the FW or clinician. Occasionally he/she would also ask group members to read sections of 
the text and he/she stopped regularly to check comprehension or respond to questions. The 
types of questions asked related to study procedures such as randomisation and the 
different vaccines the child could be given during the trial. Parents and guardians asked lots 
of questions about the rabies, meningococcal and hepatitis vaccines and many also wanted 
to know more about these diseases. One mother who was consented on her own wanted 
to know how those already enrolled in the trial were faring, she was afraid about her child 
being one of the first to receive the new malaria vaccine candidate. Concerns were also 
expressed about blood tests; parents wanted to know how much blood would be taken, 
when it would be taken and why. They also wanted to know what would happen during 
home visits and what they should do if their child got ill. They were particularly concerned 
about accessing care at night, at week-ends or on public holidays. Some parents also wanted 
to know if their children could use other medicines while taking part in the MVT, and if they 
could access free care at other health facilities. 
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Decision-making about Trial Participation 
Consent represents an important part of parents' decision-making about their children's 
participation in trials. In most cases the consent process simply confirmed the parents' 
desire for their child to take part in a trial. Many mothers were 'keen to be with CDC', since 
this conferred a certain status and meant that their children would be eligible for free and 
more individualised care. Other parents approached consent with more questions and less 
certainty, as was the case for the younger mother quoted above. I also witnessed a consent 
discussion between a FW and a mother which was terminated when the FW recognised the 
mother's discomfort. This mother had been approached at the MCH clinic that morning and, 
whilst she had agreed to come and find out more about the MVT, her body language clearly 
betrayed her reluctance. The FW gave her the consent form to take home to give her more 
time to consider her decision. 
What people knew about; had heard about, or had seen or experienced of the KEMRI/CDC 
programme played a significant role in their decision-making about trial participation. 
'I thought of joining the study because I had heard that they help people a lot. And that is 
why 1 decided to join 
Mother of a RP 03 
There is a neighbour of mine who went there and told me that malaria people are 
recruiting babies, and then I decided to go because they will help the life of my baby. 
Mother of a MP 04 
The first mother cited here had not only heard that researchers helped people a lot she had 
also received help from KEMRI/CDC nurses during a difficult labour. She like many others 
had come to value the presence of researchers at their local health facility. Mothers in 
Karemo are very concerned about the health and well-being of their children, and are 
keen 
to access the best possible care for them. Those who were familiar with KEMRI/CDC's work 
appreciated the benefits of trial participation reimbursement for travel, free treatment 
for 
their child, readily available medication, home visits and potential protection against 
common diseases; - and were not hesitant about providing consent. 
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Conversely mothers who knew very little about KEMRI/CDC, or had only just found out 
about the MVT when frequenting a health facility for a different reason, were more 
hesitant. Indeed one could argue that being required to provide consent on the same day 
one finds out about a trial does not support properly considered decision-making. 
Researchers were sensitive to this and took care to ensure that all parents understood what 
participation would involve for their children. On the rare occasions when mothers 
requested more time to discuss their decisions with their spouses or other family members, 
researchers took care to give them a copy of the consent form to take home. 
Disengagement of Fathers in Decision-making 
The absence of fathers during recruitment activities, the consent process and other study 
visits is a matter of concern. In part this disengagement of fathers can be explained by the 
division of labour at household level; in Luo society mothers are primarily responsible for 
the health and well-being of young children. This does not mean that fathers do not get 
involved. But it does mean that mothers assume leadership in this area. It is mothers who 
take children for health checks and mothers are also the primary decision-makers in the 
case of sickness. They may seek financial assistance from their husbands to cover medical 
fees. However they also access help from the household head, often the grandfather, and 
sometimes draw on personal funds, especially if they are involved in petty trade. This means 
that women are used to making decisions alone about their children's health. 
Whilst men accept women's leadership in caring for young children they like to preserve 
their position and feel undermined and devalued if their wives do not consult them about 
important decisions. According to Luo customs children and their mothers belong to their 
fathers and husbands respectively. Hence when mothers withheld information from their 
husbands about their children's participation in the RVT this had serious repercussions. 
Instead of finding out about the RVT from their wives many fathers heard rumours about 
the trial when they met with others men to drink and discuss politics. Some men did not 
find out about the trial until a FW turned up at their homes to conduct routine follow-up 
visits. FWs generally assumed that the fathers were aware of the RVT and after introducing 
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themselves continued with their checks and questions. These types of incidents could result 
in FWs being chased away and participants being withdrawn from the studies. Men were 
generally more suspicious about the RVT, and did not like FWs coming to their homes to ask 
questions about their children or their livelihood (in the case of the HDSS). Male FWs in 
particular were perceived as a threat by some fathers, who were wary about how their 
wives would respond to these younger men who arrived on motorcycles or bicycles. 
One of the main reasons why many mothers did not involve their husbands in decision- 
making about the enrolment of their children in the RVT was because they thought they 
might refuse. The following reflection from the CLVT touches on this and encapsulates well 
maternal anxieties regarding the novelty of the vaccine research programme. 
'But I think the main, main reason was that this is something new we don't know whether 
it will be good or bad so lets justgive it a try silently, then maybe in the near future if we 
see it works well then we can easily share with the husband. ' 
Female CL VT, RS 11 
Mothers were also reluctant to tell their husbands about some of the benefits of 
participation, for example; travel reimbursement. They tended to keep quiet about this 
payment in case their husbands asked them to hand over the money. Mothers were keen 
to keep hold of this money to buy food for the family and more often they chose to walk 
home rather than pay for transport. 
Not all mothers chose to exclude their husbands from decision-making and some were not 
able to involve them due to their husbands working away from home. In households where 
fathers were involved relations between family members and FWs were much more 
conducive and fathers were more positive. 
'Yeah, some of them whose, the mothers who went home and sought the consent of their 
husbands about the trials and the husbands accepted, [mmm], yeah. They are even easy to 
work with. Than the ones who started getting bits of information, yah, they would get 
information from their drinking places about blood would justget very crazy... ' 
Male Fieldworker, RS 09 
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As a result of the paternal resistance to research experienced during the RVT researchers 
made a more concerted effort to reach men for the MVT. The chief in one area helped them 
to organise a special meeting with fathers and in other areas meetings were held with 
bicycle transporters. It became apparent however, particularly in the first meeting, that 
men were reluctant to voice negative concerns in these settings. They tended to dismiss 
concerns as rumours and said that it was all right for the researchers to continue with their 
programmes. Cycle transporters were also not very willing to be detained from their work. 
Hence these meetings were of limited effectiveness in terms of fostering paternal 
engagement. As a result researchers resorted to trying to involve fathers indirectly by 
encouraging mothers to talk to their husbands about the MVT. 
Paternal disengagement clearly presents a significant challenge for researchers. In order to 
explore this theme further we conducted a sub-study in which we conducted additional 
interviews with fathers of trial participants and male community leaders. Aspects of this 
work are ongoing; however preliminary findings suggest that fathers have questions about 
underlying motives for conducting research in their communities. They perceive the 
balance of benefits to lie in favour of researchers and associate willingness to participate in 
research with lower economic status. Interviewees argued for a more active paternal role in 
decision-making about children's participation in research, and stated that researchers 
should meet fathers in their homes or places of work. Fathers of young children rarely 
attend traditional CE forums and mothers can be reluctant to share information with their 
husbands. Intra-household dynamics were viewed as influential in decision-making and 
fathers with children enrolled in the MVT described a consultative process involving both 
parents. Fear and uncertainty about vaccine side-effects, concerns about exchanging 
children's life for money and rumours about blood were some of the reasons for withdrawal 
reported by fathers. 
Discussion of the Main Themes 
In this chapter we have seen how initial concerns about the vaccine trials abated over time 
both due to growing familiarity with the KEMRI/CDC research programme and awareness of 
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the material benefits of trial participation. Trial participants' experience of care-giving in the 
RVT and MVT resulted in a more positive view of vaccine research generally and raised 
community expectations. In a bid to negotiate the 'new' to their advantage community 
concerns started to focus more on exclusion rather than inclusion. Core questions emerged 
about the boundaries of care-giving in research and the distribution of benefits at 
community level. These questions and related expectations require KEMRI/CDC to consider 
its main purpose as a research organisation and explain the constraints which control 
resource distribution and research participation. They also require researchers to think 
carefully about how to address questions of equity and justice when conducting trials in 
resource-limited settings. 
Although perhaps not to the extent one may have expected in view of the literature 
presented in chapter 2, it is evident that historic and contextual factors can influence 
community members' perceptions of immunization and vaccine research. Trust is 
fundamental and can be affected by the perceived purpose of vaccine interventions, the 
place and mode of vaccine delivery and the sources of information. Concerns were less 
apparent when there is confidence in those delivering a vaccine intervention, and where 
value is attributed to the associated care-giving. In terms of a vaccine trial these factors 
appear to override any pre-existing misapprehensions related to potential risks. 
The blood rumours which circulated at the start of the RVT and resurfaced intermittently 
throughout the RVT and the MVT reveal important underlying questions about equity and 
reciprocity. To all intents and purposes trial participants and their families see themselves as 
entrusting researchers with a material gift which forges a social relationship of obligation. 
Researchers have to learn to negotiate these obligations and understand how they can 
affect perceptions of their work. Currently researchers tend not to address the underlying 
meaning of rumours in CE, which may explain why some rumours are so intractable. 
Mothers of trial participants in contrast understand the material nature of blood rumours 
and counter negative talk by emphasising the benefits of participation and recalling positive 
interactions with researchers. What is particularly interesting about the way in which 
mothers of trial participants negotiate rumour is that they do much of this work by 
themselves. What makes them so positive about participation is their actual direct 
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involvement in research, which is lacking when it comes to some fathers. This chapter has 
highlighted the importance of involving fathers more openly and actively in decision-making 
concerning their children's participation in vaccine trials. It suggests that there is a need to 
develop procedures which will increase transparency about research aims, support 
information exchange and dialogue, and foster more discussion between parents when it 
comes to consent. 
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Chapter 11: 
Community Engagement in Public Health Facilities 
Also in the ward, there is a, there are projects going on, they are under my roof (uhuh) 
which fall under CDC, there is Mal 55 [yeah] Malaria 55, and then there is the University of 
Mexico [ok] and also there is one which is starting soon [yeah] about 
Tuberculosis vaccines. 
Hospital Nurse, CR34 
Introduction 
This chapter describes how differences in health-care provision are negotiated when 
transnational research is integrated into public health facilities. It traces challenges 
encountered in collaborative partnerships between researchers, health officials and health 
professionals, and provokes thinking about ethical questions which arise in the conduct of a 
paediatric MVT in a district hospital and peripheral rural health centres and dispensaries in 
Siaya District. 
To discuss the challenges encountered I have combined insights from my ethnographic 
fieldwork with the practical experiences of investigators and their professional partners as 
shared with me during interviews and informal conversations. Participant observation of 
trial procedures, CE and collaborative processes was undertaken between October 2008 and 
December 2009. The experience of integrating research into public health facilities and 
related challenges and questions were further explored in 15 SSIs and 4 FGDs. SSIs involved 
2 hospital nurses, 1 hospital doctor, 1 health centre administrator, 1 hospital medical 
Superintendant and 10 researchers from KEMRI/CDC. The first FGD was held with 5 nurses 
from SDH, the second and third involved members of health facility committees from a 
health centre and a dispensary, and the fourth FGD was held with members of the District 
Health Management Committee. Many other people whom I interviewed throughout the 
course of my fieldwork commented on differences between the health-care provided within 
a trial and that provided to general patients admitted to government or non-governmental 
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facilities. These interviewees included district and county officials, CAB members and 
parents whose children had been admitted to the ward either as KEMRI/CDC trial 
participants or routine government patients 
From the data presented in this chapter it is evident that whilst collaborative partners were 
in principle committed to the integration of research in places where general routine care is 
being provided, boundaries between scientific practice and general care were drawn in 
order to facilitate practice. Two paradigms of care giving - 1) 'research' and 2) 'general care' 
- were contrasted in terms of therapeutic relationships, accountability structures, working 
cultures and access to resources. Collaborative agreements between the health facilities 
and KEMRI/CDC provided a formal framework but did not account for all challenges that 
arose within the spatial and social dynamic or in decision-making processes. The additional 
challenges related to differences of care giving, material inequalities and distinctions of 
health-care provision. In this chapter I argue for the public articulation of these challenges in 
order to ensure that problems of inequity are not transferred from the domain of 
collaborative operations to the domain of personal morality, but rather can be continuously 
negotiated with all partners to achieve better solutions. 
To frame my core findings I start with a chapter specific review of pertinent literature which 
touches on questions of collaborative ethics, models of health research, the location of 
science and boundary work. Hence this chapter includes a theoretical overview, a 
description and analysis of my main findings and a summary of core themes and questions. 
Review of Relevant Literature 
Recent debates about the ethics of research in developing countries have drawn attention 
to some of the difficulties of applying international ethics guidelines in diverse local contexts 
(1997, Marshall, 2007, Kleinman, 1999, Emanuel et al., 2004, Lurie and Wolfe, 1997). In 
response Emanuel et al (2004) devised an ethical framework for clinical research 
in 
developing countries which would provide unified and consistent guidance. This 
framework 
emphasises the importance of collaborative partnership in transnational research 
including 
it as one of eight ethical principles. The authors argue strongly that due consideration must 
260 
be paid to developing partnerships between researchers, health policy makers, and the 
community in the design and application of trials in developing countries. Indeed the 
explicit and detailed reference to collaboration in this framework sets it apart from a similar 
model devised for use in developed countries (Emanuel et al., 2004). The principle of 
collaborative partnership and related benchmarks are viewed as central to efforts to 
minimize the potential for exploitation in clinical research conducted in economically 
disadvantaged settings. Benatar & Singer (2000) similarly emphasise the need for 
international researchers to have some understanding of and be sensitive to the social, 
economic and political milieu that frames the context in which their research takes place. 
They support calls for alliances between research stakeholders and broader CE programmes 
and urge that conceptual progress needs to be matched in equal measure by translation in 
practice (Benatar and Singer, 2010). In their view this will help to advance solidarity across 
the globe and support progress by enhancing capabilities and social justice rather than 
sustaining dependency. 
There is strong advocacy for the research undertaken in poor countries to be integrated into 
the public health-care systems and to contribute to improved health-care in the community 
where the trials are undertaken (Benatar and Singer, 2010, Emanuel et al., 2004). What is 
meant by 'integration' raises broader questions about where research takes place and who 
is involved in its execution. There are at least three different ways in which research can be 
integrated although the level and manner of integration differs between these models. For 
example one could argue that investigator-initiated trials run by government health staff in 
public health facilities are fully integrated. A health professional identifies a problem 
affecting practice and develops a research protocol to identify practical solutions. In this 
instance research findings are likely to be applied and translated into policy with minimal 
delay. 
The other two ways involve the collaboration of external organisations with government 
health officials. In fact a research organisation may adopt different modes of integration for 
different types of study and even at different times in a single study. The main distinguishing 
factor is the extent to which research takes place within public health facilities and the level 
of daily interaction between research staff and health facility staff. Broadly speaking it is 
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possible to differentiate two different models, although overlaps can occur between these 
models in practice. In one model of integration research participants are recruited from 
clinics within public health facilities and attended to in buildings which are also accessible to 
routine patients. There may be some spaces which are restricted to research participants; 
however the research processes are visible to other patients, and researchers and 
government health staff have to collaborate closely in order to perform their separate 
duties. In practice research becomes another means of accessing care within a public health 
facility, and the facilities benefit from additional staff, resources and infrastructural 
improvements. Research staff and hospital staff interact on a daily basis and research 
participants receive care in places where routine hospital patients are also attended to. The 
collaboration with hospital staff and ministry of health officials facilitates the study and, 
depending on the intervention, may help to speed the translation of findings into policy and 
practice. The MVT mainly adopted this type of integration; hence this chapter primarily 
looks at the challenges and opportunities encountered in this kind of collaboration. 
In the other model of integration research is conducted within public health premises but 
participants are seen in separate research facilities. There is an overarching collaboration 
between researchers and government health officials. However they do not interact on a 
daily basis and the research participants are attended to separately from hospital patients. 
Research is removed from regular practice in this model, and whilst this can minimise some 
of the challenges it also reduces some of the benefits of the former model. Researchers may 
also have to work harder at disseminating and translating their findings into policy. 
The integration of research in public health facilities is just one way of conducting bio- 
medical trials. In other places of the world there has been a rapid growth of free-standing 
research facilities which support industry-sponsored commercial research. Petryna (2009) 
documents the ways that commercial medical science, with all its benefits and risks, is being 
conducted in such facilities and how it impacts on local health systems and emerging drug 
markets. Whilst we can drawn some parallels from Petryna's analysis it is also important to 
recognise that her work describes and for-profit research conducted primarily by contract 
research organisations. The research conducted by public health collaborations like 
KEMRI/CDC has different goals and is accountable to global sponsors, some of whom are 
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Philanthropic bodies. One core dilemma is however cross-cutting, namely questions of 
distributive justice which arise when research is conducted in places where the standard of 
routine healthcare is constrained by a lack of resources. In fact there are some who would 
argue that research should only be conducted in places where the health systems can 
provide the same level of care provided by within research trials (de Cenival, 2008). Whilst 
this extreme position appears morally defensible, it is also impracticable and may extend 
the 10/90 research gap - where research and development expenditure is concentrated in 
the North with only 10% of health research money spent in the South although 90% of 
disease resides there (Edejer, 1999) - and preclude developments which could strengthen 
health system capacity. In practice the question facing those seeking to redress the 10/90 
health research gap is: How can research protocols be applied equitably in resource-limited 
settings in view of inherent differences in access to human and material resources? 
This is a huge challenge and my aim in this chapter is to contribute to a clearer formulation 
of some of the constituent problems. I will draw on practical examples to elucidate these 
complexities and to demonstrate how the integration of research into public health facilities 
depends on close collaboration between researchers, health officials, health professionals 
and community representatives. 
Collaborative Partnerships & the Conduct of Trials 
Partnership has become a dominant paradigm within the field of global health and has been 
defined by Buse & Walt (Buse and Walt, 2000) as 'a collaborative relationship which 
transcends national boundaries and brings together at least three parties, among them a 
corporation (and/or industry association) and an intergovernmental organization, so as to 
achieve a shared health-creating goal on the basis of a mutually agreed division of 
labour (p. 
550)'. This definition captures the relationships between sponsors, research organisations 
and governmental bodies in the conduct of medical trials but does not encompass the 
broader community who are included within the Emanuel et al (2004) framework. This 
framework describes six constituents of collaborative partnership: local representation; 
sharing responsibility in decision-making; mutual respect; minimization of disparities 
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between researchers and sponsors from developed countries and host communities; fair 
benefits for the local community; and fair distribution of the tangible and intangible rewards 
of research amongst partners (Emanuel et al., 2004). Partnership is understood in broad 
terms. However in practice the role and remit of community representatives in the conduct 
of trials can vary across research sites. 
Collaborative partners must address key questions in the implementation of research: 
where will trials take place, how will competing interests and demands be managed, and 
how will ethical issues that arise in the conduct of studies will be resolved? Efficacy trials in 
particular need to take place where the target diseases are most prevalent and where 
general health and socio-economic indicators can be poor. These realities combined with 
limited social and health infrastructure mean that investigators must balance ideals and 
practicalities in decisions about where to situate trials. Many public health scientists prefer 
to integrate their work into public health facilities in order to promote capacity-building and 
better care for all children. Simultaneously in the evaluation of an experimental therapy 
they need to prioritise the safety of individual participants and maintain high scientific 
standards in order to comply with trial standards and regulations. This leads to the 
emplacement of 'global science' within local public health settings and the juxtaposition of 
two paradigms of care giving: 'research' and 'general'. In this situation, the way that 
researchers and collaborators manage competing demands and negotiate differences 
determines the level of blending that is feasible, from full integration, to partial integration 
or complete separation, where research takes place outside of public health facilities. 
The `Where'of Science 
Social studies of science have long drawn attention to the ambivalent relationship between 
scientific enquiry and location. The 'where of science' is however beginning to gain 
importance as a category of analysis in determining the legitimacy of knowledge. Thomas 
Gieryn (2002) describes the 'laboratory' with its intrinsic epistemic virtues of precision and 
control versus the 'field', where unadulterated reality lends credibility to scientific claims. 
The relationship between the two is subject to debate with some arguing that the field must 
in effect become a laboratory before it can serve as an authoritative space for knowledge 
making (Latour, 1999), whereas others make a case for preserving and drawing on both field 
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and laboratory simultaneously in a complementary way (Gieryn, 2006). In an ethnography of 
applied agricultural science, Henke (2000) refers to 'making a place for science' arguing that 
not only are the lines between laboratory and field blurred but that science must address 
the local context. For Henke (2000), the way that researchers interact with the 'lay public' 
dictates the practice of making a place for science and governs the extent to which science 
shapes these locations. This type of engagement can take on particular importance when 
research is conducted in African health systems, because the encounter between scientists 
and their (lay and professional) public is overlaid by differential access to resources, 
technologies and expertise. Space is here a matter of inside and outside, in terms of access 
to and exclusion from resources, healthcare expertise and care-giving which is not 
immediately available within the local system. 
The geography of African economic engagement is discussed by Ferguson(2005) who argues 
that current political-economic conditions have resulted in resource-rich enclaves becoming 
a central element of social organization. In transnational medical research boundaries are 
not drawn so unambiguously, and the interests that sustain or transcend boundaries 
between research and general care are not as simple as in the economic practices explored 
by Ferguson. Importantly, the boundaries are often challenged by the fundamentally 
humanitarian and inclusive ethos of public health scientists. The conduct of world class 
research on the other hand requires researchers to work under scientific standards that 
differ from those of the field in order to comply with international standards and 
regulations, communicate with international partners and sponsors and complete 
administrative duties. To accommodate these requirements, distinct spaces generally need 
to be made either within or alongside field facilities, so that research duties can be 
accomplished and participants' safety ensured. These conflicting pressures require 
researchers to combine immersion in local realities with demands to maintain international 
standards. In many instances this results in differences between the care-giving provided to 
research participants and general patients. For example, even where researchers tend to 
sick participants within a general hospital ward alongside other patients, their 
higher 
patient-to-staff ratios means they can monitor research participants more closely. 
As noted the juxtaposition of clinical research in regular health facilities can accentuate pre- 
existing differences in standards of care and access to resources. To negotiate these 
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differences, boundaries may be formed to demarcate spaces of science from those of 
everyday health-care. These physical and social boundaries are not necessarily visible and 
may be shaped by the participation of research and general health workers, patients and/or 
others who observe practices in the clinic. This boundary work raises ethical questions that 
need to be addressed throughout the conduct of trials. 
Mindful of these differences, this chapter focuses on a hospital ward and clinics involved in 
the MVT. My aim is to explore the problem of difference at micro level in order to learn 
from the experiential experience of researchers and hospital staff and to throw analytical 
light on questions of trust, interpersonal relationships and distributive justice. Whilst these 
questions are not new to ethicists and social scientists little has been written about the way 
that differences in care-giving and assets are negotiated in collaborative transnational 
research, and how decisions are made about the use of space and resources. The 
contribution of this chapter is an analysis of these negotiations in a setting which is very 
distinct from the commercial research sites based in the United States, Brazil and Poland, 
which are the subject of other important ethnographic work (Petryna, 2009). 
Documenting the Experiential Practice of CE in Public Health Facilities 
Framework of Collaboration 
Several formal processes are followed to establish and maintain collaborations between 
KEMRI/CDC and public health facilities. These include meetings between governmental 
health officials, the district health management team, health facility committee members 
and senior researchers. Written memoranda of understanding (MOU) are then formulated 
to '... demarcate the points of agreement between "X" health facility and the KEMRI/CDC 
Research and Public Health Collaboration with regards to (reimbursement) /facilitation of 
patient care, (rent/space), electricity, provision of water and staff support, as applicable. It 
delineates general guidelines for both participating parties and outlines their roles in the 
various patient centred activities. ' In essence these written memorandums indicate that 
there is an awareness of the problems and challenges which can be encountered when 
research is integrated in public health facilities. 
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The terms of agreement cover issues relating to staff, medical care for trial participants, 
access to data, pharmacy arrangements, space arrangements, access for study monitors, 
equipment and electrical power, water supply, reimbursement to facilities where relevant, 
the relationship between parties, good faith and fairness, confidentiality, giving of notice 
and regular meetings of the parties. The MOU (Appendix II, Doc. 9) states clearly that 
KEMRI/CDC staff can only assist other health facility staff when they have completed their 
study duties. The section about the relationship between parties emphasizes the autonomy 
of each party, and stating that each is in complete control of their own operations and not 
subject to one another. The MOU documents that the study will maintain a separate 
formulary with some drugs that would not be routinely available at the hospital which can 
be used for non-study participants on a case-by-case basis at the discretion of the Principal 
Investigator of the study. 
Whilst the MOU provided the framework for collaboration in the MVT many of the details 
were worked out in everyday encounters. According to my interviewees these encounters 
were not always easy; however a shared ethos to preserve and save life created the basis 
for collaboration. 
'Paperwork can wait, ifyou look at KEMRI/CDC and MOH (Ministry of Health) what is the 
bottom line, to save lives, and all of us who went through school, when you qualified that is 
what you swore, you know you go into this profession to save lives, so research or no 
research number one is safety. ' 
Male Research Nurse, RS 15 
Benefits of Collaboration 
Research was described as a 'window of opportunity' by those working in health facilities 
which face significant constraints in the delivery of health services. 
"We are aware that the government of Kenya has brought us to the hospital 
here as staff, 
both technical and non-technical but with the present economy it is just not enough to, to 
have enough staff, to have enough materials, to have enough infrastructure 
[mmm]to be 
able to give that ideal quality care [right] to the patients [mmm] 
Male Medical Superintendent, CR 53 
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The following benefits were attributed to the integration of research into public health 
facilities by researchers and hospital staff: 
" Infrastructural renovations 
" More qualified staff (including specialists) present within the health facility 
" Researchers share resources and expertise when there is a shortfall 
" Access to medical information via research internet connection 
" Improvement in standards of care within the paediatric ward and reduced mortality 
(KEMRI/CDC, 2009) 
" Researchers assist with difficult and emergency cases 
Some questions were however raised about whether research benefits extend sufficiently to 
non participants and the wider community. Hospital staff would have liked research budgets 
to cover more supplies for general use in the wards. Similarly, health facility committee 
members thought that the free health-care provided to trials participants should also be 
made available to their families. 
Even if it is not the whole community, but it should be spread out just to a level of a family 
of or a homestead, butyou know this one is restricted just to an individual not even the 
siblings 
Male Health Facility Committee Member, CR 19 
Overall however, community representatives, health officials and hospital staff highly 
valued the benefits afforded by collaboration with KEMRI/CDC. 
Integration of Research into Public Health Facilities 
KEMRI and international collaborators, including CDC, have been conducting malaria-related 
research at SDH since the 1980s. Most of this research took place within the paediatric and 
maternity wards and the outpatients clinics at SDH. Observational studies evaluated 
paediatric and maternal mortality related to malaria, anaemia and HIV, assessed 
blood 
transfusion practices and validated an algorithm for integrated management of childhood 
illnesses (Lackritz et al., 1997, Perkins et al., 1997, Zucker et at., 1994). 
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Photo 24: SDH Paediatric Ward 
,: 
Preparations for the MVT commenced in August 2008 with a pilot study in the SDH 
paediatric ward to pre-test treatment algorithms, diagnostic procedures and trial 
equipment. KEMRI/CDC staff identified potential participants from the acute bay and 
attended to them in beds located across the ward. In this way, the pilot study was 
embedded in general ward activities and there was very little separation. The research staff 
attended to all sick children who were admitted to the ward and offered other support 
where required. There were separate research meetings and the research clinicians 
followed up research participants closely but there were also joint continuing medical 
training sessions for both researchers and general ward staff. 
The implementation of the pilot study was not without challenges. Amongst the most 
pivotal was the transfer of hospital staff to other wards, resulting in an increased work 
load 
on MVT study staff such that they were unable to meet study trial protocol-specific 
requirements. From the hospital administration's viewpoint, the presence of research 
clinicians and nurses was seen as an opportunity to distribute the limited 
hospital work 
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force to other places that suffered from inadequate staffing. When the medical 
superintendent took action to reverse this trend complaints were voiced by parents about 
the differentials in care-giving and time allocated to patients as between research and 
hospital staff. These differences became increasingly apparent as the study progressed and 
the researchers had less time to assist with general patients. The following quotation from a 
mother illustrates some of parents' dissatisfaction about variable health-care standards. 
'I saw a dif, ference, there were wards that were for KEMRI/CDC, there you see they attend 
to the kids after every short time they test the child and then the second person has 
reached, they look at the kid after every 30 minutes you see someone coming with the kids file asking questions. That is very different from where we were on the other side. If one 
person [health professional] goes round in the morning at 9 and the other one will come at 
noon and the other at 3 in the night only, but KEMRI/CDC they look at these people after 
every short time. ' 
Female CM 07 
The vaccine trial investigators' intention was to remain fully integrated within the general 
functioning of the paediatric ward when the MVT started in July 2009. They were 
committed to building capacity and had recruited a study paediatrician who would provide 
mentoring on general ward rounds when her other duties permitted. However in order to 
reduce the perception of parents of non-study participants that their children were 
receiving less attentive care, the medical superintendent advised the MVT team to use a 
separate 6-bed bay based at one end of the ward to admit and attend to research 
participants. An adjacent bay at the same end of the ward was already in use by another 
transnational research team (University of New Mexico/KEMRI); hence this space was 
referred to as the place where 'projects' operate, in other words where research is 
conducted. The bay allocated to the MVT team was visible to other general patients through 
windows in the wooden panels that separate individual bays in the ward. When admissions 
exceeded the capacity of this bay, research participants are also attended to in other bays 
alongside general patients. Research nurses and clinical officers offered assistance to 
hospital staff when called upon, particularly in emergency cases (e. g. seizures, respiratory 
and cardiac arrest). However there was less interaction during the MVT proper than there 
was during the pilot study. As a result, differences in care-giving, for example the patient-to- 
staff ratio, are more evident. The ratio was 2 nurses and 1 clinical officer for 6-10 research 
participants versus approximately 42 patients for the same number and calibre of 
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government staff. Like the rest of the ward, research patients sometimes had to share beds. 
But the research nurses took care to separate children with contagious diseases from those 
at risk, and the area was kept clean by local personnel employed by the researchers. These 
small things can make a big difference to patients and their families' experience of care- 
giving during a hospital admission. 
Distinctions in Service Provision 
As indicated above there are core distinctions in the aims and practice of research and 
general health service provision. In economically-deprived settings, general health-care 
providers provide essential services to the majority of the population. The standard of care 
is often constrained by staffing levels, access to resources and specialists (English et al., 
2004, Wamai, 2009). 
Health research and particularly clinical trials of investigational products have a primary 
objective of answering a specific scientific question in a manner that ensures participant 
safety. Trials must adhere to strict regulations and provide acceptable levels of health-care, 
which is usually the best standard possible in the particular setting. Generally, the 
staff/patient ratio is high, resources are readily available and trial participants receive 
individual attention. 
Physical and financial access to health-care also differs between the two paradigms of 
research and general care. In Kenya out-patients services for children <5 years are free at 
the point of care. However frequent unavailability of medicines results in out-of-pocket 
spending on drugs and is one of the main reasons why people avoid utilizing health-care 
facilities (Ministry of Health, 2003). In-patient services are chargeable and the following 
rates applied in 2009: on admission to the paediatric ward at SDH parents paid Ksh 100 
(approximately US $ 1.20) for a patient file and basic amenities. They also paid a basic bed 
rate of Ksh 50 (US $ 0.60) per night for supplies such as bed linen, gloves, dressings, 
cannulas and intravenous sets. Certain medications were free, such as antipyretics and 
first 
line antibiotics; others need to be bought at the hospital pharmacy or in town. X-Ray and 
laboratory investigations apart from HIV tests were chargeable for in- and out-patients and 
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amount to approximately 300 Ksh and 150 Ksh (US $4 or 2) respectively. These user fees 
placed a heavy burden on households in an area where 60-74% of people lived under the 
Poverty level (Kenya Central Bureau of Statistics, 2005), and where, according to one my 
research assistants, it cost on average Ksh 150 to feed a family of four. 
All services, medications and laboratory tests were free for research participants whose 
parents were also given travel reimbursement (150 Ksh) to reduce any financial burden 
when they are expected to present to the study site for scheduled visits and any sick visits. 
On a case-by-case basis, KEMRI/CDC could also provide transportation between peripheral 
sites to SDH or facilitate transfers to tertiary facilities. 
This analysis suggests that the core distinctions between care-giving in the research and the 
general paradigm concern questions of cost, level of attention and whether services are 
individualised and specialised or more generic and essential. 
Challenges in Practice 
In practice the integration of the MVT within SDH and the peripheral health centres resulted 
in key challenges in terms of physical constraints, sharing of working spaces and accessing 
resources. It was also evident that those in charge of these facilities considered themselves 
to be answerable to the government and the local community. They were careful to ensure 
that research was conducted in an ethical manner, did not interfere with routine services 
and did not increase waiting times or damage their reputation. 
,... and we are talking to them, first of all, we want to see whether this research they are 
bringing into the hospital has any ethical issues [mmm], that would eeh (yes), that would 
bring us into conflict with the law' 
Male Medical Superintendant, CR 53 
Physical Constraints 
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Space has to be found within facilities stretched beyond capacity, so researchers renovate 
areas and contribute to new structures. At SDH, research partners have also pooled 
resources to construct a separate building to absorb research activities, house HIV care and 
treatment services, and create a hospital conference room. This clinical research centre is 
being built to strengthen the research capacity at SDH but half of the space will also be used 
to extend hospital services. 
... we are calling it the annex [the annex], so for CDC, they are seeing, the KEMRI/CDC are 
seeing it as a clinical research centre [ok], the hospital is seeing it, is seeing it as a patient 
support centre, a resource centre [mmm]. Maybe somebody else is seeing it differently; 
everybody is looking at the same thing differently... ' 
Male Medical Superintendant, CR 53 
There are concerns at SDH about establishing separate spaces for research within the 
grounds of a public hospital. Facility managers argue strongly that research patients should 
be cared for in the regular wards and that any improvements should benefit all patients. 
Researchers similarly express the desire to continue to strive for integration and do not 
want a new structure to result in segregation. At present there are no plans to move in- 
patient study participants off the hospital ward. Careful engagement will be required to 
negotiate differing expectations. 
Social Experience of Space 
The integration of the MVT into the paediatric ward increased staffing levels and resulted in 
a reduction of paediatric mortality (KEMRI/CDC, 2009). Despite these evident advantages it 
was also apparent that communication between ward-based research clinicians and nurses 
and hospital staff was impeded by a 'superiority/inferiority complex: Greater status was 
attributed to working with a research organisation than with the government. In interviews 
both research and general staff talked about perceived differences in employment 
benefits, 
professional advancement, medical management and the need to respect 
for peoples' 
experience regardless of their status. Government hospital employees are permanent and 
pensionable members of staff whereas research clinicians are usually employed on annually 
renewable contracts. Pay scales and employment allowances are marginally 
better for 
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researchers; however they do not enjoy the same level of job security. These differentials do 
not fully explain the enhanced status attributed to those working for KEMRI/CDC. What 
matters more is research nurses' and clinicians' association with a successful and powerful 
organisation, which enables them to provide high quality care and achieve their professional 
aspirations. 
'... that even when you are internally motivated external factors such as poor facilities, lack 
of resources, your salary can lead you to become demoralized because you cannot reach 
your potential and apply your learning whereas in research you are given the training and 
tools you need to do a good job' 
Male Research Nurse, RS 12 
Time pressures are common across both the research and the general care-giving 
paradigms. A significant proportion of MVT researchers' time was taken up with paperwork 
which hospital staff find difficult to reconcile in view of the high turnover of general 
patients. Hospital staff also talked about there being a 'project' side and 'their' side and 
stated that project patients did not want to be attended to by them in case they 
do not 
provide the `special stuff (Hospital Clinician, CR 40). Such attitudes can be difficult for 
senior hospital staff to reconcile since they are responsible for the overall running of 
hospital wards. 
Sharing Resources 
MOUs are not explicit when it comes to the sharing of equipment and pharmaceutical 
resources between research projects and regular health services. Maintaining oversight over 
resources is not always clear cut as arrangements for oxygen supplies suggests. During the 
MVT research and hospital teams agreed to take turns in filling the cylinders to ensure a 
ready supply. When this arrangement lapsed, research staff found themselves in a difficult 
position for '... you know oxygen is life saving refusing somebody oxygen is refusing that 
person life, it is actually in the medical ethics it is actually a crime' 
(Female Research 
Nurse, RS 16). 
All may have concurred that 'the spirit of the MOU is to share resources when hospital has a 
shortfall' (Medical Superintendant, CR 53), but the circumstances and the cost of the 
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shortfall also played a role in decisions about resource distribution. It is easier to distribute 
new IV cannulas at Ksh 50 (US $ 0.60) a piece than oxygen cylinders which cost KES 6000 (US 
$ 80) to refill. In this instance, the MVT researchers informed the trial sponsor that they had 
to incur this cost because it would be unethical to deny oxygen. 
Decisions about resource distribution, including the provision of medications not available 
within the hospital formulary were the responsibility of the MVT Principal Investigator (PI). 
In practice PIs usually entrust these decisions to facility-based researchers who respond 
liberally and seek to help whenever possible. Where significant costs are involved they 
consult with their supervisors and triage on the basis of severity of condition and personal 
circumstances. 
Perception of Difference: `You are now special, you are under research" 
One of the clinical researchers described how uncomfortable it can be working in an 
environment where differences are so evident. One operates within one facility but to all 
intent and purposes the paradigms of research and general care-giving can seem poles 
apart. A hospital clinician likened coming from the 'other' side to the 'project' side as 
moving from the developing to the developed world. Similarly, a research doctor compared 
participation in the MVT with a medical insurance system. Based on her experience she 
maintained that trial participants attend hospitals earlier than general patients since they 
are not constrained by financial obstacles, and are assured of specialist paediatric services 
and attentive nursing care. Parents of other sick children noticed these differences and 
asked the researchers: 
'What is this all about? And we tell them this is research, these are participants in a 
clinical trial and we have to do these kinds of things. They will understand but then when 
you look at them you can feel like why wasn't I taken for the study? We respond by saying; 
it is not all children that fit the criteria. ' 
Male Research Clinician, RS 15 
Community representatives and hospital staff suggested that researchers sometimes 
reinforce this sense of exception in how they treated research participants and in the 
logistics of accessing hospital care. 
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".... in fact they (researchers) call them, they tell them on admission that they are now 
special [right], they use that word special [they use the word special? ] yeah, you are now 
special, you are under research" 
Hospital Nurse, CR 34 
"But when it comes to a research client, its just a, it's just a, I don't know, you don't buy 
anything, at the end of it you are given transport back home [right], and with the 
government client, you buy everything, ok the service you get, but at the end of it, you pay 
for everything... " 
Hospital Nurse, CR 36 
The researchers' perspective was that they were fulfilling their professional responsibility in 
line with Kenyan MOH guidelines and research procedures. Here it is important to note that 
treatment algorithms do not differ between the paradigms since both researchers and 
government health employees follow MOH guidelines. At the same time it is evident that 
researchers take great pride in their work and may communicate this to their clients thereby 
inadvertently drawing attention to existing disparities in care-giving. The discomfort 
expressed in the quotations above may have been less apparent had general standards of 
care and staffing levels been better in government facilities. 
Management of Difference 
Most interviewees were in support of the integration of research within public health 
facilities, although it was clear that the MOH hospital-based staff we talked to did not fully 
concur with the hospital manager's view that 'perceived differences in standards of care are 
just a hiccup in contrast to overall benefits' (CR 53). They appreciated the infrastructural 
improvements, additional staff and training opportunities. But they raised concerns about 
differentials in care-giving between trial participants and general patients. Researchers also 
struggled to reconcile this and some stated it would be easier if there were a separate 
research ward. The discrepancies would have been less obvious and they would not always 
have wondered 'what are the other patients thinking? ' (Female Research Clinician, RS 17). 
The improvement of governmental health facilities was also suggested as a means to 
facilitate more equitable research. 
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The integration of research into public health facilities raises questions that do not only 
occupy staff at the KEMRI/CDC site. According to a senior KEMRI/CDC researcher, some 
African trial sites are also debating this issue and some are moving towards conducting 
research in separate spaces due to similar challenges. 
Discussion of the Main Themes 
This description of the operation of two different paradigms of care-giving within one health 
facility raises questions about how to integrate research, manage difference and make 
ethical decisions of clinical import in this context. In the case of the MVT, researchers were 
fully committed to a model of integration which meant research was very visible and 
required close collaboration between research and hospital staff. However the logistical 
and scientific demands of the trial, and the challenges confronted in the clinical setting, 
required them to draw partial boundaries between research and general health-care 
practice. The formulation of an MOU provided a framework that sought to extend the 
benefits of research whilst underlining the autonomy of both agencies who were party to 
the agreement. However the spirit of the understanding with such agreements is more 
difficult to capture and can be interpreted differently depending on a given individual's 
judgement of merit. Researchers need to apply protocols that confer boundaries both in 
terms of the provision of care to participants during and after the trial and the limits of 
these benefits. For example, trial participants' siblings or the neighbours of research 
participants who are not taking part in the research are not eligible to receive the same care 
due to cost implications, although they do benefit from improvements to 
local health 
facilities. Whilst on paper these boundaries appear sensible and justifiable, in practice it can 
be difficult to reconcile differing standards of care-giving for hospitalised research patients 
and general patients suffering from the same conditions. Researchers do of course 
intervene in cases of life and death and in many other incidences; however there are 
limits 
to the extension of benefits that can seem to be contrary both to the ethical impulse of 
medical practitioners and broader communitarian values. 
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This underlines the difficulty of shifting moral responsibilities from the political/structural 
domain into that of personal relations or even professional ethics. Health practitioners make 
public oaths in which they swear to do their utmost to preserve life in all situations. This 
commitment should be met with a mutual pledge by governments to commit the resources 
necessary to provide essential and equitable health-care. Governments, research sponsors, 
pharmaceutical companies, researchers, health practitioners and local communities need to 
have an open dialogue about what is required to conduct ethical and equitable research. 
Whilst there may be no straightforward answer to the question of who is responsible for 
raising standards in public health facilities, it is clear that, within collaborative partnerships, 
government bodies need to be more engaged in capacity-building efforts. 
In the MVT, research sponsors channelled capacity funds through clinical trial alliances or 
allocated specific research funds to renovate the premises where the trial took place, so 
that, whilst the paediatric ward at SDH was described as dilapidated at the start of the MVT, 
renovations and increased staffing levels resulted in reduced mortality rates (Alsop, 2009). 
On the other hand, general hospital workers at SDH still face shortages and are not always 
able to provide the same standard of care as researchers. Hence the situation of research 
within clinical settings simultaneously extends benefits and demarcates differences in terms 
of practice and economics. 
In practice, research is demarcated through social and spatial boundaries. While the latter 
are more visual the former can be more significant in terms of fostering collaboration. These 
boundaries pertain to position, responsibilities, interpersonal relationships, the repute of 
science and access to health-care resources. Collaborative agreements are not always 
explicit about how resources can be shared between research and regular services. This can 
result in critical decisions being made by research clinicians on a case-by-case basis. In such 
instances researchers tend to form their own boundaries of ethical activity based on their 
clinical judgement, personal moral reasoning and understanding of contextual issues 
(Wainwright et al., 2007). Whilst commendable and unavoidable in emergency situations a 
more inclusive deliberation of such dilemmas before or after the event would serve to 
strengthen relationships between research and hospital staff. 
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Within the context of collaborative partnerships several questions need to be addressed. 
First, is an element of partial separation between research and general care inevitable? If, 
yes, how can we ensure that this does not lead to a decrease in improvements to clinical 
care and services for non-research patients? Clearly, the separation between research and 
regular health services does not square well with the communitarian values of reciprocity, 
equity, and justice. At the same time, how do researchers accommodate difference and 
formulate boundaries of ethical scientific activity, and how are these understood in the 
context of collaborative partnership? There is a need for more open discussion about these 
issues between researchers, hospital staff, sponsors, ethicists, patients and community 
members. Finally, and of vital importance, who is responsible for raising standards of care in 
public health facilities? Improvements in the capacity and quality of public health services 
would go a long towards reducing the differences encountered between research and 
general care. 
Ten years after Edejer's (1999) appeal to reverse the health research funding gap between 
neglected diseases and diseases more prevalent in industrialised countries, progress has 
been made to develop safe and effective interventions that can redress the burden of 
disease in developing countries. In turn this has focused attention on the regulation of 
clinical research and the protection of potentially vulnerable populations. Guidelines are 
useful in the formulation and review of research; but guidelines alone cannot capture all 
levels of ethical decision-making. Practitioners must develop their own personal or 
collective strategies to address recurring dilemmas that occur in this context. Such dilemmas 
merit urgent public articulation and negotiation at all levels - hospital, district, national, and 
international - to consider how differences in access to resources and care-giving can 
be 
addressed and minimised or ameliorated to create better solutions. 
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Chapter 12: Summary & Conclusion 
Introduction 
In this thesis I have explored the practice of CE in health research taking place in a resource- 
limited setting from as many different angles as possible in order to understand the work 
that CE is meant to do according to different people and groups who have a stake in it, and 
the work that it actually does. I have critically interrogated the assumptions and meanings 
behind this mode of intervention and documented CE's power and social effects. The 
purpose of this chapter is to synthesise the main findings and formulate an overarching 
conclusion, with reference to relevant literature and due consideration of the implications 
for the practice of CE of my findings and conclusion. 
Summary of the Main Findings 
To present this summary of the main findings I have organised the eight findings chapters 
into three parts: 1) 'The Historical Emergence & Framing of Community Engagement' (Ch. 4- 
5); 2) 'The Social Construction of Community Engagement' (Ch. 6-9); and 3) 'Responses and 
Negotiations in Community Engagement' (Ch. 10-11). 
Historical Emergence & Framing of Community Engagement 
In chapter 4I discussed how, within a time-span of 30 years, the KEMRI/CDC research 
programme evolved from a relatively small outfit undertaking small-scale studies primarily 
focussed on malaria prevalence and treatment, into a global project carrying out numerous 
clinical trials and observational studies at any given time. I argued that research which was 
initially hosted by and accountable to district or community-led health and 
development 
programmes became increasingly externally driven. This gradually altered the exercise of 
control and the direction of interactions between researchers and community members. 
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Community members became primarily the sample frame, or in some cases, the facilitators 
of research rather than instigators of and collaborators in public health programmes and 
related research. The fact that the community was no longer integral to the running of 
research programmes yet still essential as participants created a progressive distancing and 
disconnect which, by the early 215` Century, culminated in rumours as well as in public 
debate and negative media reports. From this train of events emerged the realisation that 
CE was not there by default, but had to be attended to in order to maintain support for their 
programmes and respond to increasing demands for accountability. Consequently 
researchers assumed responsibility for CE and appointed community liaison and 
communications officers. 
The contemporary framing of CE at KEMRI/CDC, described in chapter 5, suggests that CE is 
primarily about researchers reaching out to the community in which trials take place - 
principally by conveying information and teaching Iaypeople about science - rather than 
pursuing a more balanced reciprocal partnership. The latter is an implicit assumption in the 
theoretical of conception of CE, and the foundation of its assumed social value as a tool of 
ethical research practice (see chapter 1). This type of reciprocity seemed to be more evident 
in the earlier stages of community relations described in chapter 4. In the contemporary 
framing of CE the local community is presented as separate from the KEMRI/CDC 
community. In this formulation 'community' comprises: those who need to know about the 
research programme; those who participate in or seek services from this programme; those 
who live where research is taking place; and community leaders and official collaborators 
who shape public opinion. Much emphasis was placed by KEMRI/CDC staff whom I 
interviewed on information exchange, transparency about the purpose of research and 
reaching out to as many people as possible. Other potentially important aspects of CE such 
as employment, health service provision and infrastructure building were less emphasised. 
KEMRI/CDC personnel are tasked with fostering good community relationships, and 
particular personnel are delegated direct responsibility for communication, collaborating 
with community leaders and forming representative bodies (such as CABs), which can 
help 
researchers apply protocols more effectively and with reference to community norms and 
values. CE is viewed as a learning process and something that has to be planned carefully in 
order to mitigate the influence of latent cultural idioms and related rumours. These rumours 
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clearly influence researchers' thinking about the local community and underscore 
boundaries and demarcations already drawn between KEMRI/CDC and the places where 
trials take place. The contemporary framing of CE at KEMRI/CDC thus presents CE as a way 
of facilitating the smooth operation of trials and countering negative rumours and 
opposition. The overall goal is to increase community members' knowledge of and 
familiarity with science, and the principal means employed is the delivery and exchange of 
information. 
The Social Construction of Community Engagement 
The social construction of CE among different people working within KEMRI/CDC was 
elaborated on in chapter 6 by drawing on the experiences and thinking of different levels of 
personnel. As chapter 6 showed, the character of the KEMRI/CDC collaboration, and power 
dynamics both between representatives from the two organizations and within the two 
organizations influenced the public perceptions of the research programme and 
relationships with external partners. Promoting a positive image, giving careful attention to 
the content of information shared with the media and general public, and demonstrating 
'attachment' to the local community were core features of the CE approach taken at 
KEMRI/CDC. FWs, whose job is to move between research structures and the target 
community, capitalised on their position as 'people of the community', and internally 
produced newsletters ('Voice of the Community') stressed the achievements of the 
KEMRI/CDC programme and the role played by local scientists. The use of colour 
photographs and expensive glossy paper communicated inadvertently, and somewhat 
countering the stated aims of creating proximity, something about the comparatively vastly 
superior wealth and status of the research enterprise in contrast to the community, and 
showed how the exercise of science can at once be demarcated from common experience 
and yet at the same time reach closely into people's lives. In a context characterised by 
poverty the notion of 'attachment' (demonstrating affinity in order to gain trust) can require 
researchers to demonstrate material solidarity with the local community in the practice of 
CE. This chapter reveals a tension between the emphasis on information exchange and the 
need to engage materially under conditions of poverty. The subsequent chapters also 
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document how the distribution of material benefits is central to the practice of social 
relations in this cultural context. 
Chapter 7 conveyed how the role of VRs is shaped by ambiguities related to their 
employment status and their dual accountability to researchers and their villages. VRs are a 
'hybrid' since they are not in the strictest sense volunteers but neither are they contracted 
KEMRI/CDC employees; they occupy the 'grey area that exists between voluntarism and 
paid labour' (Brown, 2011). As my main findings show VRs were careful to stress their 
commitment to self-less community service since it augments their respectability at 
community level and opens up opportunities for financial gain, exposure and self- 
development. VRs' position of being both with the community and with KEMRI/CDC 
emerged as advantageous for the conduct of research. However it was also 
clearly problematic in terms of exercising trust, balancing allegiances and adequately 
representing community views. VRs association with KEMRI/CDC and proximity to trial 
participants also required them to negotiate implicit and explicit expectations for material 
and medical assistance in a cultural setting in which much importance is placed on sharing 
and mutuality. 
The concept of 'positioning' of people who travel across the imagined boundary between 
the community and KEMRI/CDC, which emerged in chapter 7, gained further prominence in 
chapter 8 on CABs. CABs are voluntary bodies whose mandate at KEMRI/CDC is to foster 
partnership between researchers and the local community. In practice CAB members highly 
valued their association with a modern and progressive project and assumed the role of 
KEMRI/CDC patron-clients rather than community advocates. Becoming a CAB member 
meant that they gained access into a circuit of knowledge about research activities, 
peripheral job opportunities and other developments. Hence, whilst CAB members help 
researchers to address local concerns and appreciate contextual issues, questions arise 
about their independence and ability or willingness to examine research projects critically. 
In chapter 9 questions of context, power and unequal resources were driven home strongly 
by elected representatives and senior government administrators. They argued that one 
cannot apply a research agenda without accounting for inadequate health services and the 
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Poverty of most trial participants. For them the material expression of solidarity was central 
to CE and provided the basis for ongoing collaboration. They also warned researchers 
against working in isolation, and stressed the importance of their own involvement as senior 
government representatives, and of improved communication and accountability. Chiefs, 
who represent the lowest tier of government administration, were more positive about 
their relationship with KEMRI/CDC. They felt that researchers understood the importance of 
their buy-in as leaders whose judgement carries significant weight at community level. 
Similarly to senior officials they also viewed research as a way of creating opportunities for 
development which could benefit their areas of jurisdiction. 
Responses and Negotiations in Community Engagement 
Chapter 10 described the diverse spectrum of community responses and concerns which 
became evident during the course of the vaccine trials. My analysis showed that the passage 
of time was a crucial factor in CE, which is easily overlooked in the tight schedules of 
collaborative research programmes. My analysis revealed that as people started to interact 
more closely with KEMRI/CDC, they began to lay aside hesitations and inherent suspicions 
which were heavily influenced by latent cultural idioms, such as 'blood stealing' rumours. 
Their attention became increasingly drawn to the benefits of trial participation and 
questions of exclusion began to dominate public concerns. Mothers of trial participants 
highly valued the standard and nature of care given to their children and were keen to 
remain attached to KEMRI/CDC. Community members also observed the 'good' associated 
with the research programme and wanted benefits (e. g. free health-care) to extend beyond 
those directly participating. Despite a growing familiarisation with and acceptance of the 
research programme, misgivings however continued to surface. Partly arising from tensions 
within the local social fabric, notably gender relations, fathers in particular, demonstrated 
active and passive resistance to their children's enrolment or continued participation in the 
vaccine research. They perceived the balance of benefits as favouring researchers and 
associated participation with poverty which, in turn, reflected badly on their paternal 
responsibility to provide for their families. It was also evident that fathers had limited 
contact with the research programme and were rarely involved in consent processes. 
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While chapter 10 focused on engagements at community level chapter 11 shifted our 
attention to engagements within public health facilities. In particular it described how 
differences in health-care provision between research participants and routine patients 
were negotiated in the general SDH paediatric ward where sick MVT participants were cared 
for by researchers. Whilst researchers and their MOH counterparts were in principle 
committed to the integration of research in places where general routine care was being 
provided, boundaries between scientific practice and general care were drawn in order to 
facilitate practice. Two paradigms of care-giving - 1) 'research' and 2) 'general care' - were 
contrasted in chapter 11 in terms of therapeutic relationships, accountability structures, 
working cultures and access to resources. Collaborative agreements provided a formal 
framework but did not account for all challenges that arose within the spatial and social 
dynamic or in decision-making processes about sharing research resources. In chapter 11 
argued for a proper public articulation of these dilemmas so that problems of inequity are 
not transferred from the domain of collaborative operations to the domain of personal 
morality, but instead are continuously negotiated with all partners to achieve better 
solutions. 
Overarching Conclusion 
Synthesised together these findings suggest that CE is socially constructed, context-specific 
and that it arises out of a particular history and framing of relationships between 
researchers and the broader community. It is also characterised by underlying ideas and 
assumptions about the nature of the 'community' and lay people, and distinct ideas about 
what 'engagement' with science and 'collaboration' in bio-medical research mean and 
involve. At KEMRI/CDC the 'local community' is viewed by staff as separate from the 
'research community' and much emphasis is placed on information exchange in order to 
address differentials or deficiencies in experience and understanding on the community's 
part. My analysis suggests, however, that CE is more contradictory and complicated than a 
simple meeting or exchange between researchers and the community, or between scientists 
and lay people. Such meetings are characterized by evident power differentials, differential 
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access to resources, and related expectations of material assistance. Neglecting such 
tensions is not helpful since it tends to relegate community concerns to being seen as less 
important than the transfer of knowledge. This is counterproductive since as my findings 
have shown, material engagements, whether in the form of care-giving for trial participants, 
infrastructural developments at government health facilities, or support for community 
projects, result in increased acceptance of research and closer collaboration between 
researchers and community members. 
This overarching conclusion underscores the fact that CE is enormously challenging in places 
where collaborative relationships are characterised by differential access to knowledge and 
resources. International health research is shaped by its access to substantial resources and 
the scale of this enterprise is particularly visible in resource-limited settings. Inequalities 
between collaborating research organisations and the community are highly conspicuous in 
such settings. To a certain extent these inequalities necessitate CE; however notions of 
'partnership' can also deflect attention away from the hierarchy and dependency which 
inevitably underlies collaborative relationships in these settings. This means that 
inequalities and related questions of social justice are rarely voiced in CE activities. 
Consequently they remain unresolved. The awkwardness of this was very evident in the 
material which I have presented in this thesis. There is a pressing need to consider how 
these unresolved questions which arise during the conduct of international bio-medical 
research can be addressed from the ground-up. 
Increasing emphasis is being paid by ethicists and health professionals to expanding the 
discourse on international health research ethics beyond interpersonal ethics to address 
more substantive questions about global health justice (Benatar and Singer, 2010, Macklin, 
2008, Meslin, 2008, Farmer, 2005). My thesis adds weight to these calls for solidarity and 
closer consideration of the ways in which the benefits of medicine, science and 
technological innovation are distributed in the conduct of bio-medical research. The moral 
arguments for the interconnectedness of the research enterprise and global health justice 
have been convincingly presented by Macklin (2008) and Benatar and Singer (2010,1998, 
2000). Impatience is now being voiced about the pace with which the translation of good 
286 
arguments into action is occurring (Benatar and Singer, 2010, Meslin, 2008). Meslin (2008) 
suggests that global health justice will not be achieved in international health research 
without a bi-directional approach that involves capacity building both from the top-down 
and from the ground-up. Whilst he welcomes the top-down focus on the development of 
guidelines and policies which seek to harmonize global research ethics regulation, he also 
pinpoints their inadequacies in terms of local application. For Meslin (2008) research ethics 
capacity from the ground-up involves sitting down with research partners, administrators, 
ethics review committee members, research participants and the communities from which 
they come, to discuss and debate the terms, concepts and practice of research with due 
consideration of the local circumstances. He cites examples where ideas about fairness in 
research were explored with research participants and clinician-researchers and debated by 
international research collaborators working in Kenya. The latter informed the development 
of an institutional framework which sought to acknowledge openly inequities in the 
application of research within institutions and between collaborating institutions and to 
redress them proactively. 
It is evident from this literature and from my thesis that questions of health and social 
justice need to be accounted for in the everyday practice of international research. The 
challenge that faces us now is how to expand the mandate of CE to debate such key 
underlying challenges of social justice and to identify practical solutions which can address 
these. Such extension could take on two directions, lateral and vertical. Laterally CE could 
include teaching community members not just about research but also about their human 
right to health-care, advocacy and political accountability. The vertical extension of CE 
recognises that researchers cannot address questions of social justice in isolation. Rather 
they need to involve funders, sponsors and national and international governmental bodies 
in order to achieve lasting change. CE in bio-medical research urgently needs to broach and 
debate interrelated questions about inequalities, health rights and accountability so that 
community members can participate in identifying solutions from the ground-up. 
Closing Statement 
287 
The central conclusion and argument of this thesis is that CE needs to be understood within 
the context of historical models for working with target communities, and the long-standing 
and developing relationships between researchers, their staff and assistants, and members 
of the wider community in which trials take place. Furthermore, far from being an 
unproblematic and unequivocal good in terms of ethical practice, CE offers a lens into new 
and pre-existing inequalities which have a detrimental effect on public health and the 
implementation of research in resource-limited settings. CE emerges from my data and my 
analysis as highly complex and immensely challenging work, which requires continuous 
efforts and cannot be limited simply to information exchange. In order to address the 
tensions and contradictions which arise in CE it is essential to discuss questions of 
inequalities and social justice openly and directly, and to engage materially, through a 
broader distribution of resources and by means of health advocacy, with the communities in 
which research takes place. There is a need to move way from 'engaging' the community on 
to an engagement with and behalf of the community. Only in these ways can CE achieve its 
fullest potential, and the course of research be steered along the correct path to the benefit 
of all. 
288 
References 
ADAZU, K., LINDBLADE, K. A., ROSEN, D. H., ODHIAMBO, F., OFWARE, P., KWATCH, J., VAN EIJK, A. 
M., DECOCK, K. M., AMORNKUL, P. N., KARANJA, D., VULULE, J. M. & SLUTSKER, L. 2005. 
Health and Demographic Surveillance in Rural Western Kenya: A Platform for. Evaluating 
Interventions to reduce Morbidity and Mortality from Infectious Diseases. American Journal 
of Tropical Medicine and Hygiene, 73,1151-58. 
ALSOP, Z. 2009. Malaria vaccine researchers face cultural challenges. Lancet, 374,104-105. 
AMORNKUL, P. N., VANDERHOUDT, H., NASOKHO, P., ODHIAMBO, F., MWAENGO, D., HIGHTOWER, 
A., BUVE, C., MISORE, A., VULULE, J., VITOK, C., GLYNN, J., GREENBERG, A., SLUTSKER, L. & 
DE COCK, K. M. 2009. HIV Prevelance and Associated Risk Factors among Individuals Aged 
13-34 Years in Rural Western Kenya. PloS One, 4, e6470. 
ANGELL, M. 1997. The Ethics of Clinical Research in the Third World. New England Journal of 
Medicine, 337,847-849. 
ARMAH, G. E., SOW, S. 0., BREIMAN, R. F., DALLAS, M. J., TAPIA, M. D., FEIKIN, D. R., BINKA, F. N., 
STEELE, A. D., LASERSON, K. F., ANSAH, N. A., LEVINE, M. M., LEWIS, K., COIA, M. L., ATTAH- 
POKU, M., OJWANDO, J., RIVERS, S. B., VICTOR, J. C., NYAMBANE, G., HODGSON, A., 
SCHÖDEL, F., CIARLET, M. & NEUZIL, K. M. 2010. Efficacy of pentavalent rotavirus vaccine 
against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan 
Africa: a randomised, double-blind, placebo-controlled trial. The Lancet, 376,606-614. 
ARNSTEIN, S. 1969. A ladder of participation Journal of the American Institute of Planners, 35,216- 
224. 
BANDEWAR, S. V., KIMANI, J. & LAVERY, J. V. 2010. The origins of a research community in the 
Majengo Observational Cohort Study, Nairobi, Kenya. BMC Public Health, 10,630. 
BEAUCHAMP, T. L. & CHILDRESS, J. F. 2009. Principles of Biomedical Research, New York Oxford 
University Press. 
BENATAR, S. R. 1998. Imperialism, research ethics and global health. Journal of Medical Ethics, 24, 
221-222. 
BENATAR, S. R. 2001. Commentary: justice and medical research: a global perspective. Bioethics, 
15, 
333-40. 
BENATAR, S. R. 2002. Reflections and recommendations on research ethics in developing countries. 
SocSci Med, 54,1131-41. 
BENATAR, S. R. & SINGER, P. A. 2000. A new look at international research ethics. British Medical 
Journal, 3221,824-826. 
BENATAR, S. R. & SINGER, P. A. 2010. Responsibilities in international research: a new look revisited. 
Journal of Medical Ethics, 36,194-197. 
BERNARD, H. R. 2011. Research Methods in Anthropology. Qualitative and Quantitative Approaches., 
Lanham, Maryland, AltaMira Press. 
BERRY, S. 1992. Hegemony on a Shoestring: Indirect Rule and Access to Agricultural Land. Africa: 
Journal of the International African Institute, 62,327-355. 
BERWICK, D., DAVIDOFF, F., HIATT, H. & SMITH, R. 2001. Refining and implementing the Tavistock 
principles for everybody in health care. BMJ, 323,616-20. 
BIG ISSUE TEAM 2004. Rarieda guinea pigs insist they were tricked into joining study. East African 
Standard. 
BLAKE, J. B. 1957. Benjamin Waterhouse and the introduction of vaccination; a reappraisal, 
Philadelphia, University of Pensylvania Press. 
BLOLAND, P. B., RUEBUSH, T. K., MCCORMICK, J. B., AYISI, J., BORIGA, D. A., OLOO, A. J., BEACH, R., 
HAWLEY, W., LAL, A., NAHLEN, B., UDHAYAKUMAR, V. & CAMBELL, C. C. 1999. Longitudinal 
289 
Cohort Study of the Epidemiology of Malaria infections in an area of Intense Malaria 
Transmission I. Description of Study Site, General Methodology, and Study Population. Am J 
Trop Med Hyg, 60,635-640. 
Author. 18th October 2011. Malaria vaccine trial raises hope. BBC News Website 
http: //www. bbc. co. uk/news/health-15358554 (accessed 18th October 2011). 
BROWN, H. 2011. Losing the voluntary spirit? Gender, governance and community in Kenya's 
Community Strategy for health. Upublished paper presented at workshop 'voluntarism in 
Africa and beyond, University of Cambridge, 17th October2011. BUSE, K. & WALT, G. 2000. Global public-private partnerships: Part I--A new development in health?. 
Bull World Health Organisation 78,549-61. 
CALHOUN, C. (ed. ) 2002. Dictionary of the Social Sciences: Oxford Reference Online: Oxford 
University Press. 
CDC/ATSDR COMMITTTEE ON COMMUNITY ENGAGEMENT. 1997. Principles of Community 
Engagement [Online]. Atlanta: Centers for Disease Control and Prevention. Available: 
http: //www. cdc. gov/phppo/pce/ [Accessed 2nd February 2011]. 
CENTERS FOR DISEASE CONTROL AND PREVENTION. 2011. FY2011 CDC Budget Summary [Online]. 
Atlanta: CDC. Available: 
http: //www. cdc. gov/fmo/topic/Budget%201nformation/appropriations_budget_form_pdf/C 
DC FY 2011_Operating_Plan_Summary. pdf [Accessed 6th December 2011). 
CENTRAL BUREAU OF STATISTICS MINISTRY OF HEALTH KENYA & ORC MACRO 2004. Kenya 
Demographic and Health Survey 2003. Calverton, Maryland: CBS, 
MoH, 
ORC Macro. 
CHABAL, P. & DALOZ, J. P. 1999. Africa Works: Disorder as Political Instrument, Bloomingon, Indiana 
University Press. 
CHAMBERS, R. 1983. Rural Development: Putting the last first London. 
CHAMBERS, R. 1992. Rural Appraisal: rapid, relaxed and participatory. IDS Discussion Paper311. 
CHANTLER, T., ANGWENYI, V., F, 0., MWACHIRO, D., ONYANGO, P., NJUGUNA, P., HAMEL, M., LANG, 
T., GEISSLER, W. & MOLYNEUX, S. 2010. 'We can't involve everyone': A Comparative Case 
study of Community Engagement Processes at two Malaria Vaccine Trial Sites in Kenya. 
RSTMH Biennial Meeting Liverpool: Royal Society for Tropical Medicince and Hygience. 
CHANTLER, T., GREEN, S., LEES, A., DIGGLE, L., MAYON WHITE, R., POLLARD, A. J. & FITZPATRICK, R. 
2006. Parental views on the introduction of an infant pneumococcal vaccine. Community 
Practitioner, 79,56-59. 
CHANTLER, T., PACE, D., WRIGHT, A., POLLARD, A. J., YU, L. M., NGUYEN-VAN-TAM, J. S. & 
MACDONALD, N. 2007a. Uptake and acceptability of influenza vaccination in day nursery 
children. Community Practitioner, 80,32-36. 
CHANTLER, T. E. A., LEES, A., MOXON, E. R., MANT, D., POLLARD, A. J. & FIZTPATRICK, R. 2007b. The 
Role Familiarity With Science and Medicine Plays in Parents' Decision Making About 
Enrolling a Child in Vaccine Research 
Qualitative Health Research, 17,311. 
CLINICAL AND TRANSLATIONAL SCIENCE AWARDS CONSORTIUM COMMUNITY ENGAGEMENT KEY 
FUNCTION COMMITTEE TASK FORCE. 2011. Principles of Community Engagement [Online). 
Atlanta: Centers for Disease Control and Prevention & the Agency for Toxic Substances and 
Disease Registry. Available: 
http: //www. atsd r. cdc. gov/com mun ityengagement/pdf/PCE_Report_508_F I NAL. pdf 
[Accessed 6th December 2011]. 
COHEN, J. 2000. Forensic Epidemiology: Vaccine Theory of AIDS Origins Disputed at Royal Society. 
Science, 289,1850-1851. 
290 
COMAROFF, J. L. & COMAROFF, J. 1999. Introduction. In: COMAROFF, J. L. & COMAROFF, J. (eds. ) 
Civil Society and the Political Imagination in Africa: Critical persspectives. Chicago, London: 
The University of Chicago Press. 
COOK, A. R. 1945. Ugandan Memories (1897-1940), Kampala, Ugandan Society. 
COSTELLO, A. & ZUMLA, A. 2000. Moving to research partnerships in developing countries. British 
MedicalJournal, 321,827-829. 
COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES (CIOMS) 2002. International 
Ethical Guidelines for Biomedical Research Involving Human Subjects. Available at: 
http: //www. cioms. ch/frame_guidelines_nov_2002. htm (accessed 9th December 2006). DAWSON, M. H. 1992. Socioeconomic Change and Disease: Smallpox in Colonial Kenya, 1880-1920. 
In: FEIERMAN, S. & JANZEN, J. (eds. ) The Social Basis for Health and Healing in Africa. 
Berkeley: University of California Press. DE CENIVAL, M. 2008. L'ethique de la recherche ou la liberte d'en sortir. Bulletin de la societe de 
Pathologie exotique, 2,98-101. 
DEVRIES, R. 1995. Toward a sociology of bioethics. Qualitative Sociology, 18,119-128. DIALLO, D. A., DOUMBO, 0. K., PLOWE, C. V., WELLEMS, T. E., EMANUEL, E. J. & HURST, S. A. 2005. 
Community permission for medical research in developing countries. Clinical Infectious 
Diseases, 41,255-9. 
DISTRICT OFFICIALS 1939. Central Province District Annual Report Nairobi: Kenya National Archives 
CP4/4/1. 
DIXON, C. W. 1962. Smallpox, London, Churchill. 
DOUMBO, 0. K. 2005. Global voices of science. It takes a village: medical research and ethics in Mali. 
Science, 307,679-81. 
DYER, C. 2010. Lancet retracts Wakefield's MMR paper BMJ, 340, c696. 
EDEJER, T. T. T. 1999. North-South research partnerships: The ethics of carrying out research in 
developing countries British Medical Journal, 319,438-441. 
EMANUEL, E. J., WENDLER, D., KILLEN, J. & GRADY, C. 2004. What makes clinical research in 
developing countries ethical? The benchmarks of ethical research. Journal of Infectious 
Disease, 189,932-7. 
ENGLISH, M., ESAMAI, F., WASSUNA, A., WERE, F., OGUTU, B., WAMAE, A., SNOW, R. & PESHU, N. 
2004. Delivery of paediatric care at the first-referral level in Kenya The Lancet, 364,1622- 
1629. 
FABIAN, J. 1990. Power and Performance. Ethnographic Explorations through Proverbial Wisdom and 
Theatre in Shaba, Zaire, Madison University of Wisconsin Press. 
FAIRHEAD, J., LEACH, M. & SMALL, M. 2006a. Public Engagement with Science? Local 
Understandings of a Vaccine Trial in the Gambia. Journal of Biosocial Sciences, 38,103-116. 
FAIRHEAD, J., LEACH, M. & SMALL, M. 2006b. Where Techno-science meets Poverty, Medical 
Research and the Economy of Blood in the Gambia, West Africa. Social Science and 
Medicine, 63,11091120. 
FARMER, P. 2005. New Malaise: Medical Ethics and Social Rights in the Global Era. Pathologies of 
Power: health, human rights, and the new war on the poor. University of California. 
FELDMAN-SAVELSBERG, P., NDONKO, F. T. & SCHMIDT-EHRY, B. 2000. Sterilizing Vaccines or the 
Politics of the Womb: Retrospective Study of a Rumor in Cameroon. Medical Anthropology 
Quarterly, 14,159-179. 
FENNER, F., HENDERSON, D. A., ARITA, I., JEZEK, Z. & LADNYI, I. D. 1988a. Early Efforts at 
Control: Variolation, Vaccination, And Isolation And Quaratine. Smallpox and its Eradication. 
Geneva: WHO. 
FENNER, F., HENDERSON, D. A., ARITA, I. & LADNYI, I. D. 1988b. Eastern Africa: Kenya, Uganda, 
United Republic of Tanzania, Rwanda and Burundi. Smallpox and its Eradication. Geneva: 
WHO. 
291 
FERGUSON, J. 2005. Seeing Like an Oil Company: Space, Security, and Global Capital in Neoliberal 
Africa. AMerican Anthropologist, 107,377-382. 
FETTER, B. S. 1969. "The Lualabourg Revolt at Elisabethville". African Historical Studies, 2,273. FETTERMAN, D. M. 1998. Ethnography : step by step London Thousand Oaks: Sage. FREIRE, P. 1972. Pedagogy of the Oppressed, London Penguin Group. 
GAMBIA GOVERNMENT/MEDICAL RESEARCH COUNCIL JOINT ETHICAL COMMITTEE 1998. Ethical 
issues facing medical research in developing countries. The Lancet, 351,286-287. GATES, B. 2011. Prepared Remarks for the Malaria Forum October 2011 [Online]. Seattle: Bill and 
Melinda Gates Foundation Available: http: //www. gatesfoundation. org/speeches- 
commentary/pages/bill-gates-2011-malaria-forum. aspx [Accessed 29th November 2011 
2011]. 
GEISSLER, P. W. 2005. 'Kachinja are coming!: Encounters around medical research work in a Kenyan 
village. Africa, 75,173-201. 
GEISSLER, P. W. 2011. Studying Trial Communities: Anthropological and Historical Inquiries into 
Ethos, Politics and Economy of Medical Research in Africa. In: GEISSLER, P. W. & MOLYNEUX, 
C. (eds. ) Evidence, Ethos and Experiment: The Anthropology and History of Medical Research 
in Africa. New York, Oxford: Berghahn Books. 
GEISSLER, P. W., KELLY, A., IMOUKHUEDE, B. & POOL, R. 2008. 'He is now like a brother, I can even 
give him some blood' Relational ethics and material exchanges in a malaria vaccine'trial 
community' in The Gambia. Social Science and Medicine. 
GEISSLER, P. W. & POOL, R. 2006a. Popular concerns about medical research projects in sub-Saharan 
Africa-a critical voice in debates about medical research ethics. Tropical Medicine and 
International Health, 12,975-982. 
GEISSLER, W. & MOLYNEUX, C. (eds. ) 2011. Evidence, Ethos, and Experiment: The Anthropology and 
History of Medical Research in Africa, New York, Oxford: Berghahn Books. 
GEISSLER, W. & POOL, R. 2006b. Popular concerns about medical research projects in sub-saharan 
Africa-a critical voice in debates about medical research ethics. Tropical Medicine and 
International Health 11,975-982. 
GIERYN, T. F. 2002. 'Three Truth-Spots'. Journal of the History of the Behavioral Sciences, 38,113- 
132. 
GIERYN, T. F. 2006. City as Truth-Spot: Laboratories and Field-Sites in Urban Studies. Social Studies of 
Science, 36,5-38. 
GIKONYO, C., BEJON, B., MARSH, V. & MOLYNEUX, S. 2008. Taking social relationships seriously: 
Lesson learned from the informed consent practices of a vaccine trial on the Kenyan Coast. 
Social Science and Medicine, 67,708-720. 
GILSON, L. 2003. Trust and health care as a social institution. Social Science & Medicine, 56 (67), 
1452-1468. 
GLASER, B. G. & STRAUSS, A. L. 1968. The Discovery of Grounded Theory: Strategies for Qualitative 
Research, London, Weidenfield and Nicholson. 
GRABOYES, M. 2010. FINES, ORDERS, FEAR 
... 
AND CONSENT? MEDICAL RESEARCH IN EAST AFRICA, 
C. 1950s. Developing World Bioethics, 10,34-41. 
GREEN, J. & THOROGOOD, N. 2004. Qualitative methods for health research, London, SAGE. 
GREENHALGH, T. 2010. Why did the Lancet take so long? BMJ, 340: c644 
GREENWOOD, B. 1998, Traditional medicine to DNA vaccines: the advance of medical research in 
West Africa. Tropical Medicine and International Health, 3,166-176. 
GUIJT, I. & SHAH, M. K. 1998. Waking Up to Power, Conflict and Process. In: GUIJT, I. & SHAH, M. K. 
(eds. ) The Myth of Community: Gender issues in participatory development 
Southampton: Intermediate Technology Publications Ltd. 
HANKINS, C. 2006. Creating effective partnerships for HIV prevention trials: report of a UNAIDS 
Consultation, Geneva 20-21 June 2005. AIDS, 20, W1-W11. 
292 
HANTMAN, J. & GOTTEMOELLER, M. 2004. Mobilization: For community involvement in microbicide 
trials. Global Campaign for Microbicides. 
HENKE, C. R. 2000. Making a Place for Science: The Field Trial. Social Studies of Science, 30,483-511. HERBERT, E. W. 1975. Smallpox inoculation in Africa. The Journal of African History, 16,539-559. HOLLOWAY, I. & WHEELER, S. 2002. Qualitative research in nursing, oxford, Blackwell Science. HOOPER, E. 1999. The River. A journey back to the source of HIV and AIDS, Little, Brown and 
Company. 
HUBERMAN, M. 1991. Linkage between researchers and practitioners: a qualitative study American 
Educational Research Journal 27,363-393. 
IMPERATO, P. J. 1968. The Practice of Variolation among the Songhai of Mali. Transactions of the 
Royal Society of Trpoical Medicine and Hygiene, 62,868-873. INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR 
REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. 1996a. Guideline for Good Clinical 
Practice E6(R1) [Online]. Available: 
http: //www. ich. org/fileadmin/PublicWeb Site/ICH_Products/Guidelines/Efficacy/E6_R1/St 
ep4/E6_R1_Guideline. pdf [Accessed 21st September 2011]. 
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR 
REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. 1996b. Guideline for Good Clinical 
Practice E6(R1). Available: 
http: //www. ich. org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/St 
ep4/E6_R1_Guideline. pdf [Accessed 21st September 2011]. JEGEDE, A. S. 2007. What led to the Nigerian Boycott of the Polio Vaccination Campaign? PLOS 
Medicine, 4, e73. 
JENNER, E. 1798. An Inquiry into the Causes and Effects of the Variolae Vaccinae; a Disease 
Discovered in some of the Western Counties of England, Particularly Gloucestershire, and 
Known by the Name of The Cow Pox'. 
JOHNSON-HANKS, J. 2006. Uncertain Honour: Modern Motherhood in an African Crisis., Chicago, 
University of Chicago Press. 
KAMADI, G. 2010. Relief as pneumonia vaccine to cost less. Daily Nation 2nd August 2010. 
KASEJE, D. C. 0. & SEMPEBWA, E. K. N. 1989. An integrated rural health project in Saradidi, Kenya. 
Social Science and Medicine, 28,1063-1071. 
KEMRI/CDC 2009. Paediatric Mortality rates on Ward 5, Siaya District Hospital. Personal 
Communication. 
KEMRI/CDC HEALTH AND DEMOGRAPHIC SURVEILLANCE SYSTEM (HDSS) 2008.6th Annual Report 
KEMRI/CDC Health and Demographic Surveillance System Kisumu, Kenya. Kisumu: 
KEMRI/CDC RESEARCH AND PUBLIC HEALTH COLLABORATION. 
KENYA CENTRAL BUREAU OF STATISTICS 2005. Geographic Dimensions of Well-Being in Kenya: Who 
are where are the poor? A constituency level profile. Nairobi: Central Bureau of Statistics. 
KILAMA, W. 2007. Towards an African-driven malaria vaccine development program: history and 
activities of the African Malaria Network Trust (AMANET). The American Journal of Tropical 
Medicine and Hygiene 77,282-8. 
KLEINMAN, A. 1999. Moral Experiences and Ethical Reflection: Can Ethnography Reconcile Them? A 
Quandary for "The New Bioethics". Daedalus, 128,69-97. 
LACKRITZ, E. M., A. W, H., ZUCKER, J. R., RUEBUSH, T. K. N., ONUDI, C. 0., STEKETEE, R. W., WERE, J. 
B., PATRICK, E. & CAMPBELL, C. C. 1997. Longitudinal evaluation of severely anemic children 
in Kenya: the effect of transfusion on mortality and hematologic recovery. AIDS, 12,1487-94. 
LANDY, D. C. & SHARP, R. R. 2010. Examining the Potential for Exploitation by Local Intermediaries. 
The American Journal of Bioethics, 10,12-13. 
LATOUR, B. 1999. Pandora's Hope: Essays on the Reality of Science Studies, Cambridge, MA, Harvard 
University Press. 
293 
LAVERY, J. V., TINDANA, P. 0., SCOTT, T. W., HARRINGTON, L. C., RAMSEY, J. M., YTUARTE-NUNEZ, C. 
& JAMES, A. A. 2010. Towards a framework for community engagement in global health 
research. Trends in Parasitology Vol. 26 No. 6,26,279-283. 
LEACH, M. & FAIRHEAD J. 2005. The Cultural and Political Dynamics of Technology Delivery: The 
Case of Infant Vaccination in Africa. Brighton Institute of Development Studies. 
LEACH, M. & FAIRHEAD, J. 2011. Being 'with MRC': infant care and the social meanings of cohort 
membership in Gambia's plural therapeutic landscapes. In: GEISSLER, W. & MOLYNEUX, C. 
(eds. ) Evidence, Ethos and Experiment: The Anthropology and History of Medical Research in 
Africa. Berghahn Books. 
LEAKEY, L. S. B. 1977. The Southern Kikuyu before 1903, Ill, New York, Academic Press. 
LONSDALE, J. 1964. A political history of Nyanza, 1883-1945. PhD dissertation, Cambridge University. LOUE, S., OKELLO, D. & KAWUMA, M. 1996. Research bioethics in the Ugandan context: a program 
summary. J Law Med Ethics, 24,47-53. 
LSHTM MALARIA CENTRE. 2011. Analysis of RTS, S vaccine trials http: //malaria. Ishtm. ac. uk/news- 
events/news/analysis-rtss-vaccine-trials [Online]. [Accessed 11th November 20111. 
LURIE, P. & WOLFE, S. M. 1997. Unethical Trials of Interventions to Reduce Perinatal Transmission of 
the Human Immunodeficiency Virus in Developing Countries. New England Journal of 
Medicine, 337,853-856. 
MACKLIN, R. 2008. Global justice, human rights and health. In: GREEN, R. M., DONOVAN, A. & JAUSS, 
S. A. (eds. ) Global Bioethics. Issues of Conscience for the Twenty-First Century. Oxford 
Clarendon Press. 
MARSH, V., KAMUYA, D., ROWA, Y., GIKONYO, C. & MOLYNEUX, S. 2008. Beginning community 
engagement at a busy biomedical research programme: experiences from the KEMRI 
CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya. Sot Sci Med, 67,721-33. 
MARSHALL, P. & KOENIG, B. A. K. 2001. Ethnographic Methods. In: SUGARMAN, J. & SULMASY, D. P. 
(eds. ) Methods in Medical Methods. Washington D. C. : Georgetown University Press. 
MARSHALL, P. A. 2007. Ethical challenges in study design and informed consent for health research 
in resource-poor settings. Special Topics in Social, Economic and Behavioural (SEB) Research 
report series; No. 5. Geneva: WHO. 
MESLIN, E. M. 2008. Achieving Global Justice in Health through Global Research Ethics: Suplementing 
Macklin's Top-down proach with one rom the ground up. In: GREEN, R. M., DONOVAN, A. & 
JAUSS, S. A. (eds. ) Global Bioethics. Issues of Conscience for the Twenty-First Century. Oxford: 
Clarendon Press. 
MILSTIEN, J., GRIFFIN, P. D. & LEE, J. W. 1995. Damage to Immunisation Programmes from 
Misinformation on Contraceptive Vaccines. Reproductive Health Matters, 3,24-28. 
MINISTRY OF HEALTH 2003. Kenya Household Health Expenditure and Utilization Survey. Nairobi 
Ministry of Health 
MINISTRY OF HEALTH 2006. "Taking the Kenya essential package for health to the Community: A 
strategy for the delivery of level one services. ". Nairobi: Ministry of Health 
MITCHELL, K., NAKAMANYA, S., KAMALI, A. & WHITWORTH, J. 2002. Balancing rigour and 
acceptability: the use of HIV incidence to evaluate a community-based randomised trial in 
rural Uganda. Social Science & Medicine, 54. 
MOLYNEUX, C. S., PESHU, N. & MARSH, K. 2004. Understanding of informed consent in a low-income 
setting: three case studies from the Kenyan coast. Social Science 
& Medicine, 59,2547-2559. 
MOLYNEUX, C. S., PESHU, N. & MARSH, K. 2005a. Trust and informed consent: insights from 
community members on the Kenyan coast. Social Science & Medicine, 61,1463-1473. 
MOLYNEUX, C. S., WASSENAAR, D. R., PESHU, N. & MARSH, K. 2005b. 'Even if they ask you to stand 
by a tree all day, you will have to do it (laughter)...! ': Community voices on the notion and 
practice of informed consent for biomedical research in developing countries. 
Social Science 
& Medicine, 61,443-454. 
294 
MORIN, S. F., MAIORANA, A., KOESTER, K. A., SHEON, N. M. & RICHARDS, T. A. 2003. Community 
consultation in HIV prevention research: a study of community advisory boards at 6 research 
513-20. 
Journal of Acquired Immune Deficiency Syndromes: JAIDS, 33(4) 
. Author. 2010 Race for improved vaccines in battle against pneumonia. Daily Nation, 11th November 
2010. 
NATIONAL AIDS/STI CONTROL PROGRAMME (NASCOP) September 2009. Kenya. 2007 Aids Indicator 
Survey: Final Report. Nairobi, NASCOP. 
NEWMAN, P. A. 2006. Towards a science of community engagement The Lancet, 367. 
NEWTON, S., CHANTLER, T. D., LINDA, YU, L. M., MCCARTHY, N., MOXON, E. R., MAYON-WHITE, R., 
FITZPATRICK, R. & POLLARD, A. J. 2006. Parental acceptability of the addition of a 
pneumococcal conjugate vaccine in the UK childhood immunisation schedule 
Primary Health Care, 16,34-39. 
NICHTER, M. 1995. Vaccinations in the third world: A consideration of community demand. Social 
Science and Medicine, 41,617-632. 
NUFFIELD COUNCIL ON BIOETHICS 2002. The Ethics of Research Realted to Healthcare in Developing 
Countries. Available at: 
http: //www. nuffieldbioethics. org/fileLibrary/pdf/errhdc fullreport001. pdf accessed on 9th 
December2006, London, Nuffield Council on Bioethics. 
NYIKA, A., CHILENGI, R., ISHENGOMA, D., MTENGA, S., THERA, M. A., SISSOKO, M. S., LUSINGU, J., 
TIONO, A. B., DOUMBO, 0., SIRIMA, S. B., LEMNGE, M. & KILAMA, W. L. 2010. Engaging 
diverse communities participating in clinical trials: case examples from across Africa. Malaria 
Journal, 9. 
OYAYA, C. 0. & RIFKIN, S. B. 2003. Health sector reforms in Kenya: an examination of district level 
planning. Health Policy, 64,113-127. 
PARKER, M. 2007. Ethnography/ethics. Social Science & Medicine, 65,2248-2259. 
PARTICIPANTS IN THE CONFERENCE ON ETHICAL ASPECTS OF RESEARCH IN DEVELOPING COUNTRIES 
2002. Fair Benefits for Research in Developing Countries. Science, 298,2133-2134. 
PASCAL, L. 1991. What Happens When Science Goes Bad. The Corruption of Science and the Origin of 
AIDS: A Study in Spontaneous Generation [Online]. Wollongong. Available: 
http: //www. uow. edu. au/arts/sts/bmartin/d issent/documents/AIDS/Pascal9l. 
html 
[Accessed 24th Novemeber 2008 
]" 
PATTERSON, K. D. 1981. Health in colonial Ghana : disease, medicine, and socio-economic change, 
Waltham, Mass, Crossroads Press. 
PERKINS, B. A., ZUCKER, J. R., OTIENO, J., JAFARI, H. S., PAXTON, L., REDD, S. C., NAHLEN, B. L., 
SCHWARTZ, B., OLOO, A. J., OLANGO, C., GOVE, S. & CAMPBELL, C. C. 1997. Evaluation of an 
algorithm for integrated management of childhood illness in an area of Kenya with 
high 
malaria transmission. Bull World Health Organisation, 75 Suppl 1,33-42. 
PETRYNA, A. 2009. When Experiments Travel: Clinical Trials and the Global Search for Human 
Subjects, Princetown, Princetown University Press. 
PHILLIPS-HOWARD, P. A. 2010. RE: Email correspondence with Tracey Chantler20th 
October 2010: 
Community relations during the large insecticide treated bed net trial in Western 
Kenya from 
1996-99. 
PHILLIPS-HOWARD, P. A., NAHLEN, B. L., ALAII, J. A., TER KUILE, F. 0., GIMNIG, J. E., TERLOUW, D. J., 
KACHUR, S. P., HIGHTOWER, A. W., LAL, A. A., SCHOUTE, E., OLOO, A. J. & HAWLEY, W. A. 
2003. THE EFFICACY OF PERMETHRIN-TREATED BED NETS ON CHILD MORTALITY AND 
MORBIDITY IN WESTERN KENYA I. DEVELOPMENT OF INFRASTRUCTURE AND DESCRIPTION 
OF STUDY SITE. Am J Trop Med Hyg, 68,3-9. 
POOL, R. & GEISSLER, W. 2006. Medical Anthropology, Maidenhead, Open University Press. 
295 
PRINCE, R. J. & GEISSLER, P. W. 2010. 'The Land is Dying' Contingency, Creativity and Conflict in 
Western Kenya, Oxford, New York, Berghahn. 
QUINN, T. C. 2000. Viral load, circumcision and heterosexual transmission. Hopkins H/V Rep, 12,1,5, 
11. 
Author. 19th October 2011. New vaccine fights malaria better, study shows. Daily Nation 
http: //www. notion. coke/News/africa/New+vaccine+fights+malaria+better++study+shows/- 
/1066/1258052/-/item/2/-/frsujr/-/index. html accessed 11th November2011. 
REYNOLDS WHYTE, S., WHYTE, M. A., MEINERT, L. & TWEBAZE, J. Forthcoming. Therapeutic 
Clientship: 
Belonging in Uganda's Mosaic of AIDS Projects. In: BIEHL, J. & PETRYNA, A. (eds. ) When People Come 
First: Anthropology and Social Innovation in Global Health. Durham: Duke University Press. 
RIFKIN, S. B. 1996. Paradigms lost: toward a new understanding of community participation in health 
programmes. Acta Trop, 61,79-92. 
ROBERTSON, A. 1998. Critical reflections on the politics of need: implications for public health. Social 
Science & Medicine, 47,1419-1430. 
ROHDE, J., CHATTERJEE, M. & MORLEY, D. E. 1993. Reaching Health forAll, Oxford, Oxford University 
Press. 
ROSNOW, R. L. 1988. Rumor as Communication: A Contextualist Approach. Journal of 
Communication, 38,12-28. 
ROSNOW, R. L. & FINE, G. A. 1976. Rumor and Gossip: The Psychology of Hearsay, New York, 
Elsevier. 
ROSS, W. D. 2002. The right and the good, Oxford, Clarendon Press SHIPTON, P. 2007. The Nature of Entrustment: Intimacy, Exchange, and the Sacred in Africa, New 
Haven & London, Yale University Press. 
SILVERMAN, D. 2005. Doing Qualitative Research., London, Sage Publications. 
SIMON, C. & MOSAVEL, M. 2010. Community Members as Recruiters of Human Subjects: Ethical 
Considerations. The American Journal of Bioethics, 10,3-11. 
SMITH, D. J. 2003. Patronage, Per Diems and the "Workshop Mentality": The Practice of Family 
Planning Programs in Southeastern Nigeria. World Development, 31,703-715. 
SMITH, M. K. 1997. 'Participant observation and informal education', the encyclopaedia of 
informal 
education. www. infed. org/research/participant observation. htm. 
[Online]. [Accessed 22nd 
March 2012]. 
SPENCER, H. C. 2011. RE: Curriculum Vitae, permission to use an extract from his CV, 10th October 
2011. 
SPENCER, H. C., KASEJE, D. C. 0. & KOECH, D. K. 1983. The Kenya Saradidi Community Malaria 
Project: 1. Response of Plasmodium falciparum isolates to chloroquine 
in 1981 and 1982. 
Transactions of the Royal Society of Tropical Medicine and Hygiene, 77,689-692. 
STEINBROOK, R. 2007. One Step Forward, Two Steps Back - Will There Ever Be an 
AIDS Vaccine? 
New England Journal of Medicine, 357,2653-2655. 
STEWART, A. J. & DEVLIN, P. M. 2006. The history of the smallpox vaccine. Journal of Infection 52, 
329-334. 
Author. 18th October 2011. Study: Vaccine reduces malaria in African children. The Washington Post 
http: //www. washingtontimes. com/news/2011/oct/18/study-vaccine-reduces-malaria-in- 
african-children/? page=all acccessed 11th November 2011. 
STRAUSS, R. P., SENGUPTA, S., QUINN, S. C., GOEPPINGER, J., SPAULDING, C., KEGELES, S. M. & 
MILLETT, G. 2001. The Role of Community Advisory Boards: Involving Communities 
in the 
Informed Consent Process. American Journal of Public Health 91,1938-43. 
STREEFLAND, P., CHOWDHURY, A. M. R. & RAMOS-JIMENEZ, P. 1999. Patterns of vaccination 
acceptance. Social Science and Medicine, 49,17051716. 
TANGWA, G. B. 2004. Between universalism and relativism: a conceptual exploration of problems in 
formulating and applying international biomedical ethical guidelines. 
J Med Ethics, 30,63-7. 
296 
TAVISTOCK GROUP 1999. A Shared Statement of Ethical Principles for Those Who Shape and Give 
Health Care. BMJ: British Medical Journal, 318,249-251. 
TEDLOCK, D. 1983. The Spoken Word and the Work of Interpretation, Philadelphia University of 
Pennsylvania Press. 
TER KUILE, F. 0., TERLOUW, D. J., KARIUKI, S. K., PHILLIPS-HOWARD, P. A., MIREL, L. B., HAWLEY, W. 
A., FRIEDMAN, J. F., SHI, Y. P., KOLCZAK, M. S., LAL, A. A., VULULE, J. M. & NAHLEN, B. L. 
2003. IMPACT OF PERMETHRJN-TREATED BED NETS ON MALARIA, ANEMIA, AND 
GROWTH IN INFANTS IN AN AREA OF INTENSE PERENNIAL MALARIA 
TRANSMISSION IN WESTERN KENYA. Am. J. Trop. Med. Hyg, 68 (Suppl 4), 68-77. 
THE RTSS CLINICAL TRIALS PARTNERSHIP 2011. First Results of Phase 3 Trial of RTS, S/AS01 Malaria 
Vaccine in African Children. New England Journal of Medicine, 10.1056/NEJMoa1102287. 
TINDANA, P. 0., ROZMOVITS, L., BOULANGER, R. F., BANDEWAR, S. V., ABORIGO, R. A., HODGSON, A. 
V., KOLOPACK, P. & LAVERY, J. V. 2011. Aligning community engagement with traditional 
authority structures in global health research: a case study from northern Ghana. Am J Public 
Health, 101,1857-67. 
TINDANA, P. O., SINGH, J. A., TRACY, C. S., UPSHUR, R. E. G., DAAR, A. S., SINGER, P. A., FROHLICH, J. 
& LAVERY, J. V. 2007. Grand Challenges in Global Health: Community Engagement in 
Research in Developing Countries. PLoS Med, 49,1451-1455. 
TURNER, P. A. 1993. I Heard it Through the Grapevine: Rumor in African American Culture, Berkeley, 
University of California Press. 
UNAIDS & AVAC. 2011. Good participatory practice: Guidelines for biomedical HIV prevention trials. 
[Accessed 29th November 2011 
http: //www. una ids. org/en/media/unaids/contentassets/documents/unaidspublication/201 
1/20110629_JC1853 GPP_Guidelines_2011. pdfJ. 
UNICEF 2001. Combatting Antivaccination Rumours: Lesson Learned From Case Studies In East Africa 
Nairobi: UNICEF. 
VARMUS, H. & SATCHER, D. 1997. Ethical Complexities of Conducting Research in Developing 
Countries. New England Journal of Medicine, 337,1003-1005. 
VAUGHN, M. 1991. Curing their ills. Colonial Power and African Illness, Cambridge, Polity Press. 
VAUGHN, M. 1994. "Health and Hegemony: representation of disease and the creation of the 
colonial subject in Nyasaland". In: ENGELS, D. & MARKS, S. (eds. ) Contesting Colonial 
Hegemony: State and Society in Africa and India. London: British Academic Press. 
WAINWRIGHT, S. P., WILLIAMS, C., MICHAEL, M., FARSIDES, B. & CRIBS, A. 2007. Ethical boundary- 
work in the embryonic stem cell laboratory. Sociology of Health & Illnes, 28,732-748. 
WALLERSTEIN, N. 1999. Power between evaluator and community: research relationships within 
New Mexico's healthier communities. Social Science & Medicine, 49,39-53. 
WAMAI, R. G. 2009. The Kenyan Health Care System-Analysis of the situation and enduring 
challenges. JMAJ, 52,134-140. 
WATTS, A. 2011. ThinkExist. com Quotations Online 1 Oct. 2011 (Online). Available: 
http: //en. thinkexist. com/quotes/alan_watts [Accessed 24th November 2011]. 
WEDER, C. & EMANUEL, E. J. 2000. Ethics. Protecting communities in biomedical research. Science, 
289 (5482), 1142-4. 
WHITE, L. 1993. Cars Out of Place: Vampires, Technology, and Labor in East and 
Central Africa. 
Representations, 27-50. 
WHITE, L. 1995. "They Could Make Their Victims Dull": Genders and Genres, Fantasies and Cures in 
Colonial Southern Uganda. The American Historical Review, 100,1379-1402. 
WHITE, L. 1997. The Needle and the State: Immunization and Inoculation 
in Africa.. Immunization 
and the State. Dehli, India. 
WHITE, L. 2000. Speaking with Vampires: Rumor and History in Colonial Africa, 
Berkeley, University 
of California Press. 
297 
WHITE, N. J. 2011. A Vaccine for Malaria. New England Journal of Medicine, 
doi: 10.1056/NEJMe1111777. 
WHO 2009. Rotavirus vaccines: an update. Weekly epidemiological record http: //www. who. int/wer 
accessed 11th November 2011,84,533-540. 
WHO. 2011.5th Global Meeting on Implementing New and Under-utilized Vaccines, 22-24 June 2011 
Workgroup 5. Optimizing immunization schedules: an operational perspective [Online]. 
http: //www. who. int/nuvi/2011_meeting_summary_immunization-schedules/en/. 
[Accessed 11th November 2011]. 
WHO & UNICEF 2005. GIVS Global Immunization Vision and Strategy 2006-2015. Geneva: WHO UNICEF. 
WILSON, M. 1951. Witch Beliefs and Social Structure. American Journal of Sociology, 46. 
WORLD HEALTH ORGANISATION. 1978. Declaration of Alma Ata: International Conference on 
Primary Health Care, Alma-Ata, USSR, 6-12 September 
1978 [Online]. Geneva: WHO. [Accessed 2nd December 2010 2010]. 
WORLD MEDICAL ASSOCIATION. 2008. WMA Declaration of Helsinki-Ethical Principles for Medical 
Research Involving Human Subjects [Online]. WMA 
http: //www. wma. net/en/30publications/10policies/b3/. [Accessed 11th November 2011]. 
ZAKUS, J. D. & LYSACK, C. L. 1998. Revisiting community participation. Health Policy & Planning, 13, 
1-12. 
ZUCKER, J., LACKRITZ, E., RUEBUSH, T., HIGHTOWER, A., ADUNGOSI, J., WERE, J. & CAMPBELL, C. 
1994. Anaemia, blood transfusion practices, HIV and mortality among women of 
reproductive age in western Kenya. Trans R Soc Trop Med Hyg, 2 Mar-Apr 88,173-6. 
ADAZU, K., LINDBLADE, K. A., ROSEN, D. H., ODHIAMBO, F., OFWARE, P., KWATCH, J., VAN EIJK, A. 
M., DECOCK, K. M., AMORNKUL, P. N., KARANJA, D., VULULE, J. M. & SLUTSKER, L. 2005. 
Health and Demographic Surveillance in Rural Western Kenya: A Platform for Evaluating 
Interventions to reduce Morbidity and Mortality from Infectious Diseases. American Journal 
of Tropical Medicine and Hygiene, 73,1151-58. 
ALSOP, Z. 2009. Malaria vaccine researchers face cultural challenges. Lancet, 374,104-105. 
AMORNKUL, P. N., VANDERHOUDT, H., NASOKHO, P., ODHIAMBO, F., MWAENGO, D., HIGHTOWER, 
A., BUVE, C., MISORE, A., VULULE, J., VITOK, C., GLYNN, J., GREENBERG, A., SLUTSKER, L. & 
DE COCK, K. M. 2009. HIV Prevelance and Associated Risk Factors among Individuals Aged 
13-34 Years in Rural Western Kenya. PloS One, 4, e6470. 
ANGELL, M. 1997. The Ethics of Clinical Research in the Third World. New England Journal of 
Medicine, 337,847-849. 
ARMAH, G. E., SOW, S. 0., BREIMAN, R. F., DALLAS, M. J., TAPIA, M. D., FEIKIN, D. R., BINKA, F. N., 
STEELE, A. D., LASERSON, K. F., ANSAH, N. A., LEVINE, M. M., LEWIS, K., COIA, M. L., ATTAH- 
POKU, M., OJWANDO, J., RIVERS, S. B., VICTOR, J. C., NYAMBANE, G., HODGSON, A., 
SCHODEL, F., CIARLET, M. & NEUZIL, K. M. 2010. Efficacy of pentavalent rotavirus vaccine 
against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan 
Africa: a randomised, double-blind, placebo-controlled trial. The Lancet, 376,606-614. 
ARNSTEIN, S. 1969. A ladder of participation Journal of the American Institute of Planners, 
35,216- 
224. 
BANDEWAR, S. V., KIMANI, J. & LAVERY, J. V. 2010. The origins of a research community in the 
Majengo Observational Cohort Study, Nairobi, Kenya. BMC Public Health, 10,630. 
BEAUCHAMP, T. L. & CHILDRESS, J. F. 2009. Principles of Biomedical Research, New York Oxford 
University Press. 
BENATAR, S. R. 1998. Imperialism, research ethics and global health. Journal of 
Medical Ethics, 24, 
221-222. 
BENATAR, S. R. 2001. Commentary: justice and medical research: a global perspective. Bioethics, 15, 
333-40. 
298 
BENATAR, S. R. 2002. Reflections and recommendations on research ethics in developing countries. 
Sac Sci Med, 54,1131-41. 
BENATAR, S. R. & SINGER, P. A. 2000. A new look at international research ethics. British Medical 
Journal, 3221,824-826. 
BENATAR, S. R. & SINGER, P. A. 2010. Responsibilities in international research: a new look revisited. 
Journal of Medical Ethics, 36,194-197. 
BERNARD, H. R. 2011. Research Methods in Anthropology. Qualitative and Quantitative Approaches., 
Lanham, Maryland, AltaMira Press. 
BERRY, S. 1992. Hegemony on a Shoestring: Indirect Rule and Access to Agricultural Land. Africa: 
Journal of the International African Institute, 62,327-355. 
BERWICK, D., DAVIDOFF, F., HIATT, H. & SMITH, R. 2001. Refining and implementing the Tavistock 
principles for everybody in health care. BMJ, 323,616-20. 
BIG ISSUE TEAM 2004. Rarieda guinea pigs insist they were tricked into joining study. East African 
Standard. 
BLAKE, J. B. 1957. Benjamin Waterhouse and the introduction of vaccination; a reappraisal, 
Philadelphia, University of Pensylvania Press. 
BLOLAND, P. B., RUEBUSH, T. K., MCCORMICK, J. B., AYISI, J., BORIGA, D. A., OLOO, A. J., BEACH, R., 
HAWLEY, W., LAL, A., NAHLEN, B., UDHAYAKUMAR, V. & CAMBELL, C. C. 1999. Longitudinal 
Cohort Study of the Epidemiology of Malaria Infections in an area of Intense Malaria 
Transmission I. Description of Study Site, General Methodology, and Study Population. AmJ 
Trop Med Hyg, 60,635-640. 
Author. 18th October 2011. Malaria vaccine trial raises hope. BBC News Website 
http. //www. bbc. co. uk/news/health-15358554 (accessed 18th October2011). 
BROWN, H. 2011. Losing the voluntary spirit? Gender, governance and community in Kenya's 
Community Strategy for health. Unpublished paper presented at workshop 'voluntarism in 
Africa and beyond, University of Cambridge, 17th October 2011. 
BUSE, K. & WALT, G. 2000. Global public-private partnerships: Part I--A new development in health?. 
Bull World Health Organisation 78,549-61. 
CALHOUN, C. (ed. ) 2002. Dictionary of the Social Sciences: Oxford Reference Online: Oxford 
University Press. 
CDC/ATSDR COMMITTTEE ON COMMUNITY ENGAGEMENT. 1997. Principles of Community 
Engagement [Online]. Atlanta: Centers for Disease Control and Prevention. Available: 
http: //www. cdc. gov/phppo/pce/ [Accessed 2nd February 2011]. 
CENTERS FOR DISEASE CONTROL AND PREVENTION. 2011. FY2011 CDC Budget Summary [Online]. 
Atlanta: CDC. Available: 
http: //www. cdc. gov/fmo/topic/Budget%201 nformation/appropriations_budget_fo rm_pdf/C 
DC_FY 2011_Operating_Plan_Summary. pdf [Accessed 6th December 2011]. 
CENTRAL BUREAU OF STATISTICS MINISTRY OF HEALTH KENYA & ORC MACRO 2004. Kenya 
Demographic and Health Survey 2003. Calverton, Maryland: CBS, MoH, ORC Macro. 
CHABAL, P. & DALOZ, J. P. 1999. Africa Works: Disorder as Political Instrument, Bloomington, Indiana 
University Press. 
CHAMBERS, R. 1983. Rural Development: Putting the last first London. 
CHAMBERS, R. 1992. Rural Appraisal: rapid, relaxed and participatory. 105 Discussion Paper311. 
CHANTLER, T., ANGWENYI, V., F, 0., MWACHIRO, D., ONYANGO, P., NJUGUNA, P., HAMEL, M., LANG, 
T., GEISSLER, W. & MOLYNEUX, S. 2010. 'We can't involve everyone': A Comparative Case 
study of Community Engagement Processes at two Malaria Vaccine Trial Sites in Kenya. 
RSTMH Biennial Meeting Liverpool: Royal Society for Tropical Medicine and Hygiene. 
CHANTLER, T., GREEN, S., LEES, A., DIGGLE, L., MAYON WHITE, R., POLLARD, A. J. & FITZPATRICK, R. 
2006. Parental views on the introduction of an infant pneumococcal vaccine. 
Community 
Practitioner, 79,56-59. 
299 
CHANTLER, T., PACE, D., WRIGHT, A., POLLARD, A. J., YU, L. M., NGUYEN-VAN-TAM, J. S. & 
MACDONALD, N. 2007a. Uptake and acceptability of influenza vaccination in day nursery 
children. Community Practitioner, 80,32-36. 
CHANTLER, T. E. A., LEES, A., MOXON, E. R., MANT, D., POLLARD, A. J. & FIZTPATRICK, R. 2007b. The 
Role Familiarity With Science and Medicine Plays in Parents' Decision Making About 
Enrolling a Child in Vaccine Research 
Qualitative Health Research, 17,311. 
CLINICAL AND TRANSLATIONAL SCIENCE AWARDS CONSORTIUM COMMUNITY ENGAGEMENT KEY 
FUNCTION COMMITTEE TASK FORCE. 2011. Principles of Community Engagement [Online). 
Atlanta: Centers for Disease Control and Prevention & the Agency for Toxic Substances and 
Disease Registry. Available: 
http: //www. atsdr. cdc. gov/com m unityengagement/pdf/PCE_Repo rt_508_FI NAL. pdf 
[Accessed 6th December 2011]. 
COHEN, J. 2000. Forensic Epidemiology: Vaccine Theory of AIDS Origins Disputed at Royal Society. 
Science, 289,1850-1851. 
COMAROFF, J. L. & COMAROFF, J. 1999. Introduction. In: COMAROFF, J. L. & COMAROFF, J. (eds. ) 
Civil Society and the Political Imagination in Africa: Critical perspectives. Chicago, London: 
The University of Chicago Press. 
COOK, A. R. 1945. Ugandan Memories (1897-1940), Kampala, Ugandan Society. 
COSTELLO, A. & ZUMLA, A. 2000. Moving to research partnerships in developing countries. British 
Medical Journal, 321,827-829. 
COUNCIL FOR INTERNATIONAL ORGANIZATIONS OF MEDICAL SCIENCES (CIOMS) 2002. International 
Ethical Guidelines for Biomedical Research Involving Human Subjects. Available at: 
http: //www. cioms. ch/frame_guidelines_nov2002. htm (accessed 9th December 2006). 
DAWSON, M. H. 1992. Socioeconomic Change and Disease: Smallpox in Colonial Kenya, 1880-1920. 
In: FEIERMAN, S. & JANZEN, J. (eds. ) The Social Basis for Health and Healing in Africa. 
Berkeley: University of California Press. 
DE CENIVAL, M. 2008. L'6thique de la recherche ou la libert6 d'en sortir. Bulletin de la Societe de 
Pathologie exotique, 2,98-101. 
DEVRIES, R. 1995. Toward a sociology of bioethics. Qualitative Sociology, 18,119-128. 
DIALLO, D. A., DOUMBO, 0. K., PLOWE, C. V., WELLEMS, T. E., EMANUEL, E. J. & HURST, S. A. 2005. 
Community permission for medical research in developing countries. 
Clinical Infectious 
Diseases, 41,255-9. 
DISTRICT OFFICIALS 1939. Central Province District Annual Report Nairobi: Kenya National Archives 
CP4/4/1. 
DIXON, C. W. 1962. Smallpox, London, Churchill. 
DOUMBO, 0. K. 2005. Global voices of science. It takes a village: medical research and ethics 
in Mali. 
Science, 307,679-81. 
DYER, C. 2010. Lancet retracts Wakefield's MMR paper BMJ, 340, c696. 
EDEJER, T. T. T. 1999. North-South research partnerships: The ethics of carrying out research 
in 
developing countries British Medical Journal, 319,438-441. 
EMANUEL, E. J., WENDLER, D., KILLEN, J. & GRADY, C. 2004. What makes clinical research in 
developing countries ethical? The benchmarks of ethical research. Journal of Infectious 
Disease, 189,930-7. 
ENGLISH, M., ESAMAI, F., WASSUNA, A., WERE, F., OGUTU, B., WAMAE, A., SNOW, R. & PESHU, N. 
2004. Delivery of paediatric care at the first-referral level in Kenya 
The Lancet, 364,1622- 
1629. 
FABIAN, J. 1990. Power and Performance. Ethnographic Explorations through 
Proverbial Wisdom and 
Theatre in Shaba, Zaire, Madison University of Wisconsin Press. 
FAIRHEAD, J., LEACH, M. & SMALL, M. 2006a. Public Engagement with Science? Local 
Understandings of a Vaccine Trial in the Gambia. Journal of Biosocial 
Sciences, 38,103-116. 
300 
FAIRHEAD, J., LEACH, M. & SMALL, M. 2006b. Where Techno-science meets Poverty, Medical 
Research and the Economy of Blood in the Gambia, West Africa. Social Science and 
Medicine, 63,11091120. 
FARMER, P. 2005. New Malaise: Medical Ethics and Social Rights in the Global Era. Pathologies of 
Power: health, human rights, and the new war on the poor. University of California. 
FELDMAN-SAVELSBERG, P., NDONKO, F. T. & SCHMIDT-EHRY, B. 2000. Sterilizing Vaccines or the 
Politics of the Womb: Retrospective Study of a Rumor in Cameroon. Medical Anthropology 
Quarterly, 14,159-179. 
FENNER, F., HENDERSON, D. A., ARITA, I., JEZEK, Z. & LADNYI, I. D. 1988a. Early Efforts at Control: 
Variolation, Vaccination, And Isolation And Quaratine. Smallpox and its Eradication. Geneva: 
WHO. 
FENNER, F., HENDERSON, D. A., ARITA, I. & LADNYI, I. D. 1988b. Eastern Africa: Kenya, Uganda, 
United Republic of Tanzania, Rwanda and Burundi. Smallpox and its Eradication. Geneva: 
WHO. 
FERGUSON, J. 2005. Seeing Like an Oil Company: Space, Security, and Global Capital in Neoliberal 
Africa. American Anthropologist, 107,377-382. 
FETTER, B. S. 1969. "The Lualabourg Revolt at Elisabethville". African Historical Studies, 2,273. 
FETTERMAN, D. M. 1998. Ethnography : step by step London Thousand Oaks: Sage. 
FREIRE, P. 1972. Pedagogy of the Oppressed, London Penguin Group. 
GAMBIA GOVERNMENT/MEDICAL RESEARCH COUNCIL JOINT ETHICAL COMMITTEE 1998. Ethical 
issues facing medical research in developing countries. The Lancet, 351,286-287. 
GATES, B. 2011. Prepared Remarks for the Malaria Forum October2011 [Online]. Seattle: Bill and 
Melinda Gates Foundation Available: http: //www. gatesfoundation. org/speeches- 
commentary/Pages/bill-gates-2011-malaria-forum. aspx [Accessed 29th November 2011 
2011]. 
GEISSLER, P. W. 2005. `Kachinja are coming!: Encounters around medical research work in a Kenyan 
village. Africa, 75,173-201. 
GEISSLER, P. W. 2011. Studying Trial Communities: Anthropological and Historical Inquiries into 
Ethos, Politics and Economy of Medical Research in Africa. In: GEISSLER, P. W. & MOLYNEUX, 
C. (eds. ) Evidence, Ethos and Experiment: The Anthropology and History of Medical Research 
in Africa. New York, Oxford: Berghahn Books. 
GEISSLER, P. W., KELLY, A., IMOUKHUEDE, B. & POOL, R. 2008. 'He is now like a brother, I can even 
give him some blood' Relational ethics and material exchanges in a malaria vaccine'trial 
community' in The Gambia. Social Science and Medicine. 
GEISSLER, P. W. & POOL, R. 2006a. Popular concerns about medical research projects in sub-Saharan 
Africa-a critical voice in debates about medical research ethics. Tropical Medicine and 
International Health, 12,975-982. 
GEISSLER, W. & MOLYNEUX, C. (eds. ) 2011. Evidence, Ethos, and Experiment: The Anthropology and 
History of Medical Research in Africa, New York, Oxford: Berghahn Books. 
GEISSLER, W. & POOL, R. 2006b. Popular concerns about medical research projects 
in sub-saharan 
Africa-a critical voice in debates about medical research ethics. Tropical Medicine and 
International Health 11,975-982. 
GIERYN, T. F. 2002. 'Three Truth-Spots'. Journal of the History of the Behavioral Sciences, 38,113- 
132. 
GIERYN, T. F. 2006. City as Truth-Spot: Laboratories and Field-Sites in Urban Studies. Social Studies of 
Science, 36,5-38. 
GIKONYO, C., BEJON, B., MARSH, V. & MOLYNEUX, S. 2008. Taking social relationships seriously: 
Lesson learned from the informed consent practices of a vaccine trial on the Kenyan Coast. 
Social Science and Medicine, 67,708-720. 
GILSON, L. 2003. Trust and health care as a social institution. Social Science & Medicine, 56 
(67), 
1452-1468. 
301 
GLASER, B. G. & STRAUSS, A. L. 1968. The Discovery of Grounded Theory: Strategies for Qualitative 
Research, London, Weidenfield and Nicholson. GRABOYES, M. 2010. FINES, ORDERS, FEAR ... AND CONSENT? 
MEDICAL RESEARCH IN EAST AFRICA, 
C. 1950s. Developing World Bioethics, 10,34-41. 
GREEN, J. & THOROGOOD, N. 2004. Qualitative methods for health research, London, SAGE. GREENHALGH, T. 2010. Why did the Lancet take so long? BMJ, 340: c644 GREENWOOD, B. 1998. Traditional medicine to DNA vaccines: the advance of medical research in 
West Africa. Tropical Medicine and International Health, 3,166-176. GUIJT, I. & SHAH, M. K. 1998. Waking Up to Power, Conflict and Process. In: GUIJT, I. & SHAH, M. K. 
(eds. ) The Myth of Community: Gender issues in participatory development 
Southampton: Intermediate Technology Publications Ltd. 
HANKINS, C. 2006. Creating effective partnerships for HIV prevention trials: report of a UNAIDS 
Consultation, Geneva 20-21 June 2005. AIDS, 20, W1-W11. 
HANTMAN, J. & GOTTEMOELLER, M. 2004. Mobilization: For community involvement in microbicide 
trials. Global Campaign for Microbicides. 
HENKE, C. R. 2000. Making a Place for Science: The Field Trial. Social Studies of Science, 30,483-511. 
HERBERT, E. W. 1975. Smallpox Inoculation in Africa. The Journal of African History, 16,539-559. 
HOLLOWAY, I. & WHEELER, S. 2002. Qualitative research in nursing, Oxford, Blackwell Science. 
HOOPER, E. 1999. The River. A journey back to the source of HIV and AIDS, Little, Brown and 
Company. 
HUBERMAN, M. 1991. Linkage between researchers and practitioners: a qualitative study American 
Educational Research Journal 27,363-393. 
IMPERATO, P. J. 1968. The Practice of Variolation among the Songhai of Mali. Transactions of the 
Royal Society of Trpoica/ Medicine and Hygiene, 62,868-873. 
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR 
REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. 1996a. Guideline for Good Clinical 
Practice E6(R1) [Online]. Available: 
http: //www. ich. o rg/fi leadm in/Pu blic_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R 1/St 
ep4/E6_R1_Guideline. pdf [Accessed 21st September 2011]. 
INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR 
REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE. 1996b. Guideline for Good Clinical 
Practice E6(R1). Available: 
http: //www. ich. org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E6_R1/St 
ep4/E6_R1_Guideline. pdf [Accessed 21st September 2011]. 
JEGEDE, A. S. 2007. What led to the Nigerian Boycott of the Polio Vaccination Campaign? PLOS 
Medicine, 4, e73. 
JENNER, E. 1798. 'An Inquiry into the Causes and Effects of the Variolae Vaccinae; a Disease 
Discovered in some of the Western Counties of England, Particularly Gloucestershire, and 
Known by the Name of The Cow Pox'. 
JOHNSON-HANKS, J. 2006. Uncertain Honour: Modern Motherhood in an African Crisis., Chicago, 
University of Chicago Press. 
KAMADI, G. 2010. Relief as pneumonia vaccine to cost less. Daily Nation 2nd August 2010. 
KASEJE, D. C. 0. & SEMPEBWA, E. K. N. 1989. An integrated rural health project in Saradidi, Kenya. 
Social Science and Medicine, 28,1063-1071. 
KEMRI/CDC 2009. Paediatric Mortality rates on Ward 5, Siaya District Hospital. Personal 
Communication. 
KEMRI/CDC HEALTH AND DEMOGRAPHIC SURVEILLANCE SYSTEM (HDSS) 2008.6th Annual Report 
KEMRI/CDC Health and Demographic Surveillance System Kisumu, Kenya. Kisumu: 
KEMRI/CDC RESEARCH AND PUBLIC HEALTH COLLABORATION. 
KENYA CENTRAL BUREAU OF STATISTICS 2005. Geographic Dimensions of Well-Being in Kenya: Who 
are where are the poor? A constituency level profile. Nairobi: Central Bureau of Statistics. 
302 
KILAMA, W. 2007. Towards an African-driven malaria vaccine development program: history and 
activities of the African Malaria Network Trust (AMANET). The American Journal of Tropical 
Medicine and Hygiene 77,282-8. 
KLEINMAN, A. 1999. Moral Experiences and Ethical Reflection: Can Ethnography Reconcile Them? A 
Quandary for "The New Bioethics". Daedalus, 128,69-97. 
LACKRITZ, E. M., A. W, H., ZUCKER, J. R., RUEBUSH, T. K. N., ONUDI, C. 0., STEKETEE, R. W., WERE, J. 
B., PATRICK, E. & CAMPBELL, C. C. 1997. Longitudinal evaluation of severely anemic children 
in Kenya: the effect of transfusion on mortality and hematologic recovery. AIDS, 12,1487-94. LANDY, D. C. & SHARP, R. R. 2010. Examining the Potential for Exploitation by Local Intermediaries. 
The American Journal of Bioethics, 10,12-13. 
LATOUR, B. 1999. Pandora's Hope: Essays on the Reality of Science Studies, Cambridge, MA, Harvard 
University Press. 
LAVERY, J. V., TINDANA, P. 0., SCOTT, T. W., HARRINGTON, L. C., RAMSEY, J. M., YTUARTE-NUNEZ, C. 
& JAMES, A. A. 2010. Towards a framework for community engagement in global health 
research. Trends in Parasitology Vol. 26 No. 6,26,279-283. 
LEACH, M. & FAIRHEAD, J. 2005. The Cultural and Political Dynamics of Technology Delivery: The 
Case of Infant Vaccination in Africa. Brighton Institute of Development Studies. 
LEACH, M. & FAIRHEAD, J. 2011. Being'with MRC': infant care and the social meanings of cohort 
membership in Gambia's plural therapeutic landscapes. In: GEISSLER, W. & MOLYNEUX, C. 
(eds. ) Evidence, Ethos and Experiment: The Anthropology and History of Medical Research in 
Africa. Berghahn Books. 
LEAKEY, L. S. B. 1977. The Southern Kikuyu before 1903, Ill, New York, Academic Press. 
LONSDALE, J. 1964. A political history of Nyanza, 1883-1945. PhD dissertation, Cambridge University. 
LOUE, S., OKELLO, D. & KAWUMA, M. 1996. Research bioethics in the Ugandan context: a program 
summary. J Law Med Ethics, 24,47-53. 
LSHTM MALARIA CENTRE. 2011. Analysis of RTS, S vaccine trials http: //malaria. Ishtm. ac. uk/news- 
events/news/analysis-rtss-vaccine-trials [Online]. [Accessed 11th November 20111. 
LURIE, P. & WOLFE, S. M. 1997. Unethical Trials of Interventions to Reduce Perinatal Transmission of 
the Human Immunodeficiency Virus in Developing Countries. New England Journal of 
Medicine, 337,853-856. 
MACKLIN, R. 2008. Global justice, human rights and health. in: GREEN, R. M., DONOVAN, A. 
& JAUSS, 
S. A. (eds. ) Global Bioethics. Issues of Conscience for the Twenty-First Century. Oxford 
Clarendon Press. 
MARSH, V., KAMUYA, D., ROWA, Y., GIKONYO, C. & MOLYNEUX, S. 2008. Beginning community 
engagement at a busy biomedical research programme: experiences from the KEMRI 
CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya. Soc Sci Med, 67,721-33. 
MARSHALL, P. & KOENIG, B. A. K. 2001. Ethnographic Methods. In: SUGARMAN, J. & SULMASY, D. P. 
(eds. ) Methods in Medical Methods. Washington D. C.: Georgetown University Press. 
MARSHALL, P. A. 2007. Ethical challenges in study design and informed consent for health research 
in resource-poor settings. Special Topics in Social, Economic and Behavioural 
(SEB) Research 
report series; No. S. Geneva: WHO. 
MESLIN, E. M. 2008. Achieving Global Justice in Health through Global Research Ethics: Suplementing 
Macklin's Top-down proach with one rom the ground up. In: GREEN, R. M., DONOVAN, A. & 
JAUSS, S. A. (eds. ) Global Bioethics. Issues of Conscience for the Twenty-First Century. Oxford: 
Clarendon Press. 
MILSTIEN, J., GRIFFIN, P. D. & LEE, J. W. 1995. Damage to Immunisation Programmes from 
Misinformation on Contraceptive Vaccines. Reproductive Health Matters, 3,24-28. 
MINISTRY OF HEALTH 2003. Kenya Household Health Expenditure and Utilization Survey. Nairobi 
Ministry of Health 
MINISTRY OF HEALTH 2006. "Taking the Kenya essential package for health to the Community: A 
strategy for the delivery of level one services. ". Nairobi: Ministry of Health 
303 
MITCHELL, K., NAKAMANYA, 5., KAMALI, A. & WHITWORTH, J. 2002. Balancing rigour and 
acceptability: the use of HIV incidence to evaluate a community-based randomised trial in 
rural Uganda. Social Science & Medicine, 54. 
MOLYNEUX, C. S., PESHU, N. & MARSH, K. 2004. Understanding of informed consent in a low-income 
setting: three case studies from the Kenyan coast. Social Science & Medicine, 59,2547-2559. MOLYNEUX, C. S., PESHU, N. & MARSH, K. 2005a. Trust and informed consent: insights from 
community members on the Kenyan coast. Social Science & Medicine, 61,1463-1473. MOLYNEUX, C. S., WASSENAAR, D. R., PESHU, N. & MARSH, K. 2005b. 'Even if they ask you to stand 
by a tree all day, you will have to do it (laughter)...! ': Community voices on the notion and 
practice of informed consent for biomedical research in developing countries. Social Science 
& Medicine, 61,443-454. 
MORIN, S. F., MAIORANA, A., KOESTER, K. A., SHEON, N. M. & RICHARDS, T. A. 2003. Community 
consultation in HIV prevention research: a study of community advisory boards at 6 research 
513-20. 
Journal of Acquired Immune Deficiency Syndromes: JAIDS, 33(4) 
. Author. 2010 Race for improved vaccines in battle against pneumonia. Daily Nation, 11th November 
2010. 
NATIONAL AIDS/STI CONTROL PROGRAMME (NASCOP) September 2009. Kenya. 2007 Aids Indicator 
Survey: Final Report. Nairobi, NASCOP. 
NEWMAN, P. A. 2006. Towards a science of community engagement The Lancet, 367. 
NEWTON, S., CHANTLER, T. D., LINDA, YU, L. M., MCCARTHY, N., MOXON, E. R., MAYON-WHITE, R., 
FITZPATRICK, R. & POLLARD, A. J. 2006. Parental acceptability of the addition of a 
pneumococcal conjugate vaccine in the UK childhood immunisation schedule 
Primary Health Care, 16,34-39. 
NICHTER, M. 1995. Vaccinations in the third world: A consideration of community demand. Social 
Science and Medicine, 41,617-632. 
NUFFIELD COUNCIL ON BIOETHICS 2002. The Ethics of Research Related to Healthcare in Developing 
Countries. Available at: 
http: //www. nuffi'eldbioethics. org/fileLibrary/pdf/errhdcJulreport001. pdf accessed on 9th 
December 2006, London, Nuffield Council on Bioethics. 
NYIKA, A., CHILENGI, R., ISHENGOMA, D., MTENGA, S., THERA, M. A., SISSOKO, M. S., LUSINGU, J., 
TIONO, A. B., DOUMBO, 0., SIRIMA, S. B., LEMNGE, M. & KILAMA, W. L. 2010. Engaging 
diverse communities participating in clinical trials: case examples from across Africa. Malaria 
Journal, 9. 
OYAYA, C. 0. & RIFKIN, S. B. 2003. Health sector reforms in Kenya: an examination of district level 
planning. Health Policy, 64,113-127. 
PARKER, M. 2007. Ethnography/ethics. Social Science & Medicine, 65,2248-2259. 
PARTICIPANTS IN THE CONFERENCE ON ETHICAL ASPECTS OF RESEARCH IN DEVELOPING COUNTRIES 
2002. Fair Benefits for Research in Developing Countries. Science, 298,2133-2134. 
PASCAL, L. 1991. What Happens When Science Goes Bad. The Corruption of Science and the Origin of 
AIDS: A Study in Spontaneous Generation [Online]. Wollongong. Available: 
http: //www. uow. edu. au/arts/sts/bma rtin/dissent/documents/AIDS/Pascal9l. html 
[Accessed 24th November 2008 
I. 
PATTERSON, K. D. 1981. Health in colonial Ghana : disease, medicine, and socio-economic change, 
Waltham, Mass, Crossroads Press. 
PERKINS, B. A., ZUCKER, J. R., OTIENO, J., JAFARI, H. S., PAXTON, L., REDD, S. C., NAHLEN, B. L., 
SCHWARTZ, B., OLOO, A. J., OLANGO, C., GOVE, S. & CAMPBELL, C. C. 1997. Evaluation of an 
algorithm for integrated management of childhood illness in an area of Kenya with high 
malaria transmission. Bull World Health Organisation, 75 Suppl 1,33-42. 
304 
PETRYNA, A. 2009. When Experiments Travel: Clinical Trials and the Global Search for Human 
Subjects, Princetown, Princetown University Press. 
PHILLIPS-HOWARD, P. A. 2010. RE: Email correspondence with Tracey Chantler 20th October 2010: 
Community relations during the large insecticide treated bed net trial in Western Kenya from 
1996-99. 
PHILLIPS-HOWARD, P. A., NAHLEN, B. L., ALAII, J. A., TER KUILE, F. 0., GIMNIG, J. E., TERLOUW, D. J., 
KACHUR, S. P., HIGHTOWER, A. W., LAL, A. A., SCHOUTE, E., OLOO, A. J. & HAWLEY, W. A. 
2003. THE EFFICACY OF PERMETHRIN-TREATED BED NETS ON CHILD MORTALITY AND 
MORBIDITY IN WESTERN KENYA 1. DEVELOPMENT OF INFRASTRUCTURE AND DESCRIPTION 
OF STUDY SITE. Am J Trop Med Hyg, 68,3-9. 
POOL, R. & GEISSLER, W. 2006. Medical Anthropology, Maidenhead, Open University Press. 
PRINCE, R. J. & GEISSLER, P. W. 2010. 'The Land is Dying' Contingency, Creativity and Conflict in 
Western Kenya, Oxford, New York, Berghahn. 
QUINN, T. C. 2000. Viral load, circumcision and heterosexual transmission. Hopkins HIV Rep, 12,1,5, 
11. 
Author. 19th October 2011. New vaccine fights malaria better, study shows. Daily Nation 
h ttp: //www. nation. co. ke/News/africa/New+voccine+fights+molaria+be tter++s tu dy+sh o ws/- 
/1066/1258052//item/2//frsujr/-/index. html accessed 11th November2011. 
REYNOLDS WHYTE, S., WHYTE, M. A., MEINERT, L. & TWEBAZE, J. Forthcoming. Therapeutic 
Clientship: 
Belonging in Uganda's Mosaic of AIDS Projects. In: BIEHL, J. & PETRYNA, A. (eds. 
) When People Come 
First: Anthropology and Social Innovation in Global Health. Durham: Duke University Press. 
RIFKIN, S. B. 1996. Paradigms lost: toward a new understanding of community participation in health 
programmes. Acta Trop, 61,79-92. 
ROBERTSON, A. 1998. Critical reflections on the politics of need: implications 
for public health. Social 
Science & Medicine, 47,1419-1430. 
ROHDE, J., CHATTERJEE, M. & MORLEY, D. E. 1993. Reaching Health for All, Oxford, Oxford University 
Press. 
ROSNOW, R. L. 1988. Rumor as Communication: A Contextualist Approach. Journal of 
Communication, 38,12-28. 
ROSNOW, R. L. & FINE, G. A. 1976. Rumor and Gossip: The Psychology of Hearsay, New 
York, 
Elsevier. 
ROSS, W. D. 2002. The right and the good, Oxford, Clarendon Press 
SHIPTON, P. 2007. The Nature of Entrustment: Intimacy, Exchange, and the 
Sacred in Africa, New 
Haven & London, Yale University Press. 
SILVERMAN, D. 2005. Doing Qualitative Research., London, Sage Publications. 
SIMON, C. & MOSAVEL, M. 2010. Community Members as Recruiters of Human Subjects: Ethical 
Considerations. The American Journal of Bioethics, 10,3-11. 
SMITH, D. J. 2003. Patronage, Per Diems and the "Workshop Mentality": The Practice of 
Family 
Planning Programs in Southeastern Nigeria. World Development, 31,703-715. 
SMITH, M. K. 1997. 'Participant observation and informal education', the encyclopaedia of informal 
education. www. infed. org/research/participant observation. 
htm. [Online]. [Accessed 22nd 
March 2012]. 
SPENCER, H. C. 2011. RE: Curriculum Vitae, permission to use an extract from his CV, 10th October 
2011. 
SPENCER, H. C., KASEJE, D. C. 0. & KOECH, D. K. 1983. The Kenya Saradidi Community Malaria 
Project: 1. Response of Plasmodium falciparum isolates to chloroquine 
in 1981 and 1982. 
Transactions of the Royal Society of Tropical Medicine and 
Hygiene, 77,689-692. 
STEINBROOK, R. 2007. One Step Forward, Two Steps Back - Will There Ever Be an AIDS Vaccine? 
New England Journal of Medicine, 357,2653-2655. 
305 
STEWART, A. J. & DEVLIN, P. M. 2006. The history of the smallpox vaccine. Journal of Infection 52, 
329-334. 
Author. 18th October 2011. Study: Vaccine reduces malaria in African children. The Washington Post 
http: //www. washingtontimes. com/news/2011/oct/18/study-vaccine-reduces-malaria-in- 
african-children/? page=all accessed 11th November2011. STRAUSS, R. P., SENGUPTA, S., QUINN, S. C., GOEPPINGER, J., SPAULDING, C., KEGELES, S. M. & 
MILLETT, G. 2001. The Role of Community Advisory Boards: Involving Communities in the 
Informed Consent Process. American Journal of Public Health 91,1938-43. STREEFLAND, P., CHOWDHURY, A. M. R. & RAMOS-JIMENEZ, P. 1999. Patterns of vaccination 
acceptance. Social Science and Medicine, 49,17051716. TANGWA, G. B. 2004. Between universalism and relativism: a conceptual exploration of problems in 
formulating and applying international biomedical ethical guidelines. J Med Ethics, 30,63-7. 
TAVISTOCK GROUP 1999. A Shared Statement of Ethical Principles for Those Who Shape and Give 
Health Care. BMJ: British Medical Journal, 318,249-251. TEDLOCK, D. 1983. The Spoken Word and the Work of Interpretation, Philadelphia University of 
Pennsylvania Press. 
TER KUILE, F. 0., TERLOUW, D. J., KARIUKI, S. K., PHILLIPS-HOWARD, P. A., MIREL, L. B., HAWLEY, W. 
A., FRIEDMAN, J. F., SHI, Y. P., KOLCZAK, M. S., LAL, A. A., VULULE, J. M. & NAHLEN, B. L. 
2003. IMPACT OF PERMETHRIN-TREATED BED NETS ON MALARIA, ANEMIA, AND 
GROWTH IN INFANTS IN AN AREA OF INTENSE PERENNIAL MALARIA 
TRANSMISSION IN WESTERN KENYA. Am. J. Trop. Med. Hyg, 68 (Suppl 4), 68-77. 
THE RISS CLINICAL TRIALS PARTNERSHIP 2011. First Results of Phase 3 Trial of RTS, S/AS01 Malaria 
Vaccine in African Children. New England Journal of Medicine, 10.1056/NEJMoa1102287. 
TINDANA, P. 0., ROZMOVITS, L., BOULANGER, R. F., BANDEWAR, S. V., ABORIGO, R. A., HODGSON, A. 
V., KOLOPACK, P. & LAVERY, J. V. 2011. Aligning community engagement with traditional 
authority structures in global health research: a case study from northern 
Ghana. Am J Public 
Health, 101,1857-67. 
TINDANA, P. 0., SINGH, J. A., TRACY, C. S., UPSHUR, R. E. G., DAAR, A. S., SINGER, P. A., FROHiLICH, J. 
& LAVERY, J. V. 2007. Grand Challenges in Global Health: Community Engagement in 
Research in Developing Countries. PLoS Med, 49,1451-1455. 
TURNER, P. A. 1993.1 Heard it Through the Grapevine: Rumor in African-American Culture, Berkeley, 
University of California Press. 
UNAIDS & AVAC. 2011. Good participatory practice: Guidelines for biomedical HIV prevention trials. 
[Accessed 29th November 2011 
http: //www. unaids. org/en/media/unaids/contentassets/documents/unaidspublication/201 
1/20110629_JC1853_G PP_G u ide li nes_2011. pdf). 
UNICEF 2001. Combatting Antivaccination Rumours: Lesson Learned From Case Studies In East Africa 
Nairobi: UNICEF. 
VARMUS, H. & SATCHER, D. 1997. Ethical Complexities of Conducting Research in Developing 
Countries. New England Journal of Medicine, 337,1003-1005. 
VAUGHN, M. 1991. Curing their ills. Colonial Power and African Illness, Cambridge, Polity Press. 
VAUGHN, M. 1994. "Health and Hegemony: representation of disease and the creation of the 
colonial subject in Nyasaland". In: ENGELS, D. & MARKS, S. (eds. ) Contesting Colonial 
Hegemony: State and Society in Africa and India. London: British Academic Press. 
WAINWRIGHT, S. P., WILLIAMS, C., MICHAEL, M., FARSIDES, B. & CRIBB, A. 2007. Ethical boundary- 
work in the embryonic stem cell laboratory. Sociology of 
Health & Illness, 28,732-748. 
WALLERSTEIN, N. 1999. Power between evaluator and community: research relationships within 
New Mexico's healthier communities. Social Science & Medicine, 49,39-53. 
WAMAI, R. G. 2009. The Kenyan Health Care System-Analysis of the situation and enduring 
challenges. JMAJ, 52,134-140. 
306 
WATTS, A. 2011. ThinkExist. com Quotations Online 1 Oct. 2011 [Online]. Available: 
http: //en. thinkexist. com/quotes/alan_watts [Accessed 24th November 2011]. 
WEIJER, C. & EMANUEL, E. J. 2000. Ethics. Protecting communities in biomedical research. Science, 
289 (5482), 1142-4. 
WHITE, L. 1993. Cars Out of Place: Vampires, Technology, and Labor in East and Central Africa. 
Representations, 27-50. 
WHITE, L. 1995. "They Could Make Their Victims Dull": Genders and Genres, Fantasies and Cures in 
Colonial Southern Uganda. The American Historical Review, 100,1379-1402. 
WHITE, L. 1997. The Needle and the State: Immunization and Inoculation in Africa.. Immunization 
and the State. Dehli, India. 
WHITE, L. 2000. Speaking with Vampires: Rumor and History in Colonial Africa, Berkeley, University 
of California Press. 
WHITE, N. J. 2011. A Vaccine for Malaria. New Eng/and Journal of Medicine, 
doi: 10.1056/NEJMe1111777. 
WHO 2009. Rotavirus vaccines: an update. Weekly epidemiological record http: //www. who. int/wer 
accessed 11th November 2011,84,533-540. 
WHO. 2011,5th Global Meeting on Implementing New and Under-utilized Vaccines, 22-24 June 
2011Workgroup 5. Optimizing immunization schedules: an operational perspective [Online]. 
http: //www. who. int/nuvi/2011 meeting_summary_immunization-schedules/en/. 
[Accessed 11th November 2011]. 
WHO & UNICEF 2005. GIVS Global Immunization Vision and Strategy 2006-2015. Geneva: WHO 
UNICEF. 
WILSON, M. 1951. Witch Beliefs and Social Structure. American Journal of Sociology, 
46. 
WORLD HEALTH ORGANISATION. 1978. Declaration of Alma Ata: International Conference on 
Primary Health Care, Alma-Ata, USSR, 6-12 September 
1978 [Online). Geneva: WH). [Accessed 2nd December 2010 2010). 
WORLD MEDICAL ASSOCIATION. 2008. WMA Declaration of Helsinki-Ethical Principles for Medical 
Research Involving Human Subjects [Online]. WMA 
http: //www. wma. net/en/30publications/10policies/b3/. [Accessed 11th 
November 2011]. 
ZAKUS, J. D. & LYSACK, C. L. 1998. Revisiting community participation. Health Policy 
& Planning, 13, 
1-12. 
ZUCKER, J., LACKRITZ, E., RUEBUSH, T., HIGHTOWER, A., ADUNGOSI, J., WERE, J. & CAMPBELL, C. 
1994. Anaemia, blood transfusion practices, HIV and mortality among women of 
reproductive age in western Kenya. Trans R Soc Trop Med Hyg, 2 Mar-Apr 
88,173-6. 
307 
Appendices 
Appendix I: Research Background & Methods 
Appendix II: Research Findings 
308 
Appendix I: Research Background & Methods 
List of Documents 
10. Centers for Disease Control: Principles of Community Engagement 
11. Study Participant Details 
12. Field Notes Excerpt, February 2007 
13. AIDS vaccine conference in South Africa in October 2008, Poster 
14. Chronology of Community Engagement in the Vaccine Trials 
15. Comparative Observation Tools 
16. RSTMH Biennial Meeting September 2012, Abstract of an Oral Presentation: 
'We can't involve everyone': A Comparative Case study of Community 
Engagement Processes at two Malaria Vaccine Trial Sites in Kenya 
309 
Appendix I, Document 1: 
PRINCIPLES OF COMMUNITY ENGAGEMENT 
CDC/ATSDR Committee on Community Engagement 
Centers of Disease Control and Prevention 
Public Health Practice Program Office 
Atlanta, GA., 1997 
http: //www. cdc. *oý, v/plil2po%e/part3. litm 
Before Starting a Community Engagement Effort 
I I. Be clear about the purposes or goals of the engagement effort, and the populations and/or 
communities you want to engage. 
2. Become knowledgeable about the community in terms of its economic conditions, political 
structures, norms and values, demographic trends, history, and experience with engagement efforts. 
Learn about the community's perceptions of those initiating the engagement activities. 
For Engagement to Occur, It Is Necessary to ... 
3. Go into the community, establish relationships, build trust, work with the formal and informal 
leadership, and seek commitment from community organizations and leaders to create processes for 
mobilizing the community. 
4. Remember and accept that community self-determination is the responsibility and right of all 
people who comprise a community. No external entity should assume it can bestow to a community 
the power to act in its own self-interest. 
For Engagement to Succeed ... 
5. Partnering with the community is necessary to create change and improve health. 
6. All aspects of community engagement must recognize and respect community diversity. Awareness 
of the various cultures of a community and other factors of diversity must be paramount in designing 
and implementing community engagement approaches. 
7. Community engagement can only be sustained by identifying and mobilizing community assets, 
and by developing capacities and resources for community health decisions and action. 
8. An engaging organization or individual change agent must be prepared to release control of actions 
or interventions to the community, and be flexible enough to meet the changing needs of the 
community. 
9. Community collaboration requires long-term commitment by the engaging organization and 
its 
partners. 
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Appendix I, Document 3: 
Field Notes Excerpt 
Reflections on a Community Engagement Event which took place during my 
scoping visit to KEMRI/CDC in February 2007 
During my scoping visit to KEMRI/CDC I was invited to attend a community meeting during 
which community members would be nominated to become CAB members for an infant 
Rotavirus vaccine trial (RVT) within a couple of months. The rural area where the RVT was 
going to take place question had not previously hosted KEMRI/CDC projects although the 
research institution is well known throughout the wider district. Prior to this meeting 
project leaders including the American trial manager, who will be referred to as John, the 
American field coordinator, Emma, and the Kenyan Community liaison officer, Sam, had met 
with the chief and sub chiefs of the locality to outline the purpose of the trial and the 
reasons for setting up a CAB. Accordingly the chief had mobilised community members to 
congregate in the place where he usually holds weekly 'barazzas'. A 'barazza' is the vehicle 
for discussion of community concerns, solving disputes between neighbours and 
communicating administrative and political measures and regulations. John, Emma and 
Sam had planned how the process of nomination would be organised and had scripted the 
message that they would communicate in advance. Emma would lead and Sam would 
translate each section of the message in turn. 
When we arrived at the chief's baraza in the CDC vehicle a large group of people had already 
congregated and were sitting in a circle around the tree listening to other community 
notices. We were welcomed by the chief, who was dressed in his full uniform which 
resembles a soldier's outfit. We exchanged introductions in his office before we were led to 
the 'barazza' and seated in prime positions. 
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Community Meeting Setting 
Women & 
Children 
on grass 
The meeting was in full swing on our arrival but some people were still gathering. The above 
diagram provides some insights into gender dynamics and social order. Women especially 
those with children sat on their lessos or kangas on the grass, some older women sat 
amongst the older men on chairs and benches. Not many younger men were present at this 
meeting, and those who came tended to stand in the background where their bicycles were 
parked. On our arrival a lady representing a non-governmental organisation was telling the 
gathering about a project to support families of children with learning disabilities who were 
looking for community mentors for affected families. Emma looked at her watch as she 
waited for their turn to speak. We sat behind tables with a sound system at one end. Before 
the meeting was handed over to Emma and Sam the young people presented a sketch about 
HIV/AIDS. The story line was familiar and the most striking aspect was the crowd's 
enjoyment of the male lead performer's enactment of a young girl. 
Then attention turned to Emma, Sam, John and I who were introduced by the Chief as 
representatives of CDC. Emma, who is an outgoing, highly intelligent young woman in her 
mid twenties, greeted the gathering in Dholuo which was highly appreciated by the crowd 
(Emma previously worked as a Peace Corps Volunteer in nearby community for 2 years). 
This broke the ice and the ambience was positive even when Emma reverted to English to 
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communicate the scripted information. Amongst the crowd the prominent mother tongue 
would have been Dholuo with mixed levels of ability in spoken, oral, and aural English. 
Emma read separate portions of the text which Sam, a middle aged Kenyan of Luo origin, 
translated in to Dholuo in turn. In the middle of the message it became apparent to Emma 
that Sam had gone ahead of her and started to relate part of the next section before she 
had said it in English. This resulting tension would not have been visible to those listening in 
the crowd. Emma picked up and continued in the agreed sequence of the message, so one 
aspect would have been repeated, but this probably will have gone unnoticed by most. At 
the end of the message the chief helped Emma and Sam to explain the process of 
nomination for the CAB. People were separated into various groupings i. e. women's groups 
or churches and to decide on who to nominate from amongst these groups. This 
deliberation lasted about 20 minutes. Nominees names were then read out to the larger 
gathering who applauded them, and then the nominees gave their details to Emma and 
Sam. Overall the process appeared to go smoothly however I was left wondering whether 
the nominees were aware that they still had to go through a separate selection, interview 
process. 
After this the meeting continues with other information being related by other guests or 
community members. We were led back to the Chief's hut where we were offered cold soft 
drinks and a meal of rice, ugali, chicken and beef stew. The Chief joined us and we 
conversed politely both about the event, future activities, the vaccine trial and community 
benefits i. e. the refurbishment and extension of the local clinic. I asked the Chief about the 
concept of harambee (community fundraising) and was told that both the chief's offices and 
the local clinic had been funded by means of harambee. After lunch we left. On the way 
back to Kisian, where all 3 have desks, then we visited other chiefs to make arrangements 
for other similar meetings. Leadership in these contacts was shared mainly between Sam 
and John and it was evident at times that Sam had had previous contact. 
Back at Kisian, I unwittingly entered into a conversation between John and Emma about the 
fact that they, particularly Emma, were upset about Sam's translation. When 
I sought more 
understanding I was told it was not just about usurping the pre-defined 
format but it was 
also a gender issue. The Rotavirus study needed mothers collaboration so the 
lead should 
be taken by a woman and not a man. 
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Appendix I, Document 5: 
Chronology of Community Engagement in the Vaccine Trials 
This table shows all the CE events associated with the RVT and the MVT. Please note 
that my ethnographic fieldwork on these trials was conducted in stages (as outlined in 
chapter 1) with the most intensive part starting in October 2008 (when I received 
Ethics approval from the KEMRI Ethics Review Committee) and ending in December 
2009. The events I observed and experienced in person before that date I have shaded 
in blue. Please note I was living and involved in projects at the KEMRI/CDC research 
collaboration from June 2007. 
Time Malaria Vaccine Trial 
Community Preparations: 
" Project Manager and Field Coordinator (FC) 
consult gatekeepers initial planning 
& discussions with 
" Educational seminar for chiefs sponsors 
" Team member delegated responsibility for y 
community liaison for vaccine trials (CLVT) 
" Local field workers (FWs) appointed 
M 
" Selection of CAB members by trial team 
p 
" Training for CAB members 
1 
" Meetings with village reporters (VRs) 
" VRs & FWs inform households with 
pregnant mothers/newborns about the RVT 
July 6th: First Participants enrolled 
" Recruitment efforts increased; household Protocol & site 
development starts 
visits, talks at barazas, clinics, churches 
" This time period was described by staff as 
one of 'intense rumour and .... 
misunderstanding' 
Main foci of concerns; blood, potential 
harms and hidden agendas 
O 
" Follow up of specific concerns at household O 
level by FWs, CLVT & FC 
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ýý; 
-ý' 
January-April: Post-election Violence 
Protocol & Site development 
Specific focus on preparations for the 
hospital based Pre-Mal study which will 
test clinical procedures, diagnostics, and " KEMRI/CDC organises emergency medical equipment to be used in the MVT camps in all areas where they work 
February: Recruitment Completed 
" Meetings with hospital staff 
"A total of 1008 participants enrolled=1 st September: Pre-MVT Study starts 
group of participants ty " Recruitment and CE activities mainly " Community members informed by VRs, FWs, limited to hospital environment; CAB Members and at barazas specifically the paediatric ward 
" Frequency of CAB meetings reduced to 
p 
quarterly (global budgetary decision at co 
KEMRI/CDC) 
August: Second round of recruitment 
" Trial asked to recruit 300 more 
participants=2nd group of participants 
" Additional recruitment activities organised; 
barazas, household visits by VRs and FWs 
Nov: Study Coordinator visits the CAB 
October: Recruitment completed o " To talk about Pre-Mal & plans for MVT 
" 1308 participants now enrolled in RVT 
19th November: 15' Annual KEMRI/CDC O 
Results Dissemination Meeting 
M 
" To present and discuss findings with 
N 
community, civic and medical partners O 
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Feb/March: 
January 
Feedback meetings-1sI group of participants " CLVT visits chiefs & schedules dates to 
" To thank participants & provide information `-' speak about MVT at barazas about the end of the RVT " Study Coordinator gives overview of 
" To inform them about upcoming trials = MVT at District Health Stakeholders 
" Participants expressed concerns about Meeting continuity of care and receiving results: 'Can We get freegate ass int t i l? ' 
January- June 
p o nex tr a 
" Regular barazas at chiefs' camps 
12th Feb: Community Stakeholder Meeting 
CD 
N 
-Questions focus on practical concerns & 
why trials can't benefit more people With Sponsors & Principal Investigators (referred to as Pla b 
0 
O " Talks at churches, clinics, other groups ce o Meeting) " VRs given info at their weekly meets 
" Aim: Provide updates on the RVT, share 
" Presentation at Head Teachers forum 
experience from other African trial sites; February: 
explain technical terms; and create a 1. CAB Hospital & Field Trial Sites Visit 
platform for questions and related Focus on MVT preparations & TB field discussion. 
work 
2. Special CAB training Meeting 
Research ethics training & updates on trials 
May: 
Training for MVT trial staff 
" PI states consent form developed with 
consideration of local context 
(personal note: CAB was not involved) 
Groundbreaking at District Hospital 
" Formal event involving hospital, 
KEMRI/CDC and district leaders. 
Celebrating the start of building work 
to create a new centre. This centre will 
provide more space for research 
facilities, improved space for HIV 
Patient support services and seminar 
facilities for hospital and research 
staff 
June: 
Trial Information Leaflets piloted by 
FWs & VRs 
" Concerns raised about wording used to 
describe side effects and blood tests 
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September: 
Feedback meetings-2nd group of participants 
" To thank participants & provide information 
about the end of the RVT 
" To inform participants about the MVT 
October-December: Future Plans 
" Results Dissemination Exercise planned and 
scheduled for January-February 2010 
9th July: MVT starts 
" Participants in older age group enrolled 
End of July/August 
M" Five early withdrawals linked to 
concerns about venepuncture; individual 
follow up 
O" VRs feel disengaged; has this led to a 
misrepresentation of MVT in community? 
" Strategic discussions between 
researchers and community liaison staff 
meet with VRs 
Recruitment progresses smoothly 
Rates higher in rural than urban areas 
November/December: Future Plans 
Recruitment of infant age group 
scheduled for beginning of2010 
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APPENDIX I, Document 6 
Observation Tools 
a) Participant Observation Tool: Community Engagement Activities 
Version 6th May 2009 
b) Observation Tool: Malaria Vaccine Trial Consent Processes 
Version 6th May 2009 
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Participant Observation Tool: Community Engagement Activities 
A. General information 
Type of Meeting/Activity: 
Date: Time scheduled to start: 
Comments re start/end times: 
At end: Men Women 
School aged Children 
Any additional activities, i. e. traditional dancers: 
Place: Observers: 
Who called the meeting and why? 
Community leaders/officials in attendance: 
Type of leader No Specify, details where applicable 
a) Chief 
b) Sub chief 
c) Other District Admin Rep 
d) Village elder 
e) Ministry (Health, Agriculture etc) 
f) Health Facility Committee 
g) KEMRI or KEMRI/CDC staff 
h) CAB members 
i) Village reporters 
j) Other participants, NGO's, CBO's 
.. NNrvximate attenaance; 
At start: Men Women 
School aged Children 
Description of group composition; gender, age 
Time started: Time ended: 
ckpjch of seating arrangements 
329 
B. Information given during the meeting 
Information givers, name, position in KEMRI or KEMRI/CDC projects: 
KEMRI and other collaborators: 
KEMRI/CDC: 
Others: 
Information What & how was info shared 
Language Time taken 
i. e. flip chart, read, summarized, were 
brochures distributed, how interactive? 
KEMRI/CDC Projects 
Mal 55; RTS, S Phase 3 
Rotavirus 
Other, Specify 
KEMRI & other 
collaborators Projects 
NGO/CBO Projects 
MoH or Gov 
Administration 
330 
C. Community Reactions 
1. What was the mood of the group (any indication why)? 
a. At the beginning of the meeting, describe briefly: 
b. At the end of the meeting, describe briefly: 
2. Now did people react to information over the course of the meeting; verbally, 
non verbally? Indicate (age/gender/status), who's saying/asking what. 
3. Which information captured people's attention the most, and which was hardest to 
understand? Why and in what way and how do you know? 
4. Which topics if any caused disagreement amongst people attending the meeting and who 
(which groups/individuals) disagreed, and what was this based on? 
D. Informal discussions/observations 
1. Pre meeting: 
a. KEMRI/CDC 
b. Community members attending the meeting 
2. Post meeting 
a. KEMRI/CDC 
b. Community members attending the meeting 
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OBSERVATION TOOL: Malaria Vaccine Trial Consent Processes 
Information for the field worker/staff member administrating consent: 
Designation of person obtaining consent: 
Health Facility: 
Venue of consent process: 
Stage of Participant Flow: 
Someone present with the mother: YES/ NO Who: 
Was parent asked if they would like anyone else to be present during the consent process? 
YES/NO 
Were parents asked which language they would like to use in consent? YES/NO 
What did they say? 
Language used in consent: Kiswahili English Dholuo Kigiriama 
Child ID: 
Age of child at consent: 6-13 weeks 5-17 months 
Parent's locator details: Division Sub-location: 
Time consent started: Time consent ended: __. 
Total: 
Explanation of signature given: YES/NO 
Independent witness present: YES/NO 
Had they already been given the opportunity to read the consent 
form? YES/NO 
Were they given the opportunity to consider the consent form over a 
longer time period? 
YES/NO 
Details: 
If yes, when, where, for how long? 
During consent process was the ICF read in its entirety: 
YES/NO 
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How interactive was the session, i. e. were questions encouraged as ICF read: 
Disturbances during consent process: YES/NO 
If yes, what disturbances: 
Questions raised by parent/guardian or other person during consent process: 
How were these responded to? 
Were minimum requirements of consent form covered, if the form was just summarised? 
WHAT ARE THE BASIC requirements? Find out from Chris, Mary, Kilifi staff. 
Other information gathered informally during the consent process (for example): 
How found out about the study: 
Have they read study material in advance: YES/NO 
If yes, what kind of material: 
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Appendix 1, Document 7: 
RSTMH Biennial Meeting 8t-10th September 2010 
Abstract of an Oral Presentation: 
'We can't involve everyone': A Comparative Case study of Community Engagement 
Processes at two Malaria Vaccine Trial Sites in Kenya 
Purpose of the research 
This case study compares the practice of community engagement (CE) across two malaria 
vaccine trial sites in Kenya. Researchers based at international collaborative research 
centres in Kilifi and Kisumu are investigators in a multi-centre efficacy trial of the RTS, S 
vaccine. Drawing on ethnographic field work from both sites we share and discuss the 
implications of experiences gained while engaging the 'community' before and during the 
RTS, S trial. 
Principal results 
Both sites developed a diverse range of CE activities, which together emphasised 
communication and local representation. A difference between the sites was the 
involvement of a community based advisory board in the Kisumu site and a research 
based 
advisory group in Kilifi. In practice challenges have arisen in both sites concerning; who the 
key communities are, the selection of representatives, cooperation between parties, and 
the remit and understanding of community involvement. 
Major conclusion 
It is argued that a systematic approach to CE can help ensure that communities are not used 
as means to an end in international research. Our experience suggests that transparent 
goals, flexibility and responsiveness to the local context are also essential to 
develop and 
sustain relationships which are the cornerstone of collaborative research. 
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Author: Malaria Vaccine Trials Community Engagement Research Group* 
Members: 
Kenyan Medical Research Institute (KEMRI)-Wellcome Trust Programme, Kilifil 
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Appendix II: Research Findings 
List of Documents 
1. Big Issue Article 
2. KEMRI/CDC Standard Operating Procedure: Community Engagement and Mobilization 
3. KEMRI/CDC Standard Operating Procedure No. 11: Village Reporters 
4. Newsletter for the KEMRI/CDC Community: Dound Oganda (Voice of the People) 
S. Appointment Letter for a CAB member 
6. CAB Training Materials 
7. Chiefs' Charter of Service 
17. Malaria Vaccine Trial Power-point Presentation 
18. Memorandum of Understanding Between SDH and KEMRI/CDC 
340 
Appendix II, Document 1: 
Big Issue Article: 
'Rarieda Guinea Pigs insist they were tricked into joining the study' 
341 
y " ýa ý3ýQg oý 
gP 
8; ""6_ ýg Týý: _ Sys ýý .sSZ3 
p 
3ä i 
"sag$ý If [ 11 a31 11 51 
In 
ifi 
"sF 
ii11iW 
sý - 
! ýR 
ýý 
iý { 
ip3 
ýýn 
Iýý 
ý3ý 
Ssd 
ýý: 
ý; a 
" °n 
qo 
d5 
. -§ 
8 
I 
0 
ö 
3 
i 
a 
C 
7 
ä 
0 
( 
0* nq 
mm n 
CL 
ma 
3 
0* 0 
Im   0 
Co 
C 
01 
fD 
of 
U2 
C 
fD 
of 
'a 
H 
y 
0 
0* 
.t 
fD 
Appendix II, Document 2: 
KEMRI/CDC Standard Operating Procedure: Community Engagement and 
Mobilization 
343 
FEffective, 
idtt .; 
'ter'. 
KEMRI/CDC 
1 
im 
Research and Public Health Collaboration 
Standard Operating Procedure i SOP No: 1000-LIA-00; Supersedes: N/A 
Version: 00 
COMMUNITY ENGAGEMENT AND MOBILIZATION Effective Date: 15 OCT 2010 No. of pages: 1 to 6 
Branch Base 
Section j Community Liaison 
- --- -- -- -- Jiame Signature 
Author Ben Okoth 
QA Reviewer Daveline Nyakundi 
I Approval Authority Dr Kayla Laserson 
RIGINAL 
I -. JL 1 2010 
"_ QA DEPT 
SOP # 1000-LIA-001 
Date of signature 
I C'. 
" Cxf avjo 
I dCf74Ia 
Version No 00 version date (15 DCT2010) Supersedes version No. 
N/A 
Page 1 of 5 
Effective date 15 OCT 2010 SOP #: 1000-LIA-001 
PURPOSE/ APPLICABILITY 
1.1 Purpose. This document is available to be used by projects/studies during community entry and exit 
Process 
11 Applicability this procedure applies to all studies within KEMRI/CDC Research and Public Health 
Collaboration 
2" SUMMARY 
21 NA 
3. ABBREVIATIONS AND TERMS: 
3.1 CDC Centers for Disease Control and Prevention 
3.2. KEMRI Kenya Medical Research Institute 
3.3 DO District Officer 
34 DC District Commissioner 
61 35 CAB Community Advisory Board 
3.6 CLO Community Liaison Officer 
37 MOH Medical officer of Health 
38 VR Village Reporter 
4. EQUIPMENT AND MATERIALS: 
4.1 N/A 
5. RESPONSIBILITIES: 
51 It is the responsibility of the CLO to generate community support and acceptance for KEMRI I CDC activities 
and to mobilize the community for informed participation by following this SOP 
52 It is the responsibility of the respective study or project to contact the community liaison office when 
the 
need community mobilization services in good time 
6. PROCEDURES: 
61 Entry into the community requires the establishment of ongoing partnerships with key respected persons 
who represent the needs, concerns and wishes of the targeted community. These stakeholders may 
s,. - 
include: 
6.1 1 Members of the community, 
612 Youth groups. 
6.1.3 Women's' groups. 
6 1.4 Teachers, social workers. 
615. Local community leaders (chiefs, assistant chiefs and councilors). 
6.1 6. The District Officers. the District Commissioner. 
Version No a1 versrar, date (15 OCT2010) 
Supersedes version No. N/A 
Page 2 of 5 
Effective date 15 OCT 2010 SOP #. 1000-LIA-001 
6.1.7 The Distract and Municipal Medical Officers of Health, 
6 1.8 Religious leaders, 
61.9. Farmers. 
6.1 10 Formal and informal work-based groups, 
6.1.11 The local medical community, 
6.1 12. CDCs research staff and research scientists of KEMRI and CDC. 
6.2 Continued dialogue with provincial administration, local community leaders, opinion leaders, and existing 
networks of representatives of key community groups is important to maintain community engagement prior 
to and during the course of the study 
6.3 Establishing a community advisory board (CAB). 
6.3.1. Stakeholders from the community are identified to serve on the CAB using a community-driven 
nomination approach. It involves representatives of community groups or organizations proposing 
individuals to be selected for the CAB. 
6 
. 
3.2 The CAB functions as the pnmary link between the community and the study research team. 
6.3.3. The CAB meets on a regular monthly or as-needed basis to support study recruitment 
6.4 Study recruitment is supported by the CAB through: 
6.4 1. Disseminating information about the study, 
6.4 2 Providing feedback on community acceptance. 
6.4 3 Advising staff on participant recruitment strategy 
6.4 4, Providing an additional safeguard for participants' rights, 
6.4.5. Providing representation at community meetings. 
6.5. Meetings and discussions about the study and how to promote community awareness is organized with key 
categories of community members which may include local community leaders, school heads, youth, 
religious leaders. women's groups and opinion leaders 
6.6 The CLO or designee introduces the prospective Research Community to the study; goes over details that 
may include. 
6.6 1. Goals and objectives of the study to the target community; 
Version No. 00 version date (15 OCT2010) Supersedes version No 
N/A 
Page 3of5 
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6.6 2 Concepts and requirements important to a specific study 
6.6.3. Voluntary participation. 
6.6.4. Importance of follow-up 
6.6.5 Precaution on use of biomedical intervention 
6.6 6 Possible risks and benefits. 
6.6.7 Confidentiality. 
6.7. These meetings occur before. dunng and after recruitment is closed. 
6.8 Meetings provide a forum for ongoing dialogue between KEMRI/CDC and the community regarding study- 
related information, feedback and concerns. Questions and concerns are to be addressed adequately. 
Channels to Use for Community Entry and preparations for KEMRI/ CDC studies 
PROVINCIAL 
ADMINISTRATION MOH and OTHER PARTNERS GENER AL PUBLIC 
District Commissioner . Health Facility Management " Schools " CAB members 
Provincial 
Teams 
. Churches . Touts Commission- 
. DHMT (Monthly Meetings) 
VR's " Political Leaders 
DDO 
. 2istrict Director of Public Health 
Women groups " (Councillors/MPS) 
DDC 
. District Director of Medical 
Services Youth Groups " 
Media 
Chiels 
Provincial Director of Public " Men Groups " 
IECs 
Assistant Chierý Health 
" Other Organized Groups " Chiefs 
Village Elders 
. Provincial Director of Medical 
. Boca Boda riders Market Places 
IECs materials 
Services 
Meetings a!. .: c,. _. - 
" NGO's and CBO's (through NGO 
,, f-, d CB0 forums) 
DOs 
Activities involving all these 
stakeholders culminate to a launch 
Version No. 00 version date (15 OCT2010) Supersedes version 
No.: N/A 
Page 4of5 
Effective date 15 OCT 2010 SOP #: 1000-LIA-001 
7. QUALITY CONTROL: 
7.1 From time to time both the CLO and individual studies/projects evaluate the effectiveness of this process 
both directly and indirectly. 
8. DOCUMENT CONTROL SECTION: 
8.1 Document Control Log 
DATE PRINTED: 15 OCT 2010 NUMBER OF COPIES: 6 
SOP DISTRIBUTION 
HDSS BRANCH GAP BRANCH 
MALARIA BRANCH BASE ADMINISTRATION 
TB BRANCH IEIP BRANCH 
HIVR BRANCH INTRANET 
9. Version history 
Version Control Table 
Status 
ORIGINAL 
Date 
15 OCT 2010 
SOP No Version Pages 
00 5 
10. REFERENCES: 
10.1. NIA 
11 APPENDICES: 
11.1. Forms 
11.1.1. NIA 
11.2. Attachment 
11 21 N/A 
Version No 00 
i 1000-LIA-001 
version date (15 OCT2010) 
Supersedes version No. NIA 
Page 5 of 5 
Appendix II, Document 3: 
KEMRI/CDC Standard Operating Procedure No. 11: Village Reporters 
VILLAGE REPORTERS 
Standard Operating Procedure 11, Version 1 5t November 2011 
DEFINITION 
A Village Reporter (VR) is an individual selected by the community members at village level after 
meeting specified criteria, to support the implementation of KEMRI/CDC projects and studies. This 
individual is the interface between the community and the CDC/KEMRI staff. The VR supports all 
CDC/KEMRI projects in the designated geographic area. The support offered by VR's is an essential 
and valued component to the success of our work. The village reporters are not CDC permanent 
employees. They are engaged by projects on a need basis. 
What are the specified hiring criteria for VR's? 
The VRs are selected by members of a village in a community -driven election process. They should 
meet the following criteria. 
" Be respected members of the community. 
" Able to read and write. 
" Having basic knowledge in public health. 
" Willing and ready to work 
Key duties and Responsibilities 
" Assist in mobilizing the community at all levels through barazas and other community events. 
" Capture data on births and deaths for HDSS. Report this data to vital events supervisor on a 
regular basis. 
" Participate in trainings on new projects. Once trained, the VR's will support the education and 
awareness efforts of the project at the village level. 
" Identify key opinion leaders for KEMRI/CDC who may be interested in serving on the local 
Community Advisory Board (CAB). 
" Assist in identification of village boundaries for HDSS mapping. 
" Provide any required information to the study teams during the community entry stage for 
projects; e. g. identification of compounds, cultural practices etc. 
" Share village schedule with study teams so that knowledge of key cultural, life stage and 
market days are known. 
349 
" Encourage community members to utilize available public health services provided by 
KEMRI/ CDC i. e. HIV/AIDS services. 
" Participate in basic health education training to members of the community. 
" Introduce project staff to the community through visits to barazas, households and 
compounds. 
" Capture community concerns, suggestions and compliments about the KEMRI/CDC and 
report the same to the liaison officer for onward transmission to KEMRI / CDC management. 
  Projects intending to use the VRs should complete the Village Reporter Request Form at 
least one week in advance and forward to the Community Liaison Officer. The CLO will then 
identify the VR and avail the same to the User project. The form is available on the Intranet. 
Please specify the study area (Gem, Asembo or Karemo) the village/villages, the number of 
VR's required, and date and time needed. 
" For the scheduled VRs meetings, e. g. HDSS weekly meetings the VRs will be paid the daily 
rate of Kenyan shillings (Ksh) 350. 
" The VRs will be entitled to Ksh 250 shillings transport allowance to pay for bus fare to collect 
money at the bank. The 250 shillings is transport allowance not transport reimbursement. 
" Project field officers are responsible for completing VR time cards stating clearly the type of 
work conducted by the VR and the hours worked. Ensure that the VR and the Project Officer 
are in agreement on the hours worked. 
" Two separate projects are at liberty to utilize the services of one VR in one day provided the 
hours of usage don't overlap. 
  In the case when a VR is utilized by two projects in one day; e. g. TBOR uses a VR from 
8.00am to 10.00 am and DSS uses the services of the same VR from 1.00pm to 5.00pm, the 
VR will be paid a daily rate of Ksh 350. 
" HDSS Vital Events Supervisors will collect all time cards and submit them to the Community 
Liaison Officer (CLO). and the HDSS Field supervisor, the two will then peruse the forms to 
confirm that the entries are correct. The CLO will then take the forms and forward to finance 
office for processing. All time cards must be submitted to the CLO by the 20`h of every month 
for processing. 
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Appendix II, Document 4: 
Newsletter for the KEMRI/CDC Community: Dound Oganda (Voice of the People) 
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0 ... 9or@ A Newsletter for the KEMRI/CDC Community 
ýý 
ýý iýL 
Top: CDC employee, Daveline Nya- 
kundi shares results with a partici- 
pant; Above: A mother and a child 
who were part of the study. Below: 
Girls show off sanitary pads provided by KEMRI/CDC to them 
0 
Volume 2 Issue I 
\otavirus Vaccine proves to be effective in 
)reventing severe disease within the first 
., ear of 
life 
\ tier over nro years of research and follow- 
; p. hP\IRI/CDC has proven that the 
n ýt, ivIrus vaccine known as RotaTeq I `' can 
cffectivehv prevent severe diarrhea caused by 
Urivirus by 82°° within the first year of life. 
Results of this incredible stud- were 
di'scminated to the participating 
c, m munities in the month of January. 
I undreds of mothers and their children 
,\ ho took part in the study, community 
'. caders and other stakeholders turned up at 
" he dissemination centers of Ng'iva Primary 
>rhool, Ting' \Vang'i, Bar Olengo and at the 
"lava Villa Hotel. 
\ total of 1,308 children were enrolled into 
he study which began in Karemo division, 
ý, mva Distncr. 656 children received the 
iccine and 652 the placebo. Out of these 
! irre were 82O,, fewer vises >f severe 
rotavirus diarrhea in the first year of life for 
those who got the vaccine. 
Rotavirus is a virus that causes severe 
diarrhea among infants and children 
throughout the world leading to between 
6(1(1,01ä0 and 8? O, O00 deaths of children each 
year, especially in Africa. 
KE. NIRI/CDC Field station Director, Dr. 
Karla Laserson who has been leading a team 
from IEyIRI/CDC in the dissemination 
exercise lauded the vaccine trial and the 
subsequent results. 
If all goes well, the vaccine may he in the 
market within the next three years to help 
save the lives of the thousands of children in 
Africa and the entire world. 
Teenage Girls Benefit from KEMRI/CDC Donation 
For many young girls, growing up is a process 
that is loved and embraced. However, for 
most of those girls in Nyanza, especially for 
those from poor families, growing up can be a 
scan- process. One aspect of growing up is a 
girl's menstrual period. Many young girls from 
poor families cannot afford sanitary pads and 
therefore become cent' distressed and some 
have to miss school. 
In a bid to assist young girls in this situation, 
the Kenya Medical Research Institute and 
Centre for Disease Control Research and 
Public Health Collaboration (KI:. NIRI/CD(: ) 
, et aside about lash 360,000 for the purchase 
4 sanitary pads. 
he sanitary pads were meant to assist I OOO 
, ii, i, girls in primary schools who are 
just 
nning their menstrual periods for one year 
educing the Icv-cl of absenrcciým in 
school among these girls. The pads will be 
distributed in Kisumu, Rarieda and Siava 
districts. 
According to the World Bank, if a girl misses 
4 days of school even 4 weeks due to her 
menstrual period, she will miss 10 to 20 
percent of her school days. 
The first batch of the essential item was 
handed over at Ezra Gumbe Pnman" School 
at a ceremony presided over by the Deputy 
Research Station Director Rebecca Lee Pethel 
and Kisian Primary School both in Kisumu. 
146 boxes were donated to the Mission for 
Africa in Marnboleo, Kisumu. 8- hoxes with 
about 1500 pieces were distributed among the 
three KI, ' \IRl /CDC study areas of Karemo, 
. 
lscmbo and Siava. 
Center for Global Health Research 
pe for Pregnant Women as KEMRI/CDC Prepares to Begin Drug Trial 
1'he Head of Epidemiology in the malaria 
ranch. Dr. Peter ( )uma, said preparations 
the \Iet7oyuine (ýI`) study have been A tfiL 
a: it and the study has began. 
Is soon beg mmn it study to 
assess the bereft of \Ietloyuinc (a drug 
against malaria) for prevention among HIN' 
-infected pregnant women, who are 
current]y taking daily seprrin dose. 
c said that the evaluation would be done 
in five African countries including Benin, 
Gabon, Tanzania and Mozambique 
through the Malaria in Pregnancy (MIP) 
onsornum; a five sear program to 
aluate new and improved interventions 
r the prevention and treatment of malaria 
:n pregnancy. KEMRI/CDC is a member 
4 \MIP. Other collaborating partners are 
the Bill and Melinda Gates Foundation 
and the Vienna School of Clinical Research 
(VSCR) in Austria. 
Malaria affects approximately 50 million 
pregnancies every year, most of them in 
Africa. Many pregnant women in Africa are 
infected with I IIV which increases the 
susceptibility to malaria. 
This therefore means that current malaria 
interventions may not work properly. \IQ 
has been endorsed be researchers as one o, 
the most promising drugs to be used by 
1-11V infected women. 
During the study, two trials xvill be done at 
the same time, one in Benin, 
and Gabon which represents countries , vitl 
low I1IV prevalence (I 11V-negative women 
only) and in Kenya, Tanzania and 
Mozambique representing I IIV-positive 
pregnant women and will last for about 30 
months. 
Long-serving Employee Making a difference in Home Area 
ý" 
ieorge ( )lang (4-), the Deputy chi t ,t inc 
, ntomologN" Department is undoubtedly 
ne of the longest serving members of staff 
t KEMIRI/CDC. 19 years ago, he joined 
ie organization as a Field Assistant after 
Irving a year at KEMRI/Walter Reed 
Project through the 
request of the then 
hrad of Fntomologc 
l )i hay Beach. 
\\ co hhe joined 
1-11 \IRI/CDC, the 
i population was 
than 20 people. 
joining 
\I RI/CDC, Olang 
>u idily risen 
ýiigh the ranks to 
urrent position of 
Illt\ Entomology 
ucf. In 1999 he was 
muted to the 
. itio>n ofa Deputy 
position he held till 
'IM I j, \N lien he was promoted to his current 
office. 
In his 19 year stint, ( )lang has been a 
beneficiary of a four month CDC Atlanta- 
funded training in Epidemiology with the 
Uni-mrsin" of Emory in the USA in 2001. 
The training brought together CDC staff 
working on malaria from 20 countries. 
George was born and lives in Korando B 
Sub location - where the Kisian 
KF; MRI 
Centre is located - in Central Kisumu 
location of Kisumu \\est District and is 
married with three boy s. 
He is proud to be part of KEMRI/C1C 
which is making a difference in his own 
community. \\ hat is George's key to 
success% " Hard work, commitment and 
determination and inculcating a culture of 
trust between you and the employer is the 
key to success. " 
Center for Global Health Resr, irr, h 
o ne mine ma yach ka KEMRI/CDC chako nonro mar yath/yien. 
,i 
. 'onro cu i hrr mar vvarh \ ien mar ýIefloyuin (MQ) kaka rageng' mar Malaria kuom mine ma each to ndilo tieptrin to kendo ni kod kute mag avaki osechak kod KENIRI/CDC ka ginuwre gi jo kanvo 
mamoko ei . ifrica. 
l: uclo mar migao mar nono tuoche 
, iidemiologv) e Iambi mar KEMRI/CDC 
rcr Ouma ne owacho ni nonro ihiro tim 
-mje a bich lila Kenya, Benin, Gabon, 
.: izania 
kod Mozambique. Nonro enokau 
:, ni abich c b,, w"o riuruok mar Malaria In 
Pregnancy (AIIP) Consortium. 
KJ MRI/CDC en ja kanvo mar ruiruogni. 
Kaluore kod (pima, nonro ni ne one ni ber 
nikech tuo mar Malaria masani koro mako 
mine chiegni Million äl) ma -ach hip ka 
higa, kendo thothgi wdore ei _kfrica 
la. 
()lern bende ni mang'env kuom mine ma 
each ei Africa ni kod kute mag avaki ma 
bende miyo 'Malaria mako gi mayor akinya. 
Mae osemivo obet rich marek ahinva kaka 
invalo geng' ruo mar Malaria kA itit o kod 
vedhe ma ou-injore nikechvedhe ma indilo 
ne avaki samoro okwinjre kod yedhe mag 
Malaria c co makare. 
Yien mar Metloquin osepwodhi kod jolonc 
kaka oath manvalo two makarc kuom 
geng'o ruo mar Malaria kuom mine man 
kod kute mag avaki. Bende osevudorc ni 
onge hinvruok maw-, uok bang tivo kod MQ 
epinjc Africa, mac mivo en c okang' ma 
malo los ipime kod vedhe mamoko. Bende 
wachore ni ober la mine ma each otiyo 
kode ka gidhi 
)tvodh. 
E. ndalo mag nonro, ibiro teure nvatieng' 
arivo, mokwongo ibiro tim e pinje niag 
Benin kod Gabon kuom mine ina nach to 
onge kute mag avaki. 
\lachielo enotim Kenya, 'I'anzania kod 
Mozambique kuom mine ma each kendo ni 
kod kure mag avaki. Nonro duto biro ka-, vo 
linde mar d\-eche 30. 
Jatich ma Osetiyo Aming'a kelo Lokruok e Gweng'e 
lang kod higni 47. en Jalup jatelo mi igao mar Entomology kendo en achiel 
nom jogo ma osetiyo kuom kinde 
athothie moloyo e riuruok mar KEMRIi 
CDC. Ne ochako 
1990 kakajakony 
weche mag pap 
hang tiyo kuom 
i, -, a achiel e 
umbi mar 
FMRI/Walter 
d ka ne 
a\ c kod Dr. 
beach mane 
" ne 
)mologV 
ogo. 
whako ka 
\IR1 /CDC w 
J jotich marin 
'i) kende. 
. ika ne odonj 
\ xka koro kama 
enne kawuono. 1999 ne othule malo ma 
oViere kaka jalup ogai mar jodi pap. 21N13. 
ne ochak orhule nvaka a use ma sam. 
E hike mar 19 sani, higa mar 2001 ne 
otvdo thuolo mar dhi somo kuom dw"cche 
ang'wen e piny L'S. \ ka ichudo ne kod 
CDC Atlanta to kod Mbalarianv mar 
Emory kama ne osomoc Fpidicmolog. 
Somo no bende ne ov vcne koda jotij 
kidienje mag malaria koa e pinjc 20 
ma CDC niticre. I Liga mar 2(107 ne otimo 
Diploma e weche mag taro project. 
()lang en ja gweng' ma Korando B 
Sublocation, Central Kisumo 1e cation ei 
Kisumu West District. En kod min of 
kendo \v'asavc osegwcdhe kod vawuori 
adek ma sani dito. 
Olang mor kendo opwov, o tijc KEMfRI/ 
CDC egwcng'c kod mier mamoko. Mogik 
to owacho niva, " (finge rich maber kata 
marach. Jatich nvaka ti matek, bed kod 
luoro kcndo chanre maber. " 
(enter for Global Heahh Rewr' 
t "8"["", T" 
1 on kod m-ithindgi mane jokan) o mag 
ýnro ne ochopo kar rommgi kaa achiel 
-d jotelo mag ()panda kod ji mamoko e 
onde mane obagie budho kaka Ng'iv-a 
, mare, Ting' Wang'i, Bar Olengo to kod 
.. 1s{awa mar Siava Villa. 
nonro ni, m-ithindo 656 ne ovudo chanjo 
mar Rotas irus ka mamoko 652 ne ovudo ma 
au ungo ni placebo. Duro ne gin 
m-irhindoll)59. Nonro ne om-iso ni chanjo 
flu otivo maker marom 82'- ei higa 
mo kwongo mar nyathi, riendeni too mar 
diup mar Roravirus ne odok pinn- kuom 82° o 
kuom nvithindo mane ovudo chanjo. 
ýnro ne ochopo kar rommgi kaa achiel 
-d jotelo mag ()panda kod ji mamoko e 
onde mane obagie budho kaka Ng'i). a 
, mare, Ting' Wang'i, Bar Olengo to kod 
. Igawa mar 
Siava Villa. 
Malo. Daveline Nyakundi mar CDC nyiso duoko ne ja kanyo 
mar nonro. Diere: Miyo kod 
ayathine manenie nonro. P/ny Nyiri sungo otamba ma ''EMRI/CDC ochiwo. 
A Newsletter for the KEMRI/CDC Community 
Volume 2 Issue I 
hanjo mar Tuo Diep Osefwenyore ni Geng'o 
uo e Hik Nyathi Mokwongo. 
ip ni mar 2010. migao mar KEMRI/ ý. 
r 1)C mocha osudo mbele e tije mar rimo Tuo diep mar Rota kelo dicp manyalo neko 
nro kod two kam-alda ne ngima mar ne nvithindo ma6-%var hod madito e pim- 
anda, bang' golo ayanga d-, roko mag ngima kendo okelo tho ne nvithindo ma 
: iý mro mar chanjo mar tuo mar Rotavirus. kwandgi ni e kind 6110,000 hod 870,000 higa 
Dwroko ne ogol avanga ne ogendni mane ka higa molovo to e piny Africa. Nonro mar 
utie e nonro. chanjo ne ochaki avanga Siava district higa 
mar 2007. 
)arelo maduong' e Field Station mar 
KEMRI/CDC 
. 
kjuoga Kayla Laserson ma 
bende ne orelo ne jotich mag KEMIRI%CDC 
e gold ayanga duoko mar nonro, nyocha 
mor ahinya kaluore kod nonro kod duoko 
mar nonro owuon. En geno mar ji duto ni 
ka chenro obct kaka onego, to dip o ka 
chanjo mar Rotavirus okeri kaka vor thieth 
karg geng'o tuo ma nego nvithindo ticko ei 
Africa kod pint- ngima. 
Nyiri ma Dito Oyudo Kony koa kuom KEMRI/CDC 
Ne m-ithindo mathoth ma mvi, migepc mag 
dongo gin kinde ma oher kendo ogen ahim a. 
Kata kamano, mang'env kuom m-iri gi ma ae 
amvola mar jochan dongo kod pek ahinva. Ne 
thoth m"iri e kor gwenge ma Kenya, migao 
mar dhi e d-,,., e nvalo bedo mar wich kuot, 
moloto to ka nvako onge kod taulo ma mon 
tiro go ka gidhi c dwc (sanitan- pads). 
\ikech dhier, nciri mang'env oh- m'al m-ieu"o 
, gige kom kendo nikech mich kuot, chuno gi 
mondo kik gidhi e skul maka dc rum. 
Kaka achiel kuom yore mag chiwo konc, 
migao mar KE\IRI/CDC oseketo thenge 
ýiam-ongc maromo 360,000 mar nt-iewo taulo 
nviri matindo ma kola chako dhi e dwe 
, dirom 1000 ma nitie e skunde mag 
Primare 
, chiu" e districts mag Kisumu kod 
Siatva 
biro duoko piny loran mar nyiri ma 
nc skul nikech gidhi e d,, i"e . 
Kaluore kod nonro mar World Bank, ka 
nvako obare tie skul kuom ndalo ang'wen e 
kind jumbe ang'wen nikech odhi e dwe, owito 
kind 10'o gi 2()('o mag kindc mag somo malte 
te. Bcnde osecudorc ni thoth m-iri ma bare ne 
skul nikech dhi e dwc onge kod nyalo mar 
nvlcwo taulo ma gimvalo komxc go. 
Nvin mane okwongo wdo taulo ne omi }Fra 
tumbe kod Kisian Primar, School e nvasi ma 
ratipo ka otehe kod jalup ja raa tije Rebecca 
Pethel. Ofiuko mamoko 146 ne ochiNw ne 
migao mar : Mission for Africa ei Mambolco, 
Kisumu. (>fuko mamoko 87 ne ochiw c 
kwondc nonro mag KFINfRI/CDC mag Siava, 
Karemo kod. isembo. 
Kwonde gi duto, nviri matindc cka shako dhi 
e dwe ne nigi mor mokalo kendo ne odwroko 
erokamano ne ICI{\IRI/CDC. Ne gi mor nv 
koro gin vain somo kaka nvtthindo mamoko 
ma ok giluoro dhi e dwc. 
Center for Global Health Resparr h 
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0 KENYA MEDICAL RESEARCH INSTITUTE 
u 0_': ZZy< V4 ._ , ari wvLu&', kI idn mono n; ne' 
. ec, s r wwh ri . "u 
2"d AUGUST. 2007 
Dear. Ezekiel Onyango 
RE: APPOINTMEN1 AS A KEMRI/CDC COMMUNITY ADVISORY BOARD 
, MEMBER FOR KAREMO DIVISION. 
Following your selection by the community and subsequent interview for the position of 
a Community Advisory Board member (CAB) we are pleased to inform you that you 
have been offered an appointment with KF, MRI/C'DC program, studies in Karemo 
Division. 
This appointment is purely voluntary and carries with it neither a salary nor benefits. 
I understand that the MISSION STATEMENT of the Karemo CAB is 
To foster partnership between KEMRI/CDC research team and the local 
communities participating in KEMR//CDC conducted studies to benefit 
advancement of research and the community. 
And that the CAB FUNCTIONS are: 
" They serve as the ears and voice for the community and study participants. 
" CABs bring specific, unique expertise to the research process, informing 
researchers of local issues or concerns that can affect the conduct and 
successful implementation of the scientific agenda. 
" An active CAB with a committed membership is integral to fostering strong 
relationships between the communhy and the research team. 
" CA Bs can help strengthen local capacity to respond to critical research needs in 
the future. 
" CAB is critical in involving community members at all levels of the research 
process. A community's participation helps build trust and inutual 
understanding of research issues and ensures that values and cultural 
differences among various stakeholders are respected. 
Irr Search of BstNr Hoa/ff? 
\; t !t ýýý t un, lýrstand nlv RF: SPONSIB11JTIES include: 
"l trend /ut"u! (, 4 B mr'r'tinX. ý and provide tee Iback on i. º. cnes under discussion. 
"1 im i, c'once'rns fro in the communities andwisdi, 
" /)ensonw jte roºnnritnºe'nt to developing an understanding on issues where tlsei 
niUV have little e vpertise' and attend º+works! ºops. 
"1 i+t in t/ie development and implementation of conunrtnitj" education 
aclivities (health fairs, rotnºnunirr fornnºs, etc). 
" fe/rise' in the th'vvrlopment und implementation of recruitment and retention 
ýtrate iss. 
" Serve us a resource to e"o, n, nuni(y liaisons officers and research team. 
" ! )is %eminatr' stuft' information tu local community. 
f eertifi' that / have read and understood 
my re. yoncihilities. terms and conditions of this offer which I accepddo not accept. / 
will he available to We the new job hI' KE MR//('DC' Pror; ram with immediate eff ct. 
1 it{nutrerý Date 
', int cluK, 
I)k I <uscrion Kio1a. 
Itirrrh+i, Kt N4R1 ('t)( Rc'carc'h Station. 
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CAB Plan of Action Brainstorming for Friday Meeting at Siaya (23 
March 2007) 
C curse of Events. 
" Tea first (Name tags. (reimbursement, and sign-in sheet) 
" /ntroduction/ Icebreaker (Name tag ice breaker) 
" Erplaii: what CDC'/KEA/R/ is and does 
" Get a brief overview of the project 
" Flipchart---Brainstorm role of CAB... w/ ' are t'ou here? (This is not a training 
but a general introduction and overview) 
o Are i ou going to do research? Are you going to practice medicine? 
o £rplain the role of the CAB 
" Create ground rules 
" Get advice on the wati" forward 
Introduction Meeting (Bura nai ng'eruok) 
Welcome!!!! We really appreciate your coming to this meeting today and your 
willingness to participate on the community advisory board for the Rotavirus project. On 
behalf of the Centers for Disease Control (CDC). Kenya Medical Research Institute 
(KEMRI). and the whole Rotavirus Project team we would like to congratulate you on 
being chosen by your community to serve on this advisory board and we want to 
welcome you to our team. We believe that the community's input is an invaluable part of 
being successful in this area and we acknowledge that without your support and help it 
would be impossible for us to conduct good research in this area and to strive towards 
improving healthcare in the country, which are a few of the main goals of both CDC and 
KEMRI. 
Orwaku, wagovo erokamano kuom biro maru e bura ni kawono kendo yie maru 
mondo utive Community Advisory Board mar nonro mar Rotavirus. Kaka achiel 
kuom jo CDC, KEMMR1, gi ji duo mar nonro mar Rotavirus wamor kovieru gi 
jogweng' mondo utive e advisors hoard kendo waruako u mondo uti kod, sa. 
Ma en mana buch ng'cruok kendo ok en mar puonj. Obiro bedo mar woyo 
omiýo Nabiro ti-*o kaka ngimoro achiel. Wabiro miyo puonj c location ka location 
kuom locations ang engo e ndalo mabiro . Ka un}alo neno, 
jite 
maneonN ier e Communit% Advisory Board ni ka kawono kendo ibiro penju ntondo 
This is just an introductory meeting and nui a training. It will he eery interactive, so 
we will all work as a team. We will be giving trainings at each ofthe four locations in 
the very near future. If you notice, both members of the first and second 
CAB are here today and will be asked to attend the trainings. We will explain each of 
your roles later into today's discussion. 
Create! on 3/22/2(XJ7 11: 27: 00 AM 
ubiye e puonj. Wabiro lero ne ng'atoka ngat'to tije bange e woyo mar wa makaa 
kawono. 
Let us begin! Instead of giving names and introductions, which we would probably 
forget within a few minutes, we are going to play an introduction game to get to know 
and feel comfortable with one another. 
W'acbakuru! Kar mivo nying gi ng'eruok mabe wich nvalo wil go e dakika 
matin wabira Lugo tuk ng'eruok mondo wang'ere kendo wabed gi thuolo. 
Does everyone have a nametag? First, write the name or names that you want the 
board members to call you by and underneath write the location (not sub-location) 
that you are representing. Be sure not to show your neighbor what you are 
writing until the nametag is complete. 
a. Be ji to ningi gima, indiko enyinge? Mokwogo ndik nyingi kata 
nyingengi madiher ni jo board olwongi go, pinyne ndik location 
(maok sub-location) ma inchung'ne. Neni ok itang'one jabathi ngima 
indiko ntaka ji to tiek ndiko. 
2. In the top left hand comer answer this question: If you were an animal, what type 
of animal would you be? Be warned, you will have to explain your answers. 
a. Malo kor ka bat acham nduok penjo ni? De in lee kata jamni, lee 
mane madibedo? Par ni ibiro lero nwa n owoko mari. 
, jc ýq, 
3. In the top right hand corner write your occupation and what group you represent. 
You may write midwife, or nurse. or boda boda, or CBO, etc. 
a. Maio kor ka bat achich ndik tiji gi migao ma ichung'ne. Invalo ndiko 
n)-amrerwa jathieth, ja ngware kata CBO kamano kamano. 
4. In the bottom right hand comer write the person that you admire most. 
a. Pint/ kor ka bats ach ich ndik ng'ama igombo ahinya. 
5. In the bottom left hand corner, write the name of a famous person, alive or dead, 
that you would like to meet. 
a. Piny kor ka bat acham ndik nying ng'ama on"gere kata kongima 
kata kaosetho madier romogo. 
6. Now, you have 5 minutes to mingle and find out as much as you can about the 
other board members and the research team. 
a. Koro, un gi dakika abich mondo uriuru uyud mang'env kaka inyalo 
kuom ja board moro kata jo nonro. 
7. Now, hand in your nametag and we will mix them up. We will call out some of 
the things written on each of the natnetags and you will all try to guess who the 
person is. So, he sure to pay attention and get to know one another! 
Created on 3., 22/2007 11: 27: 00 AM 
a. Koro chiwXgima indike envingi mondo wariungi. Wabiro wacho 
ngik moko maondike e gik ndiko e nying moro ka moro. Kendo ubiro 
temo paro ngatno. Omiyo chik iti mondo wang'ere. 
ý. Collect your nametag as you are called out and put it on! 
a. Kaw giri mane indikoenyingi ka otwongi kendo invake. 
9. 
Why are we here today? Ango ma omiyo wan kaa kawono? 
Over the course of the day we will: Kinde mag odiochieng' wabiro: 
" Get to know members and so that they get to know one another 
o Ng'eyo jo board mondo wa ng'ere V 
" Explain the role of CIX' 
o Lero tij CDC 
" Lay down rules 
o Keto chike 
" Explain what the role of a CAB is 
o Lero tij jo CAB 
Give a very brief overview of the project 
o Miyo lendo machiek kuom nonro 
" Get advice on how to take the next step (meeting with mothers, fathers, teachers, 
etc. ) 
o Yudo pachu kaka wabiro kao okang' machielo (romo gi mine, wuone, 
jopuonj gi jomamoko). 
" Give information on the next meet i ngs/trai ni ngs 
o Nvisou rnang'eny kuom romo machielo/puonj. 
We briefly discussed what the role of CDC is. but we would like to have our CDC-Uield 
S atmw-H+feetor-to talk to us about the Centers for Disease Control. 
Nwalero matin tij CDC. to dwaher ni CDC Field Station Director onviswa 
mang'en}" kuom CDC. 
Before we go into matters concerning the Community Advisory Board it is important for 
you to have a general understanding of the project. We will hand out slides of the 
protocol or plan for the study. You can look over them while at home and come up with 
questions or concerns you may have. We will not go into great detail about the study 
now, but will address all of your questions during the trainings. It is very important that 
everyone understands the protocol and the study, so that is why we will discuss them in 
detail in smaller , maps Turm-, the trainin!. 
Created on 3/22/2007 11: 27: 00 AM 
puuj. Ber kaa ate awinjo nonro kendo maim emomiyo wabiro lerogi e grube 
tll*iindo: do. 
... 
Po -, + erPoint ... What is a Community Advisory Board and what is your role'? You tell us and we'll list 
your suggestions on the flipchart. 
Community-Advisory Board en ang'o, to tijd en ang'o? Nviswauru [o wabiro ndiko 
pachu. 
Keto motegno rinrwok kind jo nonro"gi joingweng' (e Karemo 
Division Ka): 
"... 
ý: -ý: ; 
I: ..,,,. rilti rt. Sr,. lf, 
l-; i:. tilý"rr . 
jr-; ' ii, i": I iný; l 1iß TI\r_ 
iti lilt, ', tucilr 
c Her mar nonro mar Rotavirus och AMtWo-mayr 
jogweng' maoriwore gi nonro 
c CAB ochung' tonro tnar-Rotaorus e 
ngweng'. 
" They serve as the ears and voice for the community and study 
participants. 
o Gitivo kaka -duo1 mar jong%veng gi jomanie nonro. 
" The CAB members will listen to the concerns of the community, 
with regards to CDC and the research project. 
c Jo CAR biro winjo nywak mar jong'weng kaluore gi CDC gi nonrb. 
" They will inform the research team of the concerns. 
o Gibiro nviso jo nonro nywakjo ng weng' 
" The members of the CAB and the research team will work together 
to come up with possible solutions for the problems. 
Jo CAB gi jononro biro tiyoJcaka ngimoro achiel mondo 
kiyud yot 
-mar prk morn amora. 
" n; r c'. p rtisr" to the r:: arch pi-o(v's. Ln1r, rll ui 
o CAB keloieku maling' ling' e dhi mar nonro, o jif 
rtonro pek kata n yalo chando tich ksi ;r -n%r 
r h'n-o mar non- 
4 
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Responsibilities of CAB members (Tinj jo CAB) 
" Attend local CAB meetings and provide feedback on issues under 
discussion. 
o --Biro e buch CAB gi mivo dwoko kuom pek mar jong'weng gi joma 
064mon? o 
" Voice concerns from the communities and study participants. 
elf oyo=ic m jon$-ueng' gijoma me nonro 
ýi 
i iii. 
. 
'. 
.., 
Serve as a resource to community liaison officers and research 
team. 
>-ý f11i7:. -ltC i! I(: \ I! 'IlOT T1: 7n, ii !o 
local cOi11T11UÜi(\'. 
O 
I1 I ip their Own mission statement and operating 
s It is possible that each group of f u-i11 Come up With their 
i. i! ti "tit, i[t'1 f'riý. j.. hi' ii, : Iý-i! ...:: 
ý 
-. 
(`tli-'I' ýý 11i1 : "a. lp ,. , 
'i`rs: pnI '. t 111 
Iii' c r H: 
o AA8 ka CAB biro yudo rigmajayogi gi chike. Biro nyalore Ili 
ji auchiel et +oup ka group biro yudo +ii tayogi saa nnonjt" 
bane'e n'ahiro vudo rtgima tavowa kwariwo uachu. 
C What will happen in the monthly meetings? 
Ang'o rnabiro timore e buch dwe ka dwe? 
" The group vi// meet for an hour prior to research members arriving to 
compile information heard, rumours, complaints, suggestions, etc. 
" Jo LAB him romo saa achiel kaa %o nonro pok orhopo mnnrlo , 'i riri , prk 
+ ºixun/urgik mawudire/mmrvrhorr. rn"lt ak. taro Qimnmoko. 
" The CAB will discuss issues with the CDC research tearer and both will 
discuss possible solutions and ways forward. 
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" Jo LAB biro wuoyo kuont wechego gijo nonro snag CD(' to gibiro itsuotivo kuont 
gik min)rlo tim to gt yudo yore mag dongraok 
GROUND RULES 
CH/KF. 
" Lay down rules. Let us all lay down some rules for this team (brainstorm on flip 
chart) 
Keto chike. Watee waketuru chike magwa. 
c One 
" Ng'at achiel ka achiel biro wuoyo. 
o Resp(, : fur '-iii, , pinions, / Il](It :S i1(1 right 001 wrong commcnts. 
a Lnoro pach jomoko/onge paro maber kata marach 
o Part of respect uncludes keeping what is said at these meetings 
within these meetings. Of course your role is to act as a liaison, 
but that does not mean that the community needs to know that 
BREI " 
" Achiel kuom luor en kano ngimoro amora mowach e 
buche gi. Kata obedo ni tiji en bedo kaka it jogweng' 
mano ok en ni jongweng' nyaka ng'e ni Brenda kata 
George nowacho kama e bura. 
o Active participation j we would like to hear from each one of you. 
(Remind them that the community chose them because they are 
respected We do not value the opinion of any person over 
another. º 
" Tiyo motegno/dwaher winjo kuom ng'ato ka ng'ato 
kuomu ka (Waparnegi ni jongweng' noyiero gi nikiche 
oluorgi. Ok wageno pach ng'ato moloyo ng'amachielo). 
Keep tim( 
" Rit saa 
o ATTEND MEETINGS or give notice /Missing any 3 without 
informing both the research team and the "substitute" or stand-by 
CAB member or rmssing 2 corrcccutrue meetings, whether "excused" 
Or r7r)t r, ý cH uc( /(, 7 disqualification). 
" Bi e buche kata or wach (Koso biro e bura di dek ma ok 
Toro wach ne jo nonro kata ng'ama ochungni e buch 
CAB, kata koso biro e bura ndalo ariyo maluore kata 
omiyi thuolo kata ok omiyi ibiro golf. 
(What is a substitute or "standby"? J 
  (Ng'ama ochungni en ng'a? ) 
b . ý` 
P 
a The first CAB selected is responsible for attending the meetings in 
the first year. If there is an emergency and they cannot attend, 
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the CAB member must first inform the research team and then 
contact the member of the second CAB that serves as the same 
role as them to see if they can attend the meeting. That means 
that everyone here today should be listening to the community 
throughout the project. After the first year, the second CAB 
members will be expected to attend all meetings and the first CAB 
Will be ('11 k't'; 
" CAB mokwongo moyier nyaka bi e burs mokwongo e 
higa. Kanitie ngima ochuno maok inyal biro, ja CAB 
nyaka nyis jo nonro mokwono bang'e onyis ja CAB mar 
ariyo matiyo e migao miaye ka nyalo biro e bura. Mano 
nyiso ni ji tee man ka kawono nyaka chik itgi e ngweng' 
ndalo tee mag nonro. Bang hig mokwogo, jo CAB mar 
ariyo biro dwarore ni obi e bura ka jo CAB mokwongo 
biro chung'negi 
that \+c'vve introduced ourselves, discussed the role of the CAB, and given 
ground rules we will first open this talk up for questions. then we will ask our first set 
of advise from., you as a group. 
Kaa koro wasfng'ere, wuonyo ewi tij CAB, miyo chike mokwogo wabiro miyo 
thuolo ne penjo, bange wabiro penjo u yo madutawa ngo. 
" After questions we %, ill ask them a question: What is the way forward? 
o 4aug pe.! o wabiroopenjo peujo: Watu yo mane? 
" Meetings \%ith mothers. fathers. teach rs. etr 
ttomo gi mine, wove, jo puooj, gi jo mamoko 
o( Per area) Where? \ hen :' What I unL'. ' 
o VLocation-ka location) KAnye? Chieng mane? Saa ndt? 
o Other issues to talk about at these "baruzas" 
oip O npw0'il WBb W6ýi! i Ktliýiizas" 
o How do ue reach the other mothers' females'? Hýýýw do we reach the 
pcopi, : 'i. o dwi'i nornialiy attend barazas" 
Ere kaka wanvalo yodo mine moko? Ere kakawanyalo yudo jogo 
maok hi e harazas' 
o Hovv ti(; ý\ c ica, it Itc f,, thLrs'? 11 hen Can uC s1, Lt theme together? 
o Ere kaka wanyalo yudo wuone? Sadi mawanyalo yudo gi tee 
IIov >I UId "N c urn, mt/L u teacher shaI I/ a'! 
Pre kaka wanyalo pago baraza mag jopuonje 
110vv should \iC -, u abouº gCue al inccling? 
*aka wwwalo-loso buch ji tee. 
Created on 3/22/2007 11: 27: 00 AM 
" We have listed on the flipcharts the names and contact information of each of the 
CAB members and which CAB they will serve on. 
" Wasendiko nyingu gi kaka inval yudu gi CAB ma ibiro tiyo ne. 
" Reminder of trainint s aid who is on which CAB (Chart of training times and 
membep- in cash area, including contacts) 
" ParZar peoj gi CAB viang'ato nitie. 
" Are there any other questions? Again, we look forward to working with you and 
hope that you will feel completely comfortable with asking any questions or 
addressing anv concerns. Now that we are finished, please he sure to sign the 
" Be nitie penjo moro amora? Kendo wageno tiyo kodu ka paro ni ibiro bedo 
J thuolo mar penjo penjo moro amora kata wuoyo kuom pek moro 
imora. Koro «atieko neni iketo hveti eotac manyico ni ne in ka, kau peso mar 
mtoka kato imadh soda. 
" IHANKS! 
" EROURUKAMANO! 
Study staff will provide certain routine medical services to study 
participants. This will include free diagnosis and treatment for acute 
diarrheal illness, upper respiratory illness, malaria and STIs. 
DAY- 2 
(Ask four participants to share something new they learned during day 1) 
" 
t" f 
COMMUNITY ADVISORY BOARDS (CABs) GUIDELINES 
Mission 
II 
DL 
iýýýti us IlAt3sj foster partnerships Inc hers(KfJ"k ih.. ' -; C crnmmunitiks impacted by HI%'/AIDS. IV ctive CAB with a 
i to combat AIDS. 
ý111 lI(ip strengthen local capacitN to respond to critical 
research needs in the future. 
The success of the HIV-R research mission depends upon active participation 
by the communities involved in the studies. Including community members at 
all levels of the research process helps build trust and mutual understanding of 
research issues and ensures that values and cultural differences among 
participants are respected. 
Function of the CAB 
CABs are responsible for evaluating the impact of HIV-R studies on local 
communities. They serve as a voice for the community and study participants. 
CABs bring specific, unique expertise to the research process, informing 
researchers of local issues or concerns that can affect the conduct and 
successful implementation of the scientific agenda. Each HIV-R research site 
will be linked with and support an active CAB. 
CAB members may contribute professional or personal experience. For example, 
CAB members may include health educators, lawyers, school teachers, people 
living with HIV/AIDS, women of childbearing age, gay and bisexual men, youth, 
and representatives from the religious community or community-based / non- 
governmental organizations. CABs provide advice on scientific and ethical 
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issues regarding study design, recruitment and protection of study volunteers. 
Each CAR v. ill develop their own mission statement and operating guidelines. 
Bove, and through 
reco>mn: enc3Litions from leaders in the community. of ier CAB members, study 
participants and HIV-R staff. Recruitment is viewed as ongoing, wherein new 
members are added over time as attrition occurs. All riew CAB members will 
receive an orientation and background materials prior to their first meeting. 
Responsibilities of CAB members 
" Attend local CAB gs and ovide fee ck on issues under 
discussion. 
1 Voice concerns fro comm ties and dy participants. 
\\\ Demonstrate or ent to evelopin an understanding on issues 
where they may e little e rtise; at d workshops. 
" Assist in the lopment d imple ntation of community education 
activities the fairs, co unity fo ms, media interviews, etc. ). 
" Advise in develop ent and plementation of recruitment and 
retention tegies. 
" Provide life experi ces. 
" Serve resource t commuz 
" Disse ate study i ormation 
" Rrcr and orient w CAB im 
)n officer and research team. 
community. 
Suggested CAB operating guidelines 
" The total membership should not exceed 20. 
" Membership is open to all members of the community who successfully 
complete a CAB orientation. 
"A CAB should have at least half of the membership regularly participate 
in CAB activities to be considered "active. " 
"A CAB member is considered non-active if he/she is absent from three 
meetings without contacting the CAB liaison. 
How to build and maintain a successful CAB 
" Timely orientation of new members. 
" Clearly stated purpose for CAB involvement. 
" Inclusion of CAB members in development of HIV-R research plans. 
" Provision of regular training and technical assistance to all 
CAB 
members. 
" Clearly stated standards, procedures. 
" Agreed upon norms and decision-making rules of conduct 
for the group. 
" Provision of administrative assistance. 
" Establish means of communication with CAB members. 
10 
iireucü. 
" Skilled facilitation of regular meetings. 
" Provision of refreshments. 
Cý' DEFINITION 
ý_ .. 
ral c. ý", n, "ýuiiu nrnýnii[! ý`j0 aS51SLä'. 1' 
' 
cornmu " r+ ýr`t*+i by anv form of aMproble 
71 ý1SSIS( lIlr 1)r)ß( develop 
fhc' SLX( II! ( II(H (IS ()1 tIlC' CI)IIIIlIII17111 
Community participation in the research process can happen in many ways. 
Sometimes CAB members can be nominated to form a group to advise the 
CAB Participation in the Research Process; 
At a minimum. CAB should be involved in three stages: 
1. Before the study 
)n licaith related research, oiie of the first steps for CAB members is to agr 
pie 
the study should bring some benefits to research participants or the 
communit\. 
2. during the study; 
study and address any concerns that may 
arise. As members of the community, CAB members can also be alert to issues 
or concerns about the research and communicate them to the research staff. 
3. After the study, 
2 
3 
This should be done after the end of the study mainly to share the findings of 
the study. Once the research is completed, community representatives can help 
to make results known and applied to the entire community. 
Why Have Community Advisory board? (CAB) 
ihrs activity is designed to make participants reflect on their role in the conduct of 
research. 
Ask participants to discuss with a partner for 2 minutes why they think it is 
important to have community representatives participate in the research process. 
Ask each pair to write 2 reasons on a note card. Have participants post these on 
flip chart paper and tape to a wall. To save time, ask just a few pairs to share 
aloud with the entire group. Participants can look at the cards more during a 
break. 
Roles of CAB. 
The roles of CAB sh e solrlý ad nature. hs includes; 
" Serve as the nk bets searchers an i llae nmunity i. e. eyes 
and ears researc since, they co from the community an 
know a it. 
" Advi research i study desi d implementation. 
" Pr important t on how to it and retain participants. 
" rt any adý" vent as a re of the study. 
" rl< -t the res eh team abo tumors 
Terms of Membership 
The point of CAB membership is community representation, and therefore it is 
important that community representatives be as diverse as the study 
population, fairly representing differences in sex, age and vulnerable groups. 
CAB members should agree to certain terms of membership to serve on a 
CAB. 
" ; -HI, nl the kr. lrcl shall be solely advisory in nature. 
" 'dernbers should regularly attend meetings once in a month or when 
rt'duired. 
" Cab membership is strictly voluntary. 
" Money for transportation, and other expenses directly related to CAB 
membership (such as writing materials) should be provided when 
necessary. 
" Study staff should be available to assist the CAB when required and 
provide the CAB with regular updates and meeting minutes in a timely 
fashion 
" Residence of the area. 
"A responsible member of the community. 
REPORTING FORMAT 
Let participants discuss the various ways they think we will be receiving 
feedback on the happenings in the community and how they will 
be 
communicating progress back to their "constituents". 
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What happened, where, by whom, is it positive or negative; likelihood to 
impact on the study; decision taken to arrest situation 
Discussion of achievements since last reporting 
Discussion of problems that have arisen. 
Discussion of work that lies ahead. 
Assessment of whether you will meet the objectives in the proposed 
schedule 
13 
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CHIEFS AND ASSISTANT CHIEFS SERVICE CHARTER 
CITIZENS SERVICE DELIVERY CHARTER 
The chief's office is strongly committed to customer service fairness and 
impartiality patriotism and loyalty in serving all citizens. 
....., ucuunn of persons iur Apfiruýal In Scrtin, rmnnlitlrr,; I Frev I , IJS issuance 
of Kenya Ill cards. 
Border llistricts { Parents ID card;. F reef 1-24 hours 
Recommendation ºt"ttri Irum the As, 1. ChicC 
Birth certificate Other Districts {c, sment r(-lror t, Parents II) card. Birth 
rcrt. ificate, School certificate or letter of 
Enfor : nltuº, titon. Bt ttismal card 
Y 
^ - cn of-t&, aw t oupe r ttiun and support I rit within the specific 
tdher nc t to the Chiefs Act year 
---___ ! 'ölnnteti information 
41 
Pres"ent manage and resolve I ua-ulu"tatjun and paruup., don ('ret ` -; 
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(t 
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ý)tj 
eased 111 ; 
_ 
1'nrcntý ne+ý ut t iu'. uIr uUIV card 
Identification of beneficiaries of 14u1 i ,1tt rtiti, , te of Iht deceased 
h rce Within ithin 10 Clays 
deceased Ix"rsons. csbtes Rirtl, t rrlilir. ite of h enet vimie 
('c'rtifi,. ýtiý, u nt murriaýc when applicable "v jt II) (': irrt (it 1%, dIw/t6l'1'cr1 
'CU. 11.1flT. %IEVI li! O( RTE'S) . 
0I)L-1(ELLL. A( lA , 'L1? VICIs DELVER)" 
In cases where sera ice deliver), iý perceived to be inefficient or ineffective complaints should 
be reported to: 
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Area DO 
Area DC 
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Malaria Vaccine Study 
(Mal-055) 
KEMRI/CDC, MoH and Other 
Partners 
What is Malaria 
A disease resulting from the bite of an infected female 
anophelene mosquito 
The female anophelene mosquito bites man and then transmits the parasite that causes the infection 
" There are 4 species of this parasite: 
Plasmodium falciparum 
Plasmodium vivax 
Plasmodium ovale 
Plasmodium malariae 
Of these 4 parasites, P. falciparum is the major 
cause of severe disease and death 
How do you know if one has 
Malaria? 
Hotness of the body 
" Feeling cold and shaking 
" Headache 
" Joint and muscle pain 
" Sweating 
" Vomiting 
Paleness- reduced blood 
levels in the body 
" Damage to vital organs, 
leading to infection in the 
brain, liver and lungs. 
" If not treated well and 
early enough, Malaria can 
progress very rapidly and 
death may occur within a 
short timeframe 
rr"ý411 
Why is KEMRI/CDC conducting 
the Malaria Vaccine study 
" We want to test how well the vaccine works 
in preventing malaria in children 
" Malaria is a common disease here in Siaya 
" Malaria is also the major cause of severe 
disease and death in children 
How does malaria affect your 
community 
" In this region, malaria causes the deaths 
of about 35,000 children every year 
" It is a common reason for admission to 
hospital 
"A major reason for school absenteeism 
and poor school performance 
"A major reason of both direct and indirect 
economic losses 
What are some of the ways of 
preventing Malaria? 
" Sleeping under an insecticide treated mosquito bednet 
" Seeking treatment for Malaria early enough 
" Treating Malaria with an effective drug 
" Pregnant women taking antimalarial drugs when 
attending Clinics (ANC) 
" Clearing the environment of mosquito breeding 
places 
Spraying the inside walls of houses with an " 
effective insecticide e. g. in highland areas 
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Why is malaria still in the 
increase 
" Poor preventive practices like not sleeping under 
an insecticide treated bednet, pregnant mothers 
not seeking care and treatment during 
pregnancy, poor waste disposal practices etc 
" Poor compliance with drugs 
" Wrong diagnosis and late treatment 
" Increasing Malaria causing parasite resistance 
to convectional anti-malarial drugs 
" Armed conflicts, migration of refugees 
Why is a vaccine necessary? 
" Bednets. spraying, drugs and the other control strategies 
are important and their use need to be scaled up. 
However, they are not enough 
" The mosquitoes and the Malaria causing parasites are 
very smart and they learn to resist treatment and now 
there is constant need to develop new approaches as 
the Malaria vaccine 
"A Malaria vaccine is therefore a very important part of 
the Malaria control strategy if we are to make a 
significant gain in the fight against malaria 
"Mm 
Objectives of the study 
" To evaluate how well the vaccine is 
protective against clinical malaria disease 
caused by Plasmodium falciparum in 
African male and female infants and 
children aged 
- 6-12 weeks 
- 5-17 months 
" At first vaccination if they qualify to be in the study. 
Is this vaccine safe for your 
child? 
" The vaccine has been shown to be safe in 
children in Mozambique, the Gambia, 
Tanzania, Ghana, and here in Kenya 
including in Kisumu 
" It is absolutely crucial that the vaccine 
undergoes a rigorous review and study 
before a big number of children can 
receive it 
How will your child benefit from 
the Malaria Vaccine study? 
" Each child in the malaria vaccine study will 
receive free outpatient medical care for 
approximately 3 years 
" Your child will also benefit from high level 
inpatient care should s/he be admitted at Siaya 
District Hospital 
" You will help in an important clinical trial to find 
ways to prevent malaria in children 
" Each child who participates in this study will get 
an insecticide treated bed net 
IfIF% 
Will blood be taken from your 
child in the study? 
"A small amount of blood which is not more than 
1/4 tea spoon will be taken five times for the 
entire duration of the study 
" This blood sample will be used to test if your 
child is well 
" Some of this blood will also be used to see if 
your child's body is developing the strength to 
resist malaria 
" The blood sample will not be used for anything 
else or to test your child's HIV status 
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What bad things can happen to 
your child if you join the study? 
" The malaria Vaccine just like all drugs may 
have side- effects 
" Some children may have mild fever and 
some discomfort at the vaccine site 
" Very rarely a child could have a more 
severe reaction to the vaccine 
" All these reactions are short lived and 
disappear in a short while 
What happens if you don't want 
your child to participate or you 
decide to stop being in the 
Malaria Vaccine study? 
" Participation into the Mal-055 study and any of 
our other studies is completely voluntary. You 
can refuse to have your child participate in the 
Malaria Vaccine study at any time. This will not 
affect you or your child 
" If you don't want your child to go on with the 
study, you can stop at any time 
..... _© 
Which health facilities can you 
visit? 
" The preparations to conduct the study at an 
advanced stage and the study may be 
conducted at; 
- Siaya District Hospital 
- Ng'iya Dispensary 
- Ting'wang'i Health Centre 
- Mulaha Dispensary 
- Kogelo Dispensary 
- Bar Olengo Dispensary 
" The final study sites will be communicated to 
you soon 
How many children will be in the 
study? 
" We will seek to enroll approximately 1800 
children into the study. 
- 800 children between the ages of 5- 18 
months 
- 1000 children between ages 6- 13 weeks 
ley% 
Where should I go if I have 
questions about this study? 
" Kindly approach a member of the KEMRI/CDC 
Team here in Siaya at any of the facilities where 
we conduct studies and they will link you with 
the appropriate study staff 
" Also feel free to contact; 
Christopher Odero, 
KEMRI/CDC Research Program, 
Malaria Branch, 
P. O. Box 1578-40100, 
Tel: (057) 2022902, 
Kisumu. 
fv% 
3 
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Appendix II, Document 9: 
Memorandum of Understanding 
Between 
Kenya Medical Research Institute (KEMRI)/ Centers for Disease Control and Prevention (CDC) 
Program and 
Siaya District Hospital (SDH) 
This MOU serves to demarcate the points of agreement between the Siaya District Hospital (SDH) 
and the KEMRI/CDC Program, with particular reference to the Demographic Surveillance System 
(DSS), the Rotavirus Vaccine Trial Project, the University of Maryland GEMS Diarrheal Study, and the 
TB Cohort Site Preparation Studies. It delineates general guidelines for participating parties and 
outlines their roles in the various activities. All parties have agreed it is of mutual interest to develop 
the capacity for operation of successful collaborative studies. 
Demographic Surveillance System: 
Since 1996, KEMRI/CDC Program and Siaya District Hospital (SDH) have collaborated to collect in- 
patient surveillance data from children less than 10 years old, at the pediatric ward of SDH. The 
purpose of this surveillance has been to capture hospital-related clinical and care seeking 
information from children who reside in the KEMRI/CDC Demographic Surveillance Area (DSS), with 
a particular focus on malaria. In the past, the DSS area included people living in Asembo and Gem, 
many of whom sought health care at facilities other than Siaya District Hospital. In early 2007, we 
expanded our DSS to include Karemo Division. This expansion was done mostly so that we could 
better capture heath-related information on our surveillance participants who attend the Siaya 
District Hospital. We will expand our operations at the hospital to include child, adolescent, and 
adult out-patient surveillance, and adolescent/ adult in-patient surveillance. In addition to providing 
more representative morbidity information, this expansion will allow for surveillance of other 
infectious diseases of great public health importance in this region in addition to malaria. 
Rotavirus Vaccine Trial Project: 
Rotavirus is the leading cause of severe diarrhea in infants and young children. This Rotavirus 
Vaccine Trial, which started July 6 2007, will study the Efficacy, Safety, and Immunogenicity of 
RotaTeq" Among Infants in Asia and Africa through a randomized, double-blind (and in-house 
blind), placebo-controlled trial. RotaTegTM is an oral pentavalent rotavirus vaccine indicated for the 
prevention of rotavirus gastroenteritis in infants and children. The trial will continue for 
approximately 2 years. The enrolled study population for the entire trial will comprise 
approximately 2000 infants who are between 4 and 12 weeks at the time of enrolment. 
Global Enterics Multi-center Study (GEMS): 
Diarrhea is a major cause of childhood morbidity and mortality in developing countries. The 
objective of the study is to estimate the population-based burden, microbiologic etiology and 
adverse clinical consequences of severe diarrhea among children 0-59 months of age. Seven sites 
with DSS's and high childhood mortality are participating in this project (Bangladesh, India, Pakistan, 
Kenya, Mozambique, Gambia and Mali) which is funded by the Bill and Melinda Gates Foundation 
and administered by the University of Maryland, Baltimore. Patient enrollment will begin in the fall 
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of 2007 and continue for 3 years. Each site will aim to enrol approximately 220 moderate-to-severe 
diarrhea patients per year in each of the following three age strata: -0-11months, 12-23 months and 
24-59 months. Each site will (a) collect demographic characteristics of their study population, (b) 
conduct a Health Care Services Utilization and Attitudes Surveys of households containing a child 0- 
59 months of age at baseline and at the end of the study, and (c) carry out a case-control study of 
the incidence and etiology of severe diarrhea, and to characterize pathogen-specific risk factors for 
infection, poor outcome, and mortality. In Kenya, children living in the Asembo and Gem 
communities under the Demographic Surveillance System will be eligible to participate. Children 
with severe or moderate diarrhea will be enrolled at several sites where laboratory enhanced 
surveillance for enteric diseases in children has been conducted for the last 2 years. These include 
Siaya District Hospital, Bondo District Hospital, Lwak Clinic and Hospital, Ongielo clinic, Akala clinic, 
Abidha clinic, and Njejera clinic. Additional sites will include Yala Sub-district hospital and Nyawara 
clinic. The ultimate goal of the study is to provide information needed to guide the development 
and implementation of enteric vaccines and other public health interventions that can reduce 
diarrhea) disease associated morbidity and mortality. 
TB Cohort Studies/TB Vaccine Site Preparation: 
Tuberculosis (TB) has been declared a global health emergency by the World Health Organization 
(WHO). Mycobacterium tuberculosis (Mtb), the primary causative agent of TB, is reportedly 
responsible for millions new cases of TB and deaths, making it one of the world's most lethal 
infectious agents and one that causes more adult deaths than any other pathogen. No current 
vaccine has been shown to reliably prevent pulmonary tuberculosis in adults. The proposed TB 
Cohort studies will build capacity to conduct phase III TB vaccine trials within Karemo division and 
will operate from the Siaya District Hospital. As part of these epidemiological studies in neonates 
and adolescents; we will better document and understand TB prevalence and incidence in these 
groups while improving active case finding. The studies will run for approximately three years with 
2900 neonates and 5000 adolescents recruited into both. 
I. Terms of agreement: 
Staff 
The KEMRI/CDC Field Station agrees to supply the necessary staff (both out-patient and 
in-patient) 
whose primary responsibility is to conduct all of the KEMRI/CDC studies at Siaya District Hospital. 
A 
KEMRI/CDC Primary Investigator may agree to allow its study staff to assist hospital staff in patient 
care when study procedures allow such an arrangement, after study duties are completed, and as 
approved by the KEMRI/CDC Primary Investigator. However, the KEMRI/CDC study staff can never 
be given the sole responsibility for a hospital clinic, department, or health 
facility, since at any time 
the KEMRI/CDC staff may be required for study procedures, in which situation a 
hospital staff has to 
be immediately available to take over whatever the KEMRI/CDC staff is working on. 
The Rotavirus 
Project nursing staff will assist the hospital by administering all KEPI vaccines to study participants. 
This will allow for a more timely flow of immunization visits and/or allow the MOH nursing staff at 
SDH to focus on sick visits and other services. Additionally, the Rotavirus Project will provide 
3 
clinical officers at SDH during the course of this trial (2.5 OPD and 
0.5 IPD; this ratio is dependent 
upon the number of children who are rotavirus participants who are 
hospitalized). All KEMRI/CDC 
clinical staff shall wear the proper uniform in the hospital (white coat, closed 
leather shoes, etc). 
The Siaya District Hospital agrees not to release regular Ministry staff because of the presence of 
KEMRI/CDC study staff. 
Medical care for patients 
KEMRI/CDC will not be charged for children <5 who are seen/managed in the OPD. 
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The Rotavirus Project will provide full medical care for each participant in the study, including in- 
patient care for any patient admitted to the IPD while enrolled; for these patients, KEMRI/CDC will 
facilitate payment of 60 Ksh per in-patient day. 
Data 
All data elements collected from out or in-patients at SDH for KEMRI/CDC studies will be shared with 
the hospital, including results of all lab tests performed by KEMRI/CDC. The KEMRI/CDC program 
will provide SDH with funds to hire an additional MOH Clinical Officer to assist with DSS related data 
collection, at the cost of 25,000 Ksh per month; these added personnel/supplements will help to 
maintain timely patient flow in the out-patient/MCH department. Should SDH remove a regular 
MOH CO from OPD/MCH, KEMRI/CDC will cease to cover the extra CO costs. 
Pharmacy 
Both parties have agreed to share the Pharmacy. Rotavirus Trial participants will access the normal 
hospital pharmacy for general OPD and IPD formulary needs; KEMRI/CDC will provide study 
participants with any medications not available. The Rotavirus/KEMRI/CDC formulary can be used 
for non-Rotavirus trial participants on a case-by-case basis, as approved by the Rotavirus site 
coordinator and Rotavirus site clinical officer. Specifically, the Rotavirus formulary may be used for 
severe/emergency cases when appropriate alternative medications are not available in the hospital 
formulary. In addition, for the vaccine trial(s), the CDC pharmacist will be responsible for ensuring 
the transport and conditions of the vaccines remain under the standards of good clinical practice. 
Space 
KEMRI/CDC will purchase a container to be placed outside the hospital for use by KEMRI/CDC 
studies. All costs of the container will be borne by the KEMRI/CDC Program. KEMRI/CDC is also 
embarking upon a large renovation of a clinical and office annex, to be placed next to the hospital. 
This annex will contain a conference room, clinical and training facilities, and an HIV/AIDS patient 
support center to be used in collaboration with staff at Siaya District Hospital and the Ministry of 
Health. 
The KEMRI/CDC TB cohort studies will use a room in the pediatric ward as a case verification ward 
for infants where TB suspects in the neonatal cohort study will be admitted twice a week for sputum 
inductions, gastric lavage and chest x-rays. During these admissions the study will provide in-patient 
care, pay for in-patient care costs and provide the staff to care for these infants. Additionally, a TB 
procedure room will be renovated outside the pediatric ward (space currently used as a laundry 
area). This will greatly enhance pediatric TB diagnostic capacity at Siaya district hospital. 
Siaya District Hospital agrees to allow KEMRI/CDC to have 1 office space (for the Rotavirus Trial) in 
the maternity ward until the Annex is available. In addition the KEMRI/CDC staff will also continue 
working from the OPD, MCH and IPD, for all on-going studies. 
Monitoring 
Monitoring of the KEMRI/CDC studies is done a regular basis. One or more team members of a 
particular study, or outside monitors, in the case of our clinical trials, will monitor the quality of the 
studies and visit the Siaya District Hospital on a regular basis to ensure that medical records, 
samples, and clinical records are being kept for the study participants and are in order. 
Equipment/ Power 
KEMRI/CDC will maintain a specific Rotavirus vaccine refrigerator at SDH. KEMRI/CDC may also 
provide a small generator as back-up for specific equipment during studies. The KEMRI/CDC Enterics 
Project owns stand-alone propane powered refrigerators at Siaya DH. KEMRI/CDC Field Station 
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agrees to pay 21,000 Ksh per month for its share of the shared generator power consumed at the 
Siaya District Hospital. 
Reimbursements 
All reimbursements will be made with 60 days of receipt of the invoice from Siaya District Hospital. 
Siaya District Hospital will provide the necessary documentation that the Hospital is only reimbursed 
for out-patient or in-patient costs related to patients enrolled in KEMRI/CDC studies, and as 
previously agreed. All charges will be adequately labeled. 
II. General Provisions: 
1. This MOU is not intended to, and does not, and may not be relied upon to create a right or 
benefit, substantive or procedural, enforceable by law by either party against the United 
States. 
2. Monthly meetings will be conducted between both parties throughout the course of the 
studies; however during the initial stages of the study, it may be necessary to have more 
frequent meetings. Additional reports will be provided by both parties to discuss the 
agreements and any changes needed. 
3. This agreement may be modified upon agreement by both parties. 
4. This agreement may be terminated by either party upon 30 days notice. 
5. The Principal KEMRI/CDC contact for this MOU is Dr. K. Laserson 
6. The Principal Siaya District Hospital contact for this MOU is Dr. J. Omoto 
7. Both parties hereby agree to the terms laid out by this Memorandum of Understanding, and 
agree that it is in the best interest of the community and all members involved that these 
collaborative studies are a success. 
Signed 
Dr. K. Laserson, KEMRI/CDC 
Date 
Dr. J. Omoto, Medical Superintendent, Siaya District Hospital 
Cc: Dr. J. Kioko, Provincial Medical Officer, Dr J. Vulule, Director Center for Global Health Research 
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